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The daf-2 gene is a key regulator of growth, metabolism and longevity in the nematode 
Caenorhabditis elegans. The DAF-2 receptor functions in a pathway that is analogous 
to  mammalian  insulin/  insulin-like  growth  factor  signalling  and  determines  whether 
animals proceed with full reproductive development or arrest in a long-lived diapausal 
state known as the dauer larva.  Temperature-sensitive hypomorphic mutants of daf-2 
constitutively  arrest  as  dauers  when  raised  at  non-permissive  temperatures.  At 
permissive temperatures the animals develop into adults that are long-lived compared to 
wild-type adults. These alleles of daf-2 can be separated into two distinct classes (1 and 
2) based on their pleiotropic phenotypes. In addition to their phenotypic differences, the 
two classes also differ in their epistatic interactions with other genes involved in dauer 
formation, suggesting that the DAF-2 receptor has multiple signalling outputs.
In this thesis  I  have  investigated the nature  of the daf-2  allele  class difference 
using  a  range  of methods,  including  sequence  analysis  and  homology  modelling  of 
mutant receptors. This generated the prediction that signalling flux through the receptor 
is  a determinant of the  class difference,  with class 2  alleles having an asymmetrical 
alteration  in  signal  transduction  through  DAF-2.  Experimental  testing  of  these 
predictions suggest that  some phenotypes  such Eat  and Unc may  be associated with 
asymmetrical signalling, while others such as early larval arrest may be correlated with 
a reduction in receptor level at the plasma membrane.
A  comparative  analysis  of  the  DAF-2  receptor  with  its  homologues  from 
Caenorhabditis  briggsae,  Caenorhabditis remane i and the parasitic nematode Brugia 
malayi  suggests the  large C-terminal  extension  in the  Caenorhabditis  species,  which 
shorter in Brugia and not present in vertebrates, is an adaptive trait that has evolved by 
exon duplication for rapid growth and development and may contribute to the shortevity 
of these species. In addition, I have also performed an analysis of ins-7 and ins-35, two 
putative  ligands of DAF-2 that are  differentially regulated by the transcription factor 
DAF-16, using RNAi. Knockdown of both these genes lead to slight lifespan extension 
(-10-20%) at 20°C in all genetic backgrounds and slight suppression (-10%) at 25°C in 
long-lived  daf-2  mutant  backgrounds  compared  to  controls.  This  suggests  that  INS 
peptides  may  function  as  agonists  a  20°C  and  antagonists  at  25°C,  and  that  this 
behaviour may be independent of their transcriptional regulation.
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13Chapter 1 
Introduction
141.1 Insulin/ insulin-like growth factor signalling (IIS) and ageing
This thesis describes an analysis of the daf-2 gene, and the protein it encodes,  in the 
nematode  Caenorhabditis  elegans.  The  DAF-2 receptor  is  a member of the  insulin 
receptor (IR) superfamily of proteins. Even though Kimura et al elucidated the sequence 
of the daf-2 gene in 1997, a number of questions concerning its confusing genetics and 
the aspects of its predicted amino acid sequence remain. The DAF-2 receptor sits atop 
the insulin/insulin-like growth factor signalling (IIS) pathway in C.  elegans,  in which 
there  is currently  intense  interest,  as this  pathway  is a major regulator of longevity. 
Hypomorphic  mutations  in  several  components  of the  IIS  pathway  in  C.  elegans, 
including daf-2, lead to lifespan extension (Figure 1.1 and 1.7) (Friedman and Johnson, 
1988b).
C.  elegans  is  not the  only  species  in which the  IIS  pathway  is  a regulator of 
longevity.  Mutations  in  the  Drosophila  melanogaster  IIS  pathway  can  also  cause 
extension  of  lifespan.  Like  DAF-2,  mutations  in  dlnR  (D.  melanogaster  insulin 
receptor)  can  extend  lifespan (Figure  1.1).  However,  unlike  DAF-2,  these  mutations 
only lead to lifespan extension in heteroallelic combinations, as most alleles of dinr are 
homozygous lethal (Tatar et al., 2001). A second component of the IIS pathway that 
leads to lifespan extension in D. melanogaster is CHICO, which is the fly homologue of 
the  mammalian  insulin  receptor  substrate  (IRS)  proteins  (Clancy  et  al,  2001). 
Interestingly, the mutation in CHICO is semi-dominant as heterozygotes are also long- 
lived.
The IIS pathway has recently been found to play a role in regulation of longevity 
in mice. However, analysis of the IIS pathway in mice is complicated by the fact that 
the mouse genome, like that of all mammals, encodes three different members of the IR 
superfamily  of proteins.  These  are  the  insulin  receptor,  insulin-like  growth  factor-1  
receptor  (IGF-1R)  and  the  insulin-related  receptor  (IRR).  Female  mice  that  are 
heterozygous  for  an  IgflR  gene  knockout  live  33%  longer  than  wild-type  controls 
(Holzenberger et al., 2003). The insulin receptor also seems to play a role in regulation 
of longevity in mice. The fat-specific insulin receptor knockout (FIRKO) mouse is long- 
lived, with an 18% increase in mean lifespan (Bluher et al., 2003), which suggests that 
the IGF-1R has a greater role in lifespan regulation in mice than IR. The Prop-1 (Ames) 
and  Pit-1  (Snell)  dwarf mice  are  mutants  of two  transcription  factors  that  control
15pituitary  development (reviewed (Katie  and  Kahn,  2005)).  These mice  are  unable to 
release growth hormone (GH), which is needed to simulate IGF-1  release by the liver. 
This  leads  to  a reduction  in circulating  IGF-1  levels,  which  in turn  causes  lifespan 
extension (see Figure 1.1).
Potentially the regulation of longevity by IIS extends up the evolutionary tree to 
humans. Several groups have shown that certain polymorphic alleles of genes in the IIS 
pathway are enriched in populations of long-lived individuals.  One such allele is the 
IGF-IR  A+   of  the  MGF-1R  (Bonafe  et  al.,  2003).  This  variant  seems  to  reduce 
circulating levels of IGF-1 in the individuals who carry it. Recently, an allele of GH that 
seems to reduce height in carriers and decrease their mortality has been identified (van 
Heemst et al., 2005).
Figure 1.1 Conserv ation of IIS regulated longevity pathway
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Schematic representation of the conserved elements of the IIS pathway  in C.  elegans, D.  melanogaster, 
M.  musculus and  humans.  Insulin/ IGF-1-like peptides  in all four species bind to and  activate  insulin- 
related  receptors (DAF-2  in C.  elegans,  dlnR in D.  melanogaster,  IGF-IR and  IR in M.  musculus and 
humans),  which  leads  to  the  activation  of a conserved  PI  3-kinase  pathway.  This  pathway  negatively 
regulates  transcription  factors  from  the  FOXO  family  (DAF-16  in  C.  elegans,  dFOXO  in  D. 
melanogaster, FOXO in M. musculus and humans). When FOXO transcription factors are active they up- 
regulate anti-oxidant proteins, such as SOD and catalase, as well as fat accumulation.
161.2 The human insulin receptor
The  human  insulin  receptor  (MR)  is  the  best-characterised  member  of  the  IR 
superfamily of proteins, of which DAF-2 is a member. Below I discuss the structure of 
the INSR gene and the predicted structure of MR protein.  I also describe the clinical 
syndromes that arise from mutations in MR, as well as classification system that is used 
to describe the molecular effects of the mutation on the receptor (Figure 1.4).
1.2.1  The human insulin receptor gene
The human insulin receptor is transmembrane receptor tyrosine kinase (RTK) that is a 
key regulator of growth and metabolism (Le Roith and Zick, 2001;  Saltiel and Kahn, 
2001). The principal function of the receptor is to regulate blood glucose concentration. 
However, stimulation of the receptor by its peptide hormone insulin also promotes cell 
growth and differentiation, and lipid, glycogen and protein synthesis in fat,  liver and 
muscle tissue.  The cDNA sequence of the MR gene was determined in  1985  by two 
different groups (Ebina et al., 1985b; Ullrich et al., 1985). The cDNA isolated by these 
two  groups  differed  by  36bp,  which  in turn  lead to  a difference  of 12  amino  acids 
between the two predicted protein sequences.
Sequencing  of the  human  insulin  receptor  gene  (INSR)  by  Seino  et  al.,  1989 
revealed that the two different cDNA sequences presented by Ullrich et al.  (1985) and 
Ebina et al. (1985a), were in fact two splice isoforms of the INSR gene. The INSR gene 
has 22 exons and spans >120kb on chromosome 19. Exon 11 (36bp) of the INSR gene is 
differentially spliced to give rise to two isoforms. The exon 11 (+) isoform is known as 
the A isoforms and represents the sequence identified by Ebina et al. (1985a). The exon 
ll(-) isoform is known as the B isoform and represents the sequence the presented by 
Ullrich et al.  (1985). Throughout this thesis the numbering of MR residues will use the 
same format as Ebina et al. (1985a).
171.2.2 Structure and processing of the MR protein
The mature MR protein is a heterotetramer composed of two covalently linked chains. 
Each  chain  is  itself a  dimer  that  is  composed  of an  a-subunit  and  p-subunit,  these 
subunits  are  derived  from  a  single  proreceptor and are  linked  by  a disulphide  bond 
between cysteines  647  and  872  (Cheatham  and  Kahn,  1992;  Lu and  Guidotti,  1996; 
Sparrow et al., 1997). The a-p chains are linked by four disulphide bonds between the 
equivalent cysteine residues 524, 682, 683 and 685 in adjacent a-subunits (Schaffer and 
Ljungqvist,  1992;  Sparrow  et al.,  1997;  Wu  and  Guidotti,  2004).  The  final  subunit 
structure of the mature MR protein is C X 2P2 (Figure 1.2).
The a-subunit of each receptor chain is entirely extracellular, while the p-subunit 
contains a portion that is extracellular, the transmembrane domain and the cytoplasmic 
tyrosine kinase domain.  The a-subunit contains two repeats of a leucine rich domain 
(LI  and L2) (Bajaj et al.,  1987; Ward and Garrett, 2001) separated by a cysteine rich 
(CR) domain similar to that found in the epidermal growth factor receptor (Bajaj et al., 
1987; Ward et al.,  1995).  This is followed by the FnO domain (Marino-Buslje et al., 
1998; Mulhem et al., 1998; Ward, 1999), which is a fibronectin type III domain. The a- 
subunit also contains the first half of the Fnl domain, which is also a fibronectin type III 
domain;  the  other  half of this  domain  is  part  of the  P-subunit.  The  Fnl  domain  is 
interrupted by an insert region that spans the a-subunit and p-subunits that contains a 
tetrabasic endoproteolytic cleavage site.
The  p-subunit  contains the  other  half of the  Fnl  domain  followed  by  a third 
fibronectin type III domain, known as Fn2 (Schaefer et al.,  1992). The transmembrane 
domain then follows these domains and the rest of the  p-subunit, which contains the 
tyrosine  kinase  (TK)  domain  and  a  short  C-terminal  (CT)  extension,  is  cytoplasmic 
(Ebina et al., 1985b; Ullrich et al., 1985).
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Panel a  shows a cartoon of the a2{ 3 2  structure of the insulin receptor. The left half of the diagram shows 
the boundaries of the 22 exons of the  insulin-receptor gene.  The right half of the diagram  outlines the 
predicted  boundaries of the protein  modules.  Orange  arrowheads  indicate 7V-glycosylation  sites.  Green 
arrowheads  indicate  ligand-binding  ‘hot  spots’  that  have  been  identified  by  single-amino-acid  site- 
directed mutagenesis. Panel b shows the domain organization of the insulin receptor. The diagram depicts 
a model of predicted or actual modular structures. The three-dimensional structure of the insulin molecule 
is also shown. Image taken from (De Meyts and Whittaker, 2002).
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19The A and B splice isoforms of the INSR gene give rise to MR proreceptors that 
are 1382 and 1370 amino acids long, respectively. Each proreceptor undergoes series of 
processing  steps  that  leads  to  the  formation  of the  mature  MR  protein.  The  initial 
monomeric translation product (Mi) of the INSR  gene has an apparent mass of -170 
kDa,  under  non-reducing  SDS-PAGE  conditions,  that  is  rapidly  converted  to  a 
monomeric product (M2) with a mass -190 kDa within the endoplasmic reticulum (ER) 
(Olson  et  a l,  1988).  The  conversion  between  the  Mi  and  M2  products  is  likely  to 
involve  the  formation of intramolecular disulphide bonds and AMinked  glycosylation 
(Olson et al.,  1988)  and requires the  ER lectin  chaperones calnexin and  calreticulin 
(Bass  et  al.,  1998).  The  M2  products  then  self-associate  through  intermolecular 
disulphide bonds to form a proreceptor dimer (D) within the pre-frvms-Golgi network. 
The  D  product  then  undergoes  carbohydrate  maturation  and  proteolytic  cleavage  to 
yield the mature tetrameric receptor within the trans-Golgi (Bass et al.,  1998; Olson et 
al, 1988), which is then transported to the plasma membrane.
The  binding  of  insulin  to  MR  in  the  plasma  membrane  leads  to 
autophosphorylation of the receptor at tyrosines 1158, 1162 and 1163 (Ellis et a l, 1986; 
White et a l,  1988), which in turn leads to activation of the tyrosine kinase domain and 
phosphorylation  of substrates  (Flores-Riveros  et  al,  1989;  Rosen  et a l,  1983).  The 
activated  ligand-receptor complex is rapidly  internalized into endosomes in liver and 
muscle  cells  (Eckel  and Reinauer,  1988;  Khan  et al,  1989;  Khan et al,  1986)  and 
adipocytes (Klein et al,  1987) (Kublaoui et al,  1995). The endocytosis of the ligand- 
receptor complex has the dual effect of concentrating the activated complex within the 
endosomes  and  allowing  it to  phosphorylate  substrates that  a  spatially  distinct  from 
those  at  the  plasma  membrane  (reviewed  in  Bevan  et  al,  1996).  The  endosome  is 
acidified  by  active  transport of protons  into  the  endosomal  lumen through  an  ATP- 
driven proton pump, which causes the insulin ligand to dissociate from its receptor and 
be degraded by an insulin-specific protease (reviewed in Knutson,  1991  and Bevan et 
a l,  1996).  The  unbound  receptor  is  then  dephosphorylated  by  a  phosphotyrosine 
phosphatase, which might be associated with the endosomal  membrane (Faure et al., 
1992), before either being recycled to the plasma membrane via the Golgi apparatus or 
degraded via a lysosomal pathway (reviewed in Knutson, 1991).
201.2.3 Signalling through the insulin receptor
The insulin receptor is a key regulator of metabolism and growth and one of its major 
signalling  outputs  is  the  PI  3-kinase  complex  (Shepherd  et  al.,  1995).  The  insulin 
receptor does not directly interact with the PI 3-kinase complex; instead activation of 
the  tyrosine  kinase  domain  of the  receptor  leads  to  phosphorylation  of the  insulin 
receptor substrate proteins (IRS-1  to -4), which then interact with p85  (the regulatory 
subunit of the PI 3-kinase complex) (Sun et al., 1991; White et al., 1985). Activation of 
the PI 3-kinase complex results in the phosphorylation of the lipid phosphatidylinositol- 
(4,5)-bisphosphate  (PIP2) to phosphatidylinositol-3,4,5-triphosphate  (PIP3)  (Whitman 
et  al.,  1988).  Elevated  levels  of PIP3  act  as  a  secondary  messenger  that  activates 
multiple  signalling  pathways  leading  to  an  increase  in  glycogen,  lipid  and  protein 
synthesis, as well as cell growth and differentiation (see Figure 1.3) (reviewed in Saltiel 
and Khan, 2001).
In addition to signalling through the PI 3-kinase complex, the insulin receptor also 
activates the Ras/ Mitogen-activated protein (MAP) kinase pathway and the CAP/ Cbl 
pathway (Pirola et al., 2004; Saltiel and Kahn, 2001).  The CAP/ Cbl pathway is also 
involved in the regulation of glucose uptake, while the Ras/ MAP kinase pathway is 
involved with cell proliferation and differentiation (see Figure  1.3). Activation of Ras 
signalling by the insulin receptor involves recruitment of the Grb2.Sos complex, which 
can bind to either phosphorylated IRS-1  or She. Activation of Ras by both the insulin 
receptor  and  the  IGF-1  receptor  is  predominately  transduced  via  She  and  requires 
receptor internalization (Ceresa et al., 1998; Chow et al., 1998; Sasaoka et al., 1994).
21Figure 1.3 Signalling through the insulin receptor
MAP kinase
PTEN
SHIP2
receptors
Glucose
transport
Akt  aPKC
Glucose metabolism 
Glycogen/lipid/protein synthesis 
Specific gene expression
Cell growth 
Differentiation
General gene 
expression
Glucose lnsulin/IGF-1
Diagram  showing the three main pathways  activated  by both the  insulin  and  IGF-1  receptors.  Both  of 
these receptors mediate their signal transduction through phosphorylation of adaptor proteins, such IRS-1 
to -4, Gab-1, CAP and She, which in turn recruit different effector proteins. The major output of both the 
insulin  and  IGF-1  receptor  is the PI  3-kinase complex.  Both receptors also can activate the Ras/ MAP 
kinase  pathway,  predominately  through  She,  which  requires  receptor  internalization.  The  CAP/  Cbl 
pathway  is  involved  in regulating glucose uptake and functions additively to the PI 3-Kinase pathway. 
Image taken from (Saltiel and Kahn, 2001).
221.2.4 Mutations affecting the human insulin receptor
The INSR gene has been extensively studied for its potential role in the pathogenesis of 
many different human diseases. Over 50 naturally occurring mutations that affect MR 
have been identified (reviewed in Krook et al, 1997a and Taylor et al, 1992). Mutation 
of MR results  in  severe  insulin resistance,  which can manifest  itself as one  of three 
clinical  syndromes:  type  A  insulin  resistance,  Rabson-Mendenhall  syndrome  and 
leprechaunism.  Recently  several point mutations have recently  been  identified  in the 
human IGF-1  receptor gene (Abuzzahab et al, 2003; Kawashima et al., 2005). These 
mutations result in intrauterine and postnatal growth retardation.
Type A insulin resistance is generally defined by the presence of three symptoms. 
These  are  insulin resistance,  acanthosis nigricans  (a skin condition that causes  light- 
brown or black marks, often on the armpits, groin, and neck) and hyperandrogenism, 
which is the elevation of male sex hormones in female patients. Because this syndrome 
has hyperandrogenism as a symptom, it is usually only diagnosed it women. However, 
there  are  cases  where  male  patients  have  been  diagnosed  as  being  type  A  insulin 
resistant,  if they present insulin resistance and acanthosis nigricans in the absence of 
other clinical symptoms (Taylor et al, 1992).
Rabson-Mendenhall  syndrome  is  defined  by  the  presence  of several  different 
symptoms. Firstly, patients have extreme insulin resistance. They also have acanthosis 
nigricans,  as  well  as  abnormalities  of their  teeth  and  nails,  and  pineal  hyperplasia. 
Rabson-Mendenhall  syndrome  is  usually  regarded  as  being  intermediate  to  type  A 
insulin  resistance  and  leprechaunism.  Leprechaunism  and  Rabson-Mendenhall 
syndrome have very similar clinical symptoms, making it difficult to separate the two. 
The  main  difference  between  diagnoses  of either  syndrome  is  the  age  at  which  the 
patient  dies.  Patients  with  Rabson-Mendenhall  syndrome  are  not  expected  to  reach 
puberty, while patients with leprechaunism usually die within the first year of infancy.
Mutations  that  affect  the  INSR  gene  can  be  classified  by  their  effect  on  the 
receptor (Taylor et al,  1992). There are five different points at which mutations might 
affect the receptor; these are listed in Table 1.2.1. Type 1  mutations affect transcription 
of the  INSR  mRNA.  Type  2  mutations  affect  transport  of the  receptor  to  plasma 
membrane, through defective processing of the proreceptor. Type 3 mutations affect the 
insulin binding affinity of the receptor. Type 4 mutations affect the signalling output of
23the receptor, usually by altering kinase activity. Type 5 mutations affect the number of 
receptors at the cell surface by interfering with receptor endocytosis and its subsequent 
recycling or degradation. Mutations can actually result in more than one type of defect 
in the receptor. For example, the R252C mutation of MR reduces the transport of the 
receptor to cell surface (type 2), reduces insulin binding (type 3), alters the signalling 
output of the receptor (type 4) and reduces the internalization of the receptor (type 5) 
(Hamer et al., 2002).
Table 1.2.1 Classification of mutations in INSR gene/ /iIR protein
Type of 
mutation
Synthesis and 
translation of 
mRNA
Transport to 
plasma 
membrane
Insulin-
binding
affinity
Transmembrane 
signalling/ 
kinase activity
Endocytosis, 
recycling 
and 
degradation 
of receptor
1 X
2 X
3 X
4 X
5 X
Classification system for mutations affecting MR.  The crosses mark the biological time point at which 
each mutation affects receptor function. Type 1  mutations affect biosynthesis of the receptor, type 2 affect 
maturation  and  transport to the  cell  surface, type  3  affect  insulin-binding affinity,  type 4  affect signal 
transduction and type 5 affect receptor turnover.
Figure 1.4 Types of defect affecting INSR gene/ hlR protein
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A diagrammatic representation of Table 1.2.1
241.2.5 Biochemical analysis of mutations in the insulin receptor
The sequencing of the INSR cDNA by Ebina et al.  (1985a) and Ullrich et al.  (1985) 
enabled the design of expression constructs for both wild-type and mutant receptors that 
could  be  expressed  in  a  heterologous  cell  system.  Typical  cell  lines  used  in  these 
heterologous  expression  systems  are  Chinese  hamster  ovary  (CHO),  COS  7  (simian 
kidney  cells),  NIH  3T3-L1  adipocytes  (murine  fibroblast-derived  cell  line),  Rat-1 
fibroblasts or HTC hepatoma cells (reviewed in Tavare and Siddle,  1993).  CHO cells 
were the first cell line to be used for heterologous expression of wild-type MR (Ebina et 
al., 1985a). These cells have a low level of expression of endogenous insulin receptors, 
typically  -2800  per  cell  (Ebina et  al.,  1985a),  and  have  well  know  insulin-binding 
kinetics (Podskalny et al.,  1984). Similarly, all the cell lines also have low expression 
levels  of endogenous  receptors,  -2000-5000  per cell,  there  are  no  receptor-null  cell 
lines so endogenous receptor effects must be considered when interpreting data from 
these cell lines (Tavare and Siddle, 1993).
251,3 Introduction to Caenorhabditis elegans
In this section I describe the features of C.  elegans that make it a useful organism for 
the study of ageing. I then present the IIS pathway in worms and the interesting genetics 
of daf-2.
1.3.1  Caenorhabditis elegans as a model organism
Caenorhabditis elegans is a convenient model organism for the study of a broad range 
of avenues of biological  investigation, particularly ageing research.  The reproductive 
cycle of C. elegans is three days from egg to fertile adult (depending on the temperature 
at  which  animals  are  cultured),  and  the  adult  lifespan  is  approximately  two  weeks. 
Adults are only ~ 1.2mm in length and so can be grown and handled in large quantities. 
They are also bacteriovores and can be maintained on many different types of bacteria, 
but are usually grown on E. coli strain OP50 (Brenner, 1974), either on agar plates or in 
liquid culture.  One the most convenient aspects  of C.  elegans biology is its mode of 
sexual reproduction. The majority of animals tend to be self-fertilising hermaphrodites, 
which allows the creation of isogenic lines, and facilitates the formation of homozygous 
mutants. However, males are produced at low frequency, which are able to mate with 
the hermaphrodites. This enables backcrossing and the ability to make strains carrying 
multiple mutations. The entire cell lineage of C.  elegans has been determined (Sulston 
and  Horvitz,  1977),  which  makes  this  organism  very  attractive  for  developmental 
studies. Finally, strains can be frozen and stored for many years at -70°C, which allows 
the  building  of  large  strain  collections  without  having  to  continuously  culture  the 
animals.
The genetics and genomics of C. elegans are also very well developed.  The entire 
genome has been  sequenced (Consortium,  1998), and is currently the only metazoan 
genome to be truly finished (i.e. no gaps) (Hodgkin, 2005). The genome contains over 
22,000 predicted genes, and is available in a public database curated by the Wormbase 
consortium  (www.wormbase.org).  The  ease  of  mutagenesis  in  C.  elegans,  with 
chemical mutagens such as ethyl methane sulfonate, has resulted in many different and 
well-characterised mutants that are freely available from the Caenorhabditis Genetics
26stock  Center  (CGC),  maintained  at  the  University  of  Minnesota 
(http://biosci.umn.edu/CGC/CGChomepage.htm).
1.3.2 Genetics and nomenclature
Genetic loci in C. elegans are given names consisting of three or four italicized letters, a 
hyphen, and an italicized Arabic number, e.g., daf-2 or rskn-1.  This can be followed by 
an italicized Roman numeral to indicate the chromosome on which the gene is located, 
e.g., daf-2 III or rskn-1 I. The three or four letter abbreviations can refer either to the 
mutant phenotype of the gene (daxier formation abnormal, in the case of daf-2) or the 
product of the gene (RSK-pMnety, RSK-p90 kinase homolog,  in the case of rskn-1). 
Alleles of genes are given in brackets after the gene name, with no spaces and in italics, 
as combination of the lab allele designation and an allele number. For example, the lab 
allele designation for the Gems lab is wu, so a daf-2 mutant isolated in our lab would be 
daf-2 (wu 123).  Phenotypes are generally written as three letter abbreviations, these have 
a  capital  letter  and  are  non-italicized,  e.g.  Unc  (uncoordinated)  or  Egl  (egg-laving 
defective). For a more thorough list of nomenclature guidelines see the CGC guidelines 
webpage (http://biosci.umn.edu/CGC/Nomenclature/nomenguid.htm).
1.3.3 Overview of C elesans biology and its lifecycle
Caenorhabditis elegans is a free-living terrestrial nematode (Riddle et al., 1997; Wood, 
1988).  There are two different sexes:  hermaphrodites and males, which occur at low 
frequency in laboratory cultures. Sex determination within this species is based on the 
autosome to sex chromosome ratio; hermaphrodites are XX and males are XO.  Adult 
hermaphrodites have 959 somatic nuclei and males have 1031.
C.  elegans proceeds through four larval stages during its reproductive life cycle, 
from egg to sexually mature adult. These are stages are referred to as LI, L2, L3 and L4 
(Figure 1.5); each stage is punctuated by a moult of the collagen cuticle surrounding the 
worm. Under optimal growth conditions the reproductive life cycle is complete in about 
3  days; wild type worms then have a maximum life span of 2-3  weeks.  However,  in 
poor growth conditions such as overcrowding or high temperature the worms are able to
27moult  to  an  alternative  third  stage  known  as  the  dauer  larva  (Cassada  and  Russell,
1975).
The  dauer larvae  are arrested in a diapausal  state that has  several behavioural, 
morphological  and  metabolic  adaptations  that  allows  the  worms  to  survive  harsh 
environments and to resume normal growth once conditions improve. The decision to 
enter  the  dauer  stage  is  made  during  the  LI  stage  and  is  based  on  a  series  of 
environmental cues (reviewed in Riddle and Albert,  1997).  The first of these cues is 
concentration of a dauer pheromone in the environment, which is constitutively released 
by the animals, and  so represents the population density of the worms.  Recently, the 
structure dauer pheromone  ‘daumone’  was chemically determined and found to be  a 
heptanoic acid derivative (Jeong et al., 2005). Food availability modulates the response 
to daumone, such that high daumone to low food ratios promote dauer formation, while 
the opposite conditions promote full reproductive development and recovery of dauer 
larva.  Temperature also modulates the response to the daumone/food ratio,  such that 
higher temperatures promote dauer formation at lower daumone/food ratios.
The worms enter the dauer larval stage via an extended L2 stage, known as L2d. 
The L2d stage usually last 13 hours, as opposed to 7 for the normal L2 stage. During the 
L2d  stage  the  worm  prepares  to  enter  the  dauer  stage  by  accumulating  fat  in  its 
intestinal and hypodermal cells. The L2d stage does not commit the worm to dauer larva 
formation, should growth conditions improve the L2d animals can moult to the normal 
L3 stage.
The worms are able to survive as dauer larvae for up to 70 days whilst retaining 
the ability to resume normal development and become fertile adults (Klass and Hirsh,
1976).  The  length  of time  spent  as  a  dauer  larva  has  no  effect  on  the  post-dauer 
maximum life span of the adult worm, for this reason the dauer larva is referred to as 
non-ageing (Klass and Hirsh,  1976).  However,  it is not yet known whether the dauer 
larva is truly non-ageing or whether the effects of ageing in the dauer larva are reversed 
before resuming normal growth.
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The lifecycle of C.  elegans takes ~3 days from egg to fertile adult in favourable conditions at 25°C.  In 
unfavourable  conditions  the  worms  can  enter  an  alternate  third  stage  known  as  the  dauer  larva.  This 
image is taken from (Braeckman et al., 2001).
1.3.4  The genetics of dauer formation
Over  30  genes  have  been  identified  as  controlling  dauer  formation  in  C.  elegans 
(Riddle  and  Albert,  1997),  most of these  are known as daf genes  (dauer formation 
abnormal). The daf genes fall into two phenotypic groups, these are known as Daf-c 
and Daf-d. The Daf-c genes give rise to worms that constitutively form dauers even at 
low population density and with abundant food. Alleles of the Daf-c genes can either be 
non-conditional, in which case they form dauers independently of environmental cues, 
or temperature-sensitive (ts), in which case mutants only form dauers when shifted to 
restrictive temperatures.  The Daf-d gene mutants are unable to enter the dauer larva 
stage  even  in  restrictive  environmental  conditions  such  as  over-crowding  and 
starvation.
29These  genes  have  been  assembled  into  3  different  but  possibly  interacting 
pathways  using  epistatic  analysis.  These  are  the  cyclic  guanosine  monophosphate 
(cGMP), transforming growth factor-p (TGF-P) and insulin/insulin-like growth factor 
signalling  (IIS)  pathways.  The  wild-type  genetic  interactions  for  some  of  the 
components of the cGMP and TGF-p pathways are  shown in Figure  1.6.  These two 
pathways, while involved in dauer formation, are outside the focus of this thesis and so 
will not be discussed further.
Figure 1.6 Genetic pathway for dauer larva formation
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This a representation of the wild-type genetic interactions between the three different pathways involved 
in dauer formation.  Daf-c genes form dauers constitutively while Daf-d genes are dauer defective.  The 
daf-ll  branch  of the  pathway  represents  cGMP  signalling,  while  the daf-1  branch  represents  TGF-P 
pathway. These to pathways integrate at daf-12, which encodes a nuclear hormone receptor (Antebi et al., 
2000).  The daf-2, age-1  and daf-16 branch represents the  IIS  pathway and  is discussed  below.  Briefly 
daf-2 and age-1 negatively regulate daf-16, promoting reproductive development, when daf-16 is active it 
promotes  dauer  development  or  in  adults  extended  longevity.  Image  taken  from  (Riddle  and  Albert, 
1997).
1.3.5  Role of IIS in dauer formation and lifespan
The IIS pathway not only regulates dauer formation but also has a role in the regulation 
of lifespan in C.  elegans. Hypomorphic mutations in several genes within the pathway 
have been shown to increase the adult lifespan. The IIS pathway (Figure 1.7) currently 
consists of 39 genes that encode insulin-like peptides, ins-1 to ins-37 (Duret et al., 1998; 
Gregoire et al.,  1998; Kawano et al., 2000; Kawano et al., 2003; Pierce et al., 2001),
30ins-38 (M. Costa, personal communication) and daf-28 (Li et al., 2003) (see Figure 1.8). 
The products of these genes are all predicted to be ligands, either agonists or antagonists 
(see chapter 7), for the DAF-2 receptor. The only one of the insulin-like peptide genes 
that has been shown to have a mutant phenotype is daf-28. The daf-28(sal91) allele is a 
semi-dominant  allele  that  has  a  Daf-c  phenotype  at  all  temperatures,  although  its 
severity increases with temperature (Li et al., 2003; Malone et al.,  1996; Malone and 
Thomas,  1994).  This  mutation  causes  a  12-13%  increase  in  lifespan  in  mutants 
compared to wild type worms.
The  daf-2  gene encodes a receptor tyrosine  kinase that is a member of the  IR 
superfamily  of  proteins  (for  more  details  about  daf-2  gene  structure  and  protein 
structure see chapter 4) (Kimura et al.,  1997).  Hypomorphic mutations of daf-2 have 
been shown to extend lifespan at least two-fold (Kenyon et al, 1993). Activation of the 
DAF-2  protein  leads  to  recruitment  and  activation  of the  phosphatidylinositol-3-OH 
kinase (PI 3-kinase) complex.
The  PI  3-kinase  complex in C.  elegans  consists  of two  different proteins.  The 
regulatory subunit is encoded by aap-1 (Wolkow et al., 2002) and the catalytic subunit 
of the complex is encoded by age-1 (Morris et al, 1996). age-1 was the first gene in C. 
elegans that was reported to extend lifespan (Friedman and Johnson, 1988a). The PI 3- 
kinase  complex  may  be  recruited  to  DAF-2  either  by  IST-1,  a  homologue  of the 
vertebrate insulin receptor substrate (IRS) and the D. melanogaster CHICO proteins. Or 
DAF-2 may directly recruit the PI 3-kinase complex by direct interaction with the AAP- 
1   subunit  through  its  C-terminal  extension  (Wolkow et  al,  2002).  The  PI  3-kinase 
complex  then  phosphorylates  PIP2  to  PIP3,  which  acts  as  a  secondary  messenger. 
Levels  of PIP3  can be attenuated by the  DAF-18  lipid phosphatase,  which is the  C. 
elegans homologue of the PTEN human tumour suppressor (Gil et al., 1999; Mihaylova 
et al., 1999; Ogg et al., 1997; Ogg and Ruvkun, 1998).
Elevated levels of PIP3  are thought to recruit the 3-phosphoinositide-dependent 
kinase-1   (PDK-1), a serine/ threonine kinase encoded by thepdk-1 gene (Paradis et al., 
1999), to the plasma membrane where it co-localizes with a trimeric complex formed by 
AKT-1/-2 and SGK-1  (serum- and glucocorticoid-inducible kinase-1) (Hertweck et al, 
2004;  Paradis and Ruvkun,  1998).  PDK-1  phosphorylates and activates this complex, 
which in turn phosphorylates DAF-16. Hypomorphic mutations affecting the pdk-1 and 
sgk-1 genes increase lifespan (Hertweck et al., 2004; Paradis et al, 1999). Interestingly, 
null mutations of akt-H -2 do not extend lifespan, but do have a Daf-c phenotype.
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A representation of the interaction between components of the IIS pathway  in C. elegans. There are 39 
genes that encode insulin-like peptides in the C. elegans genome, some of these are thought to bind to and 
activate the DAF-2 insulin/ IGF-1 receptor. This leads to the phosphorylation of AAP-1  (p85 homologue) 
either  directly  through  its  interaction  with  the  C-terminal  extension  of  DAF-2  or  through  IST-1 
(homologue  of  IRS-1).  This  activates  AGE-1  (pi 10  homologue)  and  leads  to  production  of PIP3. 
Elevated levels of PIP3 activate PDK-1 (3-phosphoinositide-dependent kinase-1), which in turn activates 
a trimeric complex of serine/ threonine kinases formed by AKT-1, AKT-2 (PKB homologues) and SGK-1 
(serum- and glucocorticoid-inducible kinase-1). Elevated levels of PIP3  may also directly activate these 
kinases. This complex negatively regulates DAF-16 by phosphorylating it. PIP3  levels can be attenuated 
by DAF-18 (PTEN homologue). These different components make up the only genetically defined output 
of DAF-2 and might represent the ‘A’ pathway in the model of daf-2 signalling put forward by Gems et 
al. (1998). No components of the proposed ‘B’ pathway have yet been identified.
The daf-16 gene encodes a forkhead transcription factor (Lin et al.,  1997; Ogg et 
al.,  1997). The principal role of the DAF-2/ AGE-1  pathway is to antagonize DAF-16 
activity,  by  phosphorylating  it.  When  DAF-16  is  phosphorylated  and  inactive  it  is 
localized to the cytoplasm of the cell. When DAF-16 is unphosphorylated and active it 
is localized to the cell nucleus (Henderson and Johnson, 2001). The lifespan extension 
and Daf-c phenotype caused by mutations in daf-2, age-1, pdk-1 and sgk-1 are all daf-
3216 (+)  dependent,  and are fully suppressed by daf-16 null mutants. Interestingly, the 
Daf-c phenotype of daf-28(sal91) is only partially suppressed by daf-16(m26) or daf- 
16(m27)  at 25°C (Malone et al,  1996).  This suggests that daf-28 may interact with a 
second pathway to regulate dauer formation. It is unknown whether the modest lifespan 
increase shown by daf-28(sal91) is suppressed by daf-16{-) mutants.
1.3.6  The genetics of daf-2
Detailed phenotypic analysis of 15 temperature sensitive (ts) mutants of the daf-2 gene 
has shown the existence of two overlapping classes of alleles (Gems et al., 1998). Both 
class  1   and class 2 alleles display a Daf-c phenotype at non-permissive temperatures, 
increased  maximum  lifespan  (Age)  and  increased  intrinsic  thermotolerance  (Itt 
phenotype).  However,  class  2  alleles  display  greater  pleiotropy  than  class  1   alleles 
resulting in behavioural and developmental defects, such as cessation of feeding (Eat) 
and uncoordinated movement (Unc). These alleles do not form a simple allelic series, 
with class 1  alleles simply being weaker than class 2. The el369 and m212 alleles have 
the  most  severe  Daf-c  phenotype  of all  ts  alleles,  forming  55%  and  28%  dauers, 
respectively, at 15°C, yet both are class 1  (Gems et al., 1998).
The genetics of daf-2 can become very confusing when using epistasis analysis to 
map  genetic  interactions.  At  least  three  different  genes  have  been  shown  to  have 
differing interactions with the different classes of daf-2 allele. These are daf-12 (Gems 
et al.,  1998; Larsen et al.,  1995), rop-1  (Labbe et al., 2000) and daf-9 (Gerisch et al., 
2001).  The  daf-12  gene  encodes  a  nuclear  hormone  receptor  that  lies  at  the 
convergence of the dauer formation and heterochronic pathways (Antebi et al., 2000). 
The hypomorphic daf-12(m20) allele is Daf-d, when a class 1  daf-2 allele is placed into 
this background at 25°C, the m20 allele  suppresses the Daf-c phenotype of the daf-2 
allele  and  weakly  suppresses the  Age  phenotype  (Gems  et al.,  1998;  Larsen  et al., 
1995). However, when a class 2 daf-2 allele is placed into this background at 25°C, the 
m20 allele causes an embryonic/ LI arrest phenotype and enhances the Age phenotype 
of the daf-2 allele .
The  rop-1  gene  encodes  an  RNA  quality-control  pathway  component  that 
functions in the dauer formation pathways (Labbe et al., 2000). The rop-1 (pk93) allele 
enhances the Daf-c phenotype of daf-2(el370) and daf-2(m579) (both class 2) at 22.5°C
33and suppresses the Daf-c phenotype of m41  (class  1) and m596 (originally labelled a 
class 2 allele in Gems et al., 1998, but reclassified as class 1  in this project). The daf-9 
gene  encodes  a cytochrome  P450  (Gerisch  et al,  2001;  Jia et al.,  2002).  The daf- 
9(rh50)  enhances the Age phenotype of daf-2(el370)  and weakly suppresses Age in 
daf-2(el368) (class 1) (Gerisch et al., 2001).
Gems  et  al  (1998)  proposed  that  the  daf-2  gene  has  two  different  activities 
termed daf-2  A  and daf-2B.  Class  1   alleles  are daf-2  A  (-)  daf-2  B  (+),  while  class  2 
mutants  are  daf-2A(-)  daf-2B(-).  The  daf-2A  and  daf-2B  gene  activities  may  each 
represent an output, from the DAF-2 receptor, for parallel branches controlling dauer 
formation (A and B pathways). These pathways must converge on the daf-16 gene, as 
daf-16(-) mutants suppress the pleiotropic effects of both classes of daf-2 allele (Gems 
etal., 1998).
There  is  increasing  evidence  for  the  existence  of at  least  a  second  parallel 
pathway  that  signals  through  the  DAF-2  receptor  to  antagonise  DAF-16,  which  is 
independent of the AGE-1 PI 3-kinase pathway. Firstly, activating mutants of both pdk- 
1  and akt-1  are able to fully suppress the Daf-c phenotype of the age-l(mg44) allele, 
but  only  partially  suppress  Daf-c  in  the  daf-2 (el370)  allele  (Paradis  et  al,  1999; 
Paradis  and  Ruvkun,  1998),  even  though  age-l(mg44)  is  a  non-conditional  allele 
whereas daf-2 (el370) is ts. This suggests that the DAF-2 receptor is able to antagonise 
DAF-16 through a second pathway that is independent of AGE-1 (see Figure 1.7). This 
second pathway may involve ist-1, as RNAi of ist-1  in age-l(mg44); akt-1 (mgl44gf) 
double mutants causes a large proportion of the animals to arrest as dauers (Wolkow et 
al,  2002).  She/  RAS  signalling  may  also  be  involved  in  the  second  pathway  (see 
Chapter 5). Recently it has been shown that LET-60 (RAS homologue in C.  elegans) 
modulates IIS and has a weak role in dauer formation and ageing (Nanji et al, 2005). 
Thus, daf-2  A. activity may involve the AGE-1  /PI 3-kinase pathway and daf-2B activity 
may involve the RAS pathway.
The existence of so many putative ligands (39 currently) for the DAF-2 receptor 
also implies that there might be more than one output from the receptor (Duret et al, 
1998; Gregoire et al, 1998; Kawano et al, 2000; Kawano et al, 2003; Li et al, 2003; 
Pierce  et al,  2001)  (M.  Costa,  personal  communication).  Two  of these  insulin-like 
genes,  ins-1  and  ins-18  as  well  as  human  insulin,  actually  antagonise  the  DAF-2 
receptor at high gene dosage and enhance dauer formation in both wild type worms and 
weak daf-2  mutants.  Overexpression of ins-9,  ins-22  and an  ins-19/-31  hybrid gene
34have no effect on dauer formation in either wild-type worms or weak daf-2 mutants 
(Pierce et al, 2001).
The existence of multiple insulin-like  ligands that either activate or antagonise 
the  DAF-2  receptor  could  provide  support  for  a  model  put  forward  to  explain  the 
differential effects of somatic gonad and germline ablations on life span in class  1 and 
class  2  daf-2  alleles  (Hsin  and  Kenyon,  1999).  The  somatic  gonad  in  C.  elegans 
generates a signal that acts to increase maximum life span and daf-2 activity is required 
for this effect. The germline, however, produces a signal, dependent on daf-16 and daf- 
12,  which  shortens  life  span in  an exactly  opposing  measure  to  the  somatic  gonad. 
Ablation  of  the  germline  precursors  in  both  classes  of  daf-2  allele  leads  to  an 
enhancement of the Age phenotype. Whereas ablation of the somatic gonad precursors 
in class 2 alleles leads to an enhancement of the Age phenotype,  ablation in class  1  
alleles has little effect on daf-2 (el368) and only a mild effect on the daf-2 (m41) Age 
phenotype.
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Aims
372.1 Aims of this thesis project
The overall aim of this thesis is to further our understanding of the daf-2 gene in C. 
elegans and its role in dauer formation and longevity.  Specifically this thesis seeks to 
understand the nature of the two different phenotypic classes formed by ts alleles of daf- 
2  (Gems et al.,  1998),  as well  as the  functional role  of the  large N-  and C-terminal 
extensions found in the DAF-2 protein (Kimura et al., 1997). This thesis also probes the 
role of two putative ligands of the DAF-2 receptor, INS-7 and INS-35, in determining 
longevity.
The  structure  of  the  results  chapters  of  this  thesis  is  as  follows;  chapter  4 
compares the daf-2 gene in C. elegans to its homologues in other nematodes. Chapter 5 
presents  a  sequence  analysis  of different  daf-2  alleles.  Chapter  6  tests  some  of the 
predictions about daf-2 function generated by chapter 5.  Chapter 7 moves away from 
the DAF-2 receptor and instead focuses on two of its putative ligands and their role in 
longevity. Below I set out a brief rationale behind each of the results chapters and the 
approaches used to answer these questions.
2.2  Chapter 4 Identifying daf-2 homologues in the nematodes C.  brisssae and B. 
malavi
The daf-2 gene encodes the sole member of the insulin/ IGF-1 receptor protein family 
within the C.  elegans genome (Kimura et al.,  1997). This was the only member of this 
gene  family  to  have  been  characterised  in the  nematode  phylum  at the  start  of this 
project.  The predicted DAF-2 protein, while possessing all the defining domains and 
features  of a member of the IR superfamily,  also possesses  large N-terminal  and  C- 
terminal extension (see Figure 4.3) (Kimura et al.,  1997). The N-terminal extension is 
novel and has no homology to any known proteins. The C-terminal extension is similar 
to that found in the D.  melanogaster dlnR protein (Fernandez et al.,  1995; Ruan et al., 
1995),  and  contains  several  tyrosine  residues  that  be  phosphorylated  upon  ligand 
binding. Three of these putative phosphotyrosines may serve as direct docking sites for 
the C. elegans homologues of p85, PLC-y, SHP-2 and Grb2 (Kimura et al., 1997). Thus, 
the C-terminal extension in DAF-2 may serve a similar function to the IRS proteins in
38vertebrate  IIS  pathways,  even  though  the  C.  elegans  genome  does  contain  a  gene 
encoding an IRS homologue known as IST-1, a known component of the IIS pathway 
(Wolkow et al., 2002).
Several nematode genomes have been or are being sequenced since this project 
began.  This enables rapid identification of daf-2 homologues within these species and 
allows us to ask the following questions; are the N- and C-terminal extensions seen in 
DAF-2  unique  to  C.  elegans?  Or do  they  have  a broader phylogenetic  distribution? 
Which might imply  an important role for these extensions in IIS pathway  activity in 
nematodes. Currently the daf-2 promoter remains undefined, can additional daf-2 gene 
orthologue  sequences  help  define  regulatory  elements  in  C.  elegans?  There  is 
tremendous variation in lifespans across the nematode phylum, ranging from three days 
in free-living Strongyloides ratti adults to  15 years in the parasite Loa loa (Gardner et 
al., 2004; Gems, 2000). Can some of the differences in lifespan between short-lived and 
long-lived nematodes be due to differences in their DAF-2 receptors, given that DAF-2 
is a known gerontogene?
I  have  used  several  different  approaches  to  address  these  questions.  The 
Caenorhabditis briggsae and Brugia malayi genomes have been sequenced (Ghedin et 
a l, 2004; Stein et al, 2003) and the Caenorhabditis remanei genome is currently being 
sequenced.  C.  briggsae  and  C.  remanei  are  closely  related  to  C.  elegans  and  have 
similar  lifespans  (McCulloch  and  Gems,  2003).  B.  malayi  is  a  long-lived  human 
parasitic nematode that has a lifespan of at least 6-7 years (Wang et al,  1994). I have 
sequenced the  cDNA of the daf-2 homologues  from  C.  briggsae  and B.  malayi and 
modelled  the  gene  structure  of daf-2  in  C.  remanei.  Using  these  sequences  I  have 
performed  a  comparative  analysis  of both the  daf-2  gene  and  the  predicted  DAF-2 
proteins from all four nematode species.
2.3 Chapter 5 Sequence analysis of daf-2 mutant alleles
Temperature-sensitive mutations within the daf-2 gene do not fall into a simple allelic 
series,  but  instead  can  be  separated  into  two  different  phenotypic  classes  (1  and  2) 
(Gems  et  a l,  1998).  Both  classes  display  Daf-c,  Age  and  Itt  phenotypes  at  non- 
permissive temperatures.  Class 2  alleles,  however,  also  display additional pleiotropic 
phenotypes.  These  classes  also  differ  in their  epistatic  interactions with  other  genes
39involved in dauer formation and often have opposite phenotypes (Gems et al.,  1998; 
Gerisch et al.,  2001;  Labbe  et al.,  2000;  Larsen et al.,  1995).  Currently,  there is no 
understanding  of the  molecular  nature  of the  difference  between  the  two  classes. 
However, sequencing of several class 1   and 2 alleles by Kimura et al. (1997) suggests 
that the different classes may correlate with mutations in particular regions of the DAF- 
2 protein (Gems et al., 1998). A formal model for the differences in genetic interactions 
between the two classes posits that the daf-2 gene has two activities daf-2A and daf-2  B, 
which  may  correspond  to  different  outputs  from  the  DAF-2  receptor  (‘A’  and  ‘B’ 
pathway, see Figure 1.7) (Gems et al, 1998).
The  human  insulin  and  IGF-1  receptors  have  been  well  characterised  both 
biochemically and structurally (reviewed in De Meyts and Whittaker, 2002). Given that 
DAF-2 is homologue of MR and MGF-1R, can the data available for these two receptors 
be applied to DAF-2 in order to generate hypotheses about the molecular nature of the 
two classes of daf-2 allele? Mutations in MR can be classified into 5 types depending on 
the point at which they affect receptor function (see Figure  1.4) (Taylor et al.,  1992). 
Can mutations in DAF-2 be classified using the Taylor et al. (1992) scheme? MR and 
MGF-1R both have multiple signalling outputs, such as PI 3-kinase, CAP/ Cbl and Ras/ 
MAP kinase pathways (Saltiel and Kahn, 2001). Are the different classes of daf-2 allele 
linked to mutations in DAF-2 that alter its signalling outputs? The C.  elegans genome 
contains 39 genes that encode insulin-like peptides (Duret et al.,  1998; Gregoire et al., 
1998; Kawano et al., 2000; Kawano et al., 2003; Li et al., 2003; Pierce et al., 2001; M. 
Costa, personal communication), yet daf-2 is the only gene encoding insulin/ IGF-1-like 
receptor. Does the structure of DAF-2 indicate why there are so many ligands for it?
To address these questions I have identified the lesions in several class  1   and 2 
alleles and compared the location of these mutations across the receptor to previously 
published alleles. Using this expanded repertoire of daf-2 mutations I have carried out 
an integrated analysis of DAF-2 that combines homology modelling and data mining of 
MR and MGF-1R mutants to attempt to predict the molecular effects of each mutation 
on DAF-2 function.
402.4 Chapter 6 Further analysis of daf-2 alleles
The majority of this chapter deals experiments designed to test predictions about DAF-2 
function  generated  by  the  results  of chapter  5  and  so  will  not  be  discussed  here. 
However, part of this chapter also deals with the question of the daf-2 null phenotype. 
Currently, the m65 allele is the only candidate for a daf-2 null based on epistasis data 
with daf-16 (Larsen et al., 1995; M. Nanji and D. Gems, unpublished results). Recently, 
the Japanese C. elegans knockout consortium generated a deletion allele of daf-2 at our 
request. In this chapter I compare the Daf-c phenotypes of the m65 and deletion alleles, 
both as single mutants and as daf-16; daf-2 double mutants, to determine if either or 
both represent a daf-2 null.
2.5 Chapter 7 Analysis of the ins-7 and ins-35 genes encoding putative ligands for 
DAF-2
This final results chapter deals with two of the 39 genes encoding insulin-like peptides 
in the  C.  elegans genome.  McElwee et al.  (2004) performed microarray experiments 
comparing the genome-wide expression profiles of glp-4; daf-2 double mutants to glp-4 
daf-16; daf-2 triple mutants using the Affymetrix™ C. elegans oligonucleotide array. Of 
the 39 insulin-like peptide genes in the genome only 23  are represented on this array 
platform. Nine of these ins genes show statistically significant alterations in expression 
levels  between  the  glp-4;  daf-2  double  mutants  and  the  glp-4  daf-16;  daf-2  triple 
mutants  (Table  7.1.1).  The  ins-7  and  ins-35  genes  show  the  greatest  changes  in 
expression between these two genotypes, with ins- 7 being down-regulated by -75% and 
ins-35  up-regulated -24-fold, respectively,  in glp-4; daf-2 mutants compared to glp-4 
daf-16; daf-2 triple mutants.
The current favoured hypothesis for the existence of so many insulin-like peptides 
in C.  elegans suggests that some of these proteins behave  like classical  agonists and 
activate the DAF-2 receptor, whilst others may function as antagonists and inhibit the 
receptor  (Pierce et al.,  2001).  Potentially  ins-7 may  be acting  an agonist of DAF-2, 
which  is  supported  by  the  fact  the  RNAi  of this  gene  has  been  reported  to  extend 
lifespan  (Murphy  et al.,  2003).  Conversely,  ins-35  may  be  an antagonist  of DAF-2,
41based on its up-regulation in the glp-4; daf-2 background. If ins-35 is an antagonist then 
it could represent the first example of a C.  elegans longevity hormone. RNAi of ins-35 
in daf-2 mutant background  can  test for this possibility,  as knockdown  of this  gene 
would be predicted to suppress the extended lifespan of daf-2(-) animals.
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General materials and methods
433.1 C elesans strains and culture
3.1.1 Strains
The N2 Caenorhabditis Genetics Center (CGC) male stock was used as the wild-type 
strain throughout this thesis, as the lifespan of this strain most closely resembles that of 
the original N2 isolate (Gems and Riddle, 2000). All other strains used throughout this 
thesis are listed in each chapter. Unless stated otherwise, all strains used were from the 
Gems lab strain collection or constructed by myself.
3.1.2 Routine culture of stocks
All stocks were grown in 60mm tissue culture plates (Greiner Bioscience)  containing 
nematode  growth  medium  (NGM)  agar  seeded  with  E.  coli  strain  OP50  (Brenner, 
1974). Stocks were generally maintained at 15°C unless otherwise stated. NGM agar is 
uracil-limited  and  the  OP50  strain  is  a  uracil  auxotroph,  therefore  the  NGM  agar 
prevents  overgrowth  of the  bacterial  lawn.  This  stops  the  lawn  from  obscuring  the 
worms  when  viewed  under  a  microscope.  Animals  were  inspected  using  a  Nikon 
SMZ645 dissecting scope.
Animals were transferred to fresh plates at least once a week using a thin platinum 
wire  (worm  pick).  The  worm  pick  was  always  sterilised  by  flaming  before  being 
allowed to cool down. Once cooled the pick was coated with fresh OP50 and used to 
pick up animals for transfer. The worm was then gently set down on the bacterial lawn 
of the  fresh plate and worms were  allowed to crawl  away.  For stocks maintained as 
hermaphrodite  only  cultures  3-5  gravid  adults  were  transferred  to  fresh  plates.  For 
stocks  maintained  as  mixed  male  and  hermaphrodite  cultures  6-10  L4  males  were 
transferred  to  fresh  plates  along  with  3  L4  hermaphrodites.  Males  were  initially 
generated using heat shock. Six to ten L4 hermaphrodites were exposed to 30°C for 6 
hours before being transferred back to  15°C. This procedure increases the incidence of 
X  chromosome  non-disjunction  during  meiosis  and  thus  increases  the  rate  of
44spontaneous male formation. Males were sought amongst the progeny of these worms, 
and then mated with hermaphrodites, as described above, to maintain their production.
3.1.3  Axenisation of stocks
Axenisation is an alkaline hypochlorite based method that allows fertilised eggs to be 
retrieved  from  gravid adults.  This method can be  used to  clean up  stocks that have 
become contaminated with non-OP50 bacteria or yeast. This method is also essential in 
removing OP50 cells from eggs that are being transferred onto HT115(DE3) cells for 
RNAi.  This procedure is also the first step in growing stage synchronous cultures of 
strains.
Procedure and reagents
1.  Gravid adults were washed of plates using a total volume of 6 ml of M9 buffer 
(Brenner, 1974) and into a sterile 15 ml centrifuge tube. The agar plates will retain 
some of the buffer, so the final volume in the tube should be ~5 ml.
2.  The  animals  were  then  incubated  with  2  ml  of 5%  (Volume  /Volume)  NaOCl 
solution and 1  ml of 5M KOH for three minutes. This treatment causes the gravid 
hermaphrodites to  lyse  and release  their  fertilised  eggs,  as  well  as  killing  any 
contaminants.
3.  After the alkaline hypochlorite incubation worms were centrifuged at  1000 rpm 
for 1  min. The supernatant was drawn off leaving behind a pellet of free eggs and 
lysed worms.
4.  The pellet was resuspended in  10 ml of M9 and then centrifuged again at  1000 
rpm. The supernatant was removed and the pellet resuspended in another 10 ml of 
M9 and centrifuged a further two times.
5.  After the final centrifugation, only 9.5 ml of the supernatant was removed. The 
pellet  was  resuspended  in  the  remaining  0.5  ml  of  M9.  200  pi  of  the  egg
45suspension  were  then  aliquoted  on  to  fresh  plates  seeded  with  OP50.  The 
suspension was deliberately placed away from the bacterial  lawn.  This ensured 
that larvae crawled away from the lysed bodies of the parental worms.
6.  These plates were stored overnight at 15°C. The next day the hatched larvae that 
were feeding on the bacterial lawn were transferred to new plates and the plates 
with the lysed worms were discarded.
3.1.4  Stage synchronous cultures
Stage synchronous cultures of worms are essential for certain types of experiment. For 
example,  in this thesis I  needed  stage synchronous cultures for the quantitative PCR 
analysis of daf-2 transcript levels in the daf-2(el369) allele to ensure that any difference 
measured  was  not  due  to  developmental  differences.  Stage  synchronous  cultures  of 
worms can be generated using the axenisation protocol listed above. However, instead 
of performing the last two steps listed in the protocol the pellet from the final wash is 
resuspended in 10 ml of M9. This suspension is transferred into a sterile 25 ml conical 
flask and left in a shaking incubator, rotating at 200 rpm, at 20°C for 24 hours. This 
procedure allows the eggs to hatch into LI  larvae. However, due to the absence of a 
food source all the larvae arrest in the LI diapausal state.
The arrested LI  larvae can be harvested by transferring the M9 suspension from 
the conical flask into a sterile  15  ml centrifuge tube.  The tube is then centrifuged at 
1000  rpm.  The  supernatant can then be  removed and the worms resuspended in  the 
appropriate volume of M9 that is suitable for the experiment. The resuspended worms 
can be placed onto seeded plates, either OP50 for standard culture or HT115(DE3) for 
RNAi.
463.2 Molecular biology in C elesans
3.2.1  RNA extraction
All total RNA extractions from both C.  elegans and C. briggsae were carried out using 
TRIzol reagent (Invitrogen) and following the manufacturer’s instructions. Two slightly 
different  methods  were  used  depending  on  the  purpose  of the  RNA  sample.  RNA 
samples for the synthesis and sequencing of cDNA from different daf-2 alleles and the 
Cb-daf-2 gene (Chapter 4) were smaller scale preparations extracted without the use of 
a ribolyser. RNA used in the daf-2(el369)  QPCR experiments was extracted with the 
use  of a  ribolyser,  which  increases  yield,  and  were  larger  scale  preparations.  Both 
methods are outlined below.
Procedure and reagents
Small-scale extractions
1.  For the small-scale RNA extractions, worms were grown in mixed stage cultures 
at  15°C  on  six  to  ten  60mm  tissue  culture  plates  per  strain.  When  the  plates 
reached high-population density and were close to exhausting the OP50 lawn the 
animals were washed from the plates into a 15 ml centrifuge tube using  10 ml of 
M9. The plates were grown to high-density to maximise the amount of nematode 
RNA recovered and minimise the amount of bacterial RNA recovered.
2.  The  worms  were  then  centrifuged  at  1000  rpm  to  pellet  the  worms  and  the 
supernatant removed. The worms were then resuspended in 200 pi of M9, which 
was  then  transferred  into  a  1.5  ml  centrifuge  tube  (RNase  and  DNase-free, 
Anachem).
3.  800 pi of TRIzol reagent (Invitrogen) was then added to the tube and vortexed for 
30 min at room temperature (RT) and then left to incubate for a further 15 min at 
RT.
474.  The worm-TRIzol mixture was then centrifuged at 14,000 rpm at 4°C for 10 min 
to deposit the insoluble worm cuticles. The supernatant was then transferred to a 
new 1.5 ml centrifuge tube. The rest of the TRIzol extraction was then carried out 
according to the manufacturer’s instructions.
5.  The  RNA pellet  formed  by  the  extraction process  was then  air-dried  at 65°C, 
before  being  dissolved  in  50  pi  of RNase-free  water  (Invitrogen).  5  pi  of the 
dissolved RNA was diluted into  1   ml of RNase-free water (1:200 dilution)  and 
was placed in a spectrophotometer to measure the quantity of RNA produced by 
the extraction. The rest of the sample was stored at -80°C until required.
Large-scale extractions
1.  For the large-scale RNA extractions used in the QPCR experiments worms were 
grown in synchronous culture (section 3.1.4). Worms were grown on four 100mm 
plates per strain at 15°C until they reached the L4 stage. They were then shifted to 
25°C overnight, before they were washed into 15 ml centrifuge tubes using 10 ml 
of M9.
2.  The worms were then centrifuged at 1000 rpm for 1  min to pellet the animals. The 
supernatant was removed  and  the worms  were  resuspended  in  1   ml  of TRIzol 
reagent.  The  TRIzol-worm  suspension was transferred  into  a Lysing  Matrix  D 
tube (Q-biogene) and frozen at -80°C overnight. This was done to help disrupt the 
worm cuticle and increase yield of RNA
3.  The Lysing Matrix D tube was then thawed out at RT. Once thawed the tube was 
placed in a FP220 ribolyser (Q-biogene) and subjected to two 30 second cycles of 
homogenisation at a speed setting of 4.5 and then placed on ice.
4.  200 pi of chloroform (CHCI3) was then added to the homogenate and the mixture 
was vortexed for 15 seconds before being left to incubate at RT for 3 min.
485.  The homogenate-chloroform mixture was then centrifuged at  14,000 rpm at 4°C 
for  15  min  to  deposit  the  insoluble  worm  cuticles.  The  aqueous  layer  of 
supernatant was then transferred to a new 1.5 ml centrifuge tube. The rest of the 
TRIzol  extraction  was  then  carried  out  according  to  the  manufacturer’s 
instructions.
6.  Drying  of the  RNA pellet and quantification of the  RNA yield  was  carried as 
described above for the smaller scale preparations.
3.2.2  First strand cDNA synthesis
Single-stranded cDNA was synthesised from RNA samples generally using an oligo-ST 
primer.  However, for the majority of the daf-2 allele sequencing work I used a daf-2 
gene-specific primer (see chapter 5), except in the case of daf-2(el369), where I used 
both. The first strand cDNA synthesis was carried out using the Reverse-iT first strand 
cDNA synthesis kit (ABgene) and the protocol is outlined below.
Procedure and reagents
1.  5  pg  of total  RNA were  added to  a  low profile  RNase/  DNase-free  PCR tube 
(ABgene). 1   pi of oligo-6T primer or 1  pi of gene-specific primer was then added 
to the tube. RNase-free water (Invitrogen) was then added to the tube to take the 
volume of this mixture to 13 pi. The volume of water added was dependent on the 
concentration of the RNA. The mixture was then heated to 65°C and then placed 
on ice. This step helps eliminate secondary structure in mRNA that might inhibit 
reverse transcription.
2.  The  following  reagents  were  then  added to  the  PCR tube:  4  pi  of first  strand 
cDNA  buffer,  2  pi  of dNTPs  and  finally  1   pi  of the  Reverse-iTase  (ABgene 
proprietary reverse transcriptase). The mixture was gently mixed and then spun 
down in a centrifuge at 800 rpm for 1 min.
493.  The  PCR tube  was  then placed  in  a  Gene  Amp  2700  thermal  cycler  (Applied 
Biosystems). The following programme was used: 47°C for 60 min for the reverse 
transcription,  10 min at 75°C to denature the Reverse-iTase followed by  a 4°C 
hold. Once completed the first strand cDNA was stored at -20°C until needed.
3.2.3  Genomic DNA extraction
Genomic DNA (gDNA) was needed for several different purposes, such as confirming 
mutations  found  in the cDNA of daf-2 alleles (chapter 5),  following deletion alleles 
during strain construction (chapter  6) and sequencing of the upstream DNA and first 
intron from daf-2(el369) (chapter 5). In most cases genomic DNA was isolated from 5- 
10  adult  worms,  but  can  be  extracted  from  just  single  worms  when  confirming 
genotypes. The protocol for multiple worms is outlined below, the procedure for single 
worm lysis can be found in the single worm PCR section 3.2.4.
Procedures and reagents
1.  The worms were first placed in 10 pi of filter-sterilised lysis buffer in a PCR tube. 
This is made up in RNase-free water and has the final composition;
50mM KC1 
lOmM Tris (pH8.3)
2.5mM MgCl2
0.45% Nonidet P-40
0.45% Tween 20
0.0 1% gelatin 
60 pg/ml proteinase K
2.  The worms were then frozen at -80°C for 10 min to help break up the cuticle. The 
PCR tube was placed in a thermal cycler.  The following programme was used: 
65°C for 60 min,  15 min at 95°C to denature the proteinase K followed by a 4°C 
hold. Once completed the genomic DNA was stored at -20°C until needed.
503.2.4 PCR protocols
I have used several different types of PCR protocol in this thesis. For the amplification 
of cDNA and gDNA fragments for use in sequencing I usually used a standard PCR 
protocol.  For  difficult templates,  colony  PCR from  bacterial  cells  (chapter  7)  or for 
single worm PCR for genotyping (chapter  6) I employed touchdown PCR. All PCRs 
were  carried  out using  2x  Reddy  Mix  PCR master mix  (ABgene)  containing  1.5mM 
MgCh. The different methods are outlined below.
Procedures and reagents
Standard PCR
1.  Generally  1   pi of template DNA (either cDNA or gDNA) was added to  12 pi of 
RNase/ DNase free water in a PCR tube.  1   pi of each relevant (5’ and 3’) primer 
was then added to the tube to give a volume of 15 pi.  15 pi of the 2x Reddy  Mix 
PCR master mix was then added into the tube and gently mixed by pipetting.
2.  The PCR tube was then place in the thermal cycler and the following program was 
used:
94°C for 5 min
Followed by 35 cycles of 
94°C for 30 seconds,
55°C for 30 seconds,
72°C for X minutes (see Table 3.2.1)
4°C final hold
Once the PCR was completed,  10 pi of the sample was visualised on an agarose 
gel to confirm amplification and the rest was stored at -20°C until needed.
51Touchdown PCR
In a touchdown PCR the annealing temperature decreases by 1°C every cycle for a user- 
defined  number  of  cycles.  This  procedure  can  help  eliminate  non-specific  primer 
binding so that there is better amplification of the desired fragment.
1.  Generally  1   pi of template DNA (either cDNA or gDNA) was added to  12 pi of 
RNase/ DNase free water in a PCR tube. In the case of colony PCR I resuspended 
some bacterial cells sampled with my worm pick in  12 pi of water.  1  pi of each 
relevant (5’ and 3’) primer was then added to the tube to give a volume of 15 pi. 
15  pi  of the 2x Reddy  Mix PCR master mix was then added into the tube  and 
gently mixed by pipetting.
2.  The PCR tube was then place in the thermal cycler and the following program was 
used:
94°C for 5 min
Followed by 10 cycles of 
94°C for 30 seconds,
65°C* for 30 seconds (*decreases by 1°C every cycle for first 10 cycles)
72°C for X minutes (see Table 3.2.1)
Followed by 25 cycles of 
94°C for 30 seconds,
55°C for 30 seconds,
72°C for X minutes (see Table 3.2.1)
4°C final hold
Once the PCR was completed,  10 pi of the sample was visualised on an agarose 
gel to confirm amplification and the rest was stored at -20°C until needed.
52Single worm PCR
For single worm PCR I always used touchdown PCR. Single worms were placed in 2.5 
pi of lysis buffer (section 3.2.3) in a PCR tube. The tube was then frozen for 10 min at - 
80°C to help disrupt the cuticle of the worm.  The tube was then placed in a thermal 
cycler and the  following programme was used:  65°C  for 60 min,  15  min at  95°C  to 
denature  the proteinase  K followed by a 4°C  hold.  The tube was removed  from  the 
cycler and kept on ice.  1   pi of relevant primer was added to the lysate followed by 5.5 
pi of RNase/ DNase free water to bring the volume in the PCR tube to 10 pi. Finally 10 
pi of 2x ReddyMix PCR master mix was then added into the tube and gently mixed by 
pipetting. The PCR tube was then placed into a thermal cycler and the touchdown PCR 
protocol  described  above  was  used.  Once  the  PCR  cycle  was  complete  the  entire 
reaction mixture was run out on an agarose gel for visualisation.
Quantitative PCR (QPCR)
All  QPCR  reactions  were  carried  out  in  an  ABI  PRISM  7000  sequence  detection 
system.  I  used  2x  Absolute  SYBR  green  ROX  PCR  master  mix  (ABgene)  for  the 
reactions, following the manufacturer’s instruction. The final volume of the reaction in 
each  well  was  25  pi.  All  reactions  were  set  up  according  to  plate  layout  given  in 
Chapters 6 and 7. The ama-1 primers were both used at a final concentration of 50nM. 
The daf-2 primers were used at a final concentration of 300nM for F2F and 50nM for 
FIR. The ins-7 primers were used at a final concentration of 300nM for ws-7Fwd and 
50nM for ins- 7Rev. The ins-35 primers were used at final concentration of 300nM for 
both primers. The relevant cDNA template was added in 2 pi aliquots to each reaction, 
except for 2x and 4x N2 cDNA samples, which were added in 4 pi and  8  pi aliquots 
(using a  lx stock) to each reaction (see plate layouts). Reactions were set up in a 96- 
well Thermo-Fast PCR plate (ABgene) and sealed with ABsolute QPCR optically clear 
adhesive film. The PCR protocol for the ABI PRISM 7000 sequence detection system 
was as follows: 50°C for 2 min, 95°C for 15 min (denatures antibody bound to Taq) then 
40 cycles of 95°C for 15sec, 55°C for 30sec, 72°C for 30sec. The reactions were always 
run with the dissociation protocol switched on.
53Table 3.2.1 Extension times used in all PCR protocols
Size of DNA fragment to 
be amplified
< 0.5Kb < 1Kb < 2Kb < 3Kb
Extension time to be used 
(X)
30 seconds 1   minute 2 minute 3 minute
3.2.5 Electrophoresis of DNA fragments in agarose gels
All PCR products were run agarose gels to ensure successful PCR and amplification of 
the correct product. Similarly, the products of all restriction digests (see chapter 7) were 
checked to ensure they were correct by running the product through an agarose gel. For 
DNA products less than 1Kb in length I used a 1% gel (Weight/Volume) made up with 
lx TAE buffer, for products greater than 1Kb I used a 0.8% gel. All gels contained 2 pi 
of ethidium bromide per 50 ml of agarose gel. Most samples were run in 10 pi volumes, 
except  for  DNA  from  single worm  PCR and  restriction  digests,  in  which the  entire 
reaction volume was run.  All samples were run with  10  pi of Reddy  Run  1Kb  DNA 
ladder  (ABgene)  to  aid  identification of fragment  sizes.  Bands were  then  visualised 
using a UV transilluminator.  Images of the bands were then captured using a digital 
camera and saved as tiff files, for future reference.
3.2.6 Sequencing of DNA fragments
Sequencing of PCR amplified DNA was used in obtaining the cDNA sequences of the 
Cb-daf-2 and Bm-daf-2 gene (chapter 4), locating and confirming the site of mutations 
in  daf-2  alleles (chapter  5),  confirming the  identity  of daf-2\  daf-28 double  mutants 
(chapter  6)  and  confirming  the  identity  of RNAi  constructs  (chapter  7).  Sequencing 
reactions  were  carried  out  using  Big  Dye  Termination  mix  version  2.0  (Applied 
Biosystems).  Given  the  volume  of sequencing  carried  out  in  my  project,  I  used  a 
dilution protocol that allows good quality sequencing reads to be achieved from just an 
eighth of the normal quantity of Big Dye, thereby achieving 1600 reactions from a 200 
reaction kit.
54Procedures and reagents
1.  First, the DNA to be sequenced was purified form the PCR mixture.  This was 
done in two different ways. For fragments that had amplified only a single product 
the DNA was precipitated from the PCR master mix using the Microclean reagent 
(Microzone)  and  following  the  manufacturer’s  instructions.  For  PCR reactions 
that generated multiple bands the correct band (determined by size) was extracted 
from  the  gel  and  purified  using  the  Qiaquick  gel  extraction  kit  (Qiagen)  and 
following the manufacturer’s instructions.
2.  Once purified the DNA was resuspended in 30 pi of RNase/ DNase free water. 5.5 
pi of the DNA sample was then added to  a PCR tube.  The following reagents 
were then added to the tube: 5 pi of Better Buffer (Microzone),  1   pi of Big Dye 
Termination mix version 2.0 (Applied Biosystems) and 2 pi of RNase/ DNase free 
water. Finally, 1.5 pi of the relevant primer was added to the mix (5’ primer for a 
+ strand read or the 3’ primer for a -  strand read).
3.  The tube was then place in a thermal cycler and the following programme was 
used;
25 cycles of
96°C for 10 seconds 
55°C for 5 seconds 
60°C for 4 minutes 
4°C final hold
4.  Once the  sequencing reaction was complete the  sample was removed  from the 
cycler  transferred  from  the  PCR  into  a  1.5  ml  centrifuge  tube  and  the  DNA 
precipitated  by  incubation  with  80  pi  of  80%  isopropanol  for  10  min  at  RT 
followed by centrifugation 13000 rpm for 10 min.
555.  The  supernatant  was  discarded  and  the  pellet  washed  with  150  pi  with  70%
isopropanol before being centrifuged again at  13000 rpm for  10 min. Again the
supernatant was discarded and sample was air-dried at 65°C.
6.  The sample was then mixed with 10 pi of high purity formamide  mix and heated
at 65°C for 5 min. Samples were then transferred to 96-well plates and then heated 
for a further 4 min at 96°C and then cooled on ice for 5 min before being loaded 
into an ABI PRISM 3100 Genetic Analyzer™ (Applied Biosystems). Alice Smith 
and Mari Wyn Burley, the Goldstein lab sequencing technician and lab manager, 
respectively, carried out this final  step and then kindly emailed the reads upon 
completion of the run to me.
Not all sequencing reactions were carried out as above. Towards the end of my project, 
samples were sequenced using the DNA sequencing service provided by the Wolfson 
Institute for Biomedical Research at UCL (http://www.ucl.ac.uk/WIBR/services/dnaA. 
This service does not have a minimum sample number requirement and so was used for 
the  final  few reactions  of this project.  This  service  carries  out  sequencing  reactions 
using a chain-termination mix from Beckman-Coulter.  Sequencing PCRs were carried 
out by the service, so only the DNA template and primer had to be provided. Data was 
emailed to me as scf files. This did not affect the methods of analysis listed below.
3.2.7  Sequence data analysis
I used two different methods for analysing the sequence data. Firstly, for the sequencing 
of the Cb-daf-2 and Bm-daf-2 genes the abi data files for each gene were loaded into the 
SeqMan module of the Lasergene suite V5.51  (DNASTAR). This program is a contig 
generator and so as sequencing reads were added to the master file for each gene, the 
program  would  automatically  align the reads  to  generate  the  most  likely  contiguous 
sequence. The final contigs represented the cDNA sequence of each gene. The contig 
was then entered into the EditSeq module of the Lasergene suite and translated in silico 
to generate the predicted protein sequence for these genes.
For the  sequence  analysis  of the daf-2 alleles I  converted the abi  data files to 
EditSeq files. This conversion allowed me to enter the sequence files that corresponded
56to the + and -  strand reads for each cDNA fragment into the MegAlign module of the 
Lasergene  suite.  This module aligned the reads for each fragment with the wild-type 
sequence of that fragment using the ClustalX algorithm and highlighted nucleotides in 
the reads that did not match the wild-type sequence. If a nucleotide did not match the 
wild-type sequence and was the same in both the + and -  strand read it was treated as 
the putative mutation in that allele. The changed nucleotide was then incorporated into 
an  EditSeq  file  with  the  rest  of the  daf-2  cDNA  wild-type  sequence.  This  mutated 
cDNA was then translated in silico to generate the mutant protein sequence. The mutant 
protein  sequence  was  then  aligned  with  the  wild-type  DAF-2  sequence  using  the 
ClustalW algorithm and the program highlighted the changed amino acid.
3.2.8 Protein extraction
Protein samples for use in western blotting were prepared using a simple whole animal 
lysate method (Johnstone,  1999).  Worms were grown to high-population density on a 
single 60mm plate and then washed into a 15 ml centrifuge tube with 3 ml of M9. The 
worms were then pelleted by centrifugation at 1000 rpm for 1  min. The supernatant was 
then removed and 5 volumes of SDS-sample buffer (Laemmli, 1970) were added to the 
estimated volume of worms (typically -100 pi). The mixture was then transferred into a
1.5  ml centrifuge tube and boiled for 5 min at 100°C. Samples were then centrifuged at 
14000 rpm in a refrigerated centrifuge at 4°C for  1   min to pellet the non-solubilised 
worms. Samples were then ready to run in a polyacrylamide gel.
3.2.9 Protein gels
A  Mini-Protean  3  (Bio-rad)  cell  and  casting  assembly  were  used  for  SDS- 
polyacrylamide  gel  electrophoresis  and  casting,  respectively,  following  the 
manufacturer’s instructions.  A range of different strength resolving gels were tried in 
the westerns and the mixes for each of these is listed in Table 3.2.2, whilst the stacking 
gel was always 3.75%.
The  resolving  gel  was  made  up  in  a  15  ml  centrifuge  tube  by  adding  the 
acrylamide  solution,  followed  by  the  3M  Tris-HCl  (pH  8.8)  buffer,  the  10%  SDS
57solution and finally the water. The solution was then gently mixed by inverting the tube 
several times. The casting cassette for the gel was prepared and once ready to receive 
the gel the ammonium persulphate and TEMED were added to the resolving gel mix. 
Again the solution was mixed by inverting the tube and then the solution was poured 
into the casting cassette with a disposable 10 ml pipette, up to the point where the top of 
the gel was 5mm from the bottom of the gel combs. The rest of the gel solution was 
discarded and the resolving gel in the casting cassette was overlaid with 1  ml of t-amyl 
alcohol, as recommended by the manufacturer.
The resolving gel was allowed to  set for  1   hour before the t-amyl  alcohol was 
drained off and the stacking gel poured on top. The stacking gel was made up in a 15 ml 
centrifuge tube and consisted of 280 pi of 40% acrylamide solution, 750 pi 0.5M Tris- 
HC1 (pH 6.8), 30 pi 10% SDS solution and 1.914 ml water. As with the resolving gel, 
the stacking gel solution was gently mixed by inversion of the tube, before the addition 
of 22.5 pi  10% ammonium persulphate solution and 3 pi TEMED. Again the tube was 
mixed by inversion and the stacking gel was poured on top of the resolving gel with a 5 
ml disposable pipette until it reached the top of the casting cassette. The stacking gel as 
then allowed to for lhour before the gel combs were removed and the gel was loaded 
into the electrophoresis cell and filled with lx Tris-glycine buffer (Laemmli,  1970). 20 
pi of the relevant protein sample was then loaded in to each well in the stacking gel 
using gel-loading tips (ABgene). I used  10 pi of SeeBlue™  Plus 2 (Invitrogen) as my 
molecular weight ladder, which was always loaded into the first well on the left of the 
gel.  The gel was then run at  100V until the bromophenol blue marker in the protein 
samples entered the resolving gel,  at which point the voltage was increased to  120V. 
The gel was run until the bromophenol blue marker reached the end of the resolving gel. 
At  this  point  the  gel  was  ready  for  electrophoretic  transfer  of the  proteins  on  to  a 
blotting membrane.
58Table 3.2.2 Resolving gel mixes
Components for 10 ml 5% Resolving Gel 7% Resolving Gel 10% Resolving Gel
40% Acrylamide (37:1)* 1.25 ml 1.75 ml 2.5 ml
3M Tris-HCl (pH 8.8) 1.25 ml 1.25 ml 1.25 ml
10% SDS (W/V)a 0.1 ml 0.1 ml 0.1  ml
Water 7.315 ml 6.815 ml 6.065 ml
10% Ammonium 
persulphate (W/V)a
75 pi 75 pi 75 pi
TEMED 10 pi 10 pi 10 pi
* Ratio of acrylamide to 
a solutions made up with
3.2.10 Western blotting
nsacrylamide
water
The protein gel was removed the electrophoresis cell. The stacking gel was discarded 
and the resolving gel placed into Towbin buffer to incubate for 30 min. Towbin buffer 
is made up of lx Tris-glycine buffer (Laemmli, 1970) supplemented with methanol to a 
final  concentration  of  20%  (V/V).  A  piece  of  Hybond  nitrocellulose  membrane 
(Amersham Biosciences), cut to be slightly larger than the gel, was incubated in Towbin 
buffer for 10 min. Two pieces of extra-thick Protean blotting paper (Bio-rad), cut to be 
slightly  larger than the membrane, were  incubated  in Towbin buffer for  5  min.  One 
piece  of blotting  paper  was  placed  on  the  anode  plate  of  a  Trans-Blot  Semi-Dry 
electrophoretic transfer cell (Bio-rad). The nitrocellulose membrane was then placed on 
top  of the  blotting  paper.  Air  bubbles  between  the  paper  and  the  membrane  were 
removed using a 5 ml disposable pipette. The gel was then placed on the membrane, so 
that the ladder remained on the left of the blot, again bubble were removed with a 5 ml 
pipette. The second piece of blotting paper was then placed on top of the gel. Bubbles 
were removed as before, then the cathode plate was put on top of the stack followed by 
the safety cover. The cell was run at 20V for 45 min
After  removal  from  the  Trans-Blot  cell  the  gel  was  stained  with  Coomassie 
brilliant blue solution (Laemmli, 1970) to observe the efficiency of protein transfer. The 
membrane was stained  with a  0.1%  solution  of Ponceau  S  dye  in  5%  acetic  acid to 
confirm the presence of protein.  The membrane was then destained by  incubation in 
distilled water for 2 min. The membrane was then blocked overnight at 4°C with a 5% 
milk powder solution made up with PBS-Tween buffer.
59On the  following day the membrane was transferred to  fresh  5% milk powder 
solution and incubated with the primary antibody at the required dilution for 90 min on 
a shaker at room temperature. After the primary antibody incubation the membrane was 
washed with a  15-minute incubation in PBS-Tween buffer followed by two  5-minute 
incubations. The membrane was then transferred to fresh 5% milk powder solution and 
incubated with the peroxidase-linked secondary antibody at the required dilution for 1  
hour on a shaker at room temperature. After this incubation the membrane was washed 
with  a  15-minute  incubation  in  PBS-Tween  buffer  followed  by  four  5-minute 
incubations.  Binding  of  the  antibody  was  detected  using  the  ECL  plus 
chemiluminescence  detection  kit  (Amersham  Biosciences)  according  to  the 
manufacturer’s  instructions.  The  ECL-treated  membrane  was  placed  into  a  BioMax 
cassette (Kodak) in a dark room. A sheet of Hyperfilm (Amersham Biosciences) was 
then  exposed to  the  membrane  in  side  the  BioMax  cassette  for  1   min  before  being 
developed  with  a Kodak X-Omat  developer.  Depending  on the  outcome  of the  first 
exposure, a second piece of Hyperfilm was exposed for either shorter or longer periods 
of time to get the best exposure.
3.2.11 RNAi by ingestion of dsRNA
Two different protocols for RNA-mediated interference (RNAi) by ingestion of dsRNA, 
produced by transformed HT115(DE3)  cells, were used in this project.  The first was 
based on the  ImM IPTG-based induction method described by Kamath et al (2000). 
However, I supplemented the NGM plates with 25 pg/ml of carbenicillin instead of with 
50 n-g/ml ampicillin. Carbenicillin is an analogue of ampicillin that is more resistant to 
breakdown at room temperature.
The second method was lactose-based induction method, originally developed by 
Eric  J.  Lambie  (personal  communication)  and  optimised  in  our  lab.  NGM  agar was 
prepared as described by Brenner (1974), except peptone concentration was reduced to 
a 10th of standard from 2.5 g/L to 0.25 g/L. The agar was then supplemented with 0.2% 
lactose and 25  ng/ml carbenicillin. The peptone was reduced to prevent overgrowth of 
the HT115(DE3) cells as this strain of E. coli is not a uracil auxotroph like OP50, and is 
able to metabolise lactose.
60Animals were grown on the RNAi treatment for at least three generations before 
phenotyping.  All  strains  were  maintained  at  15°C  before  being  shipped  to  the 
experimental temperature. This was done to prevent dauer formation in class 1  alleles of 
daf-2, which have an increased Daf-c phenotype, even on L4440 control plates, at 20°C 
(see chapter 6).
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Identifying daf-2 homologues in the nematodes 
Caenorhabditis briggsae and Brugia malayi
624.1 Introduction
In this chapter I perform a comparative analysis of the daf-2 gene, and the protein it 
encodes, with its homologues in three different nematode species. At the  start of my 
project  no  other  nematode  daf-2  sequences  were  available,  which  limits  the 
understanding not only of the gene but also of features of the DAF-2 protein, such as its 
novel N- and C-terminal extensions.  To gain further insight into daf-2 function in C. 
elegans  and  its  evolution  within the  nematode  phylum,  and  to  improve  the  protein 
sequence alignments used in modelling the structure of the DAF-2 receptor (see Chapter 
5)  I  sequenced the homologues of this gene  in  Caenorhabditis briggsae  and Brugia 
malayi, whose genomes were in the process of being sequenced. I have also created a 
model  of the  daf-2  gene  homologue,  and  its predicted  protein,  in  a  third  nematode 
species Caenorhabditis remanei, whose genome is currently being sequenced.
4.1.1  The daf-2 gene in C. elesans
The daf-2 gene has  17 exons and spans 33.038 kb (Figure 4.2), the mRNA is 5795 bp 
and the translated protein is 1846 amino acids long. The predicted amino acid sequence 
shares 35%, 34% and 33% identity with the human insulin, IGF-1  and insulin-related 
receptors, respectively (Kimura et al., 1997). The DAF-2 protein has a novel 121 amino 
acid  (aa)  N-terminal  extension  before  the  predicted  signal  peptide,  an  N-terminal 
extension is also found in dlnR (Fernandez et al.,  1995; Ruan et al.,  1995), but not in 
any of the other characterised IRRs where the start codon is immediately followed by 
the signal peptide (Figure 4.3).
The DAF-2 receptor also has a large C-terminal extension (326aa following the 
kinase  domain).  Similar  extensions  are  found  in  all  characterised  invertebrate  IRRs, 
apart  from  the  insulin  receptor-like  RTKs  from Sycon  raphanus  (Skorokhod  et  al., 
1999). Most are smaller than DAF-2’s, apart from the extension in dlnR, which is -400 
amino acids long (Fernandez et al.,  1995; Ruan et al.,  1995). Another exception to this 
is  the  trematode  Schistosoma  mansoni  SmRTK2  protein  (AF314754).  However,  my 
own alignment of this protein with other IRRs suggests that the C-terminal sequence of 
this protein may be longer than reported.
63A characteristic feature of these C-terminal extensions is the presence of multiple 
tyrosine  residues,  which may  be phosphorylated  upon receptor activation  and  act  as 
binding sites for proteins with SH2 domains. For example, the C-terminal extension in 
DAF-2  contains  11  tyrosine  residues,  at  least  four  of which  may  be  putative  SH2- 
binding  sites (Kimura et al.,  1997).  The  C-terminal  extension is thought to  function 
similarly to the insulin receptor substrate (IRS) proteins, even though C.  elegans does 
have a gene encoding an IRS homologue known as ist-1 (Wolkow et al., 2002).
4.1.2  Identifying daf-2 homologues in other nematodes
Of the seven invertebrate IRRs that had been sequenced prior to 2001, DAF-2 was the 
only sequence from the phylum nematoda. However, by this time two other nematode 
species  were  in  the  process  of  having  their  genomes  sequenced.  These  were 
Caenorhabditis briggsae (Stein et al., 2003) and Brugia malayi (Ghedin et al., 2004). 
Caenorhabditis briggsae is also a soil dwelling nematode similar to C.  elegans and has 
had its genome sequenced to act as tool for comparative genomics with C. elegans. The 
two  species  are  thought  to  have  diverged  approximately  80-110  million  years  ago 
(MY  A)  during  the  Cretaceous  period,  but  remain  almost  indistinguishable 
morphologically  (Stein  et  al.,  2003).  Both  species  are  hermaphroditic,  and  like  C. 
elegans low-frequency male formation also occurs in C. briggsae.  Surprisingly though, 
this appears to be a convergent trait as the sister species of C. briggsae, Caenorhabditis 
remanei and the as yet unnamed Caenorhabditis species CB5161  are both dioecious, 
and all three species share a more recent ancestor than with C. elegans (Kiontke et al., 
2004). The genome of C.  remanei is currently being sequenced and CB5161  is being 
prepared for sequencing.
Brugia malayi is a parasitic nematode that infects humans and causes lymphatic 
filariasis, commonly referred to as elephantiasis.  This disease can be caused by three 
different parasitic nematodes.  Wuchereria bancrofti is the major cause of this disease 
and  is  endemic  in  Africa,  India,  the  Pacific  islands,  Caribbean,  South  America  and 
Southeast Asia. Brugia malayi and the closely related Brugia timori are found only in 
Southeast Asia, B. timori being restricted to eastern Indonesia (Cox, 2000). Even though 
W.  bancrofti  is  the  major  cause  of lymphatic  filariasis,  B.  malayi  was  chosen  for 
genome sequencing due to fact that it can be cultured in laboratory conditions (Ghedin
64et  al.,  2004).  In  terms  of B.  malayi  relatedness  to  C.  elegans,  the  two  species  are 
estimated to  have  diverged  approximately  450  MY  A,  during  the  Ordovician  period, 
based on sequence divergence of their globins (Vanfleteren et a l, 1994); M. L. Blaxter, 
personal communication).  However, the divergence dates for both C.  briggsae and B. 
malayi from C.  elegans should be treated with some scepticism as there  is no  fossil 
record  for the nematode phylum with which to calibrate the molecular  clock.  In the 
context of IIS and the study of ageing it is notable that the lifespan of B. malayi adults is 
at least 6-7 years (Gems, 2000).
Figure 4.1 Phylogenetic relationship between Brusia and Caenorhabditis
    C. remanei
unknown
C. briggsae
--------------  80-110  MYA
----------  C. elegans
-450 MYA 
-----------------------------------   B. malayi
A simplified phylogenetic tree that shows the relationship between Brugia malayi (clade Spirurina) and 
Caenorhabditis  elegans,  Caenorhabditis  briggsae  and  Caenorhabditis  remanei  (clade  Rhabditina).  B. 
malayi is thought to have diverged from the Caenorhabditis species -450 million years ago (MYA).  C. 
briggsae and  C.  remanei are  sister species  whose phylogenetic relationship with  each other is  currently
unresolved (Cho et al., 2004;  Kiontke et al., 2004), they are thought to have diverged  from C.  elegans 80-
110 MYA (Stein et al., 2003).
4.1.3  The value of comparative analysis of nematode insulin/IGF-lR receptors
The  existence  of  these  three  nematode  genome  sequencing  projects  provides  an 
opportunity  for  better  understanding  of nematode  insulin/IGF-lR  receptors,  since  it 
allows rapid identification of the daf-2 orthologues in each species. By comparing the 
amino acid sequences of the DAF-2 protein from the three nematode species with other 
IRRs I hoped to identify regions that have a functional role in all IRRs, the nematode 
phylum  or  only  in  the  Caenorhabditis  genus.  The  ability  to  compare  the  genomic
Rhabditina
—  Spirurina
65sequence  around  the  daf-2  locus  in  multiple  species  of nematode  may  also  help  to 
identify conserved regulatory elements, especially as the daf-2 promoter in C.  elegans 
remains uncharacterised.
664.2 Materials and Methods
4.2.1 Strains and cDNA samples
The following nematode strains were used for sequencing the C. briggsae and B. malayi 
daf-2  homologues:  AF16  Caenorhabditis  briggsae  (Gujarat)  (Fodor  et  al.,  1983) 
obtained  from  CGC  and  Brugia  malayi  TRS  strain  (Foster  et  al.,  2004),  two 
independent  samples  were  provided  by  both  Yvonne  Harcus  &  Rick  Maizels, 
University of Edinburgh and David Guiliano & Murray Selkirk, Imperial College. An 
aliquot  of  first  strand  cDNA  (kindly  provided  by  Mark  L.  Blaxter,  University  of 
Edinburgh) and a X phage cDNA library of B. malayi microfilariae (kindly provided by 
Murray Selkirk) were also used as template in the sequencing of the B.  malayi daf-2 
homologue.
4.2.2 Identification of genomic region for daf-2 homologues
Candidate genomic regions for the daf-2 homologues in both C. briggsae and B. malayi 
were  identified  by  performing  a  TBLASTN  (Altschul  et  al,  1990)  search  of the 
respective genome assemblies using the amino acid sequence of the C.  elegans DAF-2 
protein.  The  search  for  the  C.  briggsae  daf-2  homologue  was  carried  out  on  the 
cb25.AGP8  assembly  of  the  C.  briggsae  genome  (http://www.sanger.ac.uk/cgi- 
bin/blast/submitblast/c_briggsae).  The  B.  malayi  search  (http://tigrblast.tigr.org/er- 
blast/index.cgi?project=bmal) was carried out on the BMA1  scaffold assembly of the 
genome.  The TBLASTN search for the C.  remanei daf-2 homologue was carried out 
using  the  pCAP  v2  assembly  of  the  genome 
(http://www.genome.wustl.edu/projects/cremanei/cremanei_BLAST/cremanei_client.pl)  with 
both the DAF-2 and C6-DAF-2 (first version, see 4.31  for details) protein sequences. 
The DNA sequence of the top BLAST hit in each case was then analysed in silico to 
model the structure of the homologous daf-2 gene (see below).
674.2.3 Modelling of the gene structure of daf-2 homologues
The high scoring pairs (HSP) within each of the best BLAST hits were  imported as 
individual protein sequence files into the EditSeq™ module of the Lasergene suite v5.51 
(DNASTAR). These HSP protein files were then aligned against their respective contig 
using the protein finder function in the GeneQuest™ module of Lasergene and treated as 
putative exons. This procedure resulted in a preliminary model of the gene structure for 
all  three  daf-2  homologues.  The  consensus  splice  donor  and  acceptor  sites  as 
determined for C. elegans were then inputted into the contig sequences. Putative cDNA 
sequences for each of the daf-2 homologues were constructed by linking splice donor 
and acceptor sites that were in frame with the aligned HSP/ putative exon segments.
4.2.4 Initial primer design
Initial primers for the amplification of cDNA fragments from the C.  briggsae and B. 
malayi daf-2 transcripts were designed based on the putative cDNA models constructed 
in GeneQuest™. Primers were designed using the Primer3 WWW interface (Rozen and 
Skaletsky,  2000)  (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi).  Primers 
were generally designed to amplify overlapping fragments 350 bp-500 bp in size. A list 
of the main primer pairs used in the sequencing of the C.  briggsae and B.  malayi daf-2 
cDNAs can be found in Table 4.2.1 and 4.2.2, respectively.
4.2.5 Sequencing of the Cb-daf-2 and Bntrdaf-2 genes
Total RNA from C. briggsae mixed stage worms was isolated using the same procedure 
as that employed for C.  elegans (see chapter 3.2.1). Total RNA from adult B.  malayi 
was  extracted  by  placing  3-12  worms  into  a  Lysing  Matrix  D  tube  (Q-biogene) 
containing  1ml  of TRIzol  (Invitrogen).  The  worms  were  then  subjected  to  two  30- 
second cycles of homogenisation in FP220 ribolyser (Q-biogene) using a speed setting 
of 4.5.  Subsequent extraction of RNA  from the TRIzol  homogenate was carried out 
according to the manufacturers instructions.  Methods for first strand cDNA  synthesis 
from the RNA and amplification of and sequencing of overlapping fragments by PCR
68can be found in chapter 3 (sections 3.2.2, 3.2.4 and 3.2.6). The sequencing reads were 
assembled  into  contiguous  cDNA  sequences  using  the  method  described  in  chapter 
3.2.7.
The confirmed cDNA sequences for the two daf-2 genes were then aligned against 
the genomic contigs, from the BLAST searches, using the Meg  Align™  module of the 
Lasergene suite. Alignments were performed with a ClustalX algorithm. The alignments 
were then hand adjusted to take account of consensus splice sites.  This process then 
gave the final genomic structure of the gene.
4.2.6  Protein sequence alignments
All  protein  alignments  were  carried  using  the  default  settings  on  the  ClustalW 
(Thompson et al.,  1994) server (http://www.ebi.ac.uk/clustalw/). The alignments were 
then  hand-adjusted  using  the  BioEdit®  sequence-editing  programme  (Tom  Hall, 
http://www.mbio.ncsu.edu/BioEdit/bioedit.html).
69Table 4.2.1 Primer pairs used in sequencing Cb-daf-2 cDNA:
5’ primer 5’-sequence-3’ 3’ primer 5’-sequence-3’
Product
size
SL1 GGTTTAATT  ACCC  AAGTTTG AG FlsublR CTACGTCGCGTTCTGTGACTAC 440 bp
FlsublF TGAGCACAATCACCTCCTCTAA FIR AGTGCCAGTGACTTCTCGCAAA 582 bp
F2F CATTCATCTATGGCGGGGGACA F2R AGTCTCCGTCACCGACCACTCG 395 bp
F3F TGTGGTTCGAAACGGTGGCATC F3R GAGCATCACAGCCACCCAGACA 362 bp
F4F CGCCAGAAGGAGAACGATGTCA F4R CCAACGCCTTGGGAAATGTGTC 363 bp
F5F AAATGCGATGGACCGTGTGAGA F5R TGGCATTCTTGTTGCCAAACACA 367 bp
F6F GCGATCGCTTTTTGAGGATAATCG F6R TGAACACCGATGACCACGAGTC 386 bp
F6F* GCG  ATCGCTTTTTGAGGAT  AAT  CG F7R GCGTGCACATCGATATCCAGCTCT 693 bp
F8F TGGGATCCACCACACCATAGCA Cbrig5Tev TCCTGGTCCTTTTCGTTGGGTGT 431 bp
F9F GTCGCCACCCGTTATGAAGACG F10R TGGCATGCTTGGATTGTGATCG 569 bp
FI IF TGGTTGTTGGGG  AATCTG  A  AGC  A F11R TT  CGG  AC  A  AAT  CGCGG  AAT  ACG 354 bp
F12F TTCGATCCAACCACCCATGGTA F12R CCTCTCCCAGTGTCACCGACTCC 355 bp
F13F CC  ATT  G  ACG  ATT  GGG  AGCTGG  A F13R TCGTCGAATACCTCCTCCTCTCG 352 bp
F14F T  GAGAGCCAAGCGAGAGGAGGA F14R GCCGAGGGTGATCAGCTCGTAG 368 bp
F15F CGACATTTGGAGTTTCGGAGTGG F15R GTCCAGCTCCTCAGGCGGATTA 352 bp
F16F CCATGGAGGACACGGAACCACT F16R TAGGCACATCTGCTGCCACGTC 384 bp
F17F CACAGTCGTGGACCGAGTGACA F17R CCGCCTGCATTTGCTTCTGTTT 394 bp
F18F G  AG  AGGG  ACT  AC GGTT  G AC  AG  A Exon26R CTCCT  CG ATG  AG  ACGTT  CTGTT 443 bp
Exon25-
26fwd AAGGATCGCCTTCGAAAAAT Oligo dT TTTTTTTTTTTT TTTTTTVN Incomplete
Primer pairs used to sequence Cb-daf-2 cDNA sequence. Fragments are overlapping and are ordered from 
the  5’  to  the  3’  end  of the  sequence.  *The  F7F  primer was  designed  based  on  the  model  of the  gene 
structure, however this primer sequence did not anneal to the actual cDNA, so  F6F was used with  F7R 
instead.
70Table 4,2.2 Primer pairs used in sequencing Bm-daf-2 cDNA:
5’ primer 5’-sequence-3’ 3’ primer 5’-sequence-3’
Product
size
SL1 GGTTT  AATT  ACCCAAGTTTGAG BM1R TCAACAGATGTCCTGTAATGACG 359 bp
BM1F TCAAGACAAGGAAACGAATGAA BM11R GCTGGTCCGATGAGTATTTGA 390 bp
Exon311ongfwd TGAGTGCTCTTCGATCGTTAAA BM4R CCTT  GGTAAACG  AC  ATTTTTGC 511 bp
BM4F GACCAGGTTGTGACGATGATG BM2R TTCCTTTTTCTGGTTCGAAATG 1038 bp
BM21F CCGATATGGATCATCGAAAA BM5R ACCCTGTATGCAAGTATGATGC 1147 bp
BMmidFwd TGAAAATGCCGTTCAAAATCTA Exon20rev TGCACATTCACCGAAGGT  AA 1030 bp
Exonl7fwd GGAACGAGAAGGTGTGGTGT BM6R ATACCAAAAATCCGGACAACC 1096 bp
BM3F CTACGTGACTACCTGCGGTCTA BMendrev TGTCCTGCACT  AGCAGTTCGT  A 707 bp
Ctermfwd T  CCAATCAAATGAATACGGATG Oligo dT TTTTTTTTTTTTTTTTTTVN 525 bp
Primer  pairs  used  to  sequence  Bm-daf-2  cDNA  sequence.  Fragments  are  overlapping  and  are  ordered 
from the 5’ to the 3’ end of the sequence.
714.3 Results
At  the  start  of my  project  the  only  nematode  gene  encoding  a  member  of the  IR 
superfamily  of  proteins  was  daf-2  in  C.  elegans.  The  DAF-2  protein  has  novel 
extensions at both termini, whose function is unknown. To gain further insight into the 
novel  features  of the  DAF-2  protein  and the  evolution  of its  gene,  I  sequenced  its 
orthologues in the nematodes C. briggsae and B. malayi. I have also modelled the gene 
structure of the daf-2 orthologue in C.  remanei, whose genome sequence is currently 
being assembled.
4.3.1  Identification of the Caenorhabditis bris2sae daf-2 homologue
The TBLASTN search of the C. briggsae genome with the DAF-2 amino acid sequence 
yielded the  following  ~1.4Mb  supercontig  cb25.FPC4030  (EMBL:  CAAC01000074)
'yo'y
with an E-value of 8.6e'  .  This contig was analyzed in silico to create a model of both
the  gene and its cDNA (see methods).  From the  BLAST  search there  were  no  HSP 
alignments for amino acids N-terminal of residue 135 or C-terminal of residue 1805 of 
the  C.  elegans  DAF-2  sequence.  Therefore  the  cDNA  model  for  C.  briggsae  daf-2 
sequence was incomplete at the 5’ and 3’ ends and did not have putative start and stop 
codons or either of the untranslated regions (UTRs).
To  help  amplify  the  5’  end  of the  cDNA  sequence  I  used  a  primer  with  the 
sequence of the SL1  trans-spliced leader in conjunction with a cDNA specific primer. 
The SL1 trans-spliced leader is a short 22-nucleotide RNA segment that is spliced onto 
the 5’ end of many mRNAs, not only in C.  elegans, but also through out the nematode 
phylum (Blumenthal and Steward, 1997). To amplify the 3’ end of the cDNA sequence 
I used an oligo-6T primer in conjunction with a cDNA-specific primer.
Two PCR reactions were performed per cDNA fragment, and both strands of each 
amplicon  were  sequenced,  giving  4-fold  coverage  of the  cDNA  sequence  of each 
fragment. As the cDNA fragments were designed to overlap, many parts of the cDNA 
sequence  were  actually  covered  by  eight  different  reads.  The  sequencing  reads 
confirmed that there is an additional thymidine nucleotide between positions  598450
72and  598451  of the  cb25.FPC4030  contig.  This  additional  nucleotide  is  essential  in 
preserving the frame of the C. briggsae daf-2 cDNA sequence.
The original C.  briggsae daf-2 (Cb-daf-2) sequence (GenBank: AY382557) was 
deposited in GenBank database on 05/09/2003. However, this sequence will be updated 
after submission of this thesis due to subsequent identification of an additional exon at 
the  3’  end  of the  gene.  This resulted  from  a  TBLASTN  search  of the  C.  briggsae 
genome using the O-DAF-2 sequence (see below), which suggested that the submitted 
Cb-daf-2 gene might have an additional exon at the 3’  end.  This additional exon has 
been confirmed by sequencing; however, the sequence of 3’ UTR was still incomplete 
at the time of writing this thesis. The Cb-daf-2 gene is located on the minus strand of 
the cb25. FPC4030 supercontig. The Cb-daf-2 gene is greater than 27 kb in length with 
26 exons (Table 4.3.1 and Figure 4.2). The cDNA is 5618 bp in length, excluding the 3’ 
UTR, and contains an open reading frame (ORF) of 5424 bp, which encodes a protein 
of 1807 amino acids (see Figure 4.3).
4.3.2  Identification of the Brusia malavi daf-2 homologue
The B.  malayi search of the  BMA1  scaffold assembly using the  DAF-2  amino  acid 
sequence returned the following -34 kb contig TIGR_assembly_14419 (CA:  1384396) 
with an E-value  1.5e’118.  For B.  malayi there were no HSP alignments N-terminal of 
residue 146 and C-terminal of residue 1734 of the DAF-2 sequence. So like the Cb-daf- 
2  cDNA  model,  this  model  was  also  incomplete  at  the  5’  and  3’  ends.  The  same 
sequencing strategy that was used to obtain the ends of the Cb-daf-2 cDNA sequence 
was employed for the B.  malayi daf-2 homologue.  Again, the majority of the cDNA 
sequence had 4-fold coverage rising to more than 10-fold in certain parts of the cDNA. 
It should be noted that I was greatly assisted in the sequencing of the B.  malayi daf-2 
homologue by Nachiket Nadkami, a former summer student in the Gems lab under my 
supervision.
Our  sequencing  of  the  B.  malayi  daf-2  homologue  identified  a  number  of 
sequencing errors in the TIGR contig. The sequencing reads identified the anonymous 
nucleotides at positions 6147 and 7108 of the 14419 contig as cytidines and another at 
position  8453  was  a  thymidine.  There  were  two  single  nucleotide  insertions  in  the 
contig:  an  additional  guanosine between positions  7359  and  7360  and  an  additional
73adenosine between positions  12127 and  12128.  There is also strong evidence that the 
adenosine nucleotide at position 7194 of the  14419 contig should be deleted from the 
sequence. This is because this nucleotide is not present in the cDNA sequence of the 
Bm-daf-2 gene and disrupts the consensus splice donor site for exon 12 of the gene.
The B.  malayi daf-2 (Bm-daf-2)  (GenBank:  AY856075)  gene is located on the 
plus strand of the TIGR_assembly_14419 contig, starting at position 2667 and ending at 
13868. The Bm-daf-2 gene is 11202 bp and spans 30 exons (see Table 4.3.2 and Figure 
4.2). The cDNA is 4617 bp long with an ORF of 4371 bp that translates into protein of 
1456 amino acids (see Figure 4.3).
4.3.3  Identification of the Caenorhabditis remanei daf-2 homologue
Recently the genome of Caenorhabditis remanei has also been sequenced and is in the 
process  of being  assembled  into  large  contigs.  Late  in  this  project  I  performed  a 
TBLASTN search of the pCAP v2 assembly of the C. remanei genome using both the 
Ce-DAF-2 and C6-DAF-2 (first version)  sequences identified a -36 kb contig named 
5.28 with an E-value of 0. Using the same methodology as described for the modelling 
of the Cb-daf-2 and Bm-daf-2 genes it was possible to develop a model of the putative 
C. remanei daf-2 (Cr-daf-2) gene.
The  Cr-daf-2  gene model  includes  a putative  start  and  stop  codon,  unlike  the 
models of the Cb-daf-2 and Bm-daf-2 genes, but does not include the 5’ and 3’ UTRs. 
The putative terminal exon and putative stop codon of the Cr-daf-2 gene were based on 
a HSP alignment of the C-terminus of the  Ce-DAF-2 sequence, which represents the 
terminal exon and stop codon of the Ce-daf-2 gene. In order to model the putative start 
codon the  11215 bp upstream of the predicted second exon of the Cr-daf-2 gene was 
scanned for all DNA sequences that contained a start codon and splice donor site that 
were in frame with the second exon. Only one such sequence was present in the entire 
upstream  sequence.  This  59  bp  segment was therefore  taken to  be the  putative  first 
exon, assuming that the 5’ UTR of the Cr-daf-2 gene is not interrupted by an intron.
Unfortunately,  due  to  time-constraints  this  model  could  not  be  confirmed  by 
sequencing the cDNA. However, based on this model the Cr-daf-2 gene, excluding the 
5’  and 3’ UTRs, is  11605 bp in length and has 16 exons (Table 4.3.3 and Figure 4.2), 
assuming that neither of the UTRs is interrupted by an intron.  The Cr-daf-2 gene is
74located on the minus strand of contig 5.28, the coding sequence of the first exon begins 
at position 26345 and the stop codon in the terminal exon ends at position 15281. The 
predicted Cr-DAF-2 protein is 1816 amino acids long (Figure 4.3).
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A schematic representation of the gene structure of the daf-2 gene  in four different species of nematode. The red rectangles represent the exons of each daf-2 gene, while the
interconnecting lines represent the introns.  The daf-2 gene from C. elegans is -33 kb in length and has 17 exons. The Cb-daf-2 gene from C. briggsae is ~27 kb in length and has
26 exons. The Cr-daf-2 gene from C. remanei and the Bm-daf-2 gene from B. malayi are both ~11   KB in length and have  16 and 30 exons, respectively.
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Comparison of the nematode DAF-2 proreceptors with the human  insulin receptor (/?IR), D.  melanogaster insulin receptor (dlnR) and the E.  multilocularis insulin receptor 
(EmIR) proreceptors. The proteins are aligned  by their signal peptides (SP) so that the differences  in  their architecture can  readily be seen.  All seven  proteins have near 
identical domain architectures, except DAF-2, C6-DAF-2, Cr-DAF-2 and dlnR, which possess large N-terminal extensions before the signal peptide.
774.3.4 Comparison of the gene size of the four nematode daf-2 genes
A comparison of the exon-intron structure of the four nematode daf-2 genes revealed a 
striking and unexpected variation in the gene structure (Figure 4.2). The C. elegans daf- 
2 gene spans -33 kb and has 17 exons (Table 4.3.4). The Cb-daf-2 gene is -27 kb long 
and yet has 26 exons (table 4.3.1). By contrast, the Cr-daf-2 is ~11  kb in length, only a 
third of the  size  of the daf-2 gene and yet has  16  exons (table 4.3.3).  The  distantly 
related Bm-daf-2 gene is also ~11  kb long, but has 30 exons (Table 4.3.2), almost twice 
the number of daf-2. The difference in the length of these four genes is mainly due to 
differences in the size and number of the introns in each gene.  The mean intron size 
varies greatly between the four genes, with the daf-2 mean being  1702.63  bp with a 
range of ~5.5 kb to 257 bp. In the Cb-daf-2 gene the mean intron size is only 868.16 bp 
with a range of ~2.9 kb to 79 bp. In contrast the mean intron size for the Cr-daf-2 gene 
is only 374.27 bp with a range of -1.5  kb to 51  bp. In the Bm-daf-2 gene the mean 
intron size is 226.72 bp and the range is 603 bp to 80 bp.
C.  elegans introns are typically much shorter than those of either vertebrates or 
yeast (Blumenthal and Steward,  1997). In fact more than half are shorter than 60 bp. 
However all of the introns in the daf-2 gene and all but two of the introns in the Cb-daf- 
2 gene are larger than this. In contrast, seven of the fifteen Cr-daf-2 introns are close to 
the 60 bp norm (Table 4.3.3). No information is as yet available on the modal intron 
size in Brugia malayi, but in the case of the Bm-daf-2 gene the majority of introns are 
between 114-268 bp (17/29 introns), five are less than 100 bp and seven are greater than 
300 bp in length (Table 4.3.2).
C.  elegans introns are typically  larger than their homologous counterpart in  C. 
briggsae (Blumenthal and Steward,  1997). This pattern holds true for daf-2 versus Cb- 
daf-2 where six out of eight introns conserved in the three Caenorhabditis daf-2 genes 
are larger in daf-2. Of the seven introns that are conserved between all four nematode 
daf-2 genes, four are larger in daf-2 and three in Cb-daf-2. By comparison, all of the Cr- 
daf-2 introns that are conserved with the other Caenorhabditis daf-2 genes are shorter 
than  their  C.  elegans  and  C.  briggsae  counterparts.  The  Bm-daf-2  gene  has  no 
conserved introns that are larger than those of C.  elegans, but one intron larger than C. 
briggsae and three larger than C. remanei.
78The major cause of the variation in the size of introns in the daf-2 gene appears to 
the accumulation of repetitive DNA sequences within each intron. For example the first 
intron  of daf-2  is  5464  bp  long,  of which  2319  bp  (42.4%)  consists  of repetitive 
elements identified using the RepeatMasker programme  (http://www.repeatmasker.org) 
with the  C.  elegans repeat library.  In total the  amount of repetitive  sequence  in the 
intronic sequence of the daf-2 gene is 13040 bp (47.9%). There are no species-specific 
libraries available yet  for the other three  nematodes,  so  it  is not possible to  do this 
analysis on their intronic sequence.
79Table 4.3.1 Exon- Intron sizes of Cb-daf-2 gene
Exon
No.
Exon Size 
(bp)
Intron
No.
Intron Size 
(bp)
Phase of 
Intron*
Amino Acid 
interrupted§
1 206 1 1741 0 W 4:15
2 57 2 2959 2 S24
3 162 3 378 0 M77:178
4 120 4 166 0 Q117: PI 18
5 137 5 453 2 SI 63
6 183 6 1132 2 K224
7 109 7 150 0 A260:1261
8 169 8 715 1 V317
9 172 9 685 1 G374
10 265 10 907 0 K462: D463
11 174 11 339 0 K520: E521
12 219 12 1033 0 Q593: F594
13 246 13 1024 0 K675: E676
14 299 14 663 2 K775
15 116 15 603 1 G814
16 184 16 2710 2 R875
17 373 17 957 0 A999:11000
18 326 18 814 2 El 108
19 472 19 496 0 K1265: T1266
20 120 20 79 0 E1305: V1306
21 273 21 1256 0 K1396: D1397
22 552 22 542 0 K1580:P1581
23 141 24 262 0 T1627: R1628
24 186 24 92 0 T1689: R1690
25 246 25 1548 0 S1771: K1772
26 111
Total Intronic sequence: 
21704 bp
♦The phase of intron refers to the codon position  interrupted by an intron: phase 0 means the intron lies 
between the third base of one codon and the first of the next codon, phase 1  introns interrupt the codon 
after the first base and phase 2 introns interrupt after the second base of the codon.
§Using  single  letter  amino  acid  code  and  treating  the  start  codon  as  the  first  amino  acid  position
80Table 4.3.2 Exon- Intron sizes of Bm-daf-2 gene
Exon
No.
Exon Size 
(bp)
Intron
No.
Intron Size 
(bp)
Phase of Intron
Amino Acid 
interrupted
1 117 1 255 0 S13: L14
2 233 2 124 2 S91
3 263 3 80 1 D177
4 95 4 225 0 L210: E211
5 208 5 249 2 R280
6 125 6 114 1 D322
7 148 7 360 2 R371
8 162 8 329 2 R425
9 209 9 170 1 C495
10 117 10 423 0 Q533: V534
11 164 11 205 2 W588
12 152 12 146 1 V639
13 120 13 229 1 G679
14 105 14 91 0 K775
15 101 15 268 2 Q747
16 250 16 258 0 W830:1831
17 88 17 236 1 A860
18 161 18 158 0 Q913: T914
19 198 19 85 0 T979: V980
20 93 20 143 0 K1010: V1011
21 141 21 141 0 K1057: V1058
22 222 22 92 0 K1131: G1132
23 177 23 95 0 Ml 190: V I191
24 82 24 204 1 G1218
25 79 25 603 2 W1244
26 138 26 160 2 W1290
27 130 27 393 0 E1333: M1334
28 123 28 408 0 E1374: T1375
29 105 29 331 0 K1409: P1410
30 312
Total Intronic sequence: 6575 
bp
81Table 4.3.3 Exon- Intron sizes of Cr-daf-2 gene
Exon
No.
Exon Size 
(bp)
Intron
No.
Intron Size 
_   (bp)
Phase of Intron
Amino Acid 
interrupted
1 59 1 1460 2 K20
2 127 2 68 0 M62: T63
3 126 3 657 0 Q104: P105
4 137 4 72 2 T150
5 189 5 357 2 T213
6 109 6 53 0 A249:1250
7 169 7 70 1 L306
8 1378 8 57 2 L765
9 116 9 383 1 A804
10 253 10 927 2 R888
11 322 11 153 0 G995:1996
12 335 12 529 2 El 107
13 1549 13 83 0 T1623: R1624
14 180 14 51 0 T1683: R1684
15 300 15 694 0 S1783:K1784
16 102
Total Intronic sequence: 
5614 bp
Table 4.3.4 Exon- Intron sizes of daf-2 gene
Exon
No.
Exon
Size
(bp)
Intron
No.
Intron
Size
(bp)
Repetitive sequence of Intron 
(bp, %)
Phase of 
Intron
Amino Acid 
interrupted
1 162 1 5464 2319(42.44%) 0 E21: E22
2 97 2 3404 1026 (30.14%) 2 R54
3 115 3 257 38 (14.79%) 0 T92: T93
4 132 4 2127 1259(59.19%) 0 Q136: P137
5 122 5 578 440 (76.12%) 2 R177
6 177 6 697 29 (4.16%) 2 E236
7 106 7 605 28 (4.63%) 0 E271:1272
8 170 8 1009 639 (63.33%) 1 M328
9 1393 9 1662 1319(79.36%) 2 H792
10 113 10 1518 1455 (95.85%) 1 A830
11 283 11 2572 1067 (41.49%) 2 R924
12 346 12 791 578 (73.07%) 0 A1039:11040
13 335 13 3183 1567 (49.23%) 2 FI 151
14 1531 14 1004 738(73.51%) 0 T1661: R1662
15 186 15 1326 426 (32.13%) 0 T1723:R1724
16 276 16 1045 112(10.72%) 0 SI815: R1816
17 252
Total Intronic 
sequence: 
27242 bp
Total Repetitive Sequence: 
13040 bp (47.87%)
824.3.5 Exon- intron structure and evolution:
Recently  it  has  become  apparent  that  intron  loss  is  a  major  feature  of  nematode 
evolution, especially within the Caenorhabditis genus (Cho et al,  2004; Kiontke et al, 
2004). At first glance the exon-intron structure of the three Caenorhabditis daf-2 genes 
compared to that of Bm-daf-2 would agree with this phenomenon, given that daf-2, Cb- 
daf-2 and Cr-daf-2 have 16, 25, and 15 introns respectively, compared to the 29 introns 
found in Bm-daf-2.  Similarly one might easily jump to the conclusion that there had 
been extensive intron loss in both daf-2 and Cr-daf-2 compared to Cb-daf-2. However, 
neither conclusion is correct. By mapping the position of the introns of the four daf-2 
genes  onto  a protein  alignment  including  three other  IR  sequences  (MR,  DlnR  and 
EmIR)  to  act  as  outgroups,  one  can  use  intron  conservation  to  map  losses  and 
potentially intron gains (Table 4.3.5). Using this technique it becomes apparent that at 
least 5  introns, Bm-daf-2 introns 4,  9,  17, 25  and 26, have been unambiguously  lost 
from the Caenorhabditis daf-2 genes when compared to the Bm-daf-2 gene. Conversely 
only  one  intron  has  been  lost  from  the  Bm-daf-2  gene  when  compared  to  the 
Caenorhabditis daf-2  genes,  equivalent to  daf-2  and Cb-daf-2  intron  7  and  Cr-daf-2 
intron 6. When compared to introns conserved between MR, DlnR and EmIR or MR 
and EmIR there is evidence that all four nematode daf-2 genes have lost five introns 
equivalent to introns 1, 4, 7, 8 and 15 from the MR gene.
Although  intron  loss  is  a  major  feature  of  nematode  evolution  all  three 
Caenorhabditis daf-2 genes have also been subject to intron gain, especially Cb-daf-2 
when compared to Bm-daf-2. The first three introns of the daf-2 and Cb-daf-2 genes and 
the intron 1  and 2 from Cr-daf-2 all map to the novel N-terminal extension that seems to 
be a feature of Caenorhabditis DAF-2 proteins. Because this feature is not present in the 
Bm-DAF-2  protein,  it  can  be  assumed  that  these  introns  must  be  Caenorhabditis 
specific  gains.  Similar  intron  gains  can  also  be  seen  at  the  C-terminus  of  the 
Caenorhabditis DAF-2 proteins. The homologous introns 15, 16 in daf-2 and 24, 25 in 
Cb-daf-2 and 14,  15 in Cr-daf-2 all map to the C-terminus of their respective proteins. 
These regions are not present in the C-terminus of the Z?m-DAF-2 protein and therefore 
must also be Caenorhabditis specific gains.
When  comparing  the  exon-intron  structure  of the  three  Caenorhabditis  daf-2 
genes, the structure of the Cb-daf-2 gene stands out as being very different from that of
83daf-2 and Cr-daf-2. The daf-2 and Cr-daf-2 genes have a near identical gene structure, 
they only differ by the presence of an additional intron, intron 2, in the daf-2 gene. At 
present it is impossible to ascertain whether this intron represents a gain in daf-2 or a 
loss in Cr-daf-2. Whereas the Cb-daf-2 gene has 10 additional introns compared to the 
other two daf-2 genes, these are introns 1, 9,  10, 11,  12,  13,  19, 20, 21  and 22. Given 
that  C.  briggsae  and  C.  remanei  are  likely  sister-species  that  share  a  more  recent 
ancestor than with C.  elegans (Cho et al, 2004; Kiontke et al, 2004) and that the Cr- 
daf-2 gene structure resembles that of daf-2 more than that of Cb-daf-2 it is quite likely 
that these additional introns all represent recent gains.
84Table 4.3.5 Position of introns across aligned protein sequences
Intron
position 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
DAF-2 1 2 3 4 5 6 7 8 .  ..  .
O-DAF-2 1 2 3 4 5 6 7 8 9 10 11 12
O-DAF-2 1 2 3 2 5 6 7
Bm- DAF-2 1 2 3 4 5 6 7 8 9 10
AIR 1 2 3 4 5 6
DlnR 1 2 3 4 5
EmIR 1 I  2 3 4 5 6 7
Intron
position 36 39
DAF-2
Cb-DAF-2
CV-DAF-2
MR
■   i  < ,
— h
— i ____________
DlnR —
EmIR 8 9 10 11 17 18 _ _
Intron
position
DAF-2
O-DAF-2
MR
DlnR
EmIR
This table  shows the  positions (red numbers) at which  introns are present in  the aligned  sequences of all  4  nematode  DAF-2  proteins and 3  outgroup  members of the  1R  superfamily  (AIR,  DlnR and  EmIR). The 
numbers in black are the actual introns from each gene that map to this position of the protein alignment. By mapping the position of each intron onto the protein alignment it is possible to calculate which introns have 
been gained and lost in the nematode daf-2 genes.
854.3,6 Identifying regulatory elements in the daf-2 genomic sequence
One of the major reasons that related nematode genomes have been sequenced is the 
possibility  of  identifying  shared  regulatory  elements  by  phylogenetic  foot  printing 
(Stein et al, 2003). In order to identify any potential shared regulatory elements for the 
daf-2 genes the DNA sequences of the intergenic space 5’of all four daf-2 genes was 
aligned  using  the  LAGAN  alignment  algorithm  on  the  mVISTA  server 
(http://genome.lbl.gov/vista/index.shtml)  (Frazer et al., 2004).  The 5’  and 3’  flanking 
genes for C. elegans and C. briggsae have already been identified (Table 4.3.6).
In order to the find the 5’ flanking genes for C. remanei and B. malayi the entire 
upstream sequence available from the contigs on which their daf-2 genes are located 
was  subjected to  BLASTX  (Gish and  States,  1993)  search of the  C.  elegans protein 
database  (Wormpep,  http://www.wormbase.org/db/searches/blat).  In  the  case  of  C. 
remanei this represented 9695 bp and for B.  malayi it was 2666 bp. Neither of these 
regions  returned  any  hits  to  the  Wormpep  database,  suggesting  that the  5’  flanking 
genes  were  further  upstream  than  the  sequence  available.  For B.  malayi  it  was  not 
possible to  identify any sequence further upstream than the ~2.7 kb available on the 
14419 contig, as the contigs are still being assembled into a larger scaffold.
There  is,  however,  a  C.  remanei  supercontig  scaffold.  A  ~2.5Mb  supercontig 
named  Contig5  was  identified by  blasting the  predicted  Cr-daf-2  genomic  sequence 
across the supercontig assembly of the C. remanei genome. A 30 kb fragment of DNA 
sequence from this contig that was upstream of the predicted start codon of the Cr-daf-2 
gene was then blasted against the Wormpep database; several genes were identified as 
being on this fragment. The closest to the start codon of Cr-daf-2 was the C.  remanei 
orthologue of Y55D5A.6 (Cr-Y55D5A.6), a cuticulin precursor. The 5’ intergenic space 
between the stop codon of the 0-Y55D5A.6 gene and the start codon of the Cr-daf-2 
gene was 15032 bp.
The alignment of the 5’ intergenic space from the four different nematodes, using 
a sequence identity threshold of 70% and a sliding window of 20 bp, failed to find any 
conserved regions between all four species. Similarly an mVISTA alignment of just the 
5’  intergenic space from the three Caenorhabditis species using the same threshold as 
before yielded small segments of sequence conservation between any pair of species,
86mostly runs of a single nucleotide, but nothing was conserved between all three (data 
not shown).
In  order  to  ensure  that  there  were  no  regulatory  elements  within  the  intronic 
sequence of the daf-2 genes or potentially the 3’ intergenic space, an alignment of the 
entire genomic sequence including the 5’ and 3’ intergenic spaces using the S-LAGAN 
algorithm  was  performed.  This  programme  takes  in  to  account  the  possibility  of 
rearrangements  within  the  sequences  being  aligned.  The  3’  flanking  genes  were 
identified using the same procedure as the 5’ flanking genes. This search only returned 
conserved regions between all four genes that represented exonic sequence; there were 
no conserved sequences within the intronic sequence or 3’ intergenic space of the four 
genes. The inability to identify any conserved elements raises two possibilities. Firstly, 
that there has been rapid evolution of the regulatory elements of the daf-2 genes in these 
different nematodes, resulting in highly divergent motifs. The other possibility  is that 
motifs  may  be  very  short,  and that the  search  criteria were  not  sensitive  enough to 
identify them.
Table 4.3.6 Genes flanking daf-2 in four nematode species
5 ’ flanking gene 5’ intergenic space daf-2 3’ intergenic space 3’ flanking gene
Y55D5A.6 14023 bp daf-2 5863 bp Y55D5A.4
CBG1733 
(orthologue of 
R10F2.1)
10155 bp Cb-daf-2 5710 bp CBG15731 (NoC. 
elegans orthologue)
0-Y55D5A.6 15032 bp Cr-daf-2 12390 bp O-T20B6.3
Not known >2666 bp Bm-daf-2 6961 bp Bm-ceh-20
4.3.7  Comparison of the amino acid sequence of DAF-2 proteins
The predicted amino  acid sequences of the  four DAF-2 proteins were compared.  Of 
particular interest was the degree of conservation of the N- and C-terminal extensions. 
The lengths of the DAF-2 proteins from the four different species are as follows: DAF-2
87is  1846aa long, C6-DAF-2 is  1807aa, O-DAF-2 is  1816aa and Bm-DAF-2 is  1456aa. 
The overall percentage of identity and similarity between all four proteins and MR is 
outlined in Table 4.3.7. The main reason why ifrw-DAF-2 is so much shorter than the 
three  Caenorhabditis DAF-2 proteins is that it lacks an N-terminal  extension (Table
4.3.8  and Figure 4.3). Rm-DAF-2 also has a much shorter C-terminal extension than the 
other nematode DAF-2  receptors.  However,  the N-terminal  extensions of C7>-DAF-2 
and O-DAF-2 are both slightly shorter than that of DAF-2.
Surprisingly the percentage  identity and similarity between O-DAF-2  and  Cr- 
DAF-2 is slightly lower than that of DAF-2 and O-DAF-2 (Table 4.3.8), even though 
C.  briggsae and C.  remanei are likely sister species and share a more recent ancestor 
than with C. elegans. This may be due to the changes in the coding sequence caused by 
the  gain of ten  additional  introns  in the  Cb-daf-2 gene.  It  should be  noted that  the 
percentage  sequence  identity and similarity between DAF-2  and MR given below is 
lower  than  that  stated  in  section  4.1.1.  The  values  given  in  that  section  are  those 
calculated by Kimura et al (1997) and do not include the N- and C-terminal extensions 
of DAF-2. Those given in Table 4.3.8 do  include the extensions so that the  level of 
overall conservation between Caenorhabditis DAF-2 proteins can be gauged.
88Table 4.3.7 The % identity and similarity of the DAF-2 proteins
DAF-2
(Identity:
Similarity)
CA-DAF-2
(Identity:
Similarity)
O-DAF-2
(Identity:
Similarity)
R/n-DAF-2
(Identity:
Similarity)
AIR*
(Identity:
Similarity)
DAF-2 50.2%: 65.5% 55%: 70.5% 30.2%: 43.6% 24.5%: 36.7%
CA-DAF-2 50.2%: 65.5% 54.9%: 67.4% 31.0%: 45.2% 26.2%: 39.1%
O-DAF-2 55.0%: 70.5% 54.9%: 67.4% 30.5%: 44.2% 25.7%: 37.7%
ZDw-DAF-2 30.2%: 43.6% 31.0%: 45.2% 30.5%: 44.2% 31.5%: 46.2%
AIR* 24.5%: 36.7% 26.2%: 39.1% 25.7%: 37.7% 31.5%: 46.2%
The percentage of shared identity and similarity (Identity: Similarity) between the four different DAF- 
2 proteins and AIR across the whole of their length.
* The % of sequence identity and similarity are smaller than those previously reported by Kimura et al 
(1997), as these alignments include the N- and C-terminal extensions.
Table 4.3.8 The position of domains within each DAF-2 protein
Protein
Domain/ Feature  ------
DAF-2 CA-DAF-2 O-DAF-2 Bm- DAF-2
N-terminal Extension 1-140 1-122 1-109 -
Signal peptide 122-142 103-123 92-110 1-16
LI 144-329 125-318 112-307 20-181
Cysteine Rich 330-490 319-474 308-463 182-336
L2 491-650 475-637 464-623 337-499
FnO 651-775 638-758 624-748 500-619
Fnl 776-1072 759-1032 749-1028 620-861
Fn2 1073-1163 1033-1120 1029-1119 862-954
Transmembrane 1185-1207 1142-1164 1138-1160 980-1002
Tyrosine Kinase 1230-1540 1187-1498 1186-1495 1058-1342
Putative SH2-binding site - 1512-1515* 1510-1513* 1347-1350
Putative SH2-binding site 1626-1629 1592-1595 1588-1591 1397-1400
Putative SH2-binding site 1649-1652 1616-1619 1612-1615 -
Putative SH2-binding site 1713-1716 1679-1682 1673-1676 -
Putative SH2-binding site 1800-1803 1758-1761 1768-1771 -
Position of domains and motifs in each of the different DAF-2 protein amino acid sequences from their 
N- to C- terminus.
*  Additional phosphotyrosines that may be a putative SH2-binding site predicted by NetPhos server, no 
tyrosine residue at equivalent position in DAF-2 sequence.
894.3.8 Conservation of N- and C-terminal extensions in the Caenorhabditis genus
Like DAF-2, the Cb-DAF-2 and O-DAF-2 proteins also have an N-terminal extension 
in  front  of their predicted  signal  peptides,  however,  it  is  shorter  in  O-DAF-2  and 
shorter  still  in  O-DAF-2  (Table  4.3.3).  These  extensions  seem  to  be  unique  to 
Caenorhabditis',  even though dlnR has a much longer N-terminal extension it shares 
very little homology with the Caenorhabditis sequences apart from the predicted signal 
peptide (Table 4.3.9 and Figure 4.3). The Caenorhabditis DAF-2 N-termini share -30% 
identity and -46% similarity. A pair of putative endoprotease cleavage sites, N-terminal 
of the putative signal peptide, is conserved in all three DAF-2 N-termini. This suggests 
that this region is cleaved off at some point during the processing of the proreceptor of 
each of these proteins. However, it is difficult to speculate on the possible function of 
these  cleaved  peptides,  as  they  do  not  have  homology  to  any  known  proteins. 
Interestingly, the putative endoprotease cleavage  sites are located at the boundary  of 
exon 3  in both daf-2 and Cb-daf-2, and exon 2  of Cr-daf-2.  The proceeding exon in 
each gene (exon 4 in daf-2 and Cb-daf-2, and exon 3 of Cr-daf-2) encodes the predicted 
signal peptide (Figure 4.4). The intervening intron in all three genes is in phase 0, which 
suggests that N-terminal extension was gained by ‘exon-shuffling’ (Gilbert, 1978).
The  three  Caenorhabditis  DAF-2  proteins  also  have  very  similar  C-terminal 
extensions,  with  the  DAF-2  and  CV-DAF-2  extensions  sharing  slightly  higher 
conservation of sequence identity and similarity (Table 4.3.10). All four putative SH2- 
binding sites identified by Kimura et al (1997) are present in both the Cfr-DAF-2 and 
O-DAF-2  C-terminal  extensions  (Figure  4.5).  Interestingly  a  screen  for  potential 
phosphotyrosines  in  the  C-terminal  extensions  of  all  three  Caenorhabditis  DAF-2 
proteins  using  the  NetPhos  (Blom  et  al,  1999)  server 
(http://www.cbs.dtu.dk/services/NetPhos/) revealed an additional putative SH2-binding 
site conserved in both O-DAF-2 and O-DAF-2 but not present in DAF-2 (Table 4.3.8 
and Figure 4.5). It is unclear from the alignment if this tyrosine residue represents a gain 
in the common ancestor of C. briggsae and C. remanei or a loss in the DAF-2 sequence.
An  interesting  feature  of the  C-terminal  extension  in  all  three  Caenorhabditis 
DAF-2 proteins is that it is composed of three repeats, each of which is encoded by an 
individual exon in the 3’ end of the gene (Figure 4.6). The position of introns between 
these  exons  is  also  conserved  between  these  three  daf-2  genes.  This  suggests  that
90elongation of the C-terminus in the Caenorhabditis DAF-2 proteins occurred via exon 
shuffling of an original final exon in an ancestor of these three species. This would also 
explain why the Zhw-DAF-2 C-terminus is shorter than that of the Caenorhabditis DAF- 
2 proteins. Thus, exon shuffling has been an important process in the evolution of the 
daf-2 gene with the Caenorhabditis genus.
Table 4.3.9 The % identity and similarity of the N- terminal extensions
DAF-2
(Identity:
Similarity)
CA-DAF-2
(Identity:
Similarity)
Cr-DAF-2
(Identity:
Similarity)
dlnR
(Identity:
Similarity)
DAF-2 32.9%: 46.2% 34.2%: 46.6% 10.9%: 18.6%
CA-DAF-2 32.9%: 46.2% 32.9%: 40.1% 6.7%: 10.7%
Cr-DAF-2 34.2%: 46.6% 32.9%: 40.1% 7.4%: 10.2%
dlnR 10.9%: 18.6% 6.7%: 10.7% 7.4%: 10.2%
The percentage of shared identity and similarity (Identity: Similarity) between the Caenorhabditis DAF-2 
proteins  and  dlnR across  their N-terminal  extensions.  The  Bm-DAF-2  protein  was  excluded  from  this 
analysis, as it has no N-terminal extension
Table 4.3.10 The % identity and similarity of the C- terminal extensions
DAF-2
(Identity:
Similarity)
CA-DAF-2
(Identity:
Similarity)
Cr-DAF-2
(Identity:
Similarity)
Am-DAF-2
(Identity:
Similarity)
dlnR
(Identity:
Similarity)
DAF-2 53.8%: 67.9% 60.1%: 72.5% 13.3%: 18.6% 12.3%: 21.3%
CA-DAF-2 53.8%: 67.9% 59.5%: 67.9% 13.3%: 19.6% 15.3%: 26.5%
Cr-DAF-2 60.1%: 72.5% 59.5%: 67.9% 10.5%: 15.1% 15.7%: 24.6%
Bm-DAF-2 13.3%: 18.6% 13.3%: 19.6% 10.5%: 15.1% 6.4%: 11.3%
dlnR 12.3%: 21.3% 15.3%: 26.5% 15.7%: 24.6% 6.4%: 11.3%
The percentage of shared  identity  and similarity (Identity:  Similarity) between the four different DAF-2 
proteins and dlnR across their C-terminal extensions..
91Figure 4.4 Alignment of N-terminus of DAF-2 proteins
DAF-2  --------------------------------------------------------------1
Cb-DAF-2  -------------------------------------------------------------- 1
Cr-DAF-2  -------------------------------------------------------------- 1
Bm-DAF-2  -------------------------------------------------------------- 1
hIR  --------------------------------------------------------------1
dlnR  MFNMPR VTKSKSKR KIKMENDMAAAAATTAKTTACTLGHICVLCRQEMLLDTCCCRQA 60
DAF-2  --------------------------------------------------------------1
Cb-DAF-2  -------------------------------------------------------------- 1
Cr-DAF-2  -------------------------------------------------------------- 1
Bm-DAF-2  -------------------------------------------------------------- 1
hIR  --------------------------------------------------------------1
dlnR  VEAVDSPASSEEAYSSSNSSSCQASSEISAEEVWFLSHDDIVLCRRPKFDEVETT  JKKRD 120
DAF-2    MTRMNIVRCRRRH  13
Cb-DAF-2    MTWKIPSSHPRLH  13
Cr-DAF-2  ------------------------------------------------ MDQLNLAYSSSIR 13
Bm-DAF-2  -------------------------------------------------------------- 1
hIR  --------------------------------------------------------------1
dlnR  VKCSGHQCSNECDDGSTKNNRQQRENFNIFSNCHNILRTLHSLLLI14FNCGIFNKRRRRQ 180
DAF-2  KILENLEEENLGPSCSSTTSTTAATEALGTTTEDMRLKQQRSSSRATEHDIVDGNHHDDE  73
Cb-DAF-2  HIWKNHR---------EEISTITSSNDVDIIQYRYYSHVINNEDNVDDVS------- EFR 57
Cr-DAF-2  FILKNLK-----------------------1SIGDVSNWTVTD  NDI------SSTTATTT--------------------------45
Bm-DAF-2  -------------------------------------------------------------- 1
hIR  --------------------------------------------------------------1
dlnR  HQQQHHHHYQHHHQQHHQQHLQRQQANVSYTKFLLLLQTLAAATTRLSLSPKNYKQQQQL  24 0
daf-2  hitmrrlrlvknsrtrrrBpdssmdcyeenppsqktsinyswiskkssmtslmllllfa  133
Cb-DAF-2  IHKMRRRRDSSSHRTRRrMiSTSSECSTSSSAP  TTSLSSLCRRTASIIFLLLSLCA 114
Cr-DAF-2  --KMRRRRIVRSSRTRRR^PESEVTSSTSSLPP-VPSFNFPQLS-TSTTRFLLLLVLCA 101
Bm-DAF-2  ------------------------------MWS---- IWIFSLLT-------VSLSAH—   17
hIR    MGT -GGRRGAAAAP----LLVAVAA-------LLLGAA—  26
dlnR  QHNQQLPRATPQQKQQEKDRHKCFHYKHNYSYSPGISLLLFILLANTLAIQAWLPAHQQ 300
DAF-2  FV®CASIVEKR------------------------------ C PIDIRN 153
Cb-DAF-2  IfHcSSIREIR-------------------------------CPPIDIRN 134
Cr-DAF-2  IF^CLSIPELR-------------------------------C PIDIRN 121
Bm-DAF-2    DDVY-----------------------------------CRSLDIRN 29
hIR  --- GHLYP EV-------------------------------CP MDIRN 42
dlnR  HLLHNDIAD LDKTALSVS -TQTRWPRSESNPTMRLSQNVKPCKSMDIRN 350
Alignment of N-termini of the four different DAF-2 proteins and AIR and dlnR. The sequences shaded in 
grey are putative endoprotease cleavage sites. The region underlined represents the putative signal peptide 
of each  protein,  as  predicted  by  the  SignalP  program  (Dyrlov  Bendtsen  et al.,  2004).  The  sequences 
highlighted in yellow are part of the LI  domain, the residues immediately N-terminal of this point are the 
predicted cleavage sites for the signal peptide, and were used as anchoring residues in the alignment of 
the N-termini. The sequences highlighted in H  are residues interrupted by phase 0 introns.
92Figure 4.5 Alignment of C-terminus of DAF-2 proteins
DAF-2 
C b-D A F-2 
C r-D A F-2 
Bm-DAF-2 
h IR  
d ln R
D AF-2
C b-D A F-2
C r-D A F-2
Bm-DAF-2
h IR
d ln R
DAF-2
C b-D A F-2
C r-D A F-2
Bm-DAF-2
h IR
d ln R
D AF-2
C b-D A F-2
C r-D A F-2
Bm-DAF-2
h IR
d ln R
D AF-2 
C b-D A F-2 
C r-D A F-2 
Bm-DAF-2 
b lR  
d ln R
DAF-2
C b-D A F-2
C r-D A F-2
Bm-DAF-2
h IR
d ln R
D A F-2 
C b-D A F-2 
C r-D A F-2 
Bm-DAF-2 
h IR  
D lnR
DAF-2 
Cb-D A F-2 
C r-D A F-2 
Bm-DAF-2 
h IR  
D lnR
-AAE-----------ASPEFRDLSFVLTDNQMILDDSE---------------- ALDLDDIDD TDM- NDQWE  1564
-  SAE----------- ASEEFKTLSFVFTENQMAMEDTE---------------- PLDLDEIYNYNP-  PEELDP  1522
-SA E----------- ASAE FKEV S FVFTE  N QMAMED S E -----------------PLDIDEIYNYEPEPDPDDI  1521
RHAE  ILNFPDDEFREMSFVMSNQMNTDDYLD-------------------EELFPITDSSR----------------- 1360
-KDD----------- LH P SFPEV SFFH SEENKAPE SEEL-------------- EMEFEDMEN  132 6
  E P  QCPNSQFKEVSFYHSEA  LQHREKERKERHQLDAFAAVPLDQDLQDREQQED  1708
VAPDVENVEVQ SD SERRN’ TD SIPLKQFKTIP P--------------------------------------------------------------- 1596
AAMDAQVMEEERK.  RRMTDSIPMKEFKSD  LRK-----------------------------------------------------------1556
EAMDHLDSEAE-NGERRHTDSIPMKEFRSDHL--------------------------------------------------------------- 1552
  1360
  VPLD  1330
ATTPLRMGDYEQNSSLDQPPESPIAMVDDQGSHLPFSLPSGFIASSTPDGQTVMATAFQN  17 68
-------------------------------------------------------------------------------------INATTSH STISID ET— PMKA  1615
  NGGGTGGGSSHSTISMGSTMIPMKP  1581
----------------------------------------------------------------------------NSSGMNSRSTISVGSGGPHTGRLRK  1577
---------------------------------------------------------------------------------------LVRTASAG----------------------HV  1370
-------------------------------------------------------------------------------------------RSSHCQ---------------------------- 1 336
IPAAQGDISATYWPDADALDGDR  YEIYDPSPKCAELPTSRSGSTGGGKLSGEQHLLPR  1828
KQRE  -SLDEEYAMNHSGGPSDAEVRTYAGD---------------------------------------------------------------164 6
KRRQGSLDEEfnaiNHSRGPSDTEIRTYTGDE-------------------------------------------------------------1631
KSRQRSLDEEYAXMNHSR  PSDTEVRHY = NDD-------------------------------------------------------------1609
DQSETSFINRPEKQQLNHSSSSGNIRUjSHN---------------------------------------------------------------1401
R E E A ---------------------RD  SSL  FKRSYEEH------------------------------------------------------------------1358
KGRQPTIMS S SHPDDVI  ".SSLQPSTASAASSNASSHTGRPSLKKTVADSVRNKANFINR  1888
-----------------DYVERDVRENDVP TRRN T GASTS SYTGGGPYCLTNRGG SNERGAGFGEAVR  1698
-----------------DYVERDVA-ADVPTRRNTGASNCSYTG-GPYCLTNRGSSNER-AGF'GEGLR  1662
-----------------DYVBRDVP-QDVPTRRNT GASTASYAG-GPY-LANRGGSNER-AGFGEGVR  1657
  NEANIQPKPICFSNRRS  1415
-------------------------------------------I P -----------------------YTH-------------- MNGGKKN---------- GRILT  1375
HLFNHKRTGSNASHKSNASNAPSTSSNTNLTSHPVAMGNLGTIESGGSGSAGSYTGTPRF  1948
LT-------DGVGSG-HLNDD-DYVMtEISSMDTRRSTGASSSSYG------------------------------VPQ-  1738
LT-------DGVGSGGHLHKDSYYSfflKQLNSMDTRRSTGASTASYG------------------------------A PP-  1704
LT-------DALGSG- HLHDD:-DYIEKEI S SMDTRRST  ASTASYG------------------------------APHP  1699
GISSWRRSVGGSDHLQSGRRKSETDISLTRFDRN'EDEF-------------------------------------------------- 1456
L P  RSNPS-------------------------------------------------------------------------------------------------------------1382
YTPSATPG GGS -34AISDNPNYRLLDESIASEQATILTTSSPNPNYEMMHPPTSLVSTNPN  2008
  TNWSGN— RGATYYTS  KAQQAATAAAAAAAALQQQQ  NGGRGDRLTQLPGT  1786
— QTKWS GSQTKGATYFE  KQKQMQAAAEAAAKKAKLS  GVGDHPW IP-T  1750
NTQTNWSGS- -RGATYYANKAQQQQQAAAAAAAAAAAAKQRTHVHLNI  RGDRLTQLPGT  1757
  1456
  1382
YMPMNETPVQMAGVTISHNPNYQPMQAPLNARQSQSSSDEDNEQEEDDEDEDDDVDDEHV  2068
GHLQSTRG GQDGDYX1YEPKNYRNNGSPSRNGNSRD  IFNGRSAFGENEHL  1836
GFN------------  DPDYTBTEPPLSK— GSPSKNGNTGYHHHGHHGPPHRGNGRTAFGETERL  1802
GHLQNK-----DE  >D*1VTEPRNTKNDGSPSKN  NTSSNRAS----------------SK  RSLF  EKERL  1806
  1456
  1382
EHIKMERMPLSRPRQRALPSKTQPPRSRSVSQTRKSPTNPNSGIGATGAGNRSNLLKENW  2128
DAF-2  IEDNEHHPLV-------------------- 184 6
C b-D A F-2  IE — 1H P------------------------------1807
C r-D A F-2  IEDTEHPLG------------------------- 1816
Bm-DAF-2  ----------------------------------------------1456
hIR    1382
D lnR   LRPASTPRPPPPN'oFI  REA  2148
Alignment of C-termini of the four different DAF-2 proteins and MR and dlnR. Residues shaded in grey 
are the putative  SH2-binding sites predicted by the NetPhos server (Blom et al.,  1999) for each of the 
DAF-2 proteins. The residues that are underlined in the dlnR C-terminal extension are predicted NetPhos 
predicted SH2-binding sites.
93Figure 4.6 Alignment of the translated sequence of final 3 exons of Caenorhabditis daf-2 genes
DAF-2  exon  15 
DAF-2  exon  16 
DAF-2  exon  17
RRNTGASTSSY---------------TG--GGPYCLTNRGGSNERGAGFGEAV---------------------RLTDGVGSGHLN------------DDDYVEKEISSMDT  172 3
RRSTGASSSSYGVPQTNWSGNRGATYYTSKAQQAATAAAAAAAALQQQQNGGRGDRLTQLPGTGHLQSTRGGQDGDYIETEPKNYRNNGS PS  1815 
-RN-GNSRDIF--------------NG------------------------    RSAFGENE--------------------- HLIE------------------------------DNEHHPLV  184 6
Cb-DAF-2  exon  24 
Cb-DAF-2  exon  25 
Cb-DAF-2  exon  2 6
-RRNTGASNCSYTGGPYCLTNRGGSNERAGFGEGLRL-------------------------TDGVGSGGHLHEDSYYSDNQLNSMDT----------------- 1689
-RRSTGASTASYGAPPQTKWSGSQTKGATYFEKQKQMQAAAEAAAKKAKLSGVGDHPVVIPTGFNGDPDYTETEPPLSKGSPS  1771 
KNGNTGYHHHGHHGPP  HRG--NGRTAFGETERL-------------------------IEEHP----------------------------------------------------------------  18 07
Cr-DAF-2  exon  14 
Cr-DAF-2  exon  15 
Cr-DAF-2  exon  16
RRNTGASTASY------------------------------AGGPYLANRGGSNERAG-----------------------------------------FGEGVRLTDALGSGHLH--DDNDYIEKEI SSMDT  1683
RRSTGASTASYGAPHPNTQTNWSGSRGATYYANKAQQQQQAAAAAAAAAAAAKQRTHVHLNEGRGDRLTQLPGTGHLQNKDEGDYIVTEPRNTKNDGSPS  178 3
--------------------------------------------------------- KNGNTSSNRASSN--------------------------------------------------------GRS  LFG------------------EKERLIEDTEHPLG-----------1816
.* .  .  *  *  ....
An alignment of the translated sequence of the last three exons of each of the Caenorhabditis daf-2 genes, exon 15 in daf-2 is homologous to exons 24 and 14 in Cb-daf-2 and 
Cr-daf-2 respectively.  Similarly  exons  16, 25  and  15  and  17, 26  and  16  are  homologous across the three species.  The  symbols  used  underneath  some of the residue  are 
standard ClustalW codes indicating the level of conservation across the residues.
944.4 Discussion
In this chapter I determined the sequence of two new nematode insulin/IGF-1 receptors 
and created a model for a third.  Comparing the  four nematode DAF-2 receptors has 
revealed a number of features of nematode daf-2 gene and protein structure, and given 
insight into the evolution of this gene within the nematode phylum.
4.4.1  daf-2 gene structure and intron losses and gains
Intron  loss has played a major part in the evolution of the nematodes especially the 
Caenorhabditis genus (Cho et al., 2004; Kiontke et al., 2004).  The daf-2 genes from 
four different species of nematode B.  malayi, C.  elegans,  C.  briggsae and C.  remanei 
generally  fit  this  pattern  of  intron  loss.  By  comparing  introns  that  are  conserved 
between these four species and several outgroup species it becomes apparent that the 
Caenorhabditis species have  lost at least five of the  introns present in the Bm-daf-2 
gene. By contrast, only one intron present in the Caenorhabditis has been lost from Bm- 
daf-2. More surprisingly the daf-2 genes in the Caenorhabditis species have at least five 
intron gains at the 5’  and 3’  ends of the gene compared to Bm-daf-2.  I postulate that 
these additional introns explain the origin of the N-terminal extension and the increased 
length of the C-terminal extension of the Caenorhabditis DAF-2 proteins, most likely 
via a process of exon shuffling (Gilbert, 1978).
In addition to the intron gains shared with C. elegans and C. remanei, the Cb-daf- 
2 gene has gained an additional 10 introns. Examples of intron gains are rare, especially 
within the Caenorhabditis genus (Coghlan and Wolfe,  2004), and the mechanism by 
which  they  occur  is  not  yet  known.  One  possible  mechanism  of intron  gain  is  the 
reverse splicing of pre-existing introns back into an alternative site in the mRNA, which 
may  then recombine  with  the  genomic  copy  of the  gene  to  introduce  an  additional 
intron.  There are several possible examples of this in the C.  elegans and C.  briggsae 
genome (Coghlan and Wolfe, 2004).  In these cases the gained introns had very high 
sequence similarity to other introns either from within the gene or other genes in the 
genome.
95My own analysis of the gained introns in Cb-daf-2 does not support the idea that 
they are related to other introns in the Cb-daf-2 gene as none have a high degree of 
sequence similarity to existing introns (data not shown). However this analysis may be 
complicated by the fact that the intronic sequence of the gene is very repetitive (when 
analysed with the C.  elegans repeat library). A search for sequence similarity amongst 
other introns across the C. briggsae genome may yield the origin of the gained introns.
Currently the genome  of the unnamed  Caenorhabditis  species  CB5161  (strain 
PB2801) is being prepared for sequencing. The position of this species with regards to 
C.  briggsae and C.  remanei, to both of whom it is highly related cannot currently be 
resolved using available molecular phylogenies (Cho et al., 2004; Kiontke et al, 2004). 
It would be both interesting and beneficial to either model or sequence the daf-2 gene 
from this species. If the daf-2 gene from this species has gene structure more similar to 
Cb-daf-2 than Cr-daf-2 it would suggest a more ancient origin for the additional introns 
found  in  Cb-daf-2.  This  could  explain  the  lack  of sequence  similarity  between  the 
gained  introns  and  conserved  introns  within  the  Cb-daf-2  gene,  as  well  as  the 
accumulation of repetitive sequence in these introns. If however the daf-2 gene structure 
from  CB5161  is  more  similar to  Cr-daf-2,  then  this  would  raise  the  more  difficult 
question of how the Cb-daf-2 gene had gained 10 introns, given that gains are rare.
4.4.2  Lack of a conserved daf-2 promoter
Analysis of the intergenic sequence 5’ of each of the four different daf-2 genes did not 
identify any conserved elements that might represent a daf-2 promoter. This may be due 
to two reasons; firstly there is a large evolutionary distance between these four species, 
the estimated date of divergence between B. malayi and C. elegans is 450 MYA (M. L. 
Blaxter,  personal  communication),  which  may  be  too  large  to  reliably  identify 
conserved  regulatory  sequences.  One  should  note  that  only  ~2.6  kb  of  upstream 
sequence was available for the Bm-daf-2 gene; potentially a more conserved element 
could lie further upstream.
The estimated date of divergence between C.  elegans and C.  briggsae is 80-110 
MYA (Stein et al, 2003) and a similar date can be estimated for the divergence of C. 
remanei and C.  elegans, given that C.  remanei and C.  briggsae are sister species and 
share  a  common  ancestor.  Even  at  this  evolutionary  distance  conserved  regulatory
96elements between  C.  elegans  and C.  briggsae  have been found for  several different 
genes (GuhaThakurta et al,  2004;  Petalcorin et al.,  2005).  One possibility  is that C. 
remanei and C.  briggsae may share a conserved regulatory element that has diverged 
from  that  of  C.  elegans.  This  possibility  may  soon  be  testable  as  two  additional 
Caenorhabditis  genomes  are  expected  to  become  available  by  the  end  of this  year 
(2005). These are the genomes of unnamed species CB5161  and C. japonica, which is 
thought  to  be the  outgroup  species  to  the  Elegans  group  of worms  (C.  elegans,  C. 
remanei, C. briggsae and CB5161).
A second possible reason for the lack of a conserved regulatory element may be 
due  to  the  fact  that  the  daf-2  gene  seems  to  lie  in  a  region  that  is  a  hotspot  for 
intrachromosomal rearrangement. The flanking genes on either side of the daf-2 gene in 
each species are different in most cases (Table 4.3.6). Take the 5’ flanking genes: daf-2 
and  Cr-daf-2  are  both  flanked  by  a  cuticulin  precursor  gene  (Y55D5A.6  and  Cr- 
Y55D5A.6). But the Cb-daf-2 gene is flanked by CBG15733, an orthologue of the C. 
elegans R10F2.1  gene. The 5’  flanking gene of Bm-daf-2 is unknown as only a small 
amount of 5’ intergenic sequence is available.
In the case of the  3’  flanking genes,  none of these  are  conserved in the  same 
location. The daf-2 3’ flanking gene is Y55D5A.4, while the 3’ flanking gene for Cb- 
daf-2 is CBG15731, a novel gene with regards to C.  elegans. A TBLASTN search of 
the  C.  remanei genome with CBG15731  does  identify a probable orthologue,  but is 
located on a different contig to that of Cr-daf-2. The 3’ flanking gene of Cr-daf-2 is Cr- 
T20B6.3, the orthologue of the C.  elegans T20B6.3  gene and the 3’  flanking gene of 
Bm-daf-2 is Bm-ceh-20, the orthologue of ceh-20.
All  of  the  C.  elegans  orthologues  of  the  different  flanking  genes,  except 
CBG15731,  which has no orthologue,  are located on the same  linkage group (III) as 
daf-2. This suggests that although the microsynteny of genes immediately around daf-2 
is  not  conserved  between  the  four  different  species  there  is  some  macroscopic 
conservation of gene order. Possibly, there are daf-2 regulatory elements (conserved or 
otherwise) further upstream, away from this rearrangement prone hotspot.
4.4.3  Conservation of the N-terminal and C-terminal extensions in DAF-2 proteins
97A major aim of this comparative analysis of different nematode DAF-2 receptors was to 
gain further insight into the extensions found at both termini of the C.  elegans DAF-2 
protein.  The N-terminal  extension of the  DAF-2 protein,  predicted by  Kimura et al 
(1997) when the daf-2 gene was originally sequenced, is also present in the predicted 
C6-DAF-2 and O-DAF-2 proteins, but not in the Bm-DAF-2 protein (Table 4.3.8 and 
Figure  4.3  and 4.4).  Thus,  this  extension  is  not universal  to  nematodes,  but  is  well 
conserved in the Caenorhabditis genus (Table 4.3.9). This implies that this extension 
has  functional  importance  within  this  genus.  The  N-terminal  extension  in  all  three 
Caenorhabditis  DAF-2  proteins  may  be  endoproteolytically  cleaved  (Figure  4.4). 
However,  it is difficult to postulate a function for this cleaved peptide,  as  it has no 
homology to any known protein domain.
The  presence  of the  N-terminal  extension  outside  the  Caenorhabditis  genus 
currently remains unknown. It will be possible to model or sequence the Cj-daf-2 gene 
when the  C. japonica genome sequence becomes available later this year.  If the N- 
terminal  extension  were  a  unique  feature  of  the  Elegans  group  within  the 
Caenorhabditis genus, then the Q-DAF-2 protein would not be predicted to have the N- 
terminal extension.
A  more  interesting  possibility  is  that  the  extension  is  a  feature  of  the 
Heterorhabditis  group  of  nematodes,  which  includes  the  Caenorhabditis  and 
Strongyloides genii, but not Brugia (Blaxter et al., 1998). The sequence of a fifth daf-2 
gene (irlk-1)  from the human parasitic nematode Strongyloides stercoralis  should be 
available shortly (H. C. Massey and J. B. Lok, personal communication). If the IRLK-1 
protein has a N-terminal extension like the Caenorhabditis DAF-2 proteins, then such a 
structure  must  have  been  present  in  the  last  common  ancestor  of  these  worms 
approximately 320 MYA (M. L. Blaxter, personal communication).
All  four  DAF-2  proteins  have  C-terminal  extensions  that  contain  putative 
phosphotyrosine residues that may act as SH2-binding sites. The C-terminal extension 
of the three Caenorhabditis DAF-2 proteins is longer than that of Bm-DAF-2. The Bm- 
DAF-2 has two putative SH2-binding sites, while DAF-2 has four (Kimura et al, 1997) 
and O-DAF-2 and O-DAF-2 have five (Table 4.3.8). At present it is not possible to 
tell whether this due to the loss of a putative site in DAF-2 or gain in the other two 
proteins. Similar C-terminal extensions are found in the majority of invertebrate IRRs, 
with the sponges being notable exceptions (Skorokhod et al,  1999). These extensions
98are  thought  to  directly  interact  with  substrates,  such  as  the  PI3  kinase,  unlike  the 
vertebrate IRRs, which rely on adaptor proteins such as the IRS family.
Many aspects of C.  elegans biology imply that this species has evolved for rapid 
population growth. The extension of the C-terminus of DAF-2 by exon shuffling may 
be such an adaptation. The number of substrates that can bind to the C-terminus of an 
IRR may affect the level of signal generation by that receptor. This being so, then the 
amplification  of  the  C-terminus  in  DAF-2,  and  the  other  Caenorhabditis  DAF-2 
proteins, may in turn lead to an amplification of signal generation by the receptor. Thus, 
one might predict that the binding of a single insulin-like ligand to a DAF-2 receptor 
molecule  would  result  in  more  PIP3  generation  than  a  single  Bm-DAF-2  receptor, 
whose C-terminal extension only has two predicted SH2-binding sites. Increased levels 
of PIP3  would lead to greater negative regulation of DAF-16, which would promote 
entry into reproductive development.
Figure 4.7 C-terminal extension as a means for promoting rapid growth
Brugia DAF-2  Caenorhabc/it/s DAF-2
U
PIP-
1
PIP3
DAF-16  DAF-16
1   1
Slower Growth  Rapid Growth and Reproduction
Longer Lifespan  Shorter Lifespan
Hypothetical model of how the extended C-terminal extension (orange segments) of the Caenorhabditis
DAF-2  proteins  contributes  to  their  rapid  lifecycle.  Binding  of  a  single  insulin-like  ligand  to  the
Caenorhabditis DAF-2 receptors allows for the activation  of a greater number of effector proteins than
the  binding  of a single  molecule to  the  Bm-DAF-2  receptor.  This  in  turn  leads  to  the  generation  of a
greater amount of PIP3  leading to greater suppression  of DAF-16,  hence more  rapid  development and
shorter lifespan.
99Given  the  conservation  of  the  N-  and  C-terminal  extensions  within  the 
Caenorhabditis genus, it is interesting that no mutations (out of 23  sequenced alleles) 
have  been  identified  in  the  DAF-2  protein  that  affect  either  of these  regions  (see 
Chapter 5).  However, there is some evidence for a functional role for the C-terminal 
extension in DAF-2 (see Chapter 6). It may be possible to test for a functional role for 
the N-terminal extension with mutations that affect the cleavage site, which might result 
in a phenotype  if their retention interferes with wild-type  DAF-2  activity.  A  similar 
effect  is  seen  in the  semi-dominant daf-28(sal91)  allele,  which has  a mutation that 
affects the endoproteolytic  cleavage  site  of the  DAF-28  protein.  The mutant protein 
behaves as a poisonous ligand of the DAF-2 receptor and causes a Daf-c phenotype (Li 
et  al.,  2003).  Overexpression  of  a  daf-28(sal91)  cDNA  construct  in  a  wild-type 
background phenocopies the effect of the homozygous mutant.  It might be informative 
to remove the cleavage  sites in the N-terminal  extension of DAF-2, through in vitro 
mutagenesis, and then overexpress this construct in wild-type worms.
100Chapter 5
Sequence analysis of daf-2 mutant alleles
1015.1 Introduction
In this chapter I aim to test the correlation between the location of a mutation in DAF-2 
and the phenotypic class of the allele bearing that mutation. I also explore the use of 
homology modelling of the DAF-2 receptor at secondary, tertiary and quaternary levels 
of protein structure and its ability to generate hypotheses as to the molecular nature of 
the difference that leads to two classes of daf-2 allele.
5.1.1  Possible correlation between location of mutation and phenotypic class
Previous phenotypic analysis of 15 temperature-sensitive (ts) alleles of the daf-2 gene 
revealed  the  existence  of two  overlapping  pleiotropic  classes  (Gems  et  al.,  1998). 
Several  of the daf-2 alleles used  in that study had had their mutations  identified by 
Kimura et al (1997). These were el365 (A580T) and el368 (S573L), both of which are 
class 1, el370 (P1465S) and el391 (P1434L), which are class 2. A further four alleles 
of daf-2  were  also  sequenced in  Kimura et al (1997),  one  of these,  mg43  (C410Y, 
P470L), is a non-conditional allele. The three other alleles were partially characterised 
in Gems  et al (1998) and assigned to  a class:  sa229 (D648N)  is class  1   and sal87 
(C469S) and sa219 (D1374N) both appear to be class 2.
Scott et al (2002) have also  sequenced  several alleles of daf-2 that had been 
characterised  in  Gems  et  al  (1998).  Two  of these  were  m579  (R437C)  and  m596 
(G547S)  both  of which were  reported as being  class  2.  Scott et al  (2002)  had  also 
reported that the e979 allele, which is class 2, had a G383E mutation. However, the m41 
allele of daf-2, which is class  1, had previously been reported to also have a G383E 
substitution  (Yu  and  Larsen,  2001)  and  this  has  been  confirmed  in  our  lab  (D. 
McCulloch and D. Gems, unpublished results).
To test for a possible  correlation between the  location of a mutation and the 
phenotypic class of the allele bearing it I  sequenced additional  alleles that had been 
assigned a class by Gems et al (1998). I also resequenced both the m41 and e979 alleles, 
in order to clarify the nature of the mutation in each allele. I also sequenced several non­
conditional alleles of daf-2, including m65 a candidate null allele, to gain further insight 
into DAF-2 function.
1025.1.2 The value of homology modelling of the DAF-2 receptor
Over  50 naturally  occurring mutations in MR have been identified and characterised 
biologically (see Taylor et al.,  1992 and Krook et al.,  1997a for detailed reviews) and 
four have also been found in the MGF-1R (Abuzzahab et al., 2003; Kawashima et al., 
2005). In addition, many mutagenesis studies have been performed on both receptors to 
identify  residues  involved  in  ligand  binding  (Mynarcik  et  al.,  1997)  and  those 
associated with signal transduction (Strack et al., 1997; Yam et al., 2001).
Crystal structures are available for the first three domains (LI, CR and L2) of 
the a-subunit of the MGF-1R (Garrett et al., 1998) and the TK domains of both the MR 
(Hubbard  et  al.,  1994)  and  MGF-1R  (Favelyukis  et  al.,  2001).  In  addition,  a  low- 
resolution  quaternary  structure  of MR  bound  to  insulin  has  been  obtained  through 
scanning electron microscopy  (Luo  et al.,  1999).  This quaternary  structure  has been 
combined with the available crystal structures from above to generate an atomic-scale 
model  of the  quaternary  structure  of MR  that  generates  a  possible  mechanism  for 
transmembrane signal transduction through the receptor (Ottensmeyer et al., 2000).
In order to gain insight into the mode of action of different DAF-2 mutations I 
performed a comparative analysis of both new and previously sequenced alleles of daf-2 
with  mutations  in MR and MGF-1R.  I  also used homology modelling of the  DAF-2 
receptor  to  gain  insight  into  the  effects  of mutations  on  the  secondary  and  tertiary 
structure of the receptor. This work was carried out in close collaboration with Acely 
Garza-Garcia,  a  PhD  student  in  the  Department  of Biochemistry  at  UCL  and  her 
supervisor Dr. Paul Driscoll.  We then attempted to gauge the impact of the structural 
changes caused by our mutations on signal transduction through the DAF-2 receptor by 
collaborating with Prof. Peter Ottensmeyer at the University of Toronto, who placed our 
mutations into a quaternary model of DAF-2.
1035.2 Materials and methods
5.2.1 Strains
The following strains carried different alleles of daf-2 that had their cDNA sequenced in 
order to determine the nature of the mutation they carried; CF1844 fer-15(b26) II; daf- 
2(mul50)  III;  fem-l(hcl7)  IV,  DR608  daf-2(m212)  III,  DR1567  daf-2(m577)  III, 
DR1568 daf-2(el371) III, DR1573  daf-2(el369) III, DR1942 daf-2(e979) III, GA156 
daf-2(m631) III; daf-18(nr2037) IV, GA158 daf-16(mgDF50) I,  daf-2(m65) III, GA310 
daf-16(mgDf50);  daf-2(tml236)  III,  JT193  daf-2(sal93)  III and JT6723  daf-2(sa223) 
III/ qCl\dpy-l9(e1259), glp-l(q339)] III. Cynthia Kenyon provided the CF1844 strain 
and James H. Thomas provided the JT193 and JT6723 strains.
5.2.2 daf-2 cDNA primer design
Initial primers for the amplification of cDNA fragments from the different daf-2 alleles 
were designed based on the daf-2 cDNA sequence of Kimura et al (1997). Primers were 
designed  using  the  Primer3  WWW  interface  (Rozen  and  Skaletsky,  2000) 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi).  Primers  were  generally 
designed to amplify overlapping fragments 350bp-500bp in size.
5.2.3 Sequencing of daf-2 alleles
Total  RNA  from mixed  stage  worms  was isolated using  the procedure  described  in 
chapter 3.2.1 for each of the daf-2 mutants used, except daf-2(sa223). This allele is non­
conditional  and was not available as a double mutant with a suppressor of its Daf-c 
phenotype. So to generate RNA for daf-2(sa223) homozygotes I grew the JT6723 strain 
on sixteen 60mm plates seeded with OP50 at 20°C.  I then washed the worms off the 
plates  and  into  a  15ml  centrifuge  tube  using  10ml  of M9.  The  worms  were  then 
centrifuged at  lOOOrpm for  lmin.  the supernatant was removed and the worms were 
resuspended in  10ml of 1%  SDS  solution (W/V). The animals were incubated in the
104SDS  solution for  1   hour, to kill all animals except dauers and unhatched eggs, before 
they were centrifuged at lOOOrpm for lmin. The supernatant was removed and the pellet 
was resuspended in  10ml of M9. The worms were then centrifuged again at  lOOOrpm 
for  lmin.  The pellet was washed a further two  times with M9,  using the procedure 
described above. After the final wash the worms were resuspended in 200pl of M9 and 
transferred on to a fresh seeded plate and left overnight at 20°C.
On the following day the worms were washed of the plate using 3ml of M9 and 
transferred into a 15ml centrifuge tube, to which 7ml of 1% SDS solution was added. 
The worms were again incubated in the SDS solution for 1   hour before being washed 
using the procedure above. The second SDS wash was necessary to kill larvae that had 
hatched from the eggs that been retained from the first SDS wash. The dauers recovered 
from the SDS washing had their RNA extracted as described in Chapter 3.2.1. Methods 
for first strand cDNA synthesis from the RNA and amplification of and sequencing of 
overlapping  fragments by  PCR can be  found  in Chapter 3  (sections 3.2.2,  3.2.4  and 
3.2.6). The sequences of the primers used for amplification and sequencing are listed in 
Table 5.2.1. The sequencing reads were analysed using the method described in Chapter 
3.2.7.
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S’
primer
5’-sequence-3’
3’
primer 5’-sequence-3’
Product
size
L GCACACATCTGATCGTCGGATTC FIR TGGCGGGTTTT  CCTC  AT  AGC  A 408bp
F2F TGAGACGGCTTCGACTTGTCA F2R CGATGCATTTCTTCTTGTGCTT 388bp
F3F T  GC  AC  AGT GGT  GG  AAGGTT  CG F3R CAT  CGTT  GAT  GGAAG  AAGT  G  A 394bp
F4F TCGAAATGGTGGTGTACGGATA F4R CGTGGCATGCTGTCGCATC 395bp
F5F ATCGGACCGGGATGTGATGC F5R GC  ACT  GTTTT GTTCG  AG  AGC 226bp
F6F TGTGATGCTCACCTGTACCTTC F6R TCCTTCAACTCGGACGCCATTC 336bp
F7F GCCGAAAATGCGTTGGCAAG Ex9FlR TGAACAGTGACTTTGCCTCAA 279bp
F8F GGCT  ACCT  GTTGGT  ACGT  C  AAT F8R CTCATCGATTCGTGGGACTT 447bp
F9F GCGGACTCGGTCTTCTTTAG F9R TAGCGTCCGAATCGACTTGC 394bp
F10F T  GGCGACGCAGATGGTGTTG F10R GCAGCGCACGTTTTCTGCTG 391 bp
FI IF CG  ATT  GT  AGCCG  AT  AAGCC  AGT F11R TGCTCGACGGCTTCTTCTTCG 384bp
F12F CGGCGATCGAATCATCTGCA Exl2rev ATCCTTGTTCCCGGCACCGTAG 289bp
Exllfwd AGC  AG  AAAACGT GCGCTGC  AA F13R TCCTT  GTT  CCCGGC  ACCGT  A 384bp
F14F GGCTCCAACGATCGCATCAA F14R TTCC  AC C  ATT  C  ACTT  C  AGT  CG 380bp
F15F CATCGTGCGGGAGCATTGAA F15R GACGAGAAGCAT  GCCGAGAATGA 399bp
F16F CTGGACCGGAAGCCGAATCC F16R TCGACGCTGGATCATCTACA 387bp
F17F CTGATGGGTGATCGTTTCG F17R CAT  CGAACAGGC  ATC  AT  ACGC 482bp
F18F TCGGGATGAGACTGTCAAGA F18R CCAGTGCTTCTGAATCGTCA 455bp
F19F CCAGCTCGTTCATCTTCTAGC F19R TCCGAACTTCCGCATCACTCG 383bp
F20F GCG  AG  AAGG  ATCGCT  GG  ATG F20R CGTGGCACCACGATTTCCACT 394bp
F21F T  G  AACG  AGG  AGCCGGTTT  CG R C  AGAGATTTGAAAAAT  GGGGT  AAAA 615bp
Primer pairs used in sequencing the daf-2 cDNA from different mutants and their wild-type product size. 
The fragments are overlapping and are listed from 5’ to 3’ in the cDNA sequence.
1065.3 Results
To gain further insight into the molecular nature of class  1   and 2 alleles of daf-2 and 
how  this  might  lead  to  their  differing  phenotypes  and  genetic  interactions  I  have 
sequenced several temperature-sensitive alleles of daf-2. I have also sequenced several 
non-conditional alleles of daf-2. This sequence data was then combined with homology 
modelling of the DAF-2 receptor and a comparative analysis of mutations that affect the 
MR and MGF-1R, to understand how these mutations affected the different levels of 
protein structure and how this might affect signalling through the receptor.
5.3.1  Selection of alleles for sequencing
The  following  temperature  sensitive  alleles  of  daf-2  were  initially  chosen  for 
sequencing: e979, el369, el371, m212, m577, mul50 and sal93. All of these alleles, 
except e979, are class 1. The e979 allele is interesting as it has the most severe Daf-c 
phenotype of the class 2 alleles at temperatures below 25°C. At 25°C the progeny of 
e979 arrest either as embryos or Lis (Gems et al.,  1998; Vowels and Thomas,  1992). 
The alleles el369 and m212 are both class 1, and yet have the most Daf-c phenotype of 
all ts alleles at  15°C forming 55% and 28% dauers, respectively (Gems et al,  1998). 
The el371, mul50 and sal93 alleles are all class  1A, which form transient dauers at 
25°C  that generally  recover within 24 hours.  The mu 150 allele  has been extensively 
used  by  the  Kenyon  lab,  and  was  included  in  this  study  at  the  request  of Cynthia 
Kenyon (Garigan et al., 2002; Hsu et al., 2003; Murphy et al., 2003). The m577 allele is 
class 1C and is the most frequently used allele of daf-2 in the Gems lab.
I  also  sequenced  the  following  non-conditional  alleles  of daf-2:  m65,  m631, 
sa223 and tml236. The m65 allele is a candidate null allele, which has an interesting 
embryonic and LI  arrest phenotype when placed in a daf-16(-) background (Larsen et 
al.,  1995)(M. Nanji and D.  Gems, unpublished results). Epistasis analysis of the m65, 
m631 and m646, a non-conditional allele bearing a nonsense mutation (K. Kimura and 
G. Ruvkun, personal communication) with daf-16 and daf-18 null alleles has revealed 
that m631 has an intermediate level of suppression between m65 and m646 (M. Nanji 
and D. Gems, unpublished results, see Chapter 6 for more details). The sa223 allele is
107an interesting allele, since Daf-c is fully maternally rescued at 15°C, and rescued sa223 
adults  are  long  lived  and  have  greatly  reduced  fertility.  The  properties  of sa223, 
especially the weakness of the Daf-c phenotype of the maternally rescued homozygotes, 
suggest weak reduction of daf-2  A. function coupled with  strong reduction of daf-2B 
function (Gems et al,  1998). The tm!236 allele is a deletion mutant of daf-2 that was 
isolated  by  the  Japanese  C.  elegans  knockout  consortium 
(http://shigen.lab.nig.ac.jp/c.elegans/index.jsp) at my request. This allele was sent as a 
heterozygote over wild type and so placed over the qCl balancer and then outcrossed a 
further two times (see Chapter 6 for details)
5.3.2  Sequencing of daf-2 alleles
The  entire  coding  sequence  of  the  daf-2  transcript  was  amplified  as  a  series  of 
overlapping fragments using the primers listed in Table 5.2.1.  These fragments were 
then sequenced on both strands. The sequencing reads for each strand were compared to 
the wild-type sequence reported by Kimura et al (1997) and the sequence of the daf-2 
predicted  gene  in  WormBase.  Fragments  that  contained  identical  nucleotide 
substitutions compared to the wild-type sequence were taken to be the mutation in the 
allele.  This region was then amplified from genomic  DNA isolated from the  mutant 
worms and sequenced to confirm the presence of the lesion.
The sequence of the mutant cDNA was translated in silico and then compared to 
the wild-type protein sequences to determine the amino acid change (see Chapter 3.2.7). 
The two wild-type protein sequences differ in length by three amino acids (1846aa and 
1843aa);  the  residues  MTR  at  the  N-terminus  are  not  present  on  the  WormBase 
sequence, which uses the second in-frame ATG codon as the start of translation instead 
of the first. I chose to use the numbering system of Kimura et al (1997) for the position 
of the mutations identified in this project. The Kimura et al (1997) protein sequence 
also differs from the WormBase protein sequence at two positions. The Kimura et al 
(1997)  sequence  has  an  arginine residue  at position  838  and a glutamine  residue  as 
position  1313.  Histidine  and  lysine  residues  occupy  the  equivalent  positions  in  the 
WormBase  sequence.  All  of  my  sequencing  reads  confirm  the  presence  of  the 
WormBase residues at these positions and not those of Kimura et al (1997). Below are 
the  positions  of the  mutations  that  have  identified  in  this  project.  A  more  detailed
108exploration of each mutation and its predicted effect on the structure and signalling of 
the DAF-2 receptor will be dealt with in subsequent sections of this chapter.
The e979 allele had previously been reported to have a G383E substitution in the 
CR domain of the DAF-2 receptor by Scott et al (2002). However, the m41 allele has 
also been reported to have the same mutation (Yu and Larsen, 2001). The m41 allele is 
class 1  and e979 is class 2 and the Daf-c phenotype of e979 is more severe than that of 
m41 (Gems et al,  1998). The m41 is the only allele of daf-2 in which dauer formation 
can be  maternally rescued (Gems et al,  1998).  I  sequenced  and phenotyped  our  lab 
stock of daf-2(e979) and resequenced and phenotyped the e979 allele used by Scott et al 
(2002). I found that the mutation in our lab stock of e979 was C146Y, which affects the 
LI  domain.  This  stock  phenotyped  as  previously  reported  in  Gems  et  al  (1998). 
Sequencing  of the  e979  allele  used  by  Scott  et al  (2002),  obtained  from  the  CGC, 
confirmed the G383E substitution in this strain. Phenotypic analysis confirmed that this 
strain was actually m41 and not e979. Based on this information we asked the CGC to 
replace their stock of daf-2(e979) with our strain.
The sal 93 allele was found to have a missense mutation that caused an A580T 
substitution affecting the L2 domain of the receptor. Kimura et al (1997) had reported 
that the  el365  allele  also  had the  same  mutation.  However,  Gems et al  (1998)  has 
reported that sal93 is a class 1A allele of daf-2, whose dauers recover at 25°C after 24 
hours,  whereas  el365  is  a  class  1C  allele,  whose  dauers  do  not  recover  at  this 
temperature.  I  resequenced  and  phenotyped  the  CB1365  strain  from  the  CGC  and 
sequenced and phenotyped our lab strain of el365. I confirmed that the CB1365 strain 
contained the A580T mutation and that its dauers recovered at 25°C. Therefore sal93 
and el365, two independently isolated alleles, have the same mutation. Our lab stock of 
el365 had a C1045Y mutation,  which is the  same mutation as the m577 allele,  and 
affects the Fnl domain. Therefore the allele characterised as el365 in Gems et al (1998) 
was in fact m577.
The el369 allele was found to have no mutation in the CDS of the daf-2 gene. 
This was confirmed by  sequencing of full-length cDNA from two  independent RNA 
extractions. This suggests that this allele might have a mutation in a regulatory element 
of the daf-2 gene (see 5.3.9 for more details). The el371 allele has a C803Y mutation 
and the m212 allele has a C883Y substitution, both affect the Fnl  domain. The mul50 
allele has a G682D substitution in the FnO domain. It should be noted that the mul50
109allele was sequenced by Sindhuja Kadambi, a former third year research project student 
in the Gems lab, under my supervision.
The sa223 allele has a missense mutation causing a R1430Q substitution within 
the TK domain of the receptor. This is the only allele, of those sequenced in this project, 
for which the same mutation affecting the equivalent residue in hiR has been identified 
(see  below).  The  tml236  allele  has  an  in-frame  561 bp  deletion  in  exon  14  that  is 
predicted to remove  187 amino acids from the TK domain. The m65 and m631 alleles 
are  both nonsense  mutants  of daf-2  (Figure  5.5).  The m631  allele has  an  R281Stop 
substitution in the LI  domain and so is predicted to produce no functional protein. The 
m65  allele has a W1449Stop  substitution in the TK domain.  It  should be noted that 
Edward Campbell, a former research technician in the Gems lab,  sequenced the m65 
allele.
5.3.3  Location of temperature-sensitive mutations across DAF-2 receptor:
The daf-2 alleles for which sequence data exist are listed in Table 5.3.1 and Figure 5.1. 
The majority of class 1   alleles have mutations that fall into the a-subunit of the DAF-2 
receptor.  These include m41, which affects the  CR domain.  The alleles m396,  el368 
and el365/ sal93 affect the L2 domain, sa229 is located in the boundary between the 
L2 and FnO domains. The mul50 allele affects FnO while the el371 and m212 alleles 
affect the a-subunit half of the Fnl domain. The m577 allele affects the (3-subunit half 
of the Fnl  domain. The class 2 alleles are equally divided between the a-subunit, with 
e979 affecting the LI  domain and m579 and sal87 both affecting the CR domain, and 
the  TK  domain of the  (3-subunit which contains the mutations caused by  the  sa219, 
el391 and el370 alleles.
The  location  of  the  mutations  shows  only  partial  correlation  with  their 
phenotypic class.  All class  1   mutations, except el369, are located in the extracellular 
portion of the DAF-2 receptor.  Class 2 alleles, however, are equally divided between 
the extracellular portion of the receptor and the cytoplasmic TK domain. Interestingly, 
none of the 23 alleles for which the sequence change has been identified affects either 
the N- or C-terminal extensions of the DAF-2 receptor.
110Table 5.3.1 Mutations in daf-2
daf-2 allele Class
Nucleotide
change
Amino Acid Change Domain
Equivalent MR 
residue
el369 1 Not in CDS None - -
e979 2 TGC-TAC C146Y LI C8
m631 NC CGA-TGA R281STOP LI T113
m41bc 1 GGA-GAA G383E CR Gap in alignment
mg43a NC
TGT-TAT;
CCC-CTC
C401Y; P470L CR C216; P289
m579c 2 CGT-JGT R437C CR R252
sal87° 2 TGT-AGT C469S CR C288
m596c 1 GGC-AGC G547S L2 G366
e l368° 1 TCA-TTA S573L L2 T392
e l365°, 
sal 93
1 TGC-TAC A580T L2 S399
sa229° 1 GAT-A  AT D648N L2/Fn0 N470
mul50 1 GGC-GAC G682D FnO G529
el  371 1 GGA-GAA G803E Fnla G623
m212 1 TGT-TAT C883Y Fnla C682
m577* 1 TGC-TAC C1045Y Fnlb C798
m646d NC CAA-TAA Q1223 STOP JM S967
sa219° 2 GAT-A  AT D1374N TK D1118
sa223 NC CGA-CAA R1430Q TK R1174
el 391° 2 CCC-CTC P1434L TK PI 178
m65 NC TGG-TAG W1449STOP TK W1193
e!370° 2 CCA-ICA P1465S TK P1209
m633d NC CGT-CAT R1510H TK R1253
tml236 NC Deletion Y1234S; d 123M 421 TK Y984; D984 1165
Mutations  in  DAF-2.  The  amino  acid  change,  where  known,  is  listed  for  each  allele,  as  well  as  the 
nucleotide change.  Alleles  listed  in  bold  were  sequenced  in this  project.  NC= non-conditional,  CDS  = 
coding sequence of gene.  a Sequence data from Kimura et al (1997).b  Data from Yu and Larsen (2001).c 
Data from Scott et al (2002).d  K. Kimura and G. Ruvkun, personal communication.  * The e l365 allele 
characterised in Gems etal (1998) is actually the m577 allele
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1125.3.4 Integrated analysis of daf-2 mutations
Using the available sequence data we performed a comparison between the predicted 
effect  of each  mutation  on  the  secondary,  tertiary  and  quaternary  structure  of the 
receptor and the mutant phenotype of the allele. In addition, we sought further insight 
into the possible molecular effects of each mutation by searching the existing literature 
for mutations affecting the equivalent residues or regions in MR and MGF-1R,  either 
naturally occurring or made by in vitro mutagenesis, to our DAF-2 mutations. To make 
this  possible  a  database  was  created  by  Acely  Garza-Garcia  and  populated  by  me, 
containing information on mutations in all three receptors coupled with our alignments 
and  the  predicted  or  known  structural  relationships  of  the  affected  residue 
(http://www.biochem.ucl.ac.uk/~garza/insulinreceptor/entry.html).  In  this  section  I 
describe the methodology employed in generating our models of the secondary, tertiary 
and quaternary structure of the DAF-2 receptor. In the subsequent sections I present a 
detailed description of each of the  mutations causing  a missense  substitution  in the 
receptor,  ordered by  structural domain.  I  will  deal  with the  nonsense  mutations  and 
el369 in separate sections towards the end of this chapter.
The first step in producing a reliable model of the 3D structure of the DAF-2 
receptor  is  to  generate  an  alignment  of the  protein  with  other  members  of the  IR 
superfamily. Nematodes and mammals are estimated to have diverged -990MYA based 
on  molecular  clock  models  (Hedges,  2002).  Given  the  large  evolutionary  distance 
between the DAF-2 receptor and MR and the fact that they share a relatively low level 
of sequence  identity and similarity (see Table 4.3.6,  in Chapter 4),  we used  a broad 
range  of members  of the  IR  superfamily  for  our  alignments.  These  were  from  six 
different phyla, including the cnidaria, platyhelminthes, nematoda, mollusca, arthropoda 
and chordata.
Crystal structures for homology modelling are available for the TK domains of 
both the MR (Hubbard et al., 1994) and MGF-1R (Favelyukis et al., 2001), as well as a 
fragment of the a-subunit of MGF-1R (Garrett et al,  1998), encoding the LI, CR and 
L2 domains. These were used as templates to model the corresponding domains of the 
DAF-2 receptor. Secondary and tertiary structure models of the DAF-2 were created by 
performing ClustalW alignments of our alignments (Thompson et al.,  1994). We used 
two  different secondary  structure prediction programs,  JPred (Cuff et al.,  1998)  and
113PSIPRED (McAlduff et al., 2002), to predict the location of a-helices and  sheets in 
the DAF-2 protein. This information was used as a guide to our manual adjustments of 
the protein alignments. The manual adjustment of the protein alignments was carried 
out using the BioEdit sequence-editing program (see Chapter 4.2.6). Acely then took the 
adjusted alignments and threaded the wild-type DAF-2 amino acid sequence around the 
crystal structure template using two different programs, SWISS-MODEL (Schwede et 
al., 2003) and MODELLER (Marti-Renom et al., 2000) to generate the models of the 
L1-CR-L2 domains and the TK domains.
Unfortunately, there are no crystal structures available for any of the Fn domains 
from any member of the IR superfamily of proteins. Instead we made use of the many 
crystal structures of fibronectin type III  domains from other proteins as templates to 
model  the  Fn domains of DAF-2.  However,  the degree  of homology  between these 
domains and any IR superfamily Fn domain is very low. For example there is only 23% 
similarity between MR FnO  and the closest fibronectin type III  domain  listed  in the 
HOMSTRAD database (Mizuguchi et al., 1998), which is the eighth fibronectin type III 
domain of the human fibronectin protein.  Once the wild-type  sequence  models were 
constructed, Acely generated models for the mutations in DAF-2.  We then compared 
the mutant and wild-type models for changes in secondary and tertiary structure.
Prof.  Peter Ottensmeyer,  University  of Toronto,  carried out modelling  of the 
quaternary structure of the DAF-2 receptor, using our alignments, based on a quaternary 
model of MR produced by his group (Ottensmeyer et al., 2000). This model provides a 
possible mechanism for signal transduction through MR upon insulin binding.  In this 
model the  CR domains of each chain in the holo-receptor act as cams that hold the 
activation loops of each chain apart, which prevents autophosphorylation, in the absence 
of insulin (Figure 5.2c). However, the binding of insulin changes the conformation of 
the  L1-CR-L2  region,  such that  the  CR domains  are  moved  upwards,  allowing  the 
activation loops to move closer and initiate transphosphorylation (Figure 5.2d).  Upon 
dissociation of insulin the receptor reverts back to its unbound state, by the release of 
torsional energy from the strained disulphide bonds that link the chains. Unfortunately, 
the quaternary model of the DAF-2 receptor did not provide insight into the impact of 
the majority of our mutations on signal transduction through the receptor. However, this 
model may provide an insight into the effect of the m212 mutation (see below).
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Panel  a:  End  view of the full-mass representation  of the  IR dimer.  Arrow:  cam-like region on the CR 
domain. Panel b: Higher density solid surface representation of the view rotated slightly from panel a to 
show  CR  loop  regions  (cams)  of atomic  structure  reaching  the  top  portion  of Fn2  domains.  Panel  c: 
Inhibitory  state:  ectodomain of dimeric  R subunits  each with  two differing  insulin  binding sites  and  a 
blocking cam. Unbound bivalent insulin: a subunits resting against cams, crossing membrane, with TK 
domains separated. Abbreviations: A-loop, activation loop; C, catalytic region. Small on-axis circles (1 
and 2) represent the a-a disulfide bonds. Arrows  indicate thermally  induced motion.  Panel d:  Insulin 
bound state:  blocking cams rotated  and a subunits resting  closer to the  center  of the ectodomain.  TK 
domains  are  in  position  for  transphosphorylation  via  A-loops.  Sets  1   and  2  indicate  schematically 
different sets of amino acids from  monomers I and II  interacting with corresponding different sites on 
insulin. Image taken and legend adapted from (Ottensmeyer etal., 2000).
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115Figure 5.3 Predicted quaternary structure of DAF-2 receptor
A:  Stereoscopic  end  view  of the  quaternary  model  of DAF-2  dimer.  The  numbered  circles  are  the 
position of different mutations within the structure of the holo-receptor.  1= e979, 2= m631, 3= m41, 
4= mg43 (C401S), 5= m579, 6= sal87, 7= mg43 (P470L), 8= m596, 9= el368, 10= el365/ sal93, 11 = 
sa229, 12= e/377, 13= m212, 14= m577, 15= m646, 16= sa219, 17= sa223, 18= el391, 19= m65, 20= 
el370 and 21= m633.
B:  Close  up  of LI  and  CR  domains  of DAF-2.  The  numbered  circles  are  the  position  of different 
mutations within the structure of the holo-receptor. Numbers have same allele designation as above.
116Figure 5.3 Predicted quaternary structure of DAF-2 receptor
C:  Close  up  of L2  and  Fn  domains  of DAF-2.  The  numbered  circles  are  the  position  of different 
mutations within the structure of the holo-receptor. 1= e979, 2= m631, 3= m41, 4= mg43 (C401S), 5= 
m579, 6= sal87, 7= mg43 (P470L), 8= m596, 9= el368,  10= el365/ sal93,  11= sa229,  12= el371, 
13= m212,  14= m577,  15= m646,  16= sa219,  17= sa223,  18= el391,  19= m65, 20= el370 and 21= 
m633.
D: Close up of TK domain of DAF-2. The numbered circles are the position of different mutations within 
the structure of the holo-receptor. Numbers have same allele designation as above.
1175.3.5 Mutations affecting the receptor L-domains
In all, six alleles of daf-2 have been found to have mutations that affect one of the L- 
domains of the DAF-2 receptor. These are e979 and m631  in the LI domain, and m596, 
el368 and el3651 sal93 in the L2 domain.
e979
This allele carries a missense mutation that results in a C146Y substitution (sequenced 
in  this  project).  This  cysteine  is  equivalent  to  C8  and  C3  of  MR  and  MGF-1R, 
respectively, and is the most N-terminal of the DAF-2 mutations. The crystal structure 
of the LI, CR and L2 domains of the MGF-1R (Garrett et al,  1998) reveals that C3 is 
involved in a disulphide bridge with C22, equivalent to Cl81  and C26 in DAF-2 and 
MR, respectively. The e979 allele is class 2 and is the only allele that causes a  100% 
embryonic  lethality/Ll-stage arrest phenotype  in  its progeny  at 25.5°C  (Gems et al., 
1998; Vowels and Thomas, 1992). This allele also has a strong Daf-c phenotype at 15°C 
causing 20% dauer formation (Gems et al., 1998). Potentially, the loss of this disulphide 
bond results in thermolabile protein that has reduced function at 15°C and no activity at 
25°C.
Next we sought information about the equivalent regions affected by the e979 
mutation in MR and MGF-1R. In these receptors, the C8/ C3  residues are four amino 
acids N-terminal of a highly conserved motif comprised of residues D12/D8 - N15/N11. 
This has been shown by alanine scanning mutagenesis to be involved in ligand binding 
(Whittaker  et  al.,  2001;  Williams  et  al.,  1995).  In  addition,  a  naturally  occurring 
mutation  of the  N15  residue  has  been  found  in  a  patient  with  Rabson-Mendenhall 
syndrome (Kadowaki et al.,  1990b). Transfection studies of an insulin receptor bearing 
the N15K substitution indicated that this mutation caused a 5-fold decrease in insulin- 
binding affinity, in agreement with mutagenesis studies. Interestingly, it also caused a 
retardation of the transport of the mature receptor to the plasma membrane, leading to 
reduced levels of the receptor on the cell surface. In addition, these receptors also had a 
severely reduced ability to autophosphorylate upon insulin-stimulation.  This suggests 
that the e979 mutation may have type 2, 3 and 4 defects (see chapter 1.2.3 and Figure 
1.4).
118The C26 residue of MR is N-terminal of V28 and G31, VI83 and G186 in DAF- 
2, all three residues are part of the second repeat of a loosely conserved glycine-centred 
motif that appears at least four times in each L-domain (Bajaj et al., 1987). The V28 and 
G31  residues  are  both  affected  by  naturally  occurring  mutations  that  have  been 
identified  in  two  different patients  with  leprechaunism  (van  der  Vorm  et  al.,  1992; 
Wertheimer  et  al.,  1994).  In  both  cases  the  patients  were  heterozygotes  for  their 
respective mutations.  Transfection studies of the V28A insulin receptor revealed that 
the mutation severely impairs proteolytic processing of proreceptor into the mature a- 
and (3-subunits. This leads to a reduction in the number of receptors on the cell surface, 
the mutation had no effect on the insulin-binding affinity of the mature receptor or its 
ability to autophosphorylate in response to insulin (Wertheimer et al.,  1994).  Similar 
transfection  studies  of the  G31R mutant revealed a more  severe phenotype  than  the 
V28A mutant. Here the proreceptor fails to be proteolytic cleaved and is not transported 
to  the  cell  surface,  the  proreceptor  was  also  unable  to  bind  insulin  or  undergo 
autophosphorylation (van der Vorm et al., 1992).
What can this tell us about the effects of e979 on DAF-2 function? The e979 
mutation is predicted to remove a disulphide bond between Cl46 and Cl81 in the DAF- 
2 receptor. The MR equivalents of these residues are C8 and C26.  C8  is proximal to 
highly conserved residues involved in the post-translational processing of the mature 
receptor, and in ligand binding, moreover, the C26 residue is part of a glycine-centred 
motif that  is  critical  in  for  correct  proteolytic  cleavage  of the  proreceptor.  Taken 
together,  this  suggests that the  e979 mutation causes (1)  severe  impairment  of post- 
translational processing of the DAF-2 receptor; (2) a reduction of the binding affinity of 
the  receptor  to  its  putative  ligands:  and/  or  (3)  its  ability  to  autophosphorylate  in 
response to ligand.
The  C146Y  substitution  in  e979  is  semi-conservative  as  both  cysteine  and 
tyrosine  are  hydrophobic  residues,  although tyrosine  is  less  so  due to  the  hydroxyl 
group present on its aromatic  side-chain.  Potentially at  15°C the  C146Y mutation  in 
e979 has a less severe effect on the post-translational processing of the DAF-2 receptor 
due to semi-conservative nature of the substitution and so phenotypically resembles the 
N15K and V28A mutations of MR.  At 25.5°C the loss of the disulphide bridge may 
completely inhibit the proteolytic processing of the DAF-2 proreceptor in a similar way 
to the G31R mutation in MR resulting in a complete lack to mature DAF-2 receptors at
119the  cell  surface,  which  in  turn  leads  to  the  embryonic  lethality/  LI-stage  arrest  of 
progeny phenotype at this temperature.
m596
This allele of daf-2 was originally classified as a class 2 allele based on the fact that it 
develops  Unc  and  Eat  phenotypes  at  25.5°C  (Gems  et  al.,  1998).  However,  it  is 
suppressed  by  daf-12(m20)  (Gems  et  al.,  1998)  and  is  only  weakly  Hyp  (hypoxia 
resistant) (Scott et al., 2002) and so has been reclassified as a class 1  allele. m596 has a 
missense  mutation  causing  a  G547S  substitution  in  the  L2  domain  of the  DAF-2 
receptor  (Scott  et  al.,  2002),  equivalent  to  G366/  G356  in  MR  and  MGF-1R, 
respectively. According to our model of the DAF-2 receptor the G547 residue is buried 
in the structure of the L2 domain and located in a turn between the fifth and sixth 1 3 - 
strands. Mutation of this residue to serine is expected to cause clashes with several of 
the neighbouring buried residues, especially N518/ N329/ S339 in DAF-2, MGF-1R and 
MR, respectively, disrupting the stability of the fold.
G547 in DAF-2, like G31   in MR, is the central glycine in the second repeat of 
the four glycine-centred motifs found in each L-domain (Bajaj  et al.,  1987). Like the 
above-mentioned  G31R  mutation  in  MR  identified  in  a  heterozygote  patient  with 
leprechaunism (van der Vorm et al.,  1992), a G366R mutation has also been identified 
in a patient with leprechaunism (Wertheimer et al.,  1994). Transfection studies of MR 
carrying  the  G366R  substitution  have  shown  that  this  mutation  impairs  the  post- 
translational processing of the receptor leading to a reduced number of mature receptors 
on the cell surface. Unlike the G31R mutation (van der Vorm et al., 1992), the G366R 
mutation  seems  to  have  no  effect  on  the  insulin  binding  affinity  or  the 
autophosphorylation of the receptor (Wertheimer et al., 1994).
We postulate, on the basis of the above, that this disruption would also lead to a 
similar impairment of the post-translational processing of the DAF-2 receptor, like the 
G366R mutation in MR, reducing the number of mature receptors on the cell surface 
without effecting either DAF-2 ligand binding or its autophosphorylation.
120el368 and el365/sal93
Three  further alleles of daf-2 mapping to the L2  domain are el368,  which causes  a 
S573L substitution (Kimura et al., 1997), and el365 and sal93, which have an identical 
nucleotide change  (see table  5.3.1)  leading to an A580T  substitution (Kimura et al, 
1997 and this study). According to the model of the DAF-2 receptor, both residues are 
buried within the structure of the L2 domain, so their mutation is likely to destabilise 
the fold.
No mutations have been found at equivalent positions in any member of the IR 
superfamily. However, these residues are part of the fourth repeat of the glycine-centred 
motif in the L2 domain (Bajaj et al., 1987). In the wild-type DAF-2 sequence the nearby 
A571 residue occupies the central role played by G390 in the equivalent fourth repeat in 
the L2 domain of MR. In all other nematode DAF-2 proteins this glycine is conserved. 
The proximity of the S573L mutation in the el368 allele to the A571  residue suggests 
that it might interfere with the role of the alanine residue in the turn between the eighth 
and ninth  strands of the L2 domain. This could result in an impairment of the post- 
translational processing of the DAF-2 receptor, as does the G547L mutation in the m596 
allele. However, the effect must be weaker since el368 is a class 1A allele where dauers 
begin to recover after 24 hours at 25.5°C, unlike m596 dauers (Gems et al., 1998).
el365/sal 93
The el365/ sal93 mutation A580T {el365 sequenced by Kimura et al, 1997 and sal93 
in  this  project)  affects  an  alanine  residue that  is  conserved  in  all  nematode  DAF-2 
receptors and two arthropod proteins, DInR and BIR. However, this alanine is replaced 
with a serine in most vertebrate members of IR superfamily (except MRR where it is 
replaced with a threonine). The equivalent residue in the fourth repeat of this motif in 
the LI  domain is also an alanine residue in almost all IR superfamily members, A261/ 
A92 in DAF-2 and AIR, which suggests some functional significance.  Given that the 
el365/ sal93 mutation affects the same repeat as the el368 mutation, suggests that it 
might cause an impairment of the post-translational processing of the DAF-2 receptor. 
A similar type of defect would be consistent with the similar phenotype of el368 and 
el365/ sal93, both are class 1A alleles (Gems et al., 1998).
1215.3.6 Mutations in the cysteine-rich (CR) domain
The CR domain of most IR superfamily members is made up of eight irregular modules, 
the  first three  of which contain four cysteine  residues,  C1-C4,  linked  in the  pattern 
C1:C3 and C2:C4. The other five modules contain only a single pair of cysteines that 
are bonded to each other. Four alleles, m41, mg43, m579 and sal87, have mutations that 
affect residues in the CR domain (Table 5.3.1).
m41
This allele is the only class 1  allele of daf-2 with a missense mutation in the CR domain. 
The m579 and sal87 alleles are both class 2, while mg43 is a non-conditional allele and 
has two  different mutations within the  CR domain.  The  m41  allele causes a G383E 
mutation in module 2 of the CR domain (Yu and Larsen, 2001)(D. McCulloch and D. 
Gems, unpublished data). This module is unusual in all nematode DAF-2 proteins in 
that it lacks the  C2 and C4 cysteines,  equivalent to Cl89 and  C200  in the MGF-1R 
structure.  We  postulate  that  in  nematodes  this  disulphide  bond  is  replaced  by  an 
intradomain salt bridge, in the case of the C.  elegans DAF-2 between E381  and R392. 
While the G383 residue is conserved amongst all nematodes, it falls into a gap in the 
alignment with all other members of the IR superfamily, making it difficult to predict 
the effect of its mutation on the structure of DAF-2.
mg43
This  non-conditional  allele  has  two  different  mutations  affecting  the  CR  domain 
(Kimura et al., 1997). The first is a C401Y substitution in module 3 of the CR domain, 
equivalent to C216/ C209 in hlR/ MGF-1R. This is the third cysteine in module three 
and predicted to  form a disulphide bond with  C393  in DAF-2,  C208/ C201  in AIR/ 
MGF-1R. The second mutation in the mg43 allele is a P470L substitution of an entirely 
conserved proline in module seven of the CR domain. Although no mutations affecting 
either of these residues have been found in any other IR superfamily member, mutations 
of similar residues have been noted in MR. A H209R substitution in MR, adjacent to the 
C208 residue that is bonded to C216, has been shown to impair several different steps in
122the  post-translational  processing  of the  proreceptor  so  that  only  10%  of the  mature 
receptor  is  transported  to  the  cell  surface.  These  receptors  retain  wild-type  binding 
affinity  and  normal tyrosine  kinase  activity  (Kadowaki  et al.,  1991).  Given that the 
C401  residue in DAF-2 is bonded to C393, which is equivalent to C208 in MR,  it is 
possible that the substitution of this residue to tyrosine in the mg43 allele also causes an 
impairment of the post-translational processing of the DAF-2 proreceptor.
The second mutation in the mg43 is a P470L substitution in module seven of the 
CR domain. A similar proline to leucine substitution is seen in the first module of the 
CR domain of MR at position 193 (Carrera et al., 1993). Like P470, the PI93 residue is 
adjacent to a cysteine involved in a disulphide bridge, the P193L mutation in MR has 
been  shown  to  prevent  dimerisation  of the  proreceptor,  inhibit  cleavage  and  block 
transport to the cell surface (Maggi et al.,  1999), although some mature receptor does 
get to the cell surface and appears to have normal insulin binding affinity (Takata et al., 
1994)  and  undergoes normal  autophosphorylation (Carrera et al.,  1993).  Potentially, 
both mutations in the mg43 allele cause defects in the post-translational processing of 
the DAF-2 proreceptor, resulting in the non-conditional phenotype of this allele.  It is 
possible that each mutation on its own would display a class 2 phenotype.
sal 87
The idea above is supported by the mutation in sal87,  a class 2  allele (Gems et al., 
1998).  The  sal87  allele  has  a  C469S  substitution  in  module  7  of the  CR  domain 
(Kimura et al., 1997). This residue is adjacent to the P470 residue mutated in mg43 and 
is predicted to form a disulphide bond with C483. Given the fact that it is adjacent to 
P470 it seems likely that the C469S mutation also leads to the same post-translational 
defects as the P470L mutation.
m579
This is a class 2  allele and has a R437C  substitution (Scott et al.,  2002)  in the  fifth 
module of the CR domain. The mutation in m579 is interesting as it is the only mutation 
in the extracellular domain of the DAF-2 receptor for which an identical mutation in 
MR  has  been  identified.  A  patient  with  type  A  insulin  resistance  accompanied  by 
acanthosis nigricans was found to be homozygous for a missense mutation causing a
123R252C  substitution  in  the  CR  domain  of  MR  (Hamer  et  al.,  2002).  Erythrocytes 
cultured from the patients revealed a 40% decrease in receptor levels on the cell surface 
and  a  five-fold  decrease  in  insulin  binding  affinity  when  compared  to  cell  from  a 
healthy individual.
Transfection  studies  of the  R252C  mutant  in  CHO  cells  revealed  that  the 
receptor has a delayed maturation of the proreceptor into the a-  and  |3-subunits,  and 
reduced transport of the mature receptor to the cell surface. The mutant receptor also 
had reduced insulin binding affinity and an almost complete lack of insulin-stimulated 
receptor  internalisation.  Interestingly  the  R252C  mutant receptor  seemed to  undergo 
normal autophosphorylation and retained a normal ability to phosphorylate the IRS-1 
and -2 adaptor proteins as well as Akt, part of the PI3  kinase pathway.  However the 
mutant  receptor  had  marked  reduction  in  its  ability  to  induce  She  and  ERK1/2 
phosphorylation,  as  well  as  reduced  incorporation  of  thymidine  into  DNA.  This 
difference in substrate phosphorylation may be due to prolonged exposure of the mutant 
receptor to  insulin due to the reduced internalisation of the receptor,  suggesting that 
receptor-mediated endocytosis may act as an important attenuator of insulin signalling.
Hamer et al (2002) suggest that the R252C substitution may cause an aberrant 
disulphide  bond  with  C3  in  the  LI  domain,  locking  the  two  domains  into  a 
conformation that is unfavourable to high-affinity ligand binding.  This is likely to be 
incorrect, since two patients with a R252H substitution in MR also suffered from type A 
insulin resistance and the mutant receptors also have reduced receptor levels on the cell 
surface as well as reduced insulin binding affinity (Maassen et al., 2003; Nakashima et 
al.,  1995). We propose instead that the molecular defects in the m579 allele, as well as 
the  R252C  and R252H  MR mutants  is  due to the  loss  of the  arginine  residue.  This 
residue is conserved in nearly all members of the IR superfamily and according to our 
model of the DAF-2 receptor R437 forms two hydrogen bonds with El 85, E30/ E26 in 
MR and MGF-1R,  in the  LI  domain (see  Figure  5.4).  This interaction  is crucial  for 
keeping  the  LI  and  CR  domain  in  their  correct  orientation  and  its  loss  would 
undoubtedly affect ligand binding in these receptors.
124Figure 5.4 Hydrogen bonds between R437 and E185 in wild-type DAF-2
R437
Cartoon of the structure of the L1-CR-L2 domains of the DAF-2 receptor. In the wild-type receptor the 
El 85 residue in the LI domain is predicted to form two hydrogen bonds with the R437 residue in the CR 
domain, based on the MGF-1R L1-CR-L2 crystal structure (Garrett et al., 1998). In the daf-2(m579) allele 
the R437 residue is mutated to a cysteine that can no longer take part in these hydrogen bonds, leading to 
a change in the orientation of the LI domain with respect to the L2 domain.
1255.3.7 Mutations in the fibronectin type III (Fnf domains
Five daf-2 alleles, all of which are class 1, have mutations affecting the Fn domains of 
the DAF-2 receptor. The sa229 allele actually falls into the boundary between the L2 
and FnO domains, while the mul50 allele actually affects the FnO domain.  The el371 
and m212 alleles affect the a-  subunit half of the Fnl  domain while the m577 allele 
affects the (3-subunit half of the Fnl domain.
sa229
This allele causes a D648N substitution (Kimura et al, 1997). Given its position at the 
boundary between the L2  and FnO  domains it is  impossible to predict the  structural 
impact of this mutation. Moreover, the D648 residue, N470/ S460 in MR and MGF-1R, 
is poorly conserved across IR superfamily members. However, in the MR two different 
mutations at the C-terminus of the L2 domain, K460E and N462S are proximal to the 
boundary between L2 and FnO.  Both increase the rate of receptor internalisation and 
degradation leading to a reduced number of receptors on the cell surface (Kadowaki et 
al., 1990a; Kadowaki et al, 1990c). Possibly, sa229 has a similar effect.
mulSO
This allele has a G682D (G502 in MR) substitution in the C strand of the FnO domain 
(sequenced in this project). No mutation of the equivalent residue has been found in any 
other  member  of  the  IR  superfamily.  However,  a  mutation  causing  an  I485T 
substitution in the B strand of the FnO domain in MR was identified in a patient with 
type A insulin resistance and lipodystrophy (Yokota et al, 1990). This mutation did not 
cause  the receptor to  have  reduced insulin-binding  affinity  when  expressed  in  CHO 
cells. But the patients own cells did have a reduced level of insulin binding suggesting 
that the mutation caused a reduction in the receptor level on the cell surface. Potentially, 
a similar effect is  caused by  mul50 allele.  However, the impairment  is  likely to  be 
weaker as the mul50 allele is class 1A and dauers formed at 25.5°C recover within 24 
hours (Garigan et al, 2002).
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This  allele  has  a  G803E  substitution  in  the  a-  subunit  half  of  the  Fnl  domain 
(sequenced in this project). This glycine residue, G623/ G609 in MR and MGF-1R, is 
part of a motif P-X-X-PNG that is highly conserved in our alignment and is located in 
between  the  B  and  C  strands  of the  Fnl  domain.  Interestingly,  the  same  motif also 
appears between the B and C strands of the Fn2 domain. This motif is not a generally 
conserved  feature  of the  fibronectin  type  III  structures  listed  in  the  HOMSTRAD 
database. A PROSITE scan (Falquet et al., 2002) of the Protein Data Bank for the P-X2- 
PNG motif retrieved more than 100 entries. This motif is generally found in tight turns, 
mostly  type  pi,  in which the  glycine  residue  displays positive  (j) and  ip  angles.  This 
would be an unfavourable conformation for the substituted glutamic acid residue for the 
mutation in the el371 allele.
m212
This  allele  is  an  atypical  class  1   allele,  i.e.  it  has  a  strong  Daf-c  phenotype  at  all 
temperatures, but is fully suppressed by daf-12(m20) (Gems et al.,  1998). m212 allele 
has a C883Y substitution (sequenced in this project), C682/ C669 in MR and MGF-1R, 
and is located in the large insert between the C and C’ strands of the Fnl domain. In MR 
the a- and (3-subunits are linked by a single disulphide bond between C647 and C872 to 
form an a-P dimer (Cheatham and Kahn, 1992; Sparrow et al., 1997). These a~p dimers 
are then linked by four class  1   disulphide bridges between the adjacent a-subunits to 
form  the  mature  tetrameric  C X 2P2  receptor.  The  four  cysteines  involved  in  the  a-a 
subunit  disulphide  bonds  are  C524  (Bilan  and  Yip,  1994;  Macaulay  et  al.,  1994; 
Schaffer and Ljungqvist, 1992), C682, C683 and C685 (Lu and Guidotti, 1996; Sparrow 
et al., 1997; Wu and Guidotti, 2002; Wu and Guidotti, 2004), equivalent to C706, C883, 
C884 and C886 in the DAF-2 receptor.  Site-directed mutagenesis of all four of these 
cysteines  to  serines  in  MR  results  in  free  a-P  dimers  that  are  incapable  of 
autophosphorylation and only transported to the cell surface at 50% of wild-type levels, 
although at sufficiently high concentration in the plasma membrane these dimers can 
associate non-covalently to produce functional tetrameric receptors (Wu and Guidotti, 
2002).
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cells is present in the mature tetrameric form, however a small proportion is present as 
free a-p dimers (Lu and Guidotti, 1996). When C524 is substituted with tryptophan the 
majority of the protein expressed in COS7 cells is not transported to the cell surface, so 
that levels of tetrameric mature receptor are only  12% of wild-type MR controls (Wu 
and Guidotti, 2004). Wu and Guidotti (2004) suggest that the bulky tryptophan residue 
causes  misfolding  of  the  proreceptor,  leading  to  its  retention  in  the  endoplasmic 
reticulum  and  subsequent  degradation.  A  similar  effect  may  be  occurring  with  the 
C883Y mutation in the m212 allele.  The tyrosine residue has a bulky aromatic side- 
chain that  may  also  cause  misfolding  of the  DAF-2  proreceptor  leading  to  reduced 
levels of the mature receptor on the cell surface. Also this mutation may also cause a 
small proportion of the DAF-2 protein to remain as free a-p dimers on the cell surface, 
which would  be  incapable  of ligand-stimulated  autophosphorylation as  seen  for  the 
C682S mutation (Lu and Guidotti,  1996). This could explain the severity of the Daf-c 
phenotype of this allele.
In the quaternary model of the MR presented by Ottensmeyer et al (2000), the 
disulphide bonds involved in the a-a subunit interaction are crucial components of the 
signal  transduction mechanism  of the  receptor.  In this  model,  the  cysteine  residues 
provide torsional resistance that maintains the ‘cams’ formed by the CR domains in the 
position  that  blocks  transphosphorylation.  Upon  insulin binding,  the  bonds  between 
these residues become strained, and the ‘cams’ are moved upwards so that the activation 
loop of each kinase domain is able contact the other and initiate autophosphorylation. 
When the insulin molecule dissociates from the receptor, the torsional energy stored by 
the  disulphide  bonds  is  released  and  this  returns  the  receptor  to  the  inactive 
conformation. Ottensmeyer et al (2000) point out in their model that loss of one these 
disulphide bonds may result in the loss of torsional resistance. This in turn would make 
the approach of the activation loops of each kinase domain more random, and so less 
efficient  at  transphosphorylation.  This  result  seems  to  correlate  well  with  the 
biochemical data above.
128m577
This allele has a mutation in the  F  strand of the  P-subunit half of the  Fnl  domain, 
causing  a  C1045Y  substitution  (sequenced  in  this  project).  The  Cl045  residue  is 
expected to  form a disulphide bond with Cl055  based on homology with C798  and 
C807,  the  equivalent  residues  in  MR,  which  have  been  shown  to  be  linked  by  a 
disulphide bridge (Sparrow et al,  1997). Site-directed mutagenesis of C798 in MR and 
C776 in MGF-1R to serines impairs the post-translational processing of the proreceptors 
of both proteins  leading to  a complete  lack of mature receptors on the  cell  surface 
(Maggi and Cordera, 2001). However, site-directed mutagenesis of the C807 residue to 
serine does not seem to have any affect on the post-translational processing of the MR 
proreceptor  or  the  insulin  binding  affinity  of the  mature  receptor  or  its  ability  to 
phosphorylate IRS-1 (Maggi et al., 1998). Given that the C798 residue has a disulphide 
bond to C807 (Sparrow et al.,  1997), it is hard to reconcile the very different effects of 
mutating each cysteine residue to a serine. It is unlikely that C1045Y mutation in the 
m577 allele would lead to a complete lack of mature DAF-2 receptor on the cell surface, 
as this allele is class 1  and forms dauers only at 25°C (Gems et al, 1998). However, the 
concept of the C1045Y mutation leading to a receptor with normal ligand binding and 
substrate phosphorylation but reduced levels on the cell surface seems to be consistent 
with the other class 1  alleles of daf-2.
5.3.8  Mutations in the TK domain
Seven alleles of daf-2 have mutations that affect the TK domain of the DAF-2 receptor. 
These are sa219,  sa223,  el391, m65,  el370,  m633 and tml236.  An additional  allele 
m646 has a mutation that affects the juxtamembrane region that is N-terminal of the TK 
domain.  All of the mutations that affect the cytoplasmic portion of the  (3-subunit are 
either class 2 or non-conditional alleles.
sa219
This allele causes a D1374N substitution in the aE helix of the TK domain (Kimura et 
al.,  1997).  This residue  is highly conserved across our alignment and the  equivalent
129residues D1118 and D1091 in the MR and MGF-1R crystal structures (Favelyukis et al., 
2001; Hubbard et al., 1994) are buried, and their carboxyl 06 atoms act as acceptors in 
three hydrogen bonds.  One oxygen atom interacts simultaneously with the protonated 
N61 atom the of HI 058/ HI031 residues in MR and MGF-1R (F1310 in DAF-2) located 
in the loop that spans aC and |34 regions of the TK domain, and with the NH-group of 
FI276/ FI249/ FI533 residue in each receptor situated after the aJ a-helix. The other 
oxygen  atom  forms  a hydrogen bond with the NH-group  of FI277/  Y1250/ VI534 
residue of each receptor. These hydrogen bonds play an important role in keeping the 
aJ helix in the correct orientation. The asparginine residue substituted for the aspartic 
acid  in  sa219  lacks  one  of the  06 atom  and  so  is  not able  to  establish the  correct 
arrangement of hydrogen bonds. This may destabilise the fold, potentially affecting the 
activity of the kinase domain.
sa223
sa223  is  an  unusual  non-conditional  allele  with  a  mutation  causing  a  R1430Q 
substitution in the P+l loop of the TK domain of the DAF-2 receptor (sequenced in this 
project).  This loop is important in determining the substrate specificity of the kinase 
domain for either tyrosine residues or serine/ threonine residues (Hubbard et al., 1994). 
The R1430 residue is equivalent to R1174 in MR and the same arginine to glutamine 
substitution of this residue has been reported in several heterozygous individuals with 
severe type A insulin resistance (Hojlund et al, 2004; Krook et al., 1995; Moller et al, 
1991; Moritz et al., 1994). Transfection studies of the R1174Q mutant receptor in CHO 
cells suggest that the basal level of receptor autophosphorylation is comparable to wild- 
type receptors. However, insulin-stimulated autophosphorylation is only 30% of wild- 
type controls (Krook et al., 1996; Moritz et al., 1994). At high concentrations of insulin 
the mutant receptors were able to phosphorylate the IRS-1  adaptor protein to -60% of 
wild-type  levels,  but were not able  to  induce the  insulin-stimulated  incorporation  of 
thymidine  into  DNA or phosphorylate the  MAP  kinase protein  (Krook et al.,  1996; 
Krook et al., 1997b).
In the  structures of MR and MGF-1R kinase domains,  both Nr|  atoms of the 
R1174/  R1147  residue  are  hydrogen-bonded  to  the  backbone  oxygen  atoms  of the 
PI209/  PI 182  and  L1213/  L1186  residues.  The  loss  of  one  of these  interactions
130probably destabilises the conformation of the P+l  loop. Both of these residues are also 
conserved in the DAF-2 receptor, PI465  and LI469, respectively.  It therefore  seems 
likely that the R1430Q mutation in sa223 has a similar effect on the kinase activity of 
the DAF-2 receptor to the R1174Q mutation in MR.
el  3 70
Interestingly, the PI465 residue that R1430 is expected to form a hydrogen bond with in 
the DAF-2 receptor is the site of the mutation in the el370 allele (Kimura et al., 1997). 
This canonical daf-2 allele is class 2 and has a proline to serine substitution; no human 
equivalent of this mutation has been reported. This residue is part of a hydrophobic core 
and  the  replacement  of the  hydrophobic  proline  with  the  polar  serine  is  likely  to 
destabilise the fold and reduce the kinase activity of the TK domain.
el391
This allele is class 2 and has a P1434L substitution (Kimura et al.,  1997), which also 
affects the P+l  loop of the DAF-2 receptor.  This proline residue is also conserved in 
MR, PI 178, and the same substitution for leucine has been identified in heterozygous 
patient with severe type A insulin resistance (Krook et al.,  1994). Transfection studies 
of PI 178L mutant receptors in CHO cells revealed them to have similar properties to 
the R1174Q mutant receptors (Krook et al.,  1996; Krook et al.,  1997b).  However the 
P1178L mutant receptors could phosphorylate the IRS-1  adaptor protein to -80%  of 
wild-type levels, when stimulated with high insulin levels (Krook et al.,  1997b).  The 
proline to leucine substitution is expected to cause unfavourable steric clashes within 
the structure of the kinase domain, which may explain the slightly weaker impairment 
of the kinase activity of the PI 178L mutant compared to the R1174Q mutant receptors. 
Potentially this is why the el391  allele displays class 2 phenotypes but sa223 is non­
conditional.
m633
This  non-conditional  allele  has  a  R1510H  substitution  (K.  Kimura  and  G.  Ruvkun, 
personal communication) affecting the loop between the aH and al helices of the DAF-
1312 TK domain. This residue is conserved across virtually all kinases and is equivalent to 
R1253  in MR.  This residue is structurally important for the stability of the fold as it 
forms a salt bridge with El 179 that is a key interaction to bring together a-helix aEF 
and the loop that spans a-helixes a-H and a-I. No equivalent mutations have yet been 
reported in MR, but it is likely that in DAF-2 this mutation severely impairs the activity 
of the kinase domain, causing its non-conditional phenotype.
5.3.9  el369 an allele with a mutation outside the daf-2 open reading frame
This allele is an atypical class 1  allele and has the most severe Daf-c phenotype of the ts 
alleles characterised in Gems et al (1998), yet is fully suppressed by daf-12(m20). Both 
strands of cDNA, synthesised from two independent RNA extractions of daf-2(el369) 
worms, were sequenced and no mutations affecting the cDNA were detected. In order to 
ensure that the el369 allele used in the sequencing, which phenotyped as in Gems et al 
(1998),  was  actually  a  daf-2  mutant  I  performed  complementation  tests  with  two 
different alleles of daf-2 for which the mutations had been identified. The el369 allele 
failed to complement either daf-2(m41) or daf-2(m577) indicating that it is an allele of 
daf-2 (data not shown).
Given  that  the  full-length  cDNA  from  el369  has  no  mutation,  the  DAF-2 
receptor produced by this allele must have a wild-type amino acid sequence. The El9 
allele of dinr also has no mutation affecting the coding sequence of the gene (Tatar et 
al.,  2001).  Interestingly,  this  is  the  only  known  allele  of  the  dinr  gene  that  is 
homozygous viable. The lack of a mutation in the coding sequence suggests that both 
daf-2 (el369) and din/*19 may have mutations in regulatory regions of their respective 
genes that cause reduced transcription of mRNA.
There  are  several  reported  cases  of  heterozygous  patients  with  either 
leprechaunism or severe type A insulin resistance in which one of the alleles has been 
shown  to  have  reduced  levels  of transcription  of the  INSR  gene,  whilst  having  no 
mutation in the coding  sequence  of that allele  (Imano et al.,  1991;  Kadowaki et al., 
1990d; Longo et al.,  1992; Ojamaa et al.,  1988; Suzuki et al.,  1995).  There is also a 
reported case of a patient with severe type A insulin resistance with acanthosis nigricans 
who appears to be a compound heterozygote for two different mutations that cause a
132decrease in the level of transcription of the INSR gene (Imano et al, 1991), although the 
exact location of the mutation has not been determined in any of these cases.
In an attempt to locate the mutation in the el369 allele ~5.2Kb of genomic DNA 
upstream of the trans-splice acceptor of exon 1   and the whole of intron 1   (~5.5Kb) of 
the daf-2 gene were sequenced. No mutations in either of these regions were detected. 
Therefore any mutation in the el369 allele must lie either further upstream than 5220bp 
of the trans-splice acceptor of exon  1   or potentially in one of the other introns of the 
daf-2 gene.
5.3.10  Nonsense mutations and the deletion allele of daf-2
In this section I deal with three nonsense alleles (m65, m631 and m646) and a deletion 
allele (tml236) of daf-2. All of these alleles are non-conditional. Epistasis analysis on 
the three nonsense alleles using null alleles of daf-16 and daf-18 has revealed that they 
can be placed into an allelic series based on their suppression by the null alleles above 
(M. Nanji and D. Gems, unpublished results). In terms of their DAF-2 activity the series 
is as follows: m65< m631< m646. Below I detail the mutation in each of the alleles, in 
the order of their premature stop codon, and the possible effect on the receptor.
m631
This allele has an opal mutation at codon 281  in the LI  domain  (sequenced  in this 
project) of the DAF-2 receptor sequence replacing an arginine residue with a stop (see 
Figure 5.5). This residue is equivalent to T113/ T107 in MR and MGF-1R. Of the three 
nonsense  alleles  this mutation  is  predicted to  truncate  the  protein  closest  to  the  N- 
terminus of the receptor resulting in no functional protein. However, based on epistasis 
data  on  the  suppression  of the  Daf-c  phenotype,  we  postulate  that  m631  is  not  a 
molecular null mutant (M. Nanji and D.  Gems, unpublished results) and that there is 
readthrough of this stop codon to produce some functional DAF-2 protein.
Nonsense mutations in the human insulin receptor gene,  leading to premature 
termination of translation,  are frequently associated with decreased levels of mRNA 
(Taylor et al., 1992). Recently, a compound heterozygote patient was identified carrying 
the mutations R108Q and K115N of the LI domain of the MGF-1R, N282 and D289 in
133DAF-2. This resulted in a third of the normal IGF-1  binding affinity leading to growth 
retardation (Abuzzahab et al., 2003). This suggests that this region is involved in ligand 
binding, thus, any functional DAF-2 protein produced by readthrough in m631  allele 
would  be  predicted  to  have  reduced  binding  affinity  for DAF-2  ligands,  as  well  as 
having reduced levels of DAF-2 receptor due to decreased mRNA levels caused by the 
premature stop codon.
m646
This  allele  has  an  ochre  mutation  that  affects  residue  Q1223  located  in  the 
juxtamembrane  region of the DAF-2  receptor  (K.  Kimura  and  G.  Ruvkun,  personal 
communication).  Like  the  m631  allele,  we  do  not  believe  that  the  m646  mutation 
represents a null allele of daf-2. This allele is predicted to have greater DAF-2 activity 
than  the  m631  and  m65  alleles  (M.  Nanji  and  D.  Gems,  unpublished  results).  The 
epistasis  results  suggest  that  some  functional  DAF-2  protein  must  be  produced  by 
readthrough of the ochre stop codon. The severity of the Daf-c phenotype of this allele 
may  be  due  to  the  combined  effects  of reduced  protein  level  due  to  the  nonsense 
mutation and a decrease in the levels of daf-2 mRNA, also caused by the premature stop 
codon.
m65
This allele has an amber mutation affecting codon  1449  (sequenced in this  project), 
encoding  a tryptophan residue,  of the  DAF-2  receptor.  This residue  is  equivalent  to 
W1193 in the aF helix of the MR TK domain and is completely conserved across our 
alignment.  Substitution  of  W1193  to  leucine  has  been  reported  for  two  unrelated 
families (Imamura et al., 1994). Transfection studies of the W1193L mutant receptor in 
COS7 and Rat-1  cells indicated that insulin-binding affinity was normal. However, the 
insulin-stimulated autophosphorylation of the mutant receptors was -80% of wild-type 
controls. In addition, the rate of proreceptor degradation was found to be 2-fold higher 
in  this  mutation  than  wild-type  controls  leading  to  a  reduced  number  of  mature 
receptors on the cell surface (Imamura et al.,  1994). At present m65 represents the best 
candidate for a null allele of daf-2.
134tml236
This allele that has 561 bp in-frame deletion in exon 14 of the daf-2 gene that removes 
187 amino acids from the TK domain of DAF-2 including the (3-strands (31- pi 0 and the 
a-helices aC, aD and aE. This deletion removes both catalytic loop and most of the 
activation loop of the kinase domain (see Figure 5.5). No equivalent in frame deletions 
of the MR have been reported. Potentially this allele has no kinase activity and may 
represent a molecular null. This allele and m65 are investigated further in chapter 6.
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A schematic representation of the predicted translation products of one deletion and three nonsense alleles of daf-2. m631 has an opal mutation at codon 281, which is in the 
LI  domain, the resulting protein product is predicted to be non-functional. m646 has an ochre mutation at codon  1223, which is in the juxtamembrane region, this protein is 
also predicted to be non-functional. The m65 allele has an amber mutation affecting codon  1449 in the TK domain; this protein  is predicted to be kinase dead. The tml236 
allele has a 187 amino acid deletion within the TK domain and is also predicted to result in a kinase dead protein.
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In this chapter I have sequenced 11  different alleles of daf-2, and located the lesion in 
10  of them.  All  previously  sequenced  alleles  have  mutations  either  in  the  ligand- 
binding portion of the receptor (formed by the L1-CR-L2 domains) or the TK domain. 
However,  in  this  project  I  have  found  mutations  in  four  alleles  that  affect  the  Fn 
domains of the DAF-2 protein, as well as a daf-2 allele with no mutation in its coding 
sequence.  To  gain  further  insight  into  the  relationship  between  allele  class  and  the 
molecular effect of each mutation we used homology modelling to predict the structural 
change  at  secondary,  tertiary  and  quaternary  levels.  In  addition,  we  performed  a 
comparative analysis between our DAF-2 mutations and mutations in MR and MGF-1R, 
to gain further insight into the molecular effect of our lesions.
5.4.1  Distribution of mutations across DAF-2 receptor
An initial  hypothesis,  based on the  sequence  data available  for  several  daf-2  alleles 
(Kimura et al,  1997; Scott et al., 2002; Yu and Larsen, 2001), suggested that class  1  
alleles had mutations affecting non-conserved residues in the L2 domain of the DAF-2 
receptor, while class 2 alleles had mutations in the CR and TK domains of the receptor. 
A  larger  survey  of the  mutations  in  24  alleles,  including  non-conditional  mutants, 
suggests a more complex pattern for the location of class  1   and 2  alleles across the 
DAF-2 receptor. In general, class  1   alleles have mutations that affect the extracellular 
domain  of the  DAF-2  receptor,  specifically  the  L2,  FnO  and  Fnl  domains  of the 
receptor.  An  exception  is  the  atypical  class  1   allele  el369,  which  has  no  mutation 
affecting the daf-2 coding sequence and therefore a wild-type amino acid sequence. The 
majority  of class  2  alleles  have  mutations affecting  the  CR and TK domains  of the 
DAF-2 receptor, although the most severe class 2 allele e979 has a mutation in the LI 
domain and is the most N-terminal of the DAF-2 mutations. We had hoped to find that 
the mutation in some alleles affected the N- and C-terminal extensions, but none were 
found. This suggests that these regions may only have a minor role in DAF-2 function.
137Table 5.4.1 Summary of the predicted molecular effects of mutations on DAF-2
daf-2
allele
Class Phenotype Molecular Effect Based on AIR and AIGF-1R mutants Type of 
Defect
el 369 1
Severe Daf-c 
phenotype at 15°C No mutation in coding sequence of daf-2 gene 1
e979 2
Severe Daf-c 
phenotype at 15°C 
100% Embryonic and 
LI arrest at 25°C 
Eat and Unc
Involved in disulphide bond to C181 
Reduced transport to cell surface 
Decreased insulin binding affinity
2,3
m631 NC Forms dauers at all 
temperatures
Nonsense allele that is predicted to form non-functional protein 1
m41 1
Strong Daf-c 
phenotype at 20°C 
Only allele to show 
maternal rescue of 
Daf-c
This residue is not present in non-nematode phyla -
mg43 NC Forms dauers at all 
temperatures
This allele has two missense mutations in DAF-2 CR domain 
First mutation involved in disulphide bond with C393 
Both are predicted to impair proreceptor processing
2
m579 2
50% Daf-c phenotype 
at 22.5°C 
Eat and Unc
Reduced transport to cell surface 
Decreased insulin binding affinity 
Greater reduction in She phosphorylation than PI3 kinase 
phosphorylation 
Reduced receptor internalisation
2, 3, 4, 5
sal87 2
-100% Daf-c 
phenotype at 20°C 
Eat and Unc
Involved in disulphide bond to C483 
Impaired transport to cell surface 
Decreased insulin binding affinity
2,3
m596 2
Formerly class 2 on 
basis of Eat and Unc 
But suppressed by 
daf-12(m20)
Central part of a structural motif in L2 
Impaired transport to cell surface 
No effect on insulin binding affinity 
No effect on autophosphorylation
2
el 368 1
Dauers recover al 
25°C after 24 hours
Impaired transport to cell surface 
No effect on insulin binding affinity 
No effect on autophosphorylation
2
el 365/ 
sal 93
1
Dauers recover at 
25°C after 24 hours
Impaired transport to cell surface 
No effect on insulin binding affinity 
No effect on autophosphorylation
2
sa229 1
Dauers recover at 
25°C after 24 hours
Accelerated degradation of receptor leading to a reduction of 
receptor levels at cell surface.
No effect on insulin binding affinity 
No effect on autophosphorylation
5
mul50 1 Dauers recover at 
25°C after 24 hours
Impaired transport to cell surface 
No effect on insulin binding affinity 
No effect on autophosphorylation
2
el 371 1 Dauers recover at 
25°C after 24 hours
No known MR and MGF-1R mutants in equivalent region 2
138Involved with class I disulphide bond between a-subunits.
m2] 2 1
Severe Daf-c 
phenotype at 15°C
Leads to reduction of holo-receptors at cell surface, as a small 
proportion of heterodimers fail to form tetramers. 2,4
May reduce efficiency of transphosphorylation based on 
quaternary model
m577 1
Only forms dauers at 
25°C
These do not recover
Involved in disulphide bond to Cl055 
Impaired transport to cell surface 
No effect on insulin binding affinity 
No effect on autophosphorylation
2
m646 NC
Forms dauers at all 
temperatures Nonsense allele that is predicted to form non-functional protein 1
-100% Daf-c
sa219 2 phenotype at 20°C 
Dauers recover after 8 
days
Reduced insulin-stimulated autophosphorylation of kinase 
domain 4
el39l 2
Severe Daf-c 
phenotype at 20°C 
Eat and Unc
Reduced insulin-stimulated autophosphorylation of kinase 
domain 4
m65 NC Forms dauers at all 
temperatures Nonsense allele that is predicted to form non-functional protein 1
el 370 2
Canonical allele of 
daf-2 
Eat and Unc
Reduced insulin-stimulated autophosphorylation of kinase 
domain 4
m633 NC Forms dauers at all Reduced insulin-stimulated autophosphorylation of kinase 4
temperatures domain
tm!236 NC Forms dauers at all 
temperatures
Deletion of activation and catalytic loops of TK domain 4
Summary of the predicted molecular effects for each of the daf-2 mutants. Alleles are listed  in the order 
of their  mutations  across  the  DAF-2  amino  acid  sequence  beginning  with  the  N-terminus.  They  are 
classified into either class  1   or 2 if they are temperature-sensitive alleles or NC if they form dauers non­
conditional ly.  The  dauer  phenotype  and  predicted  molecular  effects  of  each  mutation  are  listed  in 
columns 3  and 4. The final column uses the Taylor et al (1992) classification system to summarise the 
effects of each mutation (see Figure 1.4).
5.4.2  Possible molecular basis of the class 1 phenotype
The analysis described in this chapter has furnished much new information about the 
effects of daf-2 mutations on the primary structure of the receptor and the predicted 
effects on secondary, tertiary and, in the case of m212, quaternary structure. Moreover, 
comparisons with mammalian work  generate predictions about how these  molecular 
defects affect receptor function. But how does this information help us understand the 
daf-2 allele class difference at the molecular level? In the following discussion I survey 
the data generated, and attempt to draw from it broader conclusions about this question.
139m596 is the only class 1  allele for which a mutation in the equivalent residue in 
MR has been reported. This allele has a G546S  substitution in the L2 domain of the 
DAF-2 receptor (Scott et al., 2002), whilst the equivalent residue in MR, G366, has an 
arginine substitution (Wertheimer et al.,  1994). The G366R mutation impairs the post­
translation processing of the proreceptor, leading to a 90% reduction in levels of the 
mature receptor on the cell  surface.  This mutation did not affect the insulin-binding 
affinity of the mature receptor or its insulin-stimulated ability to autophosphorylate. If 
we assume that residues conserved between different members of the IR superfamily 
have similar structural roles within each receptor, then it seems likely that the G546S 
substitution in the m596 mutant DAF-2 receptor also reduces receptor level on the cell 
surface by same mechanism. If, like the G366R MR mutant, the G546S DAF-2 mutant 
receptor also retains wild-type ligand binding affinity and ability to autophosphorylate 
in response to ligand then potentially the phenotypes associated with the m596 allele are 
due  to  a reduced flux  of wild-type  DAF-2  signalling  output  caused  by  the  reduced 
receptor number on the cell  surface.  Thus  a candidate  molecular mechanism  for the 
class 1   mutant defects is reduced flux of wild type DAF-2 signalling output caused by 
the reduced receptor number on the cell surface.
Do the predictions of the effects of the mutations in the other class  1   alleles 
support this hypothesis?  We predict that the  mutations  in the  el368,  el365/ sal93, 
mul50 and el371  alleles also will impair post-translational processing of the  DAF-2 
proreceptor in a similar way to the m596 allele, and will also have reduced levels of 
mature DAF-2 on the cell surface. These five alleles are class 1A and form dauers that 
recover with 24 hours at 25.5°C (Garigan et al., 2002; Gems et al., 1998), unlike m596. 
This  suggests  that the postulated  impairment  of proreceptor  processing  is  milder  in 
these alleles than in m596.
By  contrast,  the above  analysis  implies that the  mutation  in the  sa229  allele 
leads to an accelerated rate of mature receptor internalisation and degradation leading to 
a reduced number of mature receptors on the cell surface, a similar effect is seen for the 
K460E and N462S mutants of MR (Kadowaki et al.,  1990a; Kadowaki et al.,  1990c). 
The sa229 allele is also class 1A (Gems et al., 1998), and so the reduction in signalling 
flux may be similar to that seen in the other five class 1A alleles.
The mutation in the m577 allele causes a C1045Y substitution; this cysteine is 
conserved across all members of the IR superfamily in our alignments and its equivalent 
in MR C798 is known to be involved in a disulphide bond with C807 (Sparrow et a l,
1401997),  which  also  conserved  across  our  alignment.  Site-directed mutagenesis  of the 
C798 residue and the equivalent C776 in MGF-1R to serine results in impairment of 
proreceptor processing  and  lack of mature receptors on the  cell  surface  (Maggi  and 
Cordera, 2001).
The m212 allele has severe Daf-c phenotype at 15°C and is one of two atypical 
class 1  alleles, the other being el369 (Gems et al., 1998). Our analysis suggests that the 
mutation  in  m212  will  have  two  consequences.  Firstly,  it  will  lead  to  a  severe 
impairment  of the  processing  of the  DAF-2  proreceptor  reducing  levels  of mature 
receptor at the cell surface. Secondly, the loss of this disulphide bond will reduce the 
torsional resistance of the remaining bonds. This leads to a more random approach of 
the  activation  loops  in  the  tyrosine  kinase  domains,  reducing  kinase  activity.  Thus, 
leading to a stronger reduction of signalling flux, which in turn leads to the  stronger 
Daf-c phenotype.
The  el369  allele  is  the  most  severe  ts  allele  of daf-2  in  terms  of its  Daf-c 
phenotype, yet is class 1   (Gems et al.,  1998). This allele has no mutation in its coding 
sequence,  so the receptor has a wild-type amino  acid sequence.  We  believe that the 
mutation  in  el369  must  affect  a regulatory  region  of the  daf-2  gene,  although  our 
attempts to locate it so far have failed. This, we postulate, causes a severe decrease in 
the transcription of daf-2 mRNA (see Chapter 6 for further investigation), which in turn 
leads to a highly reduced level of wild-type receptors on the cell surface and so a greatly 
reduced signalling flux.
In conclusion, our analysis of 9 distinct daf-2 class 1  lesions shows that in every 
case there is evidence from the mammals of lowered receptor levels (see Table 5.4.1 for 
a summary). This is either a remarkable coincidence, or it implies that this is a common 
mechanism underlying the class 1  mutant phenotype.
5.4.3  Potential molecular basis of the class 2 phenotype
The m579 and el391  alleles affect different parts of the  DAF-2 receptor.  The  m579 
allele causes a R437C substitution in the CR domain (Scott et al., 2002). This causes the 
loss of two hydrogen bonds with the El85 residue in the LI  domain; these bonds are 
crucial in keeping the LI  and CR domains in the correct orientation.  The equivalent 
mutation R252C  in MR affects proreceptor processing  leading to  a reduced  number
141mature receptors on the cell surface (Hamer et al., 2002). Unlike the G366R mutation in 
MR,  equivalent  of the  m596 mutation,  the  R252C  mutation  also  lowers  the  insulin 
binding  affinity  of  the  receptor  and  almost  completely  blocks  insulin-stimulated 
internalisation of the receptor. However, the mutant receptor seems to undergo normal 
autophosphorylation and phosphorylates the IRS-1  and -2 proteins to wild-type level. 
But there is a marked reduction in the ability of this mutant to induce She and ERK1/2 
phosphorylation and induce insulin-stimulated thymidine incorporation into DNA.
The el391 allele of daf-2 has a P1434L substitution (Kimura et al, 1997) in the 
TK  domain.  The  equivalent  mutation  P1178L  in  MR  results  in  normal  proreceptor 
processing and normal insulin binding affinity (Krook et al., 1996). However the mutant 
receptor shows a marked decrease in insulin-stimulated autophosphorylation (Krook et 
al.,  1996;  Krook et al,  1997b;  Moritz et al.,  1994),  but in response to high insulin 
concentrations can phosphorylate IRS-1 to ~80% of wild-type receptor levels. However 
like the R252C mutation the PI 178L mutant receptors also show a reduction in insulin- 
stimulated thymidine incorporation into DNA, they also have a severely reduced ability 
to phosphorylate the MAP kinase protein (homologous to ERK1/ ERK2) (Krook et al., 
1997b).
This  implies  that  in  both  the  m579  and  el391  alleles  not  only  in  there  a 
reduction in the signalling flux through the DAF-2 receptor, as in the class 1  alleles, but 
this  reduction  seems  to  be  asymmetric  in  that  these  alleles  may  have  a  greater 
impairment of the She/ MAP kinase pathway than the IST-1  (homologue of IRS-1/-2)/ 
PI3  Kinase pathway. The asymmetric nature of this reduction in signalling ability is 
achieved  in different ways in the  MR equivalents  of the  two  alleles.  In the  R252C 
mutant the reduced ability to phosphorylate She seems to be linked to the inability of 
the  receptor  to  undergo  insulin-stimulated  internalisation,  suggesting  that  receptor 
endocytosis is important for the  She/ MAP kinase pathway (Hamer et al.,  2002).  By 
contrast, in the PI 178L mutant the reduced ability to phosphorylate MAP kinase seems 
to be linked to an alteration of the kinase activity of the TK domain itself.
Is this asymmetric reduction in signalling seen in the other class 2 alleles of daf- 
2? The e979 allele has the most severe Daf-c phenotype of the class 2 alleles and has a 
100%  embryonic/  Ll-stage  arrest  phenotype  at  25.5°C  (Gems  et  al,  1998).  The 
mutation in the e979 allele is the most N-terminal mutation to affect the DAF-2 receptor 
and causes a C146Y mutation in the LI domain, which is predicted to affect a disulphide 
bond with Cl81  also in the LI  domain. Based on homology with several mutations in
142the LI  domain of MR, we expect the C146Y mutation in DAF-2 to not only impair 
processing of the proreceptor and thereby reduce the levels of the mature receptor at the 
cell surface, but to also affect the ligand binding affinity of the receptor and its ability to 
autophosphorylate in response to ligand-stimulation. We also expect that at 25.5°C the 
severity of the impairment of proreceptor processing increases, leading to a complete 
lack of receptors at the cell  surface.  This may explain the ts lethal phenotype of this 
allele.
These effects are consistent with the idea that all daf-2 alleles have mutations 
that decrease the flux of DAF-2 signalling. However, we do not know how the predicted 
impaired  autophosphorylation  ability  of  the  e979  mutant  receptor  affects  the 
phosphorylation of the She/ MAP kinase and IST-1/ PI3 kinase pathways. These latter 
remarks are also applicable to the sal87 allele.
The sa219 and el270 alleles both have mutations in the TK domain of the DAF- 
2 receptor, causing D1374N and P1465L substitution respectively (Kimura et al., 1997). 
The PI465 residue is involved in a hydrogen bond with the R1430 residue in the P+l 
loop of the TK domain based on the structures of the MR and MGF-1R (Favelyukis et 
al., 2001; Hubbard et al.,  1994). We predict that the loss of this hydrogen bond in the 
P1465L mutation in the el370 allele will result in a similar but weaker impairment of 
kinase activity to that of the el391 allele. Thus, the el370 mutation is also predicted to 
cause an asymmetric reduction in signalling from DAF-2. As for the sa219 allele there 
is no equivalent mutation in MR, but we do predict it to also affect kinase activity.
5.4.4  Nonsense and deletion alleles
The  m646 allele  has  an ochre mutation at  codon  1223  (K.  Kimura and G.  Ruvkun, 
personal  communication).  This  allele  is predicted  to  give  rise  to  a  DAF-2  receptor 
without  a  TK  domain  and  so  was  expected  to  be  a  null  allele.  However,  epistasis 
analysis of m646 and two other non-conditional alleles of daf-2 (m65 and m631) with 
null alleles of daf-16 and daf-18 has revealed the following allelic series: m65< m631< 
m646 in terms of DAF-2  activity (M. Nanji  and D.  Gems,  unpublished results).  We 
sequenced the lesions in the m65 and m631 to gain further insight into the nature of the 
DAF-2 defect in these alleles. The m631 allele has an opal mutation at codon 281 in the 
LI domain and m65 has an amber mutation in codon 1449 of the TK domain.
143The m65 allele has the least DAF-2 activity, possibly none, of these three alleles. 
This result is surprising as the mutation in m65 is the most C-terminal of the premature 
stop codons. Both m631 and m646 are predicted to produce non-functional protein, as 
these mutations  should result in receptors lacking  TK domains.  In contrast, the m65 
mutation is located towards the C-terminus of the TK domain, and is predicted to give 
rise to a receptor with both the catalytic and activation loops of the receptor. The greater 
DAF-2 activity of m631 and m646 suggests that there is translational readthrough of the 
premature stop codons, and that these alleles give rise to some functional protein.
tml236 is a deletion allele of daf-2. This allele was generated at our request by 
the Japanese C.  elegans knockout consortium. The deletion removes 561 bp of exon 14, 
leading to an  187aa deletion within the protein sequence.  This deletion removes both 
the catalytic and activation loops of the receptor, and so is expected to be a molecular 
null. In the next chapter I further investigate both m65 and tml236 in order to establish 
whether either allele or both represents a null allele of daf-2.
5.4.5  Concluding remarks
To gain further insight into phenotypic differences in daf-2 mutants, we gathered data 
on the predicted mutational effects at the primary,  secondary, tertiary and quaternary 
levels of protein structure, and the effect of equivalent mutations on MR and MGF-1R 
function.  Overall, only the coupling of the primary sequence data and its comparison 
with equivalent or similar mutations in the other two receptors has  furnished  strong 
predictions about molecular basis of the daf-2 allele class difference.
We find that class 1   alleles occur in the L2 and Fn domains, and class 2 alleles 
occur in the LI, CR and TK domains of the receptor. No mutations were found in the 
termini of the receptor. Comparison with MR and MGF-1R mutant data generates two 
predictions. Firstly, class 1  mutants have reduced levels of receptor at the cell surface, 
which retain wild-type function. Secondly, class 2 alleles may also have this defect but 
also  have  defects  in  signalling  ability,  which  is  often  asymmetrical  affecting  She 
signalling more than PI3 kinase signalling. This suggests that She signalling could be 
involved with daf-2B function. Recently, it has been shown that the RAS pathway in C. 
elegans  functions  downstream  of daf-2  and  may  be  involved  with  daf-2B  function 
(Nanji et al., 2005). This is consistent with reduced signalling via She, however, all this
144is rather tentative. Predictions generated in this chapter will be explored further in the 
next chapter.
145Chapter 6 
Further analysis of daf-2 alleles
1466.1 Introduction
The  sequencing of daf-2 alleles described in Chapter 5  leads to a number of further 
hypotheses and predictions about the nature of the defects in individual daf-2 mutants, 
and about the function of the wild type DAF-2 receptor. In this chapter I follow up on 
these predictions with a series of experimental tests. For example, I test whether the daf- 
2(el369) allele causes reduced levels of transcription arising from a possible mutation 
in a regulatory element of the daf-2 gene. I also attempted to use DAF-2 antibodies to 
confirm my predictions from the previous chapter about mutations expected to cause 
processing  defects  in  the  DAF-2  proreceptor.  I  investigate  the  correlation  between 
DAF-2  signalling  flux and  class  1   and class  2  daf-2  phenotypes through the  use  of 
RNAi.  I  have also used the daf-28(sal91)  allele,  which encodes a poisonous  DAF-2 
ligand, to probe the role of ligand-receptor interaction in determining class 1  and class 2 
phenotypes. Finally I compare the properties of the daf-2(m65) nonsense allele to that of 
the daf-2(tml236) deletion allele to determine if either represents a null allele.
6.1.1 Does daf-2(e!369) reduce gene transcription
In the previous chapter I showed that the atypical class 1  allele el369 did not contain a 
mutation in the CDS of the daf-2 gene, and so encodes a wild-type DAF-2 receptor. In 
terms of its Daf-c phenotype the el369 allele is the most severe of all characterised ts 
alleles of daf-2 (Gems et al.,  1998).  Given that the el369 allele encodes a wild-type 
DAF-2 receptor the mutant phenotype of this allele could either be due to a mutation in 
a  regulatory  region  of the  daf-2  gene  affecting  its  transcription  or  a mutation  in  a 
different gene that is tightly linked to and phenocopies the daf-2 gene. Sequencing of 
the most likely candidate regions for the mutation in el369, the ~5.2kb upstream of the 
start codon and the entire first intron, did not identify any lesion. In order to check that 
the el369 allele has a mutation that affects a regulatory element of the daf-2 gene and 
reduces  its  transcription  I  have  used  quantitative  PCR  (QPCR)  to  determine  the 
expression level of the daf-2 gene in an el369 mutant.
1476.1.2 DAF-2 antibodies and processing defect detection
Mutations in MR that cause defects in proreceptor processing can be detected through 
the use of antibodies that can detect the proreceptor and the cleaved a- and P-subunits 
of the mature receptor. In the previous chapter we predicted that several alleles of daf-2 
might  have  proreceptor  processing  defects  based  on  homology  modelling  and 
comparison to mutations known to cause such defects in MR.  These defects may be 
detectable using a similar pulse-chase labelling assay with DAF-2 receptor antibodies. 
In addition to  detecting processing defects,  DAF-2  antibodies  could  also  be  used to 
address some more fundamental questions about the receptor. For example the DAF-2 
receptor has large N- and C-terminal extensions, a feature shared with the CMDAF-2 
and Cr-DAF-2 receptors (see Chapter 4, Table 4.3.9 and 4.3.10). The dlnR receptor also 
has large extensions at both termini; the C-terminal extension is cleaved off in certain 
cells and retained in others (Fernandez et al,  1995). It is unknown whether the N- and 
C-terminal extensions of DAF-2 are cleaved off, but it may be possible to detect this 
with an appropriate antibody.
6.1.3  DAF-2 signalling flux and the class 1-class 2 phenoty pe
In the previous chapter I presented the hypothesis that the class 1   alleles of daf-2 have 
mutations that result in a reduction of wild-type  signalling flux through the receptor, 
whereas  class  2  alleles  have  mutations  that  result  in  an  asymmetrical  reduction  of 
signalling  flux through the receptor that affects the  She/ MAP  kinase pathway  more 
than the PI3  kinase pathway.  This asymmetry might be responsible  for the  different 
epistatic interactions of the two classes of daf-2 alleles observed with genes such as daf- 
12 (Gems et al., 1998; Larsen et al, 1995), daf-9 (Gerisch and Antebi, 2004) and rop-1 
(Labbe et al, 2000).
In order to further investigate the role of DAF-2 signalling flux in determining the 
class  1   and 2 phenotypes I used RNAi of daf-2 to reduce signalling flux even more in 
both class  1   and 2 alleles. I also carried out daf-2 RNAi in daf-2 class 1   and 2 double 
mutants with daf-12(m20). The daf-12(m20) allele is a hypomorphic nonsense mutation 
of the  DAF-12  nuclear  hormone  receptor  (Antebi  et  al,  2000).  This  allele  fully 
suppresses  the  Daf-c  phenotype  of  class  1   daf-2  alleles  at  25.5°C  and  partially
148suppresses the Age phenotype, whereas it leads to 100% embryonic and LI-stage arrest 
and enhancement of the Age phenotype in class 2 alleles (Gems et al.,  1998; Larsen et 
al.,  1995).  The  aim of these  experiments  was  to  see  if further reduction of DAF-2 
signalling flux could make class 1  alleles behave as class 2 alleles.
6.1.4 Ligand-receptor interaction
One possibility that might explain the differences between class 1   and class 2 alleles of 
daf-2 with extracellular mutations is their effect on ligand binding. All class  1   alleles, 
except e!369, have mutations in the extracellular portion of the DAF-2 receptor.  My 
earlier analysis indicates that these mutations do not affect ligand binding, suggesting 
that the receptor may remain sensitive to ligand stimulation. By contrast, class 2 alleles 
with mutations in the extracellular portion, such as e979, m579 and sal87, are predicted 
to alter the ability of the receptor to bind ligand and in turn affect kinase activity.
The daf-28(sal91) allele encodes a mutant insulin-like peptide that appears to act 
as a poisonous ligand (i.e. antagonistic) of the DAF-2 receptor (Li et al., 2003). If the 
above model is true, then one would expect that daf-28(sal91) would enhance the Daf-c 
phenotype of class 1   but not class 2 daf-2 mutants. I this chapter I perform these tests 
and present the results.
6.1.5 Nonsense and deletion alleles of daf-2 and the null phenotype
In the previous chapter I found that two non-conditional alleles of daf-2, m65 and m631, 
contain  nonsense  mutations  (Table  5.3.1).  A  third  non-conditional  allele  m646  had 
previously been identified as having a nonsense mutation (K. Kimura and G. Ruvkun, 
personal communication). Epistasis analysis of these three alleles with the null alleles 
daf-16(mgDf50) (Ogg et al.,  1997) and daf-18(nr2037) (Mihaylova et al.,  1999) places 
them in the following order in terms of increasing phenotypic severity m646 < m631 < 
m65 (M. Nanji and D. Gems, unpublished data) (Table 6.1.1). The daf-18(nr2037) allele 
also fully suppresses the Age phenotype of m646 and m631, but not m65, although Age 
in the  latter is  suppressed by  daf-16(mgDf50)  (M.  Nanji  and D.  Gems,  unpublished 
data). This implies that m646 and m631 retain some DAF-2 activity, most likely due to
149translational  read-through  of  the  premature  stop  codons.  The  early  larval  arrest 
phenotype of daf-2(m65) is only partially suppressed by either daf-16(mgDf50) or daf- 
18(nr2037) at 15°C and the daf-16(mgDf50)\ daf-2(m65) double mutants shows 100% 
embryonic lethality at 25°C. A similar phenotype has been previously reported with daf- 
16(m26); daf-2(m65) double mutants (Larsen et al.,  1995). m65 may be a null allele of 
daf-2.
The Japanese C.  elegans gene knockout consortium isolated the tml236 allele of 
daf-2, after our lab requested it.  This allele contains a 561 bp in-frame deletion within 
exon 14 of the daf-2 gene, which translates into a 187 amino acid deletion of a part of 
the TK domain (see Chapter 5 for more details). This allele is predicted to be kinase 
dead and so also may represent a null allele of daf-2. I compared the phenotypes of the 
m65 and tml236 alleles both individually and in combination with daf-16(mgDf50) to 
test which is more severe (and therefore more likely to be null),  and to gain further 
insight into daf-2 function.
150Table 6.1.1 Incomplete suppression of daf-2 nonsense alleles bv daf-16(0) and daf-
im
Genotype
% L4 and 
Adults
% LI and L2 % Dauers % Dead eggs N
25°C
N2 99 0 0 1 295
daf-18(nr2037) 100 0 0 0 275
daf-16(mgDf50) 100 0 0 0 325
daf-2(m65)\ daf-18 24 6 0 70 171
daf-2(m631) ; daf-18 67 26 0 7 85
daf-2(m646); daf-18 92 5 0 3 283
daf-16; daf-2(m65) 0 0 0 100 298
daf-16; daf-2(m646) 100 0 0 0 172
15°C
N2 99 0 0 1 230
daf-18(nr2037) 100 0 0 0 189
daf-16(mgDf50) 100 0 0 0 257
daf-2(m65)\ daf-18 65 6 5 24 109
daf-2(m631)\ daf-18 78 0 22a 0 172
daf-2(m646)\ daf-18 89 0 l l a 0 221
daf-16; daf-2(m65) 43 18 0 39 292
daf-16; daf-2(m646) 100 0 0 0 210
Summary of epistasis data for three nonsense alleles of daf-2 with null alleles of daf-16 and daf-18. Only 
65%  and  24%  of  daf-2(m65);  daf-18(nr2037)  double  mutants  reach  adulthood  at  15°C  and  25°C, 
respectively. A higher proportion of animals reach adulthood  in both daf-2(m631); daf-18(nr2037)  and 
daf-2(m646)\  daf-18(nr2037)  double  mutants  at these  temperatures.  This  suggests  that these  nonsense 
alleles vary  in their levels of IIS  pathway activity, which  in turn  suggests that they have some residual 
DAF-2 activity due to translation read through. The data implies that m646 has the weakest impairment of 
DAF-2  activity  followed  by  m63l  and  then  m65.  Data  from  daf-16(mgDf50)\  daf-2(m65)  and  daf- 
16(mgDf50); daf-2(m646)  double mutants also  supports this view. a Partial  dauers,  recovered within 24 
hr. Data from M. Nanji and D. Gems (unpublished results)
1516.2 Materials and Methods
6.2.1  Strains
Strains used for QPCR of el369
The following strains were used in the QPCR experiments; GA202 daf-16(mgDf50) /; 
daf-2(m212) III, GA309 daf-16(mgDf50) 7; daf-2(el369) III, GR1307 daf-16(mgDf50) I 
(Ogg et al,  1997), DR608 daf-2 (m212) III and DR1573 daf-2 (el369) III. Both of the 
daf-16; daf-2 double mutants were created by crossing males of the parental daf-2 strain 
with  daf-16(mgDf50)  hermaphrodites  at  15°C.  The  hermaphrodite  progeny  of these 
crosses were then shifted to fresh plates at 25°C as gravid adults and allowed to lay eggs 
for 24 hours before being discarded. After three days at 25°C the plates were screened 
dauers  and approximately  50  dauers were  picked to  fresh plates  for  each  cross  and 
shifted to  15°C to allow recovery. All dauers were daf-2 homozygotes, some of which 
would  be  daf-16(+)  homozygotes  and  others  daf-16(+)/  (-)  heterozygotes.  The 
recovered  dauers  were  plated  singly  and  shifted  to  25°C  once  they  had  begun  egg 
laying. Again the worms allowed to lay eggs for 24 hours before being discarded. Once 
again the plates were left at 25°C before being screened.  Plates that contained  100% 
dauer progeny were discarded and adults were picked from plates with a mixture of 
dauers and adults. These adults were daf-16; daf-2 double mutants.
Strains used for antibody and RNAi experiments
The following strains were used for the antibody work N2, GA158 daf-16(mgDf50) /; 
daf-2(m65) III and SU159 ajm-l(okl60) X; jcEx44 (Koppen et a l, 2001). The strains 
used in the RNAi experiments were DR20 daf-12(m20) X, DR1296 daf-2 (el370) III; 
daf-12(m20) X,, DR1547 daf-2(m41) III; daf-12(m20) X, DR1563 daf-2(el370) III and 
DR1564 daf-2(m41) III.
152Strains used for construction of daf-2; daf-28 double mutants
The  strains used in the daf-2;  daf-28 double mutant experiments were  CB1068  unc- 
79(el068) III, BE148 rol-9(scl48)  V, DR1566 daf-2(m579) III, DR1567 daf-2(m577) 
III, GA304 unc-79(el068) III; daf-28(sal91)  V, GA9 daf-2(m577) III; rol-9(scl48)  V, 
GA199  daf-2(m579)  III;  rol-9(scl48)  V,  GA305  daf-2(m577)  III;  daf-28(sal91)  V; 
GA306 daf-2(m579) III; daf-28(sal91) Fand JT191 daf-28(sal91) V(Li e/ al., 2003).
In order to construct the  daf-28 doubles I first constructed double mutants 
for both daf-2 alleles with rol-9(scl48), which was used as marker for daf-28 as it is 
within 2cM of this gene. The rol-9(scl48) allele has a recessive roller (Rol) phenotype. 
I crossed males of either parental daf-2 strain to rol-9(scl48) hermaphrodites at 15°C. 
The hermaphrodite progeny of these crosses were then shifted to fresh plates at 25°C as 
gravid adults. They were allowed to lay eggs for 24 hours being discarded. After three 
days at 25°C the plates were screened for Rol dauers, approximately 20 were picked for 
each daf-2 allele and shifted to fresh plates at 15°C to allow recovery. These adults were 
daf-2; rol-9 double mutants.
The  second  step  in  the  construction  of  the  daf-2;  daf-28  doubles  was  the 
construction of the unc-79(el038); daf-28(sal91) double mutant. The unc-79 gene was 
used a marker for the daf-2 gene as it is within 7cM of this  gene, this  allele has  a 
recessive uncoordinated movement (Unc) phenotype. daf-28(sal91) males were crossed 
with  unc-79(e!038)  hermaphrodites  at  15°C  and the  hermaphrodite  progeny  of this 
cross were shifted to 25°C as gravid adults and allowed to lay eggs for 24 hours. The 
daf-28(sal91) allele is semi-dominant and approximately 10% of sal91l + animals form 
dauers at 25°C (Malone and Thomas,  1994). For this reason I picked -20 Unc adults 
after three days at 25°C, which were then transferred singly to fresh plates and left at 
25°C. These adults were allowed to lay eggs for 24 hours before they were discarded. 
After three days the plates were scored for dauers, plates with no dauers were discarded. 
Approximately  30  dauers  were  picked  to  fresh  plates  and  shifted  to  15°C  to  aid 
recovery.  Once these animals had become gravid adults they were plated singly  and 
shifted  to  25°C  and  allowed  to  lay  eggs  for  24  hours  before  being  discarded,  daf- 
28(sal91)  homozygotes  form  99%  dauers  at  25°C  (Malone  and  Thomas,  1994),  so 
plates with less than -100% dauers after three days were discarded.  Several animals
153from plates with -100% dauers were picked and shifted to 15°C to aid recovery. These 
animals were unc-79(el038); daf-28(sa!91) double mutants.
The final step in the construction of the daf-2; daf-28 doubles involved crossing 
unc-79(el038); daf-28(sal91) males with daf-2; rol-9(scl48) hermaphrodites at  15°C. 
The hermaphrodite progeny were then shifted to fresh plates at 25°C and allowed to lay 
eggs for 24 hours before being discarded. The plates were then screened for dauers after 
three days, -50 non-Rol non-Unc dauers were picked to fresh plates and left at 25°C for 
a further day. The daf-28(sal91) allele forms dauers that recover at 25°C (Malone and 
Thomas,  1994), whereas daf-2(m577) and daf-2(m579) dauers do not recover at 25°C 
(Gems et al.,  1998). The plates were then scored again and animals that had remained 
dauers were picked to fresh plates and transferred to  15°C to allow recovery. At this 
point  these  dauers  could  either  be  daf-2  homozygotes;  daf-281  rol-9  heterozygotes, 
assuming no recombination had occurred between daf-28 and rol-9, or daf-2; daf-28 
homozygotes.  The  recovered  animals  were  shifted  to  fresh plates  singly  at  25°C  as 
gravid adults and allowed to lay eggs for 24 hours before being discarded. Plates were 
scored  three  days  later  and  plates  that  segregated  Rol  and  non-Rol  dauers  were 
discarded.  Plates segregating  100% non-Rol dauers were transferred back to  15°C to 
allow recovery. These animal were assumed to be daf-2; daf-28 homozygotes, which 
was confirmed by sequencing their genomic DNA for the presence of both lesions (data 
not shown).
Strains used for nonsense and deletion allele experiments
The strains used in the daf-2 nonsense and deletion allele work were GA8 mDfll III! 
qCl  [dpy-19(e!259),  glp-l(q339)]  III,  GA158  daf-16(mgDf50)  /;  daf-2(m65)  III, 
GA176 daf-16(mgDf50) I; mDfll III/ qCl \dpy-19(el259) III, glp-l(q339)] III, GA301 
daf-2(tml236) III/ +,  GA302 daf-2(tml236) III / qCl  [dpy-19(e!259) III and GA310 
daf-16(mgDf50) I; daf-2(tml236) III.
The daf-2(tml236) allele was originally shipped as a heterozygote over wild-type 
by the Japanese C.  elegans knockout consortium, as their notes said the homozygotes 
were lethal and/ or sterile. This strain had no official designation so I labelled it GA301. 
I found that the daf-2(tml236)/ + heterozygotes segregated 25% dauer progeny at 15°C 
and 20°C (data not shown). Also the deletion allele and the wild type allele could be
154detected  using  single worm  PCR with the daf-2 exon  14-specific  primers  F16F  and 
Exl4F2a (Table 5.2.1) (data not shown).
I then balanced the tml236 allele over the qCl  [dpy-19(el259) III,  glp-l(q339)\ 
inversion  by  crossing  mDfll  III/  qCl  males  with  putative  daf-2 (tml236)1  + 
heterozygotes at 20°C.  The mDfll  deficiency (Gems et al.,  1998)  is a large deletion 
within C. elegans chromosome III that deletes the daf-2 gene as well as several others, 
although the exact break points have not been characterised.  When homozygous the 
mDfll  deficiency is lethal (dead eggs). The qCl  inversion has two recessive markers 
that when homozygous results in a swollen body ‘dumpy’ (Dpy) phenotype and at 25°C 
has a germline-proliferative mutation that makes the worms sterile (Glp). Putative daf- 
2(tml236)/ + were plated  singly and allowed to  lay  eggs for 24 hours.  The parental 
worms were then checked for the presence of the tml236 deletion allele using single 
worm PCR. Plates that had progeny laid by worms that were not heterozygotes for the 
tml236  deletion  allele  were  discarded.  The  progeny  of  the  cross  were  raised  to 
adulthood and then ~20 were plated singly at 25°C and allowed to lay eggs for 24 hours. 
The plates were  kept at 25°C  for three  days before  being  scored,  plates  segregating 
dauers, Dpy Glp and wild-type worms were kept and the rest discarded.  Several wild- 
type worms from these plates were plated singly at 25°C and allowed to lay eggs for 24 
hours before being discarded. The progeny were then scored to ensure they segregated 
as 25% dauers, 25% Dpy Glp and 50% wild-type animals. The wild-type animals were 
daf-2 (tml236)/ qCl. These animals were then backcrossed twice to the mDfll III/ qCl 
strain.
To construct the daf-16(mgDf50)\  daf-2(tml236)  double mutants I  crossed daf- 
16(mgDf50)\ mDfll! qCl males with daf-2(tml236)/ qCl hermaphrodites at 20°C, and 
then shifted the mated hermaphrodites to 25°C. The worms were allowed to lay eggs for 
24 hours before being discarded. The only fertile progeny of this cross would be daf- 
16(mgDf50)/  +;  daf-2 (tml236)/  qCl  and  daf-16(mgDf50)/  +;  mDfll/  qCl  animals. 
Approximately 20 fertile hermaphrodites from this cross were plated singly at 25°C and 
allowed to lay eggs for 24 hours before being discarded. Plates that did not segregate 
any dauers after three days at 25°C were discarded, as their parents would have been 
daf-16(mgDf50)/ +; mDfll/ qCl animals. Plates with dauers were retained and -20 non- 
dauer non- Dpy Glp animals were picked and plated singly at 25°C, these animals were 
allowed to lay eggs for 24 hours before being discarded. Plates were scored three days 
later. Plates that segregated dauers and Dpy Glp animals were discarded, as were plates
155that  segregated Dpy  Glp  animals but no  dauers.  Plates that  segregated  100%  fertile 
adults were retained and several animals were transferred to 20°C for 24-hour egg lays. 
This worms were then assayed for the presence of both the daf-2(tml236) deletion and 
the  daf-16(mgDf50)  deletion.  All  worms  were  found  to  be  homozygous  for  both 
deletions and so were daf-16(mgDf50)\ daf-2(tml236) double mutants (data not shown).
6.2.2  e!369 Quantitative PCR
Analysis of the daf-2 transcript level in the daf-2 (el369) mutant was carried out using 
RNA  from daf-16(mgDf50)\  daf-2(el369)  animals.  These  double  mutants  were  used 
because they can be grown more easily than the daf-2(el369) single mutant, which has 
a  severe  Daf-c  phenotype  even  at  15°C  (Gems  et  al.,  1998).  Two  different  control 
genotypes were included in the QPCR experiments the first was daf-16(mgDf50), which 
has a wild type daf-2 gene. The second was the daf-16(mgDf50)\ daf-2(m212) double 
mutant, m212 is the second most severe allele after el369, both are class  1, also the 
mutation in m212 is known (Table 5.3.1).
Three  RNA  samples  were  prepared  for  each  genotype  using  the  methods 
described in Chapter 3. Protocols for the first strand cDNA synthesis and QPCR can be 
found in section 3.2.2 and 3.2.4 of the main materials and methods chapter. The ama-1 
gene was used as the endogenous control in all  experiments.  This gene  encodes the 
large subunit of the RNA polymerase II protein (Bird and Riddle,  1989) and has been 
used  as  a  control  gene  in  quantitative  transcript  analysis  previously  as  its  post- 
embryonic mRNA abundance is not subject to strong fluctuation (Johnstone and Barry, 
1996; Larminie and Johnstone, 1996).
Primers for ama-1 transcripts were designed using the Primer3  WWW interface 
(http://ffodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi)  (Rozen  and  Skaletsky,
2000). These primers span exon-exon boundaries in order to prevent the amplification 
of any contaminating genomic DNA within the RNA samples. The «wa-7Fwd primer 
spans the exon 1-exon 2 boundary and the ama-1 Rev primer spans the exon 2-exon 3 
boundary. The primers for the daf-2 transcripts were F2F and FIR (Table 5.2.1), which 
anneal to exon 3 and exon 4 of the daf-2 gene, respectively, which are separated by a 
257bp intron (Table 5.3.4). The primer sequences are listed in Table 6.2.1.
156Table 6.2.1 Primer pairs used in QPCR
Primer name 5’- Sequence - 3’
ama-lFwd CCCGGAGGAGATTAAACGCATG
ama-lRev CATCTTCCACGACGATCTATGA
daf-2 F2F TGAGACGGCTTCGACTTGTCA
daf-2 FIR TGGCGGGTTTTCCT  CATAGCA
Each plate had the general layout seen in Table 6.2.2. All of the QPCR experiments 
were performed using the relative  standard  curve  method  (Applied  Biosystems  user 
bulletin 2, http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf).
6.2.3  DAF-2 antibodies and Western blots
Two different polyclonal antibodies were used in the western blot analysis of the DAF-2 
receptor.  The  first  was  a  commercially  available  antibody,  cN-17  (Santa  Cruz 
Biotechnology Inc.), raised against a peptide mapping to the N-terminus of the DAF-2 
receptor. The second DAF-2 antibody, anti-DAF-2 (Genosphere Biotechnologies), was 
generated against a peptide mapping to the C-terminal extension of the receptor. The 
peptide was designed by me and has the sequence ‘CLTNRGGSNERGAGF’ equivalent 
to residues 1679-1693 of the DAF-2 receptor. The monoclonal MH27 antibody (Francis 
and Waterston, 1991) was used as control antibody and detects the AJM-1 protein from 
C.  elegans  (Koppen  et  al.,  2001).  The  MH27  antibody  was  obtained  from  the 
Developmental Studies Hybridoma Bank at the University of Iowa.
The secondary antibodies used in the western analysis were as follows polyclonal 
anti-goat IgG, monoclonal anti-goat IgG, polyclonal anti-rabbit IgG, monoclonal anti­
rabbit IgG, polyclonal anti-mouse IgG and Fc-specific anti-mouse IgG (all from Sigma). 
All  antibodies  were  peroxidase  conjugates  for  use  in  chemiluminescence  assays. 
Protocols for protein gels and western analysis can be found in Chapter 3.
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1586.2.4 daf-2 RNAi
For RNAi of the daf-2 gene, HT115(DE3) cells transformed with a construct containing 
587 bp of exon 9 of the daf-2 gene ligated into the L4440 vector were used (kindly 
provided  by  Adam  Antebi).  HT115(DE3)  cells  transformed  with  the  L4440  empty 
vector were used as the control treatment. A high penetrance lactose-based induction 
method was used for all  assays,  described  in Chapter 3.2.11.  All worm  strains were 
grown for at least three generations on RNAi bacteria at 15°C before the Daf-c assays 
were performed.
6.2.5  Daf-c assays
Daf-c assays for the strains undergoing daf-2 RNAi and for the nonsense and deletion 
allele strains were carried out at two different temperatures 20°C and 25°C. Assays for 
the daf-2\ daf-28 double mutants were carried out at 15°C, 20°C, 22.5°C and 25°C. All 
Daf-c  assay  were  carried  out as  follows:  10  gravid  hermaphrodites were transferred 
from  15°C  on to  fresh plates  and  allowed  to  lay  eggs  for  six  hours  at the  relevant 
temperature.  In most cases there were two plates per strain at each temperature.  The 
adults were then either discarded, or transferred to fresh plates at the same temperature 
that they had been laying eggs at. The progeny were then scored for dauer formation at 
the following time points: 48 hours for animals at 25°C, 72 hours for animals at 22.5°C, 
80 hours for animals at 20°C and 96 hours for animals at 15°C.
1596.3 Results
6.3.1  daf-2(e!369) transcript levels
The el369 allele of daf-2 has no mutation affecting the coding sequence of the gene or 
the UTRs of the mRNA transcript (see Chapter 5), despite having the most severe Daf-c 
phenotype  of any  ts  allele.  I  first  confirmed  that  this  allele  is  a  daf-2  mutant  by 
performing complementation tests with two different mutants for which the sequence 
change is known: m41  (Yu and Larsen, 2001) and m577 (this project, see Chapter 5). 
The  el369 allele  fails to  complement either of these  alleles  (data not  shown).  This 
excludes  the  possibility  that  el369  lies  in  a  closely  linked  gene  with  a  daf-2-like 
phenotype.
One possible  explanation for the phenotype  of this  allele  is  the  presence  of a 
mutation in a regulatory element of the daf-2 gene. Sequencing of ~5.2kb of genomic 
DNA upstream of the start codon and the entire ~5.5kb first intron of the daf-2 gene 
failed to locate the mutation. Given the size of the daf-2 gene, ~33kb, and the size of the 
5’ intergenic space, ~14kb (see Chapter 4), direct sequencing of the remaining 37kb of 
genomic DNA as a means to identify the el369 mutation was considered too laborious 
and  expensive  for my  thesis  project.  If the  el369  allele  does  have  a  mutation  in a 
regulatory  element it may  be possible to  detect its effect  on the  levels  of the  daf-2 
transcript using QPCR.
160Table 6.3.1 Relative daf-2(e!369) transcript levels
Trial
Relative abundance in 
daf-16(mgDf50) ± sd
Relative abundance in 
daf-16(mgDf50); 
daf-2  (m212) ± sd
Relative abundance in 
daf-16(mgDf50); 
daf-2(el369) ± sd
1 1  ± 0.77 21.54 ±0.98 4.74 ± 1.51
2 1 ± 1.26 1.99 ±0.38 0.76 ±0.51
3 1  ±0.85 1.18 ±0.67 1.79 ±0.62
4 1  ± 0.63 1.77 ±0.76 4.52 ±0.83
5 1  ± 0.74 1.35 ±0.54 0.50 ±0.77
6 1 ± 1.29 1.06 ± 1.32 1.32 ±0.83
7 1  ± 0.83 0.34 ± 0.62 0.23 ±0.41
8 1  ± 0.59 1.13 ±0.49 1.03 ±0.72
9 1  ±0.54 1.26 ±0.35 0.86 ± 0.47
10 1  ± 0.47 0.59 ± 0.42 0.29 ±0.41
Relative levels of daf-2 transcript in daf-16(mgDf50), daf-16(mgDfiO); daf-2(m212) and daf-16(mgDfiO); 
daf-2 (el369)  animals  across  10  independent trials.  There  is  no  clear  evidence  for  a decrease  in  daf-2 
transcript in e l369 animals.
The  QPCR  experiments  were  carried  with  daf-16(mgDfiO);  daf-2(el369)  double 
mutants as these worms are Daf-d and can easily be grown in large, stage-synchronous 
cultures,  unlike  daf-2(el369)  worms  which  will  arrest  as  100%  dauers  at  high 
population density, daf-16(0); daf-2(+) worms were used as the wild-type control, daf- 
16(0);  daf-2(m212)  double mutants were  included as  second  control  for the  general 
effects of daf-2 mutations per se on daf-2 mRNA levels. The m212 allele is the second 
most severe allele of daf-2 after el369 and its mutation has been identified (see Chapter 
5) and is not predicted to alter daf-2 transcript levels.
In  total  10  different  QPCR  experiments  have  been  performed  to  measure  the 
relative transcript levels of the daf-2 gene in daf-16(0), daf-16(0); daf-2(el369) and daf- 
16  (0); daf-2 (m212) worms (Table 6.3.1).  The  levels  of  daf-2  transcript  in  daf- 
16  (mgDfiO); daf-2(m212) were similar to the levels in daf-16(mgDfiO) in five trials. In 
two  trials  it  was  almost  double  the  daf-16(mgDfiO)  levels,  although  the  standard 
deviations overlap so these results are not significant. In the first trial the levels of daf-2 
transcript  in  daf-16  (mgDfiO);  daf-2 (m212)  was  22-fold  greater  than  the  daf- 
16  (mgDfiO).  There were two trials in which levels were lower than daf-16(mgDfiO), 
but again the standard deviations overlap so these results are not significant.
1616.3.2 Using DAF-2 antibodies to detect processing defects
In the previous chapter a combination of homology modelling and comparisons with 
both naturally occurring and induced mutations of the MR and MGF-1R implied that 
several mutants of DAF-2 might cause defects in the processing of the proreceptor. It 
has been possible to  detect  such  defects in MR by performing pulse-chase  labelling 
experiments with cultured cells and observing the various stages in the maturation of the 
receptor  with  the  use  of polyclonal  antibodies,  first  demonstrated  with  the  H209R 
mutant of MR by Kadowaki et al (1991).
In  order  to  try  and  test  my  predictions  about  mutations  that  cause  similar 
processing defects in the DAF-2 receptor, I tested two different DAF-2 antisera using 
western blots. The first was a commercially available goat polyclonal antibody, cN-17, 
from  Santa Cruz Biotechnology Inc.  This antibody was raised against a peptide that 
maps  to  the  N-terminus  of the  DAF-2  protein,  although  the  exact  sequence  of the 
peptide is not available from the company.
The second antibody, which I will refer to as anti-DAF-2, was a rabbit polyclonal 
antibody  that  was  raised  by  Geno sphere  Biotechnologies  against  a  peptide  that  I 
designed.  This  peptide  had  the  sequence  ‘CLTNRGGSNERGAGF’  and  maps  to 
residues  1679-1693  of the DAF-2 receptor.  This sequence lies within the  C-terminal 
extension of the receptor. I chose a to raise an antibody to peptide mapping to the C- 
terminus of DAF-2 for two reasons. The first was the fact that an antibody against the 
N-terminus was already available. The second reason was to see whether the C-terminal 
extension of DAF-2 is cleaved off, like the C-terminal extension of D.  melanogaster 
dlnR (Fernandez et al, 1995).
A requirement for the selection of the 15aa peptide sequence was the presence of 
a cysteine residue as either the N- or C-terminal amino acid to allow conjugation to the 
KLH  carrier  protein.  There  is  only  one  cysteine  residue  present  in  the  C-terminal 
extension of DAF-2 at position 1679. Analysis of the antigenicity of the 14 amino acids 
on either side of Cl679 using the Protean™  module of the Lasergene suite suggested 
either portion of sequence would be suitable. I decided to use the sequence C-terminal 
of Cl679 as this region is better conserved in CMDAF-2 than the sequence N-terminal 
of C1679 (Figure 6.1). The hope was that the antiserum might also recognize C6-DAF- 
2. This region is also better conserved in Cr-DAF-2.
162Figure 6.1 Alignment of peptide sequence used to raise anti-DAF-2
DAF-2  TGASTSSYTGGGPYBInrGGSNERGAGF
C b - DAF-2  TGASNCSYTG-GPY|LTNRGGSNER-AGF
Cr-DAF-2  TGASTASYAG-GPY-LANRGGSNER-AGF
■sk  ^   9c  k  k •  k  k  k  k  k » k k k k k k k k   k  k  k
Peptide chosen  for antibody.  Selection  highlighted  in green  is the region  chosen  for raising  antiserum. 
The cysteine residue for conjugation to KLH carrier protein shown in red.
The first attempt at western blotting with the two different DAF-2 antibodies was 
carried out using 1:1000 dilutions of each antibody and 1:5000 dilutions of the relevant 
polyclonal secondary antibody. I used the MH27 antibody as a positive control; this is a 
monoclonal antibody that recognizes the AJM-1  protein in C.  elegans (Koppen et al., 
2001).  Protein extracts were made from N2 and  daf-16(mgDfiO); daf-2(m65) worms. 
The m65 allele of daf-2 is nonsense mutant that has a stop codon at position 1449 of the 
DAF-2 amino acid sequence. This allele is a candidate null and its mutation is predicted 
to remove the C-terminal extension of the DAF-2 protein. The anti-DAF-2 antibody was 
raised against a peptide that maps to the C-terminal extension. Therefore a western blot 
with this antibody should show a band in the N2 protein sample that is absent in the daf- 
16(mgDfiO);  daf-2(m65) protein  samples.  The  cN-17  antibody  was  raised  against  a 
peptide that maps to the N-terminus of the DAF-2 receptor. This antibody should detect 
bands in both protein samples, however the band in the daf-16(mgDfiO); daf-2(m65) 
protein samples should have a lower molecular weight as it lacks 398aa from the C- 
terminus of the receptor.
My first blot using the conditions above detected multiple bands that were present 
in both the N2 and the daf-16(mgDfiO); daf-2(m65) protein samples. In addition these 
bands were identical in blots for each antibody (Figure 6.2). I suspected that these bands 
were not being recognized by my primary antibodies, but were instead being bound by 
the  secondary  antibodies.  I  therefore  repeated  the  blot,  but  omitted  the  primary 
antibodies and used only the secondary antibodies at the same dilution of 1:5000. The 
blot contained the same bands that had been present in my first blot confirming that the 
bands seen were the result of binding by the secondary antibodies (data not shown). One 
possible  interpretation of this finding is that the  secondary  antibodies were raised  in 
animals with nematode infections.
163The  secondary  antibodies  used  above  were  polyclonal  peroxidase-linked 
antibodies from Sigma. In an attempt to prevent the detection of these spurious bands I 
switched  to  using  monoclonal  anti-Goat  IgG  and  anti-Rabbit  IgG  antibodies  as  the 
secondary antibodies for the DAF-2 antibodies (Sigma). I used an anti-Mouse IgG Fc- 
specific  antibody  (Sigma)  as the  secondary  antibody  to  bind  the  MH27  antibody.  I 
carried  out  a  blot  in  which  only  these  secondary  antibodies  were  used,  again  at  a 
dilution of 1:5000. These antibodies did not detect any bands in either the N2 or the daf- 
16(mgDf50); daf-2(m65) protein samples (Figure 6.3). However, for unknown reasons 
both monoclonal anti-Goat IgG and anti-Rabbit IgG antibodies bound to the molecular 
weight ladder.
Using the new secondary antibodies I performed another blot. The dilution of the 
primary  antibodies  was  1:1000  and  the  secondary  antibody  dilutions  were  kept  at 
1:5000. The two different DAF-2 antibodies were incubated with protein samples from 
N2 and daf-16(mgDf50)\ daf-2(m65) worms. The MH27 antibody was only incubated 
with N2 protein extract. The MH27 antibody detected multiple bands (Figure 6.4). The 
cN-17 antibody also detected several bands. However, these bands were the same size 
in  both  the  N2  and  daf-16(mgDf50);  daf-2(m65)  protein  samples.  These  bands  are 
therefore unlikely to correspond to the DAF-2 protein. The anti-DAF-2 antibody did not 
bind to  anything  in  either protein  sample  (Figure  6.4).  I  repeated  the  western  blots 
several more times using the same conditions as above and also with primary antibody 
dilutions of 1:500. These blots displayed the same bands as seen in Figure 6.4 (data not 
shown). Suggesting that neither of the DAF-2 antisera contain significant levels of anti- 
DAF-2  antibodies,  at  least not antibodies that  bound  to  DAF-2  under  conditions  in 
which the MH27 positive control antibody bound its complementary antigen.
The MH27 monoclonal antibody recognizes the AJM-1  protein (Koppen et al.,
2001).  The ajm-1  gene  encodes  five different splice isoforms  of the  AJM-1  protein. 
Previous  analysis  of the  MH27  antibody  suggests  that  its  antigen  is  greater  than 
150KDa in weight (Francis and Waterston,  1991). Because my western blots produced 
multiple bands with the MH27 antibody when using protein samples from N2 worms I 
decided to try using protein samples from worms with a deletion allele of ajm-1  to 
ensure  that  MH27  was  actually  working  as  a positive  control.  The  SU159  strain is 
homozygous for the ajm-1 (okl 60) deletion allele. This mutation is embryonic lethal, so 
the SU159 strain carries a ajm-1 ::gfp fusion construct as an extra-chromosomal array 
that rescues the lethal phenotype of this mutant (Koppen et al., 2001). This construct
164was made using genomic DNA that includes exons 2-8 of the ajm-1  gene, which are 
common to all splice isoforms of this gene. Western blots using this strain are missing 
two bands compared to protein samples from N2 worms, which are likely to correspond 
to  the  two  largest  isoforms  of AJM-1,  but  have  a  very  bright  additional  band  that 
corresponds  to  the  AJM-1 ::GFP  fusion  protein  (Figure  6.5).  This  confirms  that  the 
conditions  used  for  western  blotting  were  capable  of generating  signal  with  anti­
nematode antibodies.  This in turn provides  support for the view that neither DAF-2 
antiserum contained sufficiently high levels of DAF-2 antibodies to be useful.
165Figure 6.2 1st attempt at western blotting with DAF-2 antibodies
cN 17  MH27  anti DAF 2
49 kDa
First attempt at western blot.  L is the molecular weight ladder. N2  is wild-type protein  sample. m65  is 
daf-16(0)\  daf-2(m65)  protein  sample.  cN-17  is the  Santa  Cruz  DAF-2  antibody,  MH27  is  the  control 
antibody and anti-DAF-2 is the Genosphere DAF-2 antibody. Note binding to similar bands in  all three 
blots when using polyclonal secondary antibodies.
Figure 6.3 Western with new secondary  antibodies only
188 kDa
98 kDa
62 kDa 
49 kDa
anti-Goat  auti-Mouse  anti-Rabbit
L  N2  m65  L  N2  m65  L  N'2  m65  N2
I
Abbreviations  as  above.  Note  that  the  anti-Goat  and  anti-Rabbit  monoclonal  antibodies  bind  the 
molecular weight ladder.
166Figure 6.4 Western blot using primary antibodies with new secondary antibodies
MH27  cN-17  anti-DAF-2
Western blot using monoclonal secondary antibodies. L is the molecular weight ladder. N2  is wild-type 
protein sample. m65 is daf-16(0)\ daf-2(m65) protein sample. Note MH27 binds multiple bands, the bands 
bound by cN-17 are the same in both protein samples, and the anti-DAF-2 antibody did bind anything.
Figure 6.5 Western blot of N2 and SU159 protein sample with MH27
MH27 
L  N2  m65  SU159
188 kDa
98 kDa  -----
62 kDa M
-Missing Bands
■  AJM-1 ::GFP
Abbreviations as above. Note that two of the bands bound by MH27 in the N2 protein sample are missing 
in the SU159 protein sample, which is a ajm-1 deletion allele, but carries a rescuing transgenic ajm-l::gfp 
fusion construct. These are likely to be the largest isoforms of AJM-1.
1676.3.4 Effect of daf-2 RNAi in class 1 and class 2 alleles
RNAi of the daf-2 gene has been shown to increase lifespan by reducing its transcript 
levels in adult worms (Dillin et al, 2002). I decided to use RNAi of daf-2 to further 
reduce transcript levels in both class 1  and 2 alleles. If my prediction that the difference 
between class 1  and class 2 alleles is the asymmetric reduction of She signalling is true 
then further reduction of daf-2 transcript levels should have no effect on the phenotype 
of class 1  alleles. However, if the absolute levels of signalling flux through the receptor 
is what determines the difference between class 1  and 2 alleles then potentially RNAi of 
daf-2 could make class 1  alleles behave as class 2.
The two classes of daf-2 allele have differing epistatic interactions with several 
other genes that regulate dauer formation. Given the opposite effects of the two classes 
when  in  combination  with  daf-12(m20)  I  wondered  if  daf-2\  daf-12(m20)  double 
mutants might act as sensitized background for RNAi of daf-2. Potentially class 1  daf-2 \ 
daf-12 double mutants, which are normally Daf-d at 25°C, might develop the embryonic 
and larval arrest phenotype of class 2 daf-2\ daf-12 double mutants.
168Table 6.3.2 class 1 and 2 RNAi at 20°C Trial 1
Genotype
RNAi
Treatment
%
Dauers
%
Dead
Eggs
%
LI &L2
% Young adult- 
arrested animals
% Late larval 
& Adults N
daf-12(m20) L4440 0 0 0 0 100 399
daf-12(m20) daf-2 0 0 0 0 100 329
daf-2 (m41) L4440 100 0 0 0 0 298
daf-2(m41) daf-2 100 0 0 0 0 133
daf-2(m41); 
daf-12(m20)
L4440 0 0 0 0 100 312
daf-2(m41)\ 
daf-12(m20)
daf-2 0 0 0 0 100 188
daf-2 (el 370) L4440 6.2 0 0 0 93.8 227
daf-2(el370) daf-2 100 0 0 0 0 35
daf-2 (e1370f 
daf-12(m20)
L4440 0 0 0 0 100 188
daf-2 (el 37  Of, 
daf-12(m20)
daf-2 0 0 2.0 98.0 0 49a
Effects of daf-2 RNAi in class 1   (m41) and class 2 {el370) alleles of daf-2 as single mutants and as daf-2; 
daf-12 double mutants at 20°C. daf-2 RNAi has no effect on m41  in either the single or double mutant, 
whereas e l370 forms  100% dauers and daf-2 (el370); daf-12(m20) double mutants arrest as sterile young 
adults. This effect is replicated in the second trial below.a In both trials the total number of worms was 
coincidently the same
T ab le 6.3.3 cla ss 1  a n d  2  R N A i a t 2 0 °C  T rial 2
Genotype RNAi
Treatment
%
Dauers
%
Dead
Eggs
%
L1&L2
% Young adult- 
arrested animals
% Late larval 
& Adults N
daf-12(m20) L4440 0 0 3.1 0 96.9 293
daf-12(m20) daf-2 0 0 0.6 0 99.4 308
daf-2 (m41) L4440 97.4 0 2.6 0 0 117
daf-2 (m41) daf-2 100 0 0 0 0 43
daf-2(m41); 
daf-12(m20) L4440 0 0 0 0 100 96
daf-2(m41);
daf-12(m20)
daf-2 0 0 0 0 100 88
daf-2  (el370) L4440 0 0 0 0 100 93
daf-2 (el 370) daf-2 0 0 100* 0 0 43
daf-2 (el 37  Of 
daf-12  (m2  0) L4440 0 0 0.9 0 99.1 114
daf-2(el370); 
daf-12(m20)
daf-2 0 0 2.0 98.0 0 49a
a In both trials the total number of worms was coincidently the same * Arrested as L2d
169Table 6.3.4 class 1 and 2 RNAi at 25°C Trial 1
Genotype
RNAi
Treatment
%
Dauers
%
Dead
Eggs
%
LI &L2
% Young 
adult-arrested 
animals
% Late larval 
& Adults
N
daf-12(m20) L4440 0 0 1.1 0 98.9 360
daf-12 (m2 0) daf-2 0 0 1.0 0 99.0 397
daf-2 (m41) L4440 99.2 0 0.8 0 0 385
daf-2 (m41) daf-2 86.1 3.0 10.9 0 0 101
daf-2(m41);
daf-12(m20)
L4440 0 0.5 0 0 99.5 398
daf-2 (m41)', 
daf-12(m20)
daf-2 0 0 8.6 91.4 0 151
daf-2 (el 370) L4440 92.5 0 7.5 0 0 228
daf-2(el370) daf-2 98.1 0 1.9 0 0 52
daf-2 (el370); 
daf-12 (m2 0)
L4440 0 0 100 0 0 140
daf-2 (el370); 
dqf-12(m20)
daf-2 0 0 100 0 0 12
Effects of daf-2 RNAi in class 1   (m41) and class 2 (el370) alleles of daf-2 as single mutants and as daf-2\ 
daf-12 double mutants at 25°C. daf-2 RNAi has no effect on daf-2(m41). However, it causes the majority 
of daf-2(m41); daf-12(m20)  animals  to  arrest as  sterile young  adults,  similar to  the  arrest seen  in  daf- 
2(el370)\ daf-12(m20)  animals at 20°C. This effect is replicated  in the second trial below,  daf-2  RNAi 
has no effect on daf-2(el370) or daf-2(el370); daf-12(m20) animals at this temperature.
T ab le 6.3.5 class 1  a n d  2  R N A i a t 2 5 °C  T rial 2
Genotype
RNAi
Treatment
%
Dauers
%
Dead
Eggs
%
LI & L2
% Young 
adult-arrested 
animals
% Late larval 
& Adults
N
daf-12 (m2 0) L4440 0 0 2.1 0 97.9 340
daf-12(m20) daf-2 0 0 0 0 100 341
daf-2 (m41) L4440 96.2 0 3.8 0 0 132
daf-2(m41) daf-2 100 0 0 0 0 55
daf-2 (m41); 
daf-12(m20)
L4440 0 1.42 13.5 0 85.1 141
daf-2 (m41); 
daf-12 (m2 0)
daf-2 0 0 11.8 88.2 0 76
daf-2 (el 370) L4440 97.3 0 2.8 0 0 109
daf-2 (el370) daf-2 82.4 0 17.7 0 0 34
daf-2 (el 37  Of 
daf-12(m20)
L4440 0 0 100 0 0 55
daf-2(el370);
daf-12(m20)
daf-2 0 0 100 0 0 18
170RNAi  of the  daf-2  gene  was  carried  out  in  the  following  backgrounds  daf- 
12 (m2 0), daf-2(m41), daf-2  (el370), daf-2(m41)\ daf-12(m20)  and daf-2(el370);  daf- 
12(m20). Two different temperatures were used (20°C and 25°C) and the lactose-based 
induction method (see Chapter 3). The trials at 20°C were included as controls to check 
for the efficacy of daf-2 RNAi, as the only observable phenotype of this construct on 
wild-type worms is lifespan extension, which was not measured in these experiments. In 
preliminary trials at this temperature daf-2 (el370) did not form dauers on L4440 control 
cells  but formed 100% dauers on daf-2 RNAi (data not shown).
At 20°C  RNAi of daf-2  in daf-2(m41)  (class  1)  was uninformative,  since both 
L4440 control and daf-2 RNAi worms formed 100% dauers (Table 6.3.2 and 6.3.3). On 
standard NGM plates seeded with OP50 this allele forms -14% dauers (Gems et al, 
1998).  Possibly  the  lactose  plates  lead  to  increased  dauer  formation  in  an  m41 
background, although this did not enhance dauer formation in el370 (Table 6.3.2 and 
6.3.3). RNAi of daf-2 in an el370 background led to 100% dauer formation in the first 
trial and 100% L2d formation in the second trial, confirming that there is knockdown of 
daf-2 levels with the use of RNAi in these trials.
RNAi  of daf-2  in  the  daf-2',  daf-12  strains  had  no  effect  on  the  m41  double 
mutant:  as  the  animals  developed  directly  into  adults.  However  daf-2  RNAi  has  an 
interesting  effect on the  el370  double  mutant.  These  worms  arrest  as  sterile  young 
adults with no gonadal development, and shifting these worms to 15°C and onto L4440 
plates does not rescue this effect (data not shown).  This phenotype is seen with daf- 
2(el370); daf-12(m20) mutants grown at 22.5°C on standard NGM plates with OP50 
(Gems et al., 1998; Larsen et al., 1995). The fact that this arrest is not seen in the L4440 
control worms suggests that it is due to the RNAi of daf-2. There also appears to be a 
reduction in fecundity of el370 doubles but not m41.
RNAi of daf-2 at 25°C had no effect on daf-12(m20) worms in either trial. Again 
there was little effect on daf-2(m41); although in the first trial there were -10% LI/ L2 
arrest this was not replicated in the second trial. RNAi of daf-2 in el370 also had no 
detectable  effect,  although the  worms  on  daf-2  RNAi  laid  fewer  eggs  than  control 
worms.  RNAi  of the  el370 double  mutants also  seemed to  reduce  fecundity  of the 
worms, compared to controls, but did not have any other effects. Critically RNAi of daf- 
2 in the m41  double mutants in both trial resulted in retarded larval development and 
ultimate arrest as sterile young adults with no gonadal development, similar to that seen 
in the el370 double mutants at 20°C. Thus, RNAi of daf-2 changes the behaviour of the
171class  1   m41  mutant into that of a class 2 mutant.  This implies that overall levels of 
signalling  flux  through  the  DAF-2  receptor  is  a  determinant  of whether  an  allele 
behaves as class 1  or class 2.
6.3.5  A n alysis of daf-2\ daf-28 d ou b le m u tan ts
The  C.  elegans genome has  39  genes that encode insulin-like peptides,  ins-1  to -37 
(Duret et al.,  1998; Gregoire et al.,  1998; Kawano et al., 2000; Kawano et al., 2003; 
Pierce et al., 2001), ins-38 (M. Costa, personal communication) and daf-28 (Li et al., 
2003). The role of these peptides remains unclear given that DAF-2 is the only member 
of the IR superfamily encoded in the worm genome, but it is postulated that some of 
these peptides are DAF-2 agonists and others antagonists.
e979,  m579  and  sal87  are  all  class  2  daf-2  alleles  with  mutations  in  the 
extracellular portion of the receptor. These alleles are predicted to have altered ligand- 
binding  affinity,  based  on  similar  mutations  in  MR  (chapter  5),  which  in  turn  is 
expected to alter their kinase activity. Class  1   alleles all have extracellular mutations, 
except  el369,  but  unlike  the  extracellular  class  2  alleles  these  mutations  are  not 
predicted to affect ligand binding and may remain responsive to ligand.
The  daf-28(sal91)  allele  is  the  only  mutant  of an  insulin-like  peptide  in  C. 
elegans that has a phenotype (Li et al., 2003). This allele is semi-dominant resulting in 
-10%  dauer formation in heterozygous  animals  (Malone  and Thomas,  1994).  When 
homozygous this allele  forms  dauers  at all temperatures,  with increasing  severity  as 
temperature  increases,  which  are  able  to  recover  (Malone  and  Thomas,  1994).  The 
sal 91  allele  has  a  missense  mutation  causing  a  R37C  substitution  that  affects  the 
proteolytic processing site of the DAF-28 peptide (Li et al., 2003). The mutant DAF-28 
peptide is believed to act as poisonous ligand that interferes with signalling role of the 
other INS peptides.
I have constructed daf-2\ daf-28(sal91) double mutants with both class 1   (m577) 
and class 2 (m579) alleles of daf-2. If the above is correct, sal91  should enhance the 
mutant phenotype of class  1, but not class 2 mutants.  I have performed Daf-c assays 
with  the  following  genotypes;  N2,  daf-28(sal91),  daf-2(m577),  daf-2(m579),  daf- 
2(m577)\  daf-28(sal91)  and  daf-2(m579);  daf-28(sal91).  Because  the  sal91  allele 
forms a proportion of dauers at all temperatures I performed the Daf-c assays at 15°C,
17220°C, 22.5°C and 25°C. It should be noted that the first trials at each temperature were 
set up on a day when temperatures in our lab exceeded 30°C due to an air conditioning 
failure; this may be account for the increased embryonic and early larval arrest seen in 
the first trial compared to the second trial at each temperature.
T ab le 6.3.6 daf-2x daf-28 D af-c at 1 5 °C  T rial 1
Genotype % Dauers % Dead Eggs % LI & L2 % Late larval & 
Adults
N
N2 0 0 5.0 95.0 120
daf-28(sal91) 0 0 10.5 89.5 76
daf-2 (m5 77) 0 0 6.2 93.8 96
daf-2 (m579) 0 0 5.0 95.0 81
daf-2 (m577)\ 
daf-28(sal91)
39.2 0 16.2 44.6 74
daf-2 (m579); 
daf-28(sal91)
0 0 7.0 93.0 43
Dauer formation  in class  1  (m577) and class 2  (m579) daf-2\ daf-28 double mutants at  15°C. The m577 
allele  does  not  form  dauers  at this  temperature.  The daf-2(m577)\  daf-28(sal91)  double  mutant  forms 
-40% dauers in both trials at 15°C, which means that daf-28 (sal 91) enhances the Daf-c phenotype of this 
allele. The daf-2 (m579); daf-28(sal91)  double mutant behaves similarly to the daf-28(sal91) mutant in 
both trials, suggesting that the m579 allele is unresponsive to the daf-28(sal91) poison ligand.
T ab le 6.3.7 daf-2:  daf-28 D af-c at 1 5 °C  T rial 2
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 1.7 98.3 351
daf-28(sal91) 8.5 0 0 91.5 271
daf-2(m577) 0 0 0.7 99.3 283
daf-2 (m579) 0 0 0 100 260
daf-2 (m5 77f 
dqf-28(sal91)
37.9 0 0 62.1 132
daf-2 (m579)\ 
daf-28(sa!91)
13.0 0 0 87.0 170
At  15°C  daf-28(sal91)  has  been  reported  to  form  8.1%  dauers  (Malone  and 
Thomas, 1994). In these Daf-c experiments at 15°C the sal91 allele formed no dauers in 
the first trial, although there was -10% LI and L2 arrest (Table 6.3.6), and 8.5% dauers
173in the  second trial (Table 6.3.7).  The m577 and m579 alleles form no dauers at this 
temperature. Addition of the sal 91  allele increased dauer formation in m577 but not 
m579 mutants in both trials. This supports the view that in m577 but not m579 mutants, 
the DAF-2 receptor remains responsive to ligand.
At 20°C the sal91  allele formed between 30-40% dauers in the two trials.  The 
m577 allele forms no dauers at this temperature. As at 15°C, the Daf-c phenotype of the 
daf-2(m571); daf-28(sal91) was greater than the single mutants. The m579 allele was 
previously been shown to form between 0% (Gems et al., 1998) and 4.2% (Labbe et al., 
2000) dauers at 20°C. Here, at 20°C the m579 allele formed no dauers in the first trial, 
and -39% dauers in the second trial (Table 6.3.9). At  20°C sal91 allele also enhanced 
the  Daf-c  phenotype  of m579  in  the  double  mutants.  However,  the  level  of dauer 
formation in the daf-2(m579)\ daf-28(sal91) strain was lower than in daf-2(m577); daf- 
28(sal91). This is despite the fact that m577 is a much weaker allele in terms of Daf-c 
than m579 (Gems et al.,  1998) (Table 6.3.10 and 6.3.11). This implies that the DAF-2 
receptor in the m579 mutation can still respond to the sal 91 poison ligand.
At 22.5°C the sal91 allele again formed between 30-40% dauers in the two trials 
(Table  6.3.10  and  6.3.11).  The  m577  allele  formed  0-0.5%  dauers,  consistent  with 
previous observations in Gems et al (1998). Again the sal91 allele enhances the Daf-c 
phenotype of the m577 allele in the double mutant.  The embryonic arrest seen in the 
double mutants, respectively, in the first trial is probably due to temperature problems 
described  earlier,  since  the  second  trial  does  not  have  any  embryonic  arrest  at this 
temperature. The m579 allele formed -90% and -98% dauers in the two trials at 22.5°C. 
This is higher than previous observations of 50% (Gems et al, 1998) and 60.9% (Labbe 
et al., 2000) at this temperature. At this temperature an interaction between m579 and 
sal 91 was undetectable due to the high level of Daf-c resulting from m579 alone.
The sal91 allele was previously found to form 99% dauers at 25°C (Malone and 
Thomas, 1994). In my two trials the sal 91 allele formed -71% and -97% dauers (Table 
6.3.12 and 6.3.13). m577 allele formed -80% and -90% dauers in the two trials, with 
-10%  LI/ L2  arrest  in both trials.  The  daf-2(m577);  daf-28(sal91)  double  mutants 
formed -31% and -71% dauers, with -62% and -13% embryonic arrest, respectively. 
The  high  degree  of embryonic  arrest  in  the  first  trial  was  most  likely  due  to  the 
temperature  problems  described  before.  The  m577 allele  on  it  own  did  not  display 
embryonic arrest at 25°C in the second trial, but the m577; sal91  double did show a 
significant level of such arrest. Possibly this means that the daf-2(m577)\ daf-28(sal91)
174double  mutant  is  behaving  as  class  2  mutant  of  daf-2,  which  often  show  some 
embryonic arrest at 25°C (Gems et al.,  1998). The daf-2(m579); daf-28(sal91) double 
mutants also show enhanced embryonic arrest compared to the m579 and sal91 alleles 
on their own. Casual observations suggest that both double mutants also have drastically 
reduced fecundity compared to the single mutants.
To further test the possibility that daf-2(m577); daf-28(sal91) behaves as a class 2 
mutant I tested the daf-2’ , daf-28 double mutants for the class 2 25°C Unc phenotype. 
Both daf-2(m579) and daf-2(m579); daf-28(sal91) alleles developed the Unc phenotype 
by the third day at this temperature (data not shown). In contrast the daf-2(m577), daf- 
28(sal91)  and daf-2(m577); daf-28(sal91) mutants had not become Unc by the sixth 
day  of monitoring.  Taken  together  results  from  these  daf-2;  daf-28  studies  provide 
support for the model derived from the sequencing and modelling studies of Chapter 5. 
It appears that class 1  mutants are more responsive to ligand to INS ligand than class 2 
mutations affecting the extracellular domain.
175Table 6.3.8 daf-2i daf-28 Daf-c 20°C Trial 1
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 1.9 98.1 208
daf-28(sal91) 21A 0 3.1 69.5 164
daf-2 (m577) 0 0 3.3 96.7 153
daf-2(m579) 0 0 8.1 91.9 197
daf-2 (m577); 
daf-28(sal91)
87.1 0 6.0 6.9 101
daf-2 (m579); 
daf-28(sa!91)
75.0 0 25.0 0 36
T ab le 6.3.9 daf-2;  daf-28 D af-c 20°C  T rial 2
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 0 100 470
daf-28(sal91) 40.9 0 0 59.1 342
daf-2 (m577) 0 0 0 100 380
daf-2(m579) 38.7 0 0 61.3 225
daf-2 (m577); 
daf-28(sal91)
97.4 0 0 2.6 151
daf-2 (m579); 
daf-2 8 (sal 91)
67.4 0 0.7 31.9 138
Dauer formation  in  class  l(/w577)  and  class 2  (m579)  daf-28 double mutants  at 20°C.  The m577
allele  does  not  form  dauers  at this  temperature.  The  daf-2(m577);  daf-28(sal91)  double  mutant forms 
between  -90-100%  dauers  in  both  trials  at  20°C,  the  enhancement  of the  Daf-c  phenotype  is  much 
stronger than at 15°C (Table 6.3.6 and 6.3.7). The daf-2(m579); daf-28(saJ91) double mutant also shows 
an enhancement of the Daf-c phenotype at this temperature.
176Table 6.3.10 daf-2: daf-28 Daf-c 22.5°C Trial 1
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 0 100 201
daf-28(sal91) 39.9 0 8.1 52.0 148
daf-2 (m577) 0.5 0 4.50 95.0 219
daf-2 (m579) 89.6 7.2 3.2 0 221
daf-2 (m5 77); 
daf-28(sal91)
61.2 35.5 3.3 0 121
daf-2(m579); 
daf-28 (sa!91)
78.4 17.7 3.9 0 51
T ab le 6.3.11  daf-2:  daf-28 D af-c 2 2 .5 °C  T rial 2
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 0 100 242
daf-28(sal91) 31.9 0 0 68.1 157
daf-2 (m577) 0 0 0 100 164
daf-2(m579) 97.8 0 2.2 0 136
daf-2 (m5 77); 
dqf-28(sal91)
97.9 0 2.1 0 95
daf-2 (m579); 
daf-28(sal91)
96.2 0 3.8 0 105
Dauer formation in class  \{m57T) and class 2 (m579)  daf-28 double mutants at 22.5°C. The m577
allele does not usually form  dauers at this temperature.  The daf-2(m577); daf-28(sal91) double mutant 
has a strong embryonic lethal phenotype in the first trial (35.5%) that is not displayed in the second trial. 
However, the Daf-c phenotype of m577 is still enhanced by daf-28(sal91). At this temperature both daf- 
2(m579)  and daf-2(m579);  daf-28(sa!91)  form  ~100% dauers,  which  obscures  any  possible  interaction 
between the two genes.
177Table 6.3.12 daf-2; daf-28 Daf-c 25°C Trial 1
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 3.4 96.6 146
daf-28(sal91) 71.4 24.4 4.2 0 119
daf-2 (m577) 80.9 10.9 8.2 0 183
daf-2 (m5 79) 86.8 3.3 9.9 0 151
daf-2 (m5 77); 
daf-28(sal91)
30.8 61.7 7.5 0 107
daf-2(m579); 
daf-28(sal91)
16.0 60.0 24.0 0 25
Table 6.3.13 daf-2: daf-28 Daf-c 25°C Trial 2
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 2.5 97.5 243
daf-28(sal91) 97.0 0 0.6 2.4 169
daf-2(m577) 90.4 0 9.6 0 156
daf-2 (m579) 84.6 1.9 13.5 0 156
daf-2 (m5 77); 
daf-28(sal91)
71.3 13.4 15.3 0 157
daf-2(m579);
daf-28(sal91)
29.2 70.8 0 0 48
Dauer formation  in  class  \{m577)  and class  2  (m579)  daf-2;  daf-28 double  mutants  at 25°C.  The  daf- 
2(m577); daf-28(sal91) double mutant has a strong embryonic lethal phenotype in the first trial, 61.7%, 
but  only  13.4%  in  the  second  trial.  This  trait  is  seen  in  class  2  alleles  of daf-2,  potentially  the  daf- 
2(m579); daf-28(sa!91) double mutant is phenocopying a class 2 allele. The daf-2(m579); daf-28(sal91) 
double mutant also has a strong embryonic lethal phenotype in both trials.
1786.3.6 Analysis of daf-2(m65) and daf-2(tm!236)
Currently there are no fully confirmed null alleles of daf-2, although Gems et al (1998) 
provide evidence that m65 is a strong candidate.  We have sequenced the m65 coding 
sequence  and identified its lesion (Chapter 5,  Table 5.3.1).  m65 contains a nonsense 
mutation with an amber stop codon replacing the W1449 codon. Two other nonsense 
alleles of daf-2 have also been identified: these are m631  (this thesis) and m646 (K. 
Kimura and G. Ruvkun, personal communication). The stop codons in both m631 and 
m646 are more N-terminal than that of m65 (Table 5.3.1). The m631 allele has opal stop 
codon at position 281  of the DAF-2 amino acid sequence and so the predicted protein 
produced by this allele will be truncated at the LI  domain and lack all activity.  The 
m646 allele has an ochre codon at position 1223 of the DAF-2 amino acid sequence and 
its predicted protein would lack the entire TK domain and C-terminal extension of the 
receptor. The m65 mutation affects the C-terminal half of the TK domain, specifically 
the aF helix that follows on from the catalytic and activation loops of the TK domain. 
So  the  predicted  protein  produced  by  this  allele  would  contain  two  of  the  most 
important parts of the TK domain.
Based on the position of the nonsense codons one might infer that m631 and m646 
represent better candidates for a daf-2 null allele. However, epistasis analysis of these 
three  nonsense mutants with null  alleles of daf-16 and daf-18 does  not  support this 
prediction (M. Nanji and D. Gems, unpublished data) (Table 6.1.1). The m646 allele is 
fully  suppressed  by  both  daf-16(mgDf50)  and  daf-18(nr2037)  at  15°C  and  25°C, 
whereas the m631 allele displays -30% LI  and L2 arrest at 25°C in a daf-18(nr2037) 
background. The m65 allele produces  100% and 70% dead eggs at 25°C in daf-16(0) 
and  daf-18(0)  backgrounds,  respectively.  This  suggests  the  following  allelic  series 
m65<  m631< m646 based  on  DAF-2  activity.  The  greater  suppression of m646 and 
m631 by daf-18(0) compared to m65 implies that these alleles must have some DAF-2 
activity, even though their predicted protein sequences lack the TK domain, and so are 
not null.  Most likely there  is  some translational  readthrough of the m631  and m646 
transcripts producing functional protein. It remains unclear whether there is readthrough 
of m65 transcript and therefore it remains the best candidate for a daf-2 null allele.
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allele of daf-2.  The tml236 allele has an in-frame 561bp deletion of exon  14, which 
leads  to  a  187  amino  acid  deletion  within  the  TK  domain  of the  DAF-2  receptor 
(Chapter 5).  This deletion removes both the catalytic and activation loops of the TK 
domain, which are both present in the m65 predicted protein, but retains the C-terminal 
extension of the DAF-2 receptor. Therefore the tml236 allele is predicted to be kinase 
dead and is a good candidate for a null allele of daf-2 on molecular grounds.
I  decided  to  assay  the  m65  and  tml236  alleles  to  see  if  it  was  possible  to 
distinguish between the two phenotypically and establish if either or both are null alleles 
of daf-2.  I  performed  Daf-c  assays  on  both  alleles  either  balanced  over  the  qCl 
inversion,  as  both  alleles  are  non-conditional,  or  as  daf-16(mgDf50);  daf-2  double 
mutants at 25°C.  This temperature  was used because of the  100%  embryonic  lethal 
phenotype observed in daf-16(mgDf50); daf-2(m65)  double mutants by  Manoj  Nanji 
and David Gems (personal communication), a similar phenotype was found with daf- 
16(m26); daf-2(m65) double mutants (Larsen et al., 1995).
In the first of two trials at 25°C I found that the m65 and tml236 alleles, when 
over the qCl balancer, segregated 23.0% and 26.0% dauers, respectively (Table 6.3.14). 
Neither of these alleles had any embryonic lethality at this temperature when over the 
balancer chromosome. When these alleles were placed in the daf-16(0) background at 
this temperature I found that tml236 allele was almost fully suppressed, although it did 
have -7% LI and L2 arrest. Unexpectedly I found that the daf-16(0); daf-2(m65) double 
mutant produced only 31.3% dead eggs, with 44.8% of animals arresting as Lis and 
L2s. Interestingly, I found that  23.96% of animals made it through to adulthood.
In the second trial at 25°C I found that only 12.9% and 15.8% of progeny arrested 
as  dauers  from the m65! qCl  and  tml236/ qCl  worms,  respectively  (Table  6.3.15). 
However, this was accompanied by a rise in the number of worms arrested as Lis and 
L2s. In this trial I found that the majority of daf-16(0); daf-2(tml236) double mutants 
reached adulthood, while  12.8% arrested as Lis and L2s.  The daf-16(0);  daf-2(m65) 
double mutants produced 42.2%  dead eggs,  22.3% Lis and L2s and 35.5% reached 
adulthood.  Possibly,  the  discrepancies  between  this  trial  and  the  first  were  due  to 
temperature fluctuations in the incubators used.
180Table 6.3.14 Daf-c of m65 and tm!236 at 25°C trial 1
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 4.0 96.0 151
daf-16(mgDf50) 0 0.5 5.4 94.1 204
daf-2(m65)/ qCl 23.0 0 1.0 76.0 183
daf-16(0f
daf-2(m65) 0 31.3 44.8 23.9 96
daf-2 (tml236)1 qCl 26.0 0 2.0 72.0 154
daf-16(0)\ 
daf-2 (tml236) 0 0 6.84 93.16 117
Table 6.3.15 Daf-c of m65 and tm!236 at 25°C trial 2
Genotype % Dauers % Dead Eggs % LI & L2
% Late larval & 
Adults
N
N2 0 0 7.4 92.6 394
daf-16(mgDf50) 0 0 2.0 98.0 197
daf-2 (m65)/qCl 12.9 0 11.8 75.3 183
daf-16(0);
daf-2(m65) 0 42.2 22.3 35.5 121
daf-2(tml236)l qCl 15.8 0 7.2 77.0 139
daf-16  (Of 
daf-2(tml236) 0 0.8 12.8 86.4 186
Dauer formation assays in m65 and tml236 single mutants and as daf-16; daf-2 double mutants. In the fist 
trial both the m65/ qCl  and tml236l qCl  segregate -25% dauers and -75% adults (of which  -25% are 
Dpy Glp). In the second trial ratio is masked by some early larval arrest. In both trial the daf-16(mgDf50f 
daf-2(m65) double mutant has high levels of embryonic and early larval arrest. Whereas, the majority of 
daf-16(mgDf50f daf-2(tml236) double mutants proceed onto adulthood, suggesting that tml236 is almost 
fully suppressed by daf-16(0) and has more DAF-2 activity than m65.
The tml236 allele must be kinase-dead,  since its deletion removes a section of 
exon 14 that encodes the catalytic and activation loops of the DAF-2 receptor. However, 
it is clear from the data above that tml236 is not a null allele of daf-2, as it is almost 
fully suppressed by daf-16(0). This allele therefore retains some DAF-2 activity.
The daf-16(0)\  daf-2(m65)  double  mutant displays  a  30-40%  embryonic  lethal 
phenotype at 25°C, indicating that DAF-2 has a DAF-16 independent function during
181embryogenesis. One possibility is that the tml236 allele is actually a null allele, and the 
m65 protein product has an antimorphic activity. I decided to test this by using RNAi of 
the daf-2 gene on both double mutants to see if reducing transcript levels affected their 
phenotype. If the m65 allele is antimorphic, then RNAi of daf-2 might reduce its mutant 
severity.  If it  is  a  null  then  RNAi  of daf-2  should  not  increase  the  severity  of its 
phenotype.
Table 6.3.16 RNAi of tm!236 and m65 at 25°C trial 1
Genotype
RNAi
treatment
%
Dauers
%
Dead Eggs
%
LI &L2
%
Late larval & 
Adults
N
daf-16(0); 
daf-2(m65)
L4440 0 92.4 6.8 0.8 132
daf-16(0); 
daf-2(m65)
daf-2 0 25.6 23.3 51.1 43
daf-16(0); 
daf-2 (tml236)
L4440 0 0 3.8 96.2 292
daf-16(0); 
daf-2(tml236)
daf-2 0 0 4.5 95.5 286
Table 6.3.17 RNAi of tml236 and m6S at 25°C trial 2
Genotype
RNAi
treatment
%
Dauers
%
Dead Eggs
%
LI & L2
%
Late larval & 
Adults
N
daf-16(0);
daf-2(m65)
L4440 0 83.1 14.7 2.2 177
daf-16(0); 
daf-2(m65)
daf-2 0 78.1 20.7 1.2 169
daf-16(0); 
daf-2 (tml236)
L4440 0 0.9 1.8 97.3 114
daf-16(0); 
daf-2 (tml236)
daf-2 0 0 5.1 94.9 118
RNAi of the daf-2 gene in daf-16; daf-2 double mutant backgrounds. Neither the daf-16(mgDf50); daf- 
2(m65)  double  mutant  or  the  daf-16(mgDf50)\  daf-2 (tml236)  double  mutant  is  affected  by  further 
reduction in levels of DAF-2 by using RNAi to knockdown daf-2 transcript levels.
In the  first trial at this temperature  over  50%  of RNAi treated  daf-16(0);  daf- 
2(m65) progeny reached adulthood, whereas  only 0.8% of controls reached adulthood. 
In the second trial only 1.2% and 2.2% of progeny from daf-2 RNAi and control worms
182reached adulthood, respectively. I conclude that RNAi of the daf-2 gene in daf-16(0); 
daf-2(m65) and daf-16(0); daf-2(tml236)  at 25°C has no effect on the severity of the 
phenotypes  of these  double  mutants.  This  implies  that  m65  is  the  best  candidate 
molecular null allele of daf-2, and is not antimorphic.
1836.4 Discussion
In this chapter I attempted to experimentally test some of the hypotheses about the role 
of DAF-2  signalling  flux  in  determining  the  class  1   and  2  phenotypes  that  were 
generated in the previous chapter.  Specifically, I asked whether the el369 allele is a 
regulatory  mutant that affects daf-2 transcript level.  I  evaluated the potential  of two 
different DAF-2 antibodies in detecting processing defects in daf-2 mutants that might 
leads to reduced levels of the receptor at the cell surface. I have also used RNAi of the 
daf-2 gene in class 1   mutants to see if they develop class 2 phenotypes in response to 
reduced  daf-2  transcript  levels.  I  also  probed  the  potential  role  of  ligand-receptor 
interaction in determining the class 1  and class 2 phenotypes by constructing daf-2\ daf- 
28 double mutants. Finally, I compared a nonsense allele and a deletion allele in order 
to identify a null allele of daf-2.
6.4.1  daf-2 transcript levels in the el369 allele
In the previous  chapter  I  identified the  molecular  lesion in  several  alleles  of daf-2. 
However, I failed to find a mutation in the either coding sequence of the el369 allele or 
the UTRs of its transcript. I confirmed that this allele was actually a daf-2 mutant by 
performing complementation tests with two alleles of daf-2 whose mutations had been 
identified. The lack of mutation in the coding sequence suggests that the lesion in el369 
affects a regulatory region of the daf-2 gene. This might lead to reduced expression of 
daf-2  mRNA  and  in  turn  reduced  levels  of DAF-2  receptor  in  the  worm.  This  is 
consistent  with  my  hypothesis  that  class  1   alleles  of daf-2  have  reduced  wild-type 
signalling flux.  I  sequenced ~5.2Kb of genomic DNA upstream of the start codon as 
well as the entire 5.5kb first intron of the daf-2 gene from el369 worms, which is where 
one would expect to find most regulatory elements, but failed to find any mutations.
Given that the daf-2 gene spans ~33Kb and the 5’ and 3’ intergenic spaces occupy 
a further ~20Kb (Chapter 4), rather than carry on sequencing I decided to directly look 
for reduced transcription of the daf-2 gene in el369 by using QPCR. The el369 allele 
has the most severe Daf-c phenotype of all ts daf-2 mutants, even though it is class  1, 
and forms 55% dauers at 15°C. This phenotype makes it very difficult to grow stage-
184specific cultures of this mutant for the RNA samples needed for QPCR, especially since 
at high population density 100% of el369 worms arrest as dauers. To get around this I 
measured the daf-2 transcript levels in daf-16(0); daf-2(el369) double mutants, which 
are Daf-d and can easily be grown in large stage-synchronous cultures, daf-16(0) worms 
were used as the control as these worms have a wild-type daf-2 gene.
One potential concern about using daf-16(0) mutants is the possibility that DAF- 
16 regulates transcription of daf-2.  This is certainly true for the orthologues of these 
genes in D.  melanogaster, where dFOXO up-regulates the expression of the dinr gene 
(Puig et al, 2003). If DAF-16 does regulate daf-2 gene expression then using the daf- 
16(0)  null  allele  may  mask  any  DAF-16  dependent  differences  in  gene  expression 
between  the  el369  allele  and  wild-type  daf-2.  However,  the  microarray  data  from 
McElwee et al (2004) does not show a significant difference in the expression of the 
daf-2 gene between daf-2 mutants and daf-16\ daf-2 mutants.
I performed a total of 10 trials of QPCR to measure the levels of daf-2 transcript 
in daf-16(0); daf-2(el369), daf-16(0); daf-2(m212) and daf-16(0) mutants. I found that 
mean levels of daf-2 transcript were lower in the el369 double mutants compared to the 
daf-16(0) control worms in only five of these trials, and in no case was this reduction 
significant (Table 6.3.1). In three trials the levels of transcript were similar between the 
two genotypes, while in two of the trials the levels of daf-2 transcript was significantly 
higher in el369 double mutants than daf-16(0) controls.
It is difficult to interpret the results of these trials. Overall, the results suggest a 
trend towards  a reduction  in  the  levels  of daf-2 transcript  in the  el369  allele.  One 
possibility is that the mutation in the el369 allele affects the transcription of the daf-2 
gene in a tissue-specific manner. It is known that daf-2 regulates both dauer formation 
and longevity in a cell non-autonomous manor (Apfeld and Kenyon,  1998; Wolkow et 
al., 2000). Therefore loss of DAF-2 activity in just a few cells can have large effects on 
the Daf-c and Age phenotypes of a worm. If the mutation in el369 abolishes or severely 
reduces the transcription of the daf-2 gene in these key cells it may cause the severe 
Daf-c phenotype of this allele without causing a detectable decrease in the levels of daf- 
2 transcript, which are measured from whole worm RNA preparations. Currently there 
are  no  methods  available  that  allow  tissue-specific  RNA  extraction  in  C.  elegans. 
Possibly, one could probe this hypothesis by looking at tissue specific effects on DAF- 
16 target gene expression using GFP.
1856.4.2 DAF-2 antibodies
In  the  previous  chapter  I  predicted that  several  alleles of daf-2  have  mutations that 
might cause processing defects in the DAF-2 proreceptor leading to a reduction in the 
level of mature receptor at the cell surface. I was interested in seeing if it was possible 
to detect the processing defects using DAF-2 antibodies. As a first step towards this I 
evaluated  the  potential  of two  different  DAF-2  antibodies  at  detecting  the  DAF-2 
protein using western blotting.
The  first  was  a  commercially  available  DAF-2  antibody  from  Santa  Cruz 
Biotechnology  Inc.  This  antibody  was  raised  against  a peptide  that  maps  to  the  N- 
terminus of the receptor. The second was anti-peptide antibody that mapped to the C- 
terminus. I deliberately targeted the C-terminal extension of the DAF-2 protein for two 
reasons. Firstly, I was interested in whether this feature is cleaved off from the receptor. 
It has been shown that the C-terminal extension of dlnR is cleaved off in a cell-specific 
manner  (Fernandez  et  a l,  1995).  Secondly,  at  this  time  point  I  had  identified  two 
nonsense mutants, m65 and m631, of daf-2 and informed of a third m646 (K. Kimura 
and  G.  Ruvkun,  personal  communication).  All  three  of  nonsense  mutations  are 
predicted to  truncate the  DAF-2  receptor before the  C-terminal extension.  Therefore 
protein samples from these alleles might be useful controls in western blotting, as a C- 
terminal antibody should not bind anything.
Unfortunately,  I  was unable to  detect any bands with the anti-DAF-2  antibody 
under  conditions  in  which  the  MH27  antibody  gave  a  positive  signal.  The  cN-17 
antibody  detected  several bands  in both N2  and daf-16(mgDf50)\  daf-2(m65)  protein 
samples. However these were same size in both protein samples, which suggested that 
this  antibody  was  not  binding  to  DAF-2,  as the  protein from  daf-16(0);  daf-2(m65) 
worms should run at a lower molecular weight as it is ~400aa shorter than wild-type. It 
may be that I did not use a high enough concentration of these antibodies, as I only went 
as  high  as  1:500  dilutions.  It  would  be  beneficial  to  try  taking  the  antibody 
concentration as high as  1:100.  Another way to test these antibodies further is to try 
immunolocalization.  Which  if  successful  could  be  used  to  directly  look  at  the 
subcellular  localization  of the  DAF-2  receptor  in mutants with predicted  processing 
defects. Overall, antipeptide antibodies are less effective than antibodies raised against 
whole proteins or protein fragments, as the short peptide sequences used may not adopt
186the same conformation it has in the native protein. Potentially, antibodies raised against 
the whole DAF-2 protein or one of its domains may be more effective.
With hindsight, the use of the MH27 monoclonal antibody as a positive control 
was  a  poor  choice.  This  antibody  is  generally  used  in  immunolocalization  assays 
(Koppen et al., 2001). The only published reference that mentions this antibody in the 
context of western blotting is Francis and Waterston (1991) in which its only mention is 
that it recognises a protein greater than 150KDa in size. My western blots of N2 protein 
samples with MH27 generated multiple bands (Figure 6.4 and 6.5), some of which were 
in the correct size range as indicated in Francis and Waterston (1991). The antigen of 
the  MH27  antibody  has  been  recently  identified  (Koppen  et al,  2001).  The  MH27 
antibody in immunolocalization assays binds to the AJM-1 protein, a component of the 
apical junction.
The ajm-1  gene is predicted to have five different splice isoforms, which may 
account for some of the multiple bands seen in the N2 sample. However, I was able to 
confirm that the  MH27  antibody  was  binding  to  the  AJM-1  isoforms  by  using  the 
SU159 strain. This strain of C.  elegans is homozygous for a deletion allele of ajm-1, 
which is lethal. This strain is rescued by an extra-chromosomal array containing exons 
2-8 of the ajm-1 gene fused to GFP (Koppen et al., 2001). A western blot of protein 
from this strain has a bright band that corresponds to the fusion protein and is missing 
two  bands  compared  to  N2  protein  samples,  which  correspond  to  the  two  largest 
isoforms of AJM-1 (Figure 6.5).
My  initial  attempts  at  western  blotting  with  both  of these  antibodies  and  my 
control  antibody  MH27  were  complicated  by the  fact  that  my  secondary  antibodies 
seemed  to  binding  worm  proteins  (Figure  6.2).  These  secondary  antibodies  were 
polyclonal so I decided to try using monoclonal anti-Goat and anti-Rabbit antibodies for 
my  DAF-2  primary  antibodies  and  an  anti-Mouse  Fc-specific  antibody  for  MH27. 
These new secondary antibodies did not appear to react with any worm proteins (Figure
6.3), although the anti-Goat and anti-Rabbit monoclonals did  seem to react with the 
molecular weight ladder. The binding of the secondary antibodies to C. elegans proteins 
suggests that the animals in which the antibodies were raised had parasitic nematode 
infections.
1876.4.3 RNAi of the daf-2 gene class 1 and 2 alleles
In the previous chapter I proposed that class 1   alleles of daf-2 have mutations that lead 
to  reduction  of  wild-type  signalling  flux  from  the  receptor.  Class  2  alleles  have 
mutations that asymmetrically reduce  signalling flux from the receptor,  affecting the 
She/ MAP kinase pathway more than the PI3 kinase pathway. I have used RNAi of the 
daf-2 gene to test the role of signalling flux in both classes of mutant as well as in daf-2\ 
daf-12 double mutants.
The critical result of this experiment is the effect of daf-2 RNAi on daf-2 (m41); 
daf-12(m20) double mutants at 25°C. These mutants develop normally into fertile adults 
on L4440 control plates (Table 6.3.4 and 6.3.5). On daf-2 RNAi, however, these worms 
arrest  as  sterile  young  adults  in  the  same  way  that  the  daf-2 (el370);  daf-12(m20) 
mutants on daf-2 RNAi at 20°C do (Table 6.3.2 and 6.3.3).  This  arrest  phenotype  may 
indicate  that  the  daf-2(41)\  daf-12(m20)  double  mutants  have  acquired  a  class  2 
phenotype. If this were true it would mean that class 1  and 2 phenotypes correlate with 
absolute levels of DAF-2 activity and that my hypothesis about asymmetrical signalling 
flux is too simplistic.
It would be  interesting to  see  if this holds true for other class  1   daf-2 \  daf-12 
double mutants, as m41  is an unusual allele in that affects a novel amino acid that is 
only present in the nematode members of the IR superfamily (Chapter 5). Possibly the 
effect  of  RNAi  on  m41  is  atypical  of  class  1   alleles.  Although  its  severe  Daf-c 
phenotype and the result above are consistent with idea that class 1  mutations generally 
reduce levels of the DAF-2 receptor at the cell surface without altering its signalling 
ability.
6.4.4 Interaction between daf-2 and daf-28
One  of the  predictions  from  the  previous  chapter  is  that  class  1   mutations  remain 
responsive to ligand, whereas class 2 extracellular mutants have ligand-binding defects. 
I constructed double mutants of both class 1  and class 2 alleles with the daf-28(sal91) 
allele. The daf-28(sal91) allele encodes a mutant insulin-like peptide that has a Daf-c 
phenotype (Li et al., 2003) and is believed to act as poisonous ligand. My expectation
188was that class  1   mutants would be responsive to this ligand, whereas class 2 mutant 
would not.
At  15°C the sal91  allele enhances the Daf-c phenotype of m577 but not m579 
(Table  6.3.6  and  6.3.7).  This  supports  our  hypothesis  that  m579  is  ligand-binding 
defective but m577 is not. This enhancement seems to increase with temperature, as the 
daf-2(m577); daf-28(sal91) double mutants Daf-c phenotype increases in severity and 
forms  almost  100%  dauers  at both 20°C  and 22.5°C  (Table  6.3.8,  6.3.9,  6.3.10  and 
6.3.11).  Interestingly  the  daf-2(m579);  daf-28(sal91)  double  mutants  also  start  to 
develop  a  Daf-c  phenotype  that  is  more  severe  than  either  parental  strain  at  20°C. 
Potentially the predicted ligand-binding defect in the m579 mutant receptor might make 
it more sensitive to the loss of activating ligands, further reducing the signalling flux 
from  the  receptor.  Another  possibility  is  that  the  alteration  in  the  ligand-binding 
properties  of  this  DAF-2  mutant  actually  makes  this  receptor  more  sensitive  to 
antagonistic ligands, which reduce the signalling flux through the receptor.
At 25°C the daf-2(m577); daf-28(sal91) had -60% embryonic lethality in the first 
trial but only -13% in the second trial (Table 6.3.12 and 6.3.13). Though these trials 
need to be repeated several more times to get a more accurate reading for the embryonic 
lethality, as there seemed to be relatively more embryonic arrest in trial 1  for all strains, 
except for N2 and daf-2(m579); daf-28(sal91), than in trial 2. There was large amount 
of embryonic lethality seen in the daf-2(m5 79); daf-28(sal91) double mutants in both 
trials at 25°C.  This was far greater than any  embryonic arrest seen in either parental 
strain. Potentially this is related the reasons outlined above.
Even  though  the  daf-2(m577);  daf-28(sal91)  double  mutants  have  some 
embryonic lethality at 25°C, which resembles a class 2 trait, they do not become Unc at 
this temperature (data not shown). This suggests that the class 1   alleles do not become 
class 2 with the introduction of daf-28(sal91).  It is more likely that the lethality can 
simply be explained by severe reduction in DAF-2 activity either by lack of activation 
by agonistic ligands or increased suppression of activity by antagonistic ligands, as a 
result of the poisonous effect of the daf-28(sa!91) allele.
1896.4.5 Phenotypic comparison of nonsense and deletion alleles of daf-2
A comparison of the m65 nonsense allele and the tml236 deletion allele shows that m65 
is still the best candidate for a null allele of daf-2. One possible explanation for the full 
suppression of the tml236 allele by daf-16(mgDf50), even though it is missing more of 
the kinase domain than the m65 allele, is the presence of the C-terminal extension in 
this allele. The properties of tml236 imply that the retention of the C-terminal extension 
in  this  allele  allows  the  receptor  to  retain  some  residual  activity.  The  C-terminal 
extension  of DAF-2  contains four putative  SH2-binding  sites  (Kimura et al.,  1997). 
These sites may allow the DAF-2 receptor to interact directly with substrates such as 
AAP-1  (Wolkow  et  al.,  2002).  Even  in  the  absence  of  ligand  stimulated 
autophosphorylation the C-terminal extension of the tml236 mutant receptor may have 
enough residual basal phosphorylation ability to recruit and activate substrates. Because 
the m65 allele is predicted to make a mutant receptor that lacks the C-terminal extension 
it may not be able to recruit substrate proteins, which may explain the severity of its 
phenotype at 25°C. Thus, unexpectedly the characteristics of tml236 provide the first 
evidence for functional activity of the DAF-2 C-terminal extension.
It still remains to be seen if the m65 allele is a true null or whether it simply has 
the greatest reduction of DAF-2  activity  of the alleles that have been characterised. 
Ultimately the only way to be sure of the daf-2 null phenotype is to isolate a deletion 
that removes the entire receptor.
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Analysis of the ins-7 and ins-35 genes encoding 
putative ligands for DAF-2
1917.1 Introduction
The  previous  chapters  of my  thesis  have  dealt with the  DAF-2  insulin/  insulin-like 
growth factor receptor. This final results chapter relates to the insulin-like peptides that 
might regulate  the receptor.  One  of the original hypotheses  at the beginning  of this 
project was that different INS peptides might differentially affect DAF-2 function. If so, 
then one might expect that some mutations in the ligand-binding portion of the receptor 
differentially affect the binding of INS peptides. This in turn might differentially affect 
the  phenotype  of the  mutant.  Currently,  relatively  little  is  known  about  ins  gene 
function.  In this chapter I  describe  studies of two ins genes,  ins-7 and ins-35, which 
show opposite regulation by daf-16.
7.1.1  Insulin-like peptides in vertebrates
The insulin molecule is a small peptide hormone that is part of a structurally related 
superfamily of proteins that share a common ‘insulin fold’ (Murray-Rust et al,  1992). 
In  vertebrates  the  major  role  of insulin  is  to  regulate  blood  glucose  concentration. 
However,  it  also  stimulates  cell  growth  and  differentiation  and  promotes  substrate 
storage in various tissues (Saltiel and Kahn, 2001). Insulin is not the only member of 
this superfamily found in vertebrates;  additional members include IGF-1  and IGF-II, 
which  have  important  roles  in  normal  growth  and  development  as  well  as  in 
maintenance of differentiated tissues (Le Roith and Butler, 1999). Other members of the 
insulin superfamily in vertebrates include the relaxins, which in humans comprise of 
relaxin-1, -2, -3 and the insulin-like peptides (INSL), INSL3, INSL4, INSL5 and INSL6 
(Wilkinson et al, 2005). Relaxin-1, -2 and INSL3 have been shown to have a role in 
pregnancy and reproduction, while the function of other members of the relaxin family 
remains unclear.
The precursor proteins of these peptides in vertebrates have a very similar domain 
arrangement of a signal sequence followed by the B chain then the C peptide and the A 
chain (Sherwood, 2004). The IGF-1 and IGF-II precursors have two additional domains 
that are C-terminal of the A chain known as the D and E domains (Smit et al,  1998). 
Even though the overall sequence similarity between the different peptides is low they
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in the B chain and four in the A chain. These cysteines are involved one intra-chain and 
two inter-chain disulphide bonds, which gives rise to the ‘insulin fold’ that structurally 
relates these different proteins. The C peptide of the insulin, relaxin-2, -3  and INSL3 
precursors is cleaved during processing to give rise to the mature hormones which are 
dimers of the A and B chains. It is predicted that other relaxins also have their C peptide 
removed during maturation (Wilkinson et al., 2005). In contrast the IGF-1  and IGF-II 
proteins retain their C peptides such that the mature hormone is formed from a single 
polypeptide.
7.1.2  Insulin-like peptides in invertebrates
Insulin-like peptides have now been identified in several different invertebrate species 
including  C.  elegans  (reviewed  in  (Pierce  et al.,  2001)),  Drosophila  melanogaster 
(Brogiolo et al., 2001), Anopheles gambiae (Krieger et al., 2004), Locusta migratoria 
(Lagueux  et al.,  1990),  three  Lepidopterans  including  Bombyx  mori,  Samia  cynthia 
ricini and Agrius convoluvuli (reviewed in (Yoshida et al.,  1998)) and in the mollusc 
Lymnaea stagnalis (reviewed in (Smit et al.,  1998)). A general feature of insulin-like 
peptides in invertebrates is that they are present in multiple copies encoded by multi­
gene  families.  For  example  five  different  molluscan  insulin-related  peptides  (MIPs) 
have been identified in L.  stagnalis (Smit et al.,  1998) and seven D.  melanogaster and 
A. gambiae insulin-like peptides have been found (DILPs and AgamlLPs respectively) 
(Brogiolo et al.,  2001;  Krieger et al.,  2004).  In B.  mori there are  at least thirty-two 
bombyxin  genes  encoding  insulin-like  peptides  (Yoshida  et  al.,  1998).  All  of the 
insulin-like peptides characterised in the insects have the canonical six cysteine residues 
forming the two inter-chain and single intra-chain disulphide bonds and a C peptide that 
is predicted to be cleaved. The five MIPs also have a C peptide that is predicted to be 
cleaved as well  the  six  canonical  cysteines.  However they  all  possess  an  additional 
cysteine residue in both the A and B chains of the proteins that are expected to form a 
third inter-chain disulphide bond (Smit et al., 1998).
In C.  elegans there are 39 genes that encode insulin-like peptides, ins-1 to ins-37 
(Duret et al.,  1998; Gregoire et al.,  1998; Kawano et al., 2000; Kawano et al., 2003; 
Pierce et al., 2001), ins-38 (M. Costa, personal communication) and daf-28 (Li et al.,
1932003).  These  insulin-like  peptides  are  highly  divergent  from  the  other  invertebrate 
insulin-like peptides. Only two of these genes, ins-1 and ins-18, are predicted to have C 
peptides that are cleaved and form dimers like vertebrate insulin. The rest of the insulin­
like peptides do not have a C peptide and are expected to remain single polypeptides 
like IGF-1 and IGF-II, although they do not possess the additional D and E domains of 
these proteins.  The insulin-like peptides can be  classified into  four structural  groups 
type y, P and a and multiple chain (Duret et al.,  1998; Pierce et al, 2001). The genes 
ins-11, -12, -13, -14, -15, -16, -17, -18, -19, -32, -37 and -38 encode the y-type insulin­
like peptides,  which have  the  canonical  six  cysteines and  are predicted  to  have the 
typical disulphide bond pattern of vertebrate insulins. The genes ins-1, -2, -3, -4, -5, -6, 
-7,  -8,  -9,  -10  and  daf-28  encode  the  (3-type  peptides.  These  peptides  have  two 
additional cysteine residues,  one in the B  chain and one in the A chain, both are C- 
terminal of the canonical cysteines in each chain. These cysteines are predicted to form 
an additional disulphide linking the A and B chain, similar to the additional disulphide 
bond seen in the MIPs, however their extra cysteines are N-terminal of the canonical 
cysteines of each chain (Smit et al, 1998). The genes ins-20, -21, -22, -23, -24, -25, -26, 
-27, -28, -29, -30, -33, -34, -35 and -36 encode the a-type peptides. These peptides also 
have the additional cysteines involved in the third inter-chain disulphide bond in the 1 3 - 
type  peptides.  However  they  lack  two  of the  canonical  cysteines  in  the  A  chain 
responsible  for  the  intra-chain  bond.  The  ins-31  gene  encodes  a  novel  multi-chain 
protein with the following domain arrangement; signal sequence - B chain - A chain - B 
chain - A chain - B chain. It is unknown if this protein is cleaved into three separate 
insulin-like peptides.
7.1.3  The role of insulin-like peptides in C. elesans
Given the large number of insulin-like peptides in C. elegans it is unsurprising that there 
is only limited information on their functional role and whether they interact with the 
IIS  pathway.  It has been  shown that  overexpression  of ins-1  and  ins-18,  as well  as 
human insulin,  results  in a weak  Daf-c phenotype  for wild type  worms  (26°C)  and 
increases  the  severity  of the  Daf-c  phenotype  in  daf-2(el365)  worms  (20°C).  This 
suggests that these genes antagonise daf-2 signalling (Pierce et al, 2001). However, it 
has  been  shown  that  in  cell  culture  chronic  exposure  to  insulin  leads  to  insulin
194resistance (Garvey et al., 1986). Thus, INS-1 and INS-18 may only be acting as DAF-2 
antagonists at high ligand concentrations.  Overexpression of ins-1  and human insulin 
also increases the mean lifespan of wild type worms over controls, while a null allele of 
ins-1 has no effect on lifespan or dauer formation. Overexpression of ins-9, -22 and of 
an ins-19! -31 double construct has no effect on dauer formation in either wild type or 
daf-2(el365) worms. However, overexpression of both ins-9 and the ins-19! -31 double 
construct cause  a significant increase in the  amount of embryonic/ LI  arrest in daf- 
2(el365) worms (26°C), a phenotype not normally associated with this class 1  allele of 
daf-2. Potentially these three genes also antagonise daf-2 signalling but only function 
during embryogenesis or early larval development. Expression of ins-19 and -31 but not 
ins-9 gene expression has been observed during embryogenesis (Pierce et al., 2001).
The daf-28 gene encodes the only insulin-like peptide in C.  elegans in which a 
mutant has been shown to have a phenotype.  The sal91  allele of daf-28 has a Daf-c 
phenotype at all temperatures, although the dauers recover within 2 hours, and increases 
lifespan by  12 -13% compared to wild type controls (Malone et al.,  1996). This allele 
behaves in a semi-dominant manner and has a missense mutation that causes a R37C 
substitution  affecting  the  predicted  proteolytic  cleavage  site  between  the  signal 
sequence  and  the  B  chain  (Li  et  al.,  2003).  The  mutant  protein  is  believed  to  be 
poisonous to wild-type DAF-28 function and other INS proteins. Overexpression of ins- 
4 and ins-6, which encode proteins with the highest sequence similarity to DAF-28, can 
rescue the Daf-c phenotype of daf-28(sal91). Interestingly the Daf-c phenotype of daf- 
28(sal91) is only partially suppressed by hypomorphic alleles of daf-16 implying that 
wild-type DAF-28, or an INS protein that the mutant poisons, interacts not only with the 
DAF-2/  DAF-16  pathway  but  some  other  parallel  pathway  that  regulates  dauer 
formation. This is unlikely to be the DAF-7 TGF-(3 pathway as Daf-d mutants in both 
daf-3 and daf-5 fail to suppress dauer formation in daf-28(sal91) (Malone et al., 1996).
The role of several ins genes has been probed through the use of RNA-mediated 
interference (RNAi). RNAi of ins-18 has been shown to extend lifespan in wild type 
worms (Kawano et al., 2000), although this result is controversial, as a second study has 
shown that RNAi of ins-18 does not extend lifespan in the RNAi hypersensitive strain 
rrf-3(pkl426)  and leads to a small  suppression of the lifespan extension seen in daf- 
2(mul50)  (Murphy  et al.,  2003).  In this  same  study  RNAi  of both  ins-1  and  ins-7 
increased the lifespan of rrf-3(pkl426) by 21.9% and 33.7% respectively, while RNAi 
of ins-21  and ins-22 had no effect.  Similarly RNAi of daf-28 has no effect on either
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lifespan  by  ins-1  RNAi  in  rrf-3(pkl426)  worms  (Murphy  et  al.,  2003)  is  hard  to 
reconcile  with  to  the  lifespan  extension  seen  in  wild  type  worms  by  ins-1 
overexpression (Pierce et al., 2001). A possible explanation for these results might be 
that INS-1 is an agonist of DAF-2, rather than an antagonist as suggested by Pierce et al 
(2001). This would explain why RNAi of ins-1 leads to lifespan extension. This would 
also  imply  that  overexpression  of ins-1  leads  to  down-regulation  of the  daf-2/  IIS 
pathway in a similar way that chronic exposure to insulin cause cultured cells to become 
insulin-resistant (Garvey et al., 1986). The suppression of lifespan by RNAi of ins-18 in 
a  daf-2  mutant  background  (Murphy  et  al.,  2003)  and  an  increase  in  the  Daf-c 
phenotype of daf-2 (el365) at 20°C by ins-18 overexpression suggest that INS-18 is a 
genuine  antagonist  of DAF-2,  casting  further  doubt  on  the  claim  by  Kawano  et al 
(2000) that ins-18 RNAi causes lifespan extension.
A key question concerning the INS peptides is why are there so many of them? 
There are several different possibilities. Firstly, the different INS proteins have different 
spatial and temporal expression (Li et al., 2003;  Pierce et al.,  2001).  This raises the 
possibility of that some of these peptides have autocrine or paracrine roles. A second 
possibility is that not all of these peptides bind to the DAF-2 receptor. In vertebrates, 
members of the relaxin family have been shown to bind G-protein-coupled receptors 
(GPCR), (reviewed in Wilkinson et al., 2005). The GPCR superfamily has undergone a 
large lineage-specific expansion in C. elegans, such that there are at least 1149 proteins 
belonging  to  this  family  (Fredriksson  and  Schioth,  2005).  However,  the  relaxin 
interaction with GPCR proteins is dependent on a 4  R-X-X-X-R-X-X-I ’ motif found in 
all members of the relaxin family. This motif is not present in any of the invertebrate 
insulin-like peptides (Wilkinson et al., 2005), which suggests that if the INS peptides do 
interact with GPCR proteins they do so in a novel manner.
There is a third, less likely possibility. The C.  elegans genome has 56 genes that 
encode members of a novel protein family. These proteins partly resemble the a-subunit 
of the DAF-2 receptor (Dlakic, 2002). However, these proteins, whilst having two full 
L-domains, have a truncated CR domain. These proteins also lack all three fibronectin 
type III  domains, but do have a transmembrane domain.  Dlakic  (2002)  suggests that 
these proteins may bind some INS peptides and that they in turn modulate the activity of 
DAF-2 through some novel interaction. However, it should be noted that the probable 
second contact site for the binding of insulin-like peptides in IR superfamily proteins is
196located  in the  Fnl  domain,  as  shown  by  in  vitro  mutagenesis  of MR  and MGF-1R 
(Mynarcik et al,  1997). This raises some doubt over whether the INS peptides could 
actually bind to these a-subunit-like proteins.
7.1.4  Microarrav analysis of ins gene expression
Recently microarray data from our lab has shown that of the 23 ins genes represented on 
the  Affymetrix™  C.  elegans  whole  genome  oligonucleotide  arrays  eight  show 
significant changes in gene expression when comparing daf-2 mutants to daf-16; daf-2 
double mutants (McElwee et al., 2004) (Table 7.1.1). Of these, two genes, ins-7 and ins- 
35,  show the  greatest change in expression levels,  ins-7 being  down-regulated by  at 
least -75% in daf-2 mutants compared to daf-16; daf-2 double mutants, while ins-35 is 
up-regulated ~24-fold in daf-2 mutants. The down-regulation of ins-7 in daf-2 mutants 
is consistent with the view that INS-7 is a DAF-2 agonist, based on the extension of 
lifespan  by  ins-7  RNAi  in  rrf-3(pkl426)  worms  (Murphy  et  al.,  2003).  The  up- 
regulation  of ins-35  in  daf-2  mutants  suggests  that  INS-35  may  antagonise  DAF-2 
function and therefore function as a longevity hormone.
In this chapter I further characterise changes in the expression of ins-7 and ins-35 
and test their role in lifespan using RNA-mediated interference (RNAi).  I have used 
quantitative PCR (QPCR) to measure the relative transcript levels of both ins-7 and ins- 
35 in daf-2 mutants compared to daf-16; daf-2 mutants. To test the role of ins-7 and ins- 
35  on  lifespan  I  used  a  lactose-induced  RNAi  protocol  that  is  more  penetrant than 
isopropylthio-p-D-galactoside (IPTG) induced RNAi (J. J. McElwee, D. S. Patel and D. 
Gems, unpublished results) in several different genetic backgrounds.
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Gene Structural Type Ratio of daf-21  daf-16; daf-2 
gene expression Log2 Ratio p-value
ins-21 a 0.899 -0.153 0.97856
ins-22 a 3.658 1.871 0.00134
ins-23 a 2.433 1.283 0.01026
ins-240 a 4.084 2.030 0.00893
ins-24a a 1.084 0.117 0.79351
ins-26 a 1.901 0.927 0.47522
ins-30 a 2.518 1.332 0.00938
ins-33 a 3.371 1.753 0.00039
ins-34 a 0.886 -0.175 0.81275
ins-35 a 24.658 4.624 9.4e1 4
ins-1 P 1.228 0.296 0.34290
ins-2 P 1.079 0.110 0.99168
ins-3 P 0.588 -0.766 0.19742
ins-4 P 0.742 -0.431 0.50619
ins-5 P 1.480 0.566 0.06508
ins-6 P 1.210 0.275 0.35704
ins-7 P 0.251 -1.997 4.7e'7
daf-28 P 1.025 0.035 0.66744
ins-11 Y 3.091 1.628 0.00692
ins-17 Y 1.131 0.177 0.54407
ins-18 Y 1.084 0.117 0.81559
ins-32 Y 0.694 -0.528 0.23891
ins-37 Y 0.927 -0.109 0.95590
ins-31 Multi-chain 1.494 0.579 0.08119
Ratio of the expression levels of the 23  ins genes present on the Affymetrix™ array in glp-4\ daf-2 double 
mutants compared  to daf-16 glp-4\ daf-2 triple mutants.  Genes  listed  in  bold have significantly altered 
expression levels between the two strains (p-value < 0.05).a There are two different probe sets for ins-24 
on the Affymetrix™  array, only one of which gives a significant change in gene expression.  Data from 
McElwee et al (2004)
1987.2 Material and Methods
7.2.1 Strains
The following strains were used for quantitative analysis of the transcript levels of ins-7 
and  ins-35:  GA133  daf-16(mgDf50)  glp-4(bn2)  I;  daf-2(m577)  III and  GA134  glp- 
4(bn2) I; daf-2(m577) III,  (McElwee et al., 2004). The following strains were used for 
RNAi lifespans: DR1567 daf-2(m577) ///(Gems et al.,  1998); GA134 glp-4(bn2ts) I; 
daf-2(m577)  III;  GA303  rrf-3(pkl426)  II;  daf-2(m577)  III;  SS104  glp-4(bn2ts)  I 
(Beanan and Strome,  1992); NL2099 rrf-3(pkl426)  II (Simmer et al.,  2002)  and N2 
CGC male stock (Gems and Riddle, 2000).
The GA303  strain rrf-3(pkI426)\ daf-2(m577) was constructed by crossing daf- 
2(m577) males with rrf-3(pkl426) hermaphrodites at 15°C. The hermaphrodite progeny 
of this cross were raised until they were gravid adults then shifted to fresh plates at 
25°C. These animals were allowed to lay eggs for 24 hours before being removed from 
the  plates.  The  progeny  were  kept  at  25°C  for  three  days,  after  which  they  were 
examined for the presence of dauers. Approximately 50 dauers, homozygous for daf- 
2(m577), were picked to fresh plates and allowed to recover at  15°C to the L4  stage. 
Once the animals were at L4 they were plated singly at 25°C and left for three days. The 
rrf-3(pkl426)  allele causes  a drastic reduction in fecundity of the hermaphrodites  at 
25°C (Sijen et al., 2001). The plates at 25°C were checked for the number of progeny 
(all dauers) and those with <10 were taken to be homozygous for rrf-3(pkl426)  and 
shifted down to  15°C to allow recovery.  Recovered L4s were then plated singly and 
shifted back to 25°C to confirm that they also had reduced fecundity at this temperature. 
After confirming the reduced fecundity phenotype,  six dauers were picked from two 
plates and shifted back to 15°C to allow recovery.
7.2.2 Quantitative PCR
The  relative  abundance  of  ins-7  and  ins-35  transcripts  in  glp-4(bn2);  daf-2(m577) 
mutant adults compared to glp-4(bn2) daf-16(mgDf50); daf-2(m577) mutant adults was
199determined using QPCR. The RNA samples used in the first two QPCR experiments 
were the same as those prepared previously for microarray analysis by McElwee et al 
(2004) and included three samples of glp-4(bn2); daf-2(m577) RNA and three of glp- 
4(bn2)  daf-16(mgDf50);  daf-2(m577).  RNA  samples  for the third  QPCR experiment 
were obtained using worms cultured at the same time as those in McElwee et al (2004) 
that had been kept  stored in TRIzol  (Invitrogen)  at -80°C  and not processed  for the 
microarray work.  These RNA samples included two glp-4; daf-2 samples and one of 
glp-4(bn2) daf-16(mgDf50); daf-2(m577).
The  sequences of the primers used in the QPCR are listed in Table  7.2.1.  The 
ama-1 primers are the same as those described previously in chapter 6. The primers for 
the  amplification  of ins-7  and  ins-35  transcripts  were  designed  using  the  Primer3 
WWW  interface  (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi)  (Rozen 
and Skaletsky, 2000). These primers do not span exon-exon boundaries, but do anneal 
to different exons in order to prevent the amplification of any contaminating genomic 
DNA within the RNA samples.  Protocols for the RNA extraction, first strand cDNA 
synthesis  and  QPCR  can  be  found  in  sections  3.2.1,  3.2.2  and  3.2.4  of the  main 
materials and methods chapter.
Table 7.2.1 Primer pairs used in QPCR
Primer name 5’- Sequence - 3’
ama-1 Fwd CCCGGAGGAGATTAAACGCATG
ama-1 Rev CATCTTCCACGACGATCTATGA
ins- 7Fwd GAAGAGTCCCTGACGAGAAAAA
/«s-7Rev TCTTCACGGCAACATTTTGAT
/«s-55Fwd TATTCATTTGCCATCTGTGGAG
ins-3 5Rev CT  CT  GGGCAGCAGAT  A  AG TTTT
In the first two QPCR experiments analysis of the expression levels of ins-7 and ins-35 
were carried on separate 96-well PCR plates due to the larger number of RNA samples 
used in these experiments. Each plate had the general layout seen in Table 7.2.2. In the 
third QPCR experiment both the ins-7 and ins-35 reactions were carried out on the same 
PCR  plate  (Table  7.2.3).  All  of the  QPCR  experiments  were  performed  using  the
200relative  standard  curve  method  (Applied  Biosystems  user  bulletin  2, 
http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf).
The ama-1 gene was used as the endogenous control in all experiments. The ratio 
of expression of ama-1 in daf-2 mutants compared to daf-16; daf-2 mutants was 1.003 
and the /?-value was 0.976 in the microarray analysis of McElwee et al (2004). This 
implies that there is no significant change in expression level of this gene between the 
two genotypes, which supports the choice of this gene as an endogenous control.
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ins-7  Z-3 5
mgDfSO; 
m577/\ 
ins-7  Z-3 5
mgDfSO; 
m577/\ 
ins-7  Z-3 5
mgDfSO; 
m577Z2 
ins-7  Z-3 5
mgDfSO; 
m577Z2 
ins-7Z-3 5
mgDfSO; 
mS77Z2 
ins-7  Z-3 5
mgDfSO; 
m577Z3 
ins-7  Z-3  5
mgDfSO; 
m577Z3 
ins-7Z-3  5
mgDfSO; 
m577Z3 
ins-7  Z-3 5
NTC= No template control
202Table 7.2.3 Plate layout for third QPCR experiment
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1/2 N2 
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1/2 N2 
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1/4 N2 
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B
1/16N2
ama-1
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1/16N2
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1/128 N2 
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ins-7
1/4 N2
ins-7
1/16 N2 
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1/16 N2 
ins-7
1/16 N2 
ins-7
D
1/64 N2 
ins-7
1/64 N2 
ins-7
1/64 N2 
ins-7
1/128 N2 
ins-7
1/128 N2 
ins-7
1/128 N2 
ins-7
NTC
ins-35
NTC 
ins-3 5
NTC
ins-35
4xN2
ins-35
4xN2
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4xN2
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E
2xN2
ins-35
2xN2
ins-35
2xN2
ins-35
lxN2 
ins-3 5
lxN2
ins-35
lxN2
ins-35
1/2 N2 
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1/2 N2 
ins-3 5
1/2 N2 
ins-35
1/4 N2 
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1/4 N2 
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1/4 N2 
ins-3 5
F
1/16 N2 
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1/16N2 
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1/16 N2 
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ins-3 5
1/64 N2 
ins-35
1/64 N2 
ins-3 5
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ins-35
1/128 N2 
ins-35
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ama-1
m577/\
ama-1
m577/\
ama-1
G
m577/2
ama-1
m577!2
ama-1
m577!2
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mgD/50;
m577/\
ama-1
mgD/50;
m577/\
ama-1
mgD/50;
m577/\
ama-1
m577/\
ins-7
m577/\
ins-7
m577/\
ins-7
m577!2 
ins-7
m577!2
ins-7
m577!2
ins-7
H
mgDpO; 
m577/\ 
ins-7
mgD/50;
m577/\
ins-7
mgD/50;
m577/\
ins-7
m577/\
ins-35
m577/\
ins-35
m577/\
ins-35
m577!2
ins-35
m577!2
ins-35
m577!2
ins-35
mgD/50;
m577/\
ins-35
mgD/50;
m577/\
ins-35
mgDpO;
m577/\
ins-35
NTC= No template control
2037.2.3 RNAi protocols
Two different methods of induction of double-stranded RNA (dsRNA) expression in 
HT115(DE3)  cells  were  employed  in  the  RNAi  experiments.  These  used  either  the 
IPTG method (Kamath et al, 2000)  or a lactose-based induction method based on a 
modification  of  a  protocol  originally  described  by  Eric  J.  Lambie  (personal 
communication).
For RNAi of ins-7, two different dsRNA expression plasmids were used. The first 
plasmid  contained  370bp  of genomic  sequence  that  included  the  entire  ins-7  gene 
(kindly provided by J. J. McElwee). The second ins-7 construct was from the Ahringer 
feeding library (Kamath et al, 2003) and contains 1144bp of genomic DNA including 
the  entire  ins-7  gene.  This  is  the  construct  that  has  been  shown  to  extend  lifespan 
(Murphy  et al,  2003).  To  avoid confusion this  will  be referred to  as the ZK1251.2 
construct  for the remainder of this  chapter.  RNAi  of the daf-2  gene  was used as  a 
positive control for lifespan extension, previously shown by Dillin et al (2002). I used 
the daf-2 construct provided by Adam Antebi, described in chapter 6.
The presence of a second plasmid in the ZK1251.2 feeding strain was discovered 
accidentally while checking that the ZK1251.2 construct contained the correct length 
insert.  PCR reactions were performed on cells from eight different bacterial colonies 
containing the ZK1251.2  construct grown on LB  + ampicillin plates.  The ZK1251.2 
insert was amplified using primers that flanked the multiple cloning site of the L4440 
vector  (kindly  provided  by  J.  J.  McElwee).  Control  reactions were  carried  on  cells 
containing L4440, ins-7 and ins-35 constructs. When the PCR reactions were run on an 
agarose gel the control PCR reactions contained only a single band, whereas all eight of 
the ZK1251.2 reactions contained two distinct bands. One band was -1.1 kb in length 
and corresponded to the ZK1251.2 insert. The other band was smaller and was the same 
size as the band in the L4440 control reaction.  This suggested that the HT115(DE3) 
cells containing the ZK 1251.2 construct were also transfected with the empty L4440 
plasmid.
For ins-35 a new construct was prepared using the primers z«s-35RNAiLeft and 
/«s-35RNAiRight (Table 7.2.4) to amplify a 639bp fragment of genomic DNA, from N2 
worms using a touchdown PCR method (Materials and Methods chapter). This fragment 
contains the entire ins-35 gene, which was then ligated into the pCR®II-TOPO® vector
204using the TOPO-TA cloning kit® and transformed into TOPIO E. coli cells (Invitrogen), 
following  the  manufacturer’s  instructions.  Transformed  cells  were  then  grown  in 
overnight culture and the plasmid DNA was extracted using a QIAprep miniprep kit 
(Qiagen). The isolated plasmid DNA was digested with Xhol and SpeI and ligated into 
the L4440 vector (Timmons and Fire,  1998), which had been linearized with the same 
restriction  enzymes.  The  recombinant  plasmid  (pDPOOl)  was  transformed  into 
chemically competent HT115(DE3) cells (Timmons et al., 2001).
Table 7.2.4 Primer pairs for RNAi constructs
Primer name 5’-Sequence-3’
TJ1192 CCCAAGCTTCCATTTATGATGTGACATTGCTCGTGG
TJ1193 GGTTGAGATTGTTTCAAGCAATTGAACCC
TJ1194 CGGGGTACCCCAGATGCCACCAATAATTTTGG
TJ1195 TGCTCTAGAGAAGAAATTAAGGACAGCACTGTTTTCG
ws-JJRNAiLeft TGAAGCAAATATTCTTGGTAATCC
ins-3 5RN A iRight CT  CT GGGC  AGC  AG AT  A  AGTTTT
In addition to the ins genes, several other genes that had shown significant up-regulation 
in the daf-2 mutants in McElwee et al (2004) were also subjected to RNAi. These genes 
are listed in Table 7.2.5 and were part of larger RNAi screen performed in our lab, but 
in the present context served as further negative controls for the general effects of RNAi 
on lifespan.
205Table 7.2.5 Genes up-regulated in daf-2 mutants
Sequence
Name
Gene Name/ Putative 
homologue?
Log2 Ratio of daf-21 daf-16; 
daf-2 gene expression p -\alue
T22B7.1 egl-13 0.696 0.02766
C15F1.7 sod-1 0.807 0
H42K12.1 pdk-1 1.136 0.00029
R11A5.4 PEPCK 2.065 0.00029
C36A4.2 cyp-25A2 0.720 0.00048
C55F2.1 AICAR transfromylase 1.466 0.00175
C06A5.7 tmd-1 0.372 0.03636
W01A11.1 Epoxide hydrolase 1.631 0
K11E8.1 unc-43 0.239 0.0303
F21A3.2 Purple acid phosphatase 0.895 0.00027
Genes that show statistically significant up-regulation  in glp-4', daf-2 double mutants compared to glp-4 
daf-16', daf-2 triple mutants. These genes were part of a  larger RNAi screen within our lab. Data from 
McElwee et al (2004)
7.2.4  Lifespan assays
The lifespan assays were carried out at 25°C using either M9 minimal media-lactose 
plates, NGM-lactose plates or IPTG plates, or at 20°C with IPTG plates. For the assays 
at 25°C all animals were raised at 15°C through at least two generations of RNAi before 
being picked at the L4 stage and shifted to the higher temperature. The majority of the 
assays had at least  100 worms to begin with, which were transferred every other day 
until the end of egg laying for non-sterile strains, after this worms were transferred as 
needed. Plates were scored for death every other day.  Death was scored as failure of 
response to prodding with a worm pick. Worms that died from internal hatching of eggs 
or ruptured vulvas were censored. All dead worms were removed from the plates.
For the 20°C lifespans worms were also raised at 15°C till the third generation on 
RNAi. Worms were then picked at the L2 stage and transferred to 25°C until the first 
day of adulthood and  shifted down to 20°C for the remainder of their lifespan.  This
206protocol is the same as that used by Murphy et al (2003) for their RNAi lifespans. Each 
assay had at least 100 worms, which were transferred every other day until the end of 
egg  laying  and  then  as  needed.  Death  was  scored  as  above.  HT115(DE3)  cells 
transformed  with  the  L4440  vector were  used  as  negative  controls  in  all  lifespans. 
Statistical analysis of lifespan data was carried out using the JMP IN® v5.1  statistics 
software  package  (SAS  Institute  Inc.).  Survival  curves  were  generated  using  the 
Kaplan-Meier method and the statistical significance of differences between the curves 
was  determined  using  a  log  rank  test.  The /7-value  for  each  lifespan  represents  the 
probability of obtaining by chance a %   value greater than the value obtained under the 
assumption that the survival curves between tested groups is the same.
2077.3 Results
Previous microarray analysis of the gene expression changes between daf-2 mutants and 
daf-16;  daf-2  double  mutants  had  shown  that  the  ins-7  and  ins-35  genes  were 
differentially regulated,  ins-7 is the  most  strongly  down-regulated  ins  gene  in  daf-2 
mutants compared to daf-16; daf-2, while ins-35 is the most up-regulated (McElwee et 
al.,  2004).  This  suggests  that  ins-7  and  ins-35  may  promote  ageing  and  longevity, 
respectively. My aim in the following studies is to verify the role of ins-7 in ageing, 
previously shown by Murphy et al (2003), and to test the role of ins-35 in longevity 
assurance.
7.3.1  Relative abundance of ins-7 and ins-35 transcripts
I have used QPCR to confirm these changes and to estimate the relative transcript levels 
of each gene in glp-4;  daf-2 mutant adults compared to glp-4(bn2)  daf-16(mgDf50); 
daf-2(m577)  mutant adults.  The  fold-changes  for both ins-7 and  ins-35  are listed in 
Table 7.3.1.  The values were calculated using the relative  standard curve method,  in 
which the quantities of the target genes (ins- 7 and ins-35) in each RNA sample were 
normalized to the ama-1  quantity  for that  sample,  under the  assumption that ama-1 
expression is invariant between genotypes and samples (see materials and methods, this 
chapter).  The mean value of the normalized transcript level for the target genes was 
calculated for each genotype. The mean value of the target gene for the daf-2 samples 
was divided by the mean value of the target gene in the daf-16; daf-2 samples to give 
the estimated fold-change. Standard deviations were calculated as recommended in the 
Applied Biosystems user bulletin 2.
In the  case  of the  first  two  QPCR  experiments  the  values  of the  normalized 
quantities  of ins-7 and  ins-35  from  the  third  RNA  sample of glp-4;  daf-2  were  not 
included in the calculations  of the  mean value  or the  standard deviation.  This RNA 
sample consistently had a 30-fold higher level of ama-1 than the other two glp-4; daf-2 
samples (data not shown) and therefore was treated as an anomalous outlier. To verify 
that this interpretation I prepared fresh RNA samples from both glp-4; daf-2 and glp-4 
daf-16; daf-2 worms that had been cultured at the same time as the previous batch and
208kept at -80°C. These RNA samples were then used in the third QPCR experiment (Table
7.2.3). The ama-1 levels in the new glp-4; daf-2 RNA samples were similar to the first 
two samples, confirming that the third sample was indeed an outlier.
Table 7.3.1 Relative transcript levels of ins- 7 and ins-35
QPCR plate
Relative expression level of ins-7 (fold- 
change ± Std dev)
Relative expression level of ins-35 (fold- 
change ± Std dev)
in daf-2 in daf-16', daf-2 in daf-2 in daf-16', daf-2
Plate 1 0.54 ± 0.28 1  ± 0.44 98.34 ±0.75 1 ± 0.45
Plate 2 0.61 ±0.59 1  ± 0.44 102.68 ±0.71 1 ± 0.27
Plate 3 0.30 ±0.26 1 ± 0.09 68.77 ± 0.20 1  ±0.17
Relative expression levels of ins-7 and ins-35  in glp-4; daf-2 double mutants compared to glp-4 daf-16', 
daf-2 triple mutants. The expression level of ins -7 is -40% less in glp-4', daf-2 than in glp-4 daf-16\ daf-2 
in both plates 1   and 2 and -70% less in plate 3. The expression levels of ins-35 is -100-fold higher in glp- 
4\ daf-2 than in glp-4 daf-16', daf-2 in both plates 1   and 2 and -70-fold higher in plate 3.
The fold-changes for ins-7 gene expression in the first two QPCR experiments are 0.54 
± 0.28 and 0.61 ± 0.59, respectively (Table 7.3.1). Not only are these values higher than 
the estimated value of 0.251  from the microarray data (Table 7.1.1), but the standard 
deviation amongst the daf-2 samples overlaps with that of the daf-16; daf-2 samples, 
indicating that the expression levels are not significantly different. In the third QPCR 
experiment  the  standard  deviations  of  the  daf-2  samples  do  not  overlap  with  the 
standard deviation of the daf-16; daf-2 sample, however in this experiment there is only 
one  sample  of  daf-16;  daf-2  RNA,  which  probably  explain  the  smaller  standard 
deviation.
The fold-change in the level of ins-35 expression is very large in all three QPCR 
experiments. In the first two experiments there is a -100-fold increase in ins-35 gene 
expression in the daf-2 samples compared to daf-16; daf-2 samples, while in the third 
experiment there is -70-fold increase in the level of ins-35.
2097.3.2 Testing the role of ins-7 and ins-35 on lifespan by RNAi
If the ins-7 and ins-35 genes promote ageing and longevity, respectively, then RNAi of 
these  genes  should increase and  decrease  lifespan,  respectively.  In total  10  different 
RNAi  constructs  were  tested  for  their  effects  on  lifespan  in  variety  of  genetic 
backgrounds.  These  constructs  included  two  different  ins-7 plasmids,  including  one 
from the Ahringer feeding library (Kamath et al., 2003), ins-35 and daf-2, as well as the 
constructs  listed  in  Table  7.2.5.  Sequencing  of the  inserts  from  the  C36A4.2  and 
C55F2.1  constructs (Table 7.2.5) from the Ahringer feeding library showed that these 
did not correspond to the  correct genes.  Therefore these clones were  excluded from 
further analysis.
ins gene RNAi using M9 minimal media-lactose plates (Trial 1)
My first trial of ins-7 and ins-35 RNAi used M9 minimal media plates with lactose as 
the inducer of dsRNA expression. RNAi was carried on N2 and daf-2(m577) animals at 
25°C. In the N2 background, RNAi of the ins genes had no significant effect on lifespan 
(Table 7.3.2 and Figure 7.1a). In the daf-2(m577) background RNAi of ins-35 lead to a 
slight increase in the mean lifespan compared to controls, but there no significant effect 
on  overall  lifespan.  The  M9  plates  seem  to  cause  a  significant  amount  of internal 
hatching in the daf-2(m577) background, but not in N2, which affects the shape of the 
lifespan curves in this background (Figure  7.1b).  These plates also  seem to partially 
reduce the  extension  lifespan  of daf-2(m5 77)  animals  compared  to  the  N2  animals. 
Potentially these plates were toxic to daf-2 animals  so  all  subsequent lifespans were 
carried on either standard IPTG plates or NGM-lactose plates.
210Table 7.3.2 ins-7 and ins-35 RNAi lifespans on M9 media-Iactose plates (Trial 1)
Genotype
RNAi
construct
Mean
Lifespan
(days)
Standard
Error
p-value
(log-rank)
N Censor
% Control 
Lifespan
N2 L4440 15.45 0.37 N/A 87 13 100
N2 ins-7 15.45 0.37 0.9964 81 19 99.99
N2 ins-35 15.46 0.31 0.2122 79 21 100.06
daf-2 (m577) L4440 17.07 1.27 N/A 36 64* 100
daf-2 (m5 7 7) ins-7 17.77 1.18 0.6969 28 72* 104.12
daf-2 (m5 77) ins-35 19.52 1.31 0.4297 40 65* 114.36
Effects of ins-7 and  ins-35 RNAi on  lifespan  in a N2  and  daf-2(m577)  background using M9  minimal 
media plates at 25°C. Neither of these genes has any effect in the N2 background. Both lead to a slight 
increase  in mean lifespan in the m577 background, but this is not statistically significant.  * The majority 
of these censored animals died from internal hatching
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Figure 7.1 ins-7 and ins-35 RNAi lifespans at 25°C using M9 minimal media plates
Trial  1  N2 Lifespans at 25°C B  Trial  1   daf-2(m577) Lifespans at 25°C
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RNAi of ins-7 and ins-35 in N2 background has no effect on 
lifespan at 25°C.
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RNAi of ins-7 and ins-35 in daf-2(m577) background has no 
effect  on  lifespan  at  25°C.  However,  a  large  proportion  of 
m577  animals  on  all  3  treatments  died  from  internal 
hatching.
212ins gene RNAi using NGM-lactose plates (Trial 2)
My second trial on RNAi on the ins genes was carried out on NGM-lactose plates at 
25°C.  RNAi was carried in the glp-4(bn2)  and glp-4(bn2); daf-2(m577)  backgrounds. 
The  glp-4(bn2)  allele  is  a  temperature-sensitive  mutation  that  blocks  germline 
proliferation at 25°C resulting in sterile adults (Beanan and Strome,  1992). In this trial 
RNAi of the daf-2 gene was used as positive control for lifespan extension.
In  the  glp-4  background  RNAi  of daf-2  lead  to  a  significant  increase  in  the 
lifespan of the worms compared to controls (Table 7.3.3 and Figure 7.2a). RNAi of ins- 
7 seemed to have no effect on lifespan in this background, while RNAi of ins-35 lead to 
small but significant extension of lifespan.
In the glp-4; daf-2 background RNAi of daf-2 also increased lifespan compared to 
controls. RNAi of ins-7 had no effect on lifespan in this background. In contrast to the 
small,  but  significant,  lifespan  extension  seen  with  ins-35  RNAi  in  the  glp-4 
background,  ins-35  RNAi  lead to  small  decrease  in the  lifespan of the glp-4;  daf-2 
worms compared to controls (Table 7.3.3 and Figure 7.2b).
Table 7.3.3 ins-7 and ins-35 RNAi lifespans using NGM-lactose plates (Trial 2)
Genotype tested
RNAi
construct
Mean
Lifespan
(Days)
Standard
Error
p-value
(log-rank)
N Censor
%
Control
Lifespan
glp-4 L4440 14.21 0.34 N/A 119 7 100
glp-4 daf-2 23.68 0.48 <0.0001 128 3 166.57
glp-4 ins-7 14.20 0.31 0.9327 145 7 99.88
glp-4 ins-3  5 15.45 0.36 0.0087 129 4 108.71
glp-4; daf-2 L4440 33.74 0.72 N/A 134 10 100
glp-4; daf-2 daf-2 40.69 0.59 <0.0001 121 5 120.59
glp-4; daf-2 ins-7 34.09 0.59 0.6656 153 4 101.03
glp-4; daf-2 ins-3 5 31.10 0.74 0.0047 119 4 92.17
Effects of ins-7 and  ins-35 RNAi on  lifespan  in  a glp-4(bn2)  and glp-4(bn2); daf-2(m577)  background 
using NGM-lactose plates at 25°C. RNAi of daf-2 was included as positive control for lifespan extension 
in both genotypes. RNAi of ins-7 has no effect on lifespan in either genotype. RNAi of ins-35 leads to a 
statistically  significant  increase  in  mean  lifespan  in the glp-4 background and  a statistically  significant 
decrease in the glp-4; daf-2 background.
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Figure 7.2 ins-7 and ins-35 RNAi lifespans at 25°C using NGM-lactose plates
A Trial 2 glp-4(bn2) Lifespans at 25°C B  Trial 2 glp-4(bn2)\ daf-2(m577) Lifespans at 25°C
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RNAi of ins-7 has no effect in glp-4 background at 25°C. RNAi 
of  ins-35  leads  to  slight  increase  in  mean  lifespan  in  this 
background (p = 0.009). RNAi of daf-2 causes a large increase in 
mean lifespan as expected.
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L4440 Control  RNAi of ins-7 has no effect in glp-4; daf-2 background at 25°C.  RNAi 
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=  0.005).  RNAi  of daf-2  causes  a  large  increase  in  mean  lifespan  as
ins-35 RNAi
of ins-35 leads to slight decrease in mean  lifespan in this background (p 
=  0.005). 
expected.
214ins gene RNAi using NGM-lactose plates (Trial 3)
The third trial of ins gene RNAi was also carried out at 25°C. In addition to carrying out 
a second replicate of the RNAi in the glp-4 and glp-4; daf-2 backgrounds I also used 
rrf-3(pkl426)  and  rrf-3 (pkl 426);  daf-2(m577)  backgrounds.  The  rrf-3  gene  encodes 
RNA-directed RNA polymerase and the pkl426 allele has an out of frame deletion in 
exon 4 that removes most of the RdRP domain (Sijen et al., 2001). The rrf-3(pkl426) 
allele is hypersensitive to RNAi and many genes that do not show a phenotype upon 
RNAi in wild type background do in rrf-3 (pkl426) (Simmer et al., 2002).
In  the  glp-4  background  daf-2  RNAi  caused  a  significant  lifespan  extension 
(Table 7.3.4 and Figure.7.3a) as seen in the second trial (Table 7.3.3). Likewise RNAi 
of ins-7 had no effect on the lifespan in the glp-4 background in this trial. Unlike the 
previous trial RNAi of ins-35 had no significant effect on lifespan in this trial.
In the glp-4; daf-2 background RNAi of daf-2 extended lifespan, replicating the 
effect seen in the previous trial. Unlike the previous trial RNAi of ins-7 in this trial lead 
to a small but significant decrease in lifespan. In this background RNAi of ins-35 lead 
to a small but significant decrease in lifespan, as seen in the previous trial (Table 7.3.4 
and Figure.7.3b).
In the hypersensitive strain rrf-3 RNAi of daf-2 also resulted in a large extension 
of lifespan compared to controls. RNAi of ins-7 had no significant effect on lifespan in 
this  background,  whereas  RNAi  of ins-35  lead  to  a  slight  decrease  in  the  lifespan 
compared to controls (Table 7.3.4 and Figure.7.3c).
RNAi  of daf-2  also  extended  the  lifespan  of rrf-3;  daf-2  worms  compared  to 
controls. While RNAi of both ins-7 and ins-35 caused a small, but significant, decrease 
in  the  lifespan  of worms  in  this  background  compare  to  controls  (Table  7.3.4  and 
Figure.7.3d).
215Table 7.3.4 ins-7 and ins-35 RNAi lifespans using NGM-lactose plates (Trial 3)
Genotype tested
RNAi
construct
Mean
Lifespan
(Days)
Standard
Error
p-value
(log-rank)
N Censor
%
Control
Lifespan
glp-4 L4440 16.35 0.43 N/A 97 3 100
glp-4 daf-2 30.97 0.53 <0.0001 100 0 189.41
glp-4 ins-7 16.41 0.45 0.8164 98 2 100.35
glp-4 ins-35 16.17 0.42 0.7244 99 1 98.92
glp-4; daf-2 L4440 34.23 0.92 N/A 94 6 100
glp-4; daf-2 daf-2 41.58 1.51 <0.0001 97 3 121.48
glp-4; daf-2 ins-7 31.77 0.80 0.0204 97 3 92.83
glp-4; daf-2 ins-3 5 32.07 0.78 0.0459 97 3 93.71
rrf-3 L4440 15.88 0.42 N/A 87 14 100
rrf-3 daf-2 24.03 0.81 <0.0001 82 4 151.27
rrf-3 ins-7 15.05 0.50 0.4374 77 4 94.75
rrf-3 ins-35 14.26 0.48 0.0233 73 8 89.74
rrf-3; daf-2 L4440 30.97 0.63 N/A 93 7 100
rrf-3; daf-2 daf-2 34.87 0.61 <0.0001 97 5 112.59
rrf-3; daf-2 ins-7 27.45 0.63 <0.0001 99 1 88.62
rrf-3; daf-2 ins-35 27.80 0.79 0.0016 74 6 89.76
Effects of ins-7 and ins-35 RNAi on lifespan in glp-4(bn2), glp-4(bn2); daf-2(m577), rrf-3 and rrf-3; daf- 
2 backgrounds  using NGM-lactose  plates  at 25°C.  RNAi  of daf-2  was  included  as  positive  control  for 
lifespan  extension  in  all  genotypes.  RNAi  of ins-7  has  no  effect  on  lifespan  in  either glp-4  or  rrf-3 
backgrounds. However, ins-7 RNAi lead to small, but significant, decreases in mean lifespan in both glp- 
4; daf-2 and rrf-3; daf-2.  RNAi of ins-35  had no effect in  the glp-4  background,  but lead to  small,  but 
significant, decreases in mean lifespan in glp-4; daf-2, rrf-3 and rrf-3; daf-2.
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Figure 7.3 ins-7 and ins-35 RNAi lifespans at 25°C using NGM-lactose plates
A Trial 3 glp-4(bn2) Lifespans at 25°C  B
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RNAi  of ins-7 and  ins-35 has  no  effect  on  mean  lifespan  in  this 
trial. As expected RNAi of daf-2 leads to lifespan extension.
L4440 Control 
daf-2 RNAi 
ins- 7 RNAi 
ins-35 RNAi
RNAi  of  ins-7  and  ins-35  both  lead  to  small  decreases  in  mean 
lifespan (p = 0.02 and 0.05, respectively) in this background.
Trial 3 glp-4(bn2); daf-2(m577) Lifespans at 25°C
C Trial 3 rrf-3 (pkl426) Lifespans at 25°C D Trial 3 rrf-3 (pkl426); dqf-2(m577) Lifespans at 25°C
L4440 Control 
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RNAi of ins-35 lead to a small decrease in mean lifespan (p = 0.02)  RNAi  of  ins-7  and  ins-35  both  lead  to  small  decreases  in  mean
in this background.  lifespan (p = <0.0001 and 0.0016, respectively) in this background.
217ins gene RNAi using IPTG plates (Trial 4)
All  of the previous trials of ins-7 and ins-35 gene were carried out at 25°C.  At this 
temperature RNAi of ins-7 did not extend lifespan in any of the backgrounds tested. 
RNAi  of ins-35  consistently  decreased  lifespan  in  the glp-4;  daf-2  and  rrf-3;  daf-2 
backgrounds, which is consistent with a longevity assurance role. Murphy et al (2003) 
have previously reported lifespan extension in the rrf-3 background with ins-7 RNAi 
using  the  ZK1251.2  construct  from  the  Ahringer  feeding  library.  However,  this 
extension was only seen at 20°C, as they did not test this background at 25°C. In the 
fourth trial I tried to replicate more closely the conditions used by Murphy et al (2003) 
to try and understand the difference. Firstly the ZK1251.2 construct from the Ahringer 
feeding library was included, in case there was something odd about our ins-7 construct. 
Secondly,  RNAi  was  carried out  in the  rrf-3  and  rrf-3;  daf-2  backgrounds  at 20°C 
instead of 25°C; possibly ms-7 RNAi effects are temperature sensitive.
RNAi of the ins-7 gene using either the ins-7 or ZK1251.2 construct lead to an 
extension  of lifespan  (Table  7.3.5  and  Figure  7.4a).  Potentially  the  effects  of ins-7 
RNAi are temperature-sensitive. RNAi of ins-35 had no effect in the rrf-3 background. 
In addition to extending lifespan in the rrf-3 background at 20°C, I found that our ins-7 
construct,  and  also  ins-35,  extended  the  lifespan  of  rrf-3;  daf-2  worms  at  this 
temperature  (Table  7.3.6  and  Figure  7.4b).  The  ZK1251.2  construct  did  not  extend 
lifespan in this background. This is consistent with the findings of Murphy et al (2003). 
Although they used the mul50 allele of daf-2 whereas I used m577, both are class  1  
alleles and have similar phenotypes.
One possible explanation for the difference in the behaviour of the two constructs 
in the rrf-3; daf-2 background is the presence of a second plasmid in HT115(DE3) cells 
containing the ZK 1251.2 construct (see Materials and methods), but not in the cells with 
the ins-7 construct.  Potentially this second plasmid leads to a dilution of the dsRNA 
corresponding  to  the  ins-7  gene  in  HT115(DE3)  cells  containing  the  ZK1251.2 
construct. Because our ins-7 construct bearing cells do not harbour a second plasmid 
they may produce more ins-7 dsRNA leading to more effective knockdown of the gene. 
This might explain why our ins-7 construct extends lifespan in rrf-3; daf-2 worms and 
why  it has a  stronger  effect  on  lifespan  in rrf-3  worms compared  to  the ZK 1251.2 
construct.  However, these results should be treated cautiously as the experiment was 
only carried out once and need to be repeated to ensure the effect is real.
218Table 7.3,5 ins-7 and ins-35 RNAi lifespans using IPTG plates (Trial 4)
Genotype tested
RNAi
construct
Mean
Lifespan
(Days)
Standard
Error
p-value
(log-rank)
N Censor
%
Control
Lifespan
rrf-3 L4440 23.46 1.03 N/A 59 1 100
rrf-3 ZK1251.2 25.16 1.26 0.0391 58 2 107.25
rrf-3 ins-7 27.27 1.35 0.0002 76 4 116.26
rrf-3 ins-35 24.71 0.90 0.1451 92 8 105.36
rrf-3; daf-2 L4440 26.86 0.58 N/A 90 10 100
rrf-3; daf-2 ZK1251.2 26.99 0.90 0.1489 65 15 100.48
rrf-3; daf-2 ins-7 32.24 0.73 <0.0001 91 9 120.04
rrf-3; daf-2 ins-3 5 29.59 0.60 0.0002 91 9 110.17
Effects of ins-7 and ins-35 RNAi on  lifespan  in rrf-3 and rrf-3; daf-2 backgrounds using IPTG plates at 
20°C. Two different ins-7 constructs were used in this trial, the ins-7 construct used in the previous trials 
and the ZK1251.2 construct ZK1251.2 is from the Ahringer feeding library and is the same construct that 
has been previously shown to extend lifespan by Murphy et al. (2003). In the rrf-3 background both ins-7 
constructs extend mean lifespan by a small amount, with the ins-7 construct having a greater effect than 
ZK1251.2.  RNAi  of ins-35  has  little  effect  on  lifespan  in  the  rrf-3  background.  In  the  rrf-3;  daf-2 
background  the  ins-7  construct,  but  not  ZK1251.2,  leads  to  mean  lifespan  extension,  as  does  ins-35 
RNAi.
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Figure 7.4 ins-7 and ins-35 RNAi lifespans at 20°C using NGM-lactose plates
A  Trial 4 rrf-3(pkl426) Lifespans at 20°C  B Trial 4 rrf-3 (pkl426)\ daf-2(m577) Lifespans at 20°C
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Both  the  ZK 1251.2  and  ins-7  constructs  lead  to  a  small 
extension  in  mean  lifespan  (p  =  0.04  and  p  =  0.0002, 
respectively), with ins-7 having the greater effect. RNAi of ins- 
35 has little effect.
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The  ins-7 and  ins-35  constructs  both  lead  to  a small  extension  in 
mean  lifespan (p = <0.0001  and p = 0.0002, respectively), with ins- 
7  having  the  greater  effect.  ZK1251.2  has  no  effect  in  this 
background.
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220Additional RNAi lifespans using NGM-lactose plates (Trial 1)
Eight additional genes were tested by RNAi for their effects on lifespan by me as part of 
a communal lab experiment. These were a subset of 50 genes whose expression profiles 
are  similar to their orthologues in D.  melanogaster.  This gene  list was generated by 
comparing  the  microarray  data  from  McElwee  et al  (2004)  to  microarray  data that 
compared the long-lived D. melanogaster mutant chico1 /+ (Clancy et al., 2001) to wild- 
type control flies (J. J. McElwee and D. Gems, unpublished data). The eight genes from 
this  set  that I  examined were  all  significantly  up  regulated  in daf-2  mutants  (Table 
7.2.5). These genes are included here, in part, as further negative controls for the effects 
of RNAi on lifespan,  especially  as the L4440  vector does not produces  dsRNA that 
correspond to any known genes. RNAi of the genes listed in Table 7.2.5 was carried out 
at 25°C using constructs from the Ahringer feeding library.  All constructs had the size 
of the insert checked by colony PCR. The C36A4.2 and C55F2.1  PCR products were 
not the size of the expected inserts and were sequenced to see if they had any homology 
to the target genes. Neither of these constructs mapped to their target genes and so were 
excluded from the analyses. All the other constructs had the correct size insert (data not 
shown).
In  this  first  trial  RNAi  was  carried  out  in  both  the  glp-4  and  glp-4;  daf-2 
backgrounds. The Antebi daf-2 construct was used as a positive control for the effect of 
RNAi on lifespan. In the glp-4 background only RNAi of daf-2 and H42K12.1, which is 
pdk-1, had a significant effect on lifespan. Hypomorphic mutations in the pdk-1  gene 
have previously been shown to increase lifespan (Paradis et al., 1999). However, this is 
the first example of RNAi of this gene increasing lifespan.  Both caused extension of 
lifespan compared to controls (Table 7.3.6 and Figure 7.5a).
In the glp-4; daf-2 background only RNAi of daf-2 leads to lifespan extension. 
RNAi of pdk-1 and C15F1.7, which is sod-1, have no effect on lifespan. All the other 
constructs lead to significant decreases in lifespan compared to the controls (Table 7.3.6 
and  Figure  7.5b).  The  fact that  so  many  genes result  in a  similar  small  decrease  in 
lifespan was a concern,  and suggested the possibility that the L4440 control lifespan 
was artefactually high in this trial.
221Table 7.3.6 Additional RNAi lifespans using NGM-lactose plates
Genotype
tested
RNAi construct
Mean
Lifespan
(Days)
Standard
Error
p-y  alue 
(log-rank)
N Censor
%
Control
Lifespan
glp-4 L4440 14.21 0.34 N/A 119 7 100
glp-4 daf-2 23.68 0.48 <0.0001 128 3 166.57
glp-4 T22B7.1  (egl-13) 14.48 0.34 0.6489 120 7 101.84
glp-4 C15F1.7 (sod-1) 14.44 0.46 0.7222 67 8 101.62
glp-4 H42K12.1 (pdk-1) 16.00 0.33 0.0001 150 5 112.55
glp-4 R11A5.4 (PEPCK) 13.43 0.31 0.1263 146 5 94.48
glp-4 C06A5.7 (tmd-1) 15.08 0.31 0.1306 128 2 106.08
glp-4 W01A11.1
(Epoxide hydroxylase) 14.68 0.36 0.2081 126 2 103.30
glp-4 K11E8.1 (unc-43) 14.64 0.31 0.3467 147 6 102.99
glp-4
F21A3.2
(Purple acid 
phosphatase)
14.18 0.31 0.8509 131 1 99.76
glp-4; daf-2 L4440 33.74 0.72 N/A 134 6 100
glp-4; daf-2 daf-2 40.69 1.00 <0.0001 121 5 120.59
glp-4; daf-2 T22B7.1 (egl-13) 25.62 0.52 <0.0001 121 3 75.94
glp-4; daf-2 C15F1.7 (sod-1) 33.05 0.68 0.3003 152 4 97.96
glp-4; daf-2 H42K12.1 (pdk-1) 32.98 0.67 0.2655 145 3 97.74
glp-4; daf-2 R11A5.4 (PEPCK) 25.70 0.59 <0.0001 119 7 76.17
glp-4; daf-2 C06A5.7 (tmd-1) 28.00 0.53 <0.0001 150 0 82.99
glp-4; daf-2 W01A11.1 
(Epoxide hydroxylase)
27.64 0.57 <0.0001 118 7 81.92
glp-4; daf-2 K11E8.1 (unc-43) 28.05 0.50 <0.0001 139 6 83.14
glp-4; daf-2
F21A3.2
(Purple acid 
phosphatase)
28.30 0.48 <0.0001 142 11 83.87
Effects of RNAi of genes that are up-regulated in glp-4; daf-2 double mutants compared to glp-4 daf-16; 
daf-2 triple mutants using NGM-lactose plates at 25°C in glp-4 and glp-4; daf-2 backgrounds. In the glp-4 
background RNAi of H42K12.1  (pdk-1)  leads to  an  extension of mean  lifespan, all other genes, except 
daf-2  control,  have  little  effect.  In  the glp-4;  daf-2  background  almost all  the  genes  except  H42K12.1 
(pdk-1) and C15F1.7 (sod-1) lead to a decrease in mean lifespan, this suggests that the L4440 control may 
have been long-lived in this trial.
222Additional RNAi lifespans using IPTG plates (Trial 2)
A second trial of the genes listed in Table 7.2.5 was carried out, this time using IPTG 
plates.  RNAi was carried out at 25°C  in an rrf-3(pkl426);  daf-2(m577)  background. 
RNAi of R11A5.4 was not carried out in this trial  due to an insufficient number of 
animals.  Instead  RNAi  of R11A5.4  in  both  this  background  and rrf-3 (pkl 426)  was 
carried in a separate third trial using IPTG plates (Table 7.3.7 and Figure 7.5c). In this 
trial only RNAi of daf-2 lead to a significant increase in lifespan compared to control 
animals (Table 7.3.7 and Figure 7.5c). RNAi of pdk-1 and sod-1 lead to non-significant 
increases in lifespan. The only RNAi construct to reduce lifespan compared to controls 
was C06A5.7 (tmd-1), which while significant has a very small effect. The results of 
this trial support the view that the L4440 control in the first trial was long-lived.
Table 7.3.7 Additional RNAi lifespans using IPTG plates (Trial 2)
Genotype
tested
RNAi construct
Mean
Lifespan
(Days)
Standard
Error
p-value
(log-rank) N Censor
%
Control
Lifespan
rrf-3; daf-2 L4440 29.27 0.98 N/A 98 2 100
rrf-3; daf-2 daf-2 32.62 0.92 0.0116 99 7 111.47
rrf-3; daf-2 T22B7.1 (egl-13) 30.10 0.90 0.7382 77 4 102.87
rrf-3; daf-2 C15F1.7 (sod-1) 31.65 0.85 0.279 95 6 108.16
rrf-3; daf-2 H42K12.1 (pdk-1) 31.14 0.72 0.9729 97 4 106.41
rrf-3; daf-2 C06A5.7 (tmd-1) 27.89 0.77 0.0027 77 4 95.29
rrf-3; daf-2 W01A11.1
(Epoxide Hydroxylase)
30.37 1.04 0.1945 100 0 103.78
rrf-3; daf-2 K11E8.1 (unc-43) 28.51 0.96 0.6218 96 1 97.43
rrf-3; daf-2
F21A3.2
(Purple acid 
phosphatase)
29.51 0.86 0.5868 100 2 100.84
Effects of RNAi of genes that are up-regulated in glp-4; daf-2 double mutants compared to glp-4 daf-16\ 
daf-2 triple mutants using IPTG plates at 25°C in a rrf-3; daf-2 background. This trial excludes R11 A5.4. 
RNAi of C06A5.7 (tmd-1) led to a small suppression of mean lifespan. All other genes had  little effect, 
except for the daf-2 control.
223RNAi of R11A5.4 (PEPCK) using IPTG at 25°C (Trial 3)
In this trial RNAi of R11  A5.4 did not have a significant effect on lifespan in the rrf-3 
background compared to the L4440 control (Table 7.3.8 and Figure 7.6a). In the rrf-3\ 
daf-2 background RNAi of R11A5.4 leads to significant reduction in lifespan compared 
to the controls (Figure 7.6b).  The verification of the effect of R11A5.4 RNAi on the 
Age phenotype of the rrf-3; daf-2 mutant is interesting since it implies that increased 
gluconeogenesis contributes to the longevity of daf-2 mutants.
Table 7.3.8 RNAi of R11A5.4 (PEPCK! using IPTG at 25°C (Trial 3)
Genotype
tested
RNAi
construct
Mean
Lifespan
(Days)
Standard
Error
p-value
(log-rank)
N Censor
%
Control
Lifespan
rrf-3 L4440 14.52 0.61 N/A 70 10 100
rrf-3 R11A5.4 13.41 0.48 0.1132 96 9 92.38
rrf-3; daf-2 L4440 33.23 0.72 N/A 96 4 100
rrf-3; daf-2 R11A5.4 27.19 0.71 <0.0001 101 4 81.82
Effect of R11A5.4  RNAi on  lifespans in rrf-3  and rrf-3; daf-2 backgrounds at 25°C using IPTG plates. 
RNAi  of R11A5.4  leads to  a small  non-significant  decrease  in  lifespan  in  an  rrf-3  background  and  a 
significant decrease in mean lifespan in an rrf-3; daf-2 background.
224Figure 7.5 Additional RNAi lifespans at 25°C
A Trial 1  additional glp-4(bn2) Lifespans at 25°C on NGM-lactose plates
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W01A11.1 RNAi 
K11E8.1  RNAi 
F21A3.2 RNAi
RNAi of H42K12.1  (pdk-1) leads to an increase in mean  lifespan (p = <0.0001). No other treatment 
other than daf-2 RNAi has a significant effect.
B Trial 1  additional glp-4(bn2); daf-2(m577) Lifespans at 25°C on NGM-lactose plates
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L4440 Control 
daf-2 RNAi 
T22B7.1 RNAi 
C15F 1.7 RNAi 
H42K12.1  RNAi 
R11A5.4 RNAi 
C06A5.7 RNAi 
W01A11.1 RNAi 
K11E8.1 RNAi 
F21A3.2 RNAi
All RNAi treatments except H42K12.1  (pdk-1) and C15H1.7 (sod-1) lead to significant decreases 
in mean lifespan compared to control, suggesting that the L4440 control was actually long-lived.
C Trial 2 additional rrf-3(pk!426); daf-2(m577) Lifespans at 25°C on IPTG plates
L4440 Control 
daf-2 RNAi 
T22B7.1 RNAi 
C15F1.7 RNAi 
H42K12.1 RNAi 
C06A5.7 RNAi 
W01A11.1 RNAi 
K11E8.1 RNAi 
F21A3.2 RNAi
In  this  trial  only  RNAi  of C06A5.7  (tmd-1)  had  any  effect  on  lifespan,  other  than  the  daf-2 
control. This treatment lead to small but significant decrease in lifespan (p = 0.003).
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Figure 7.6 R11A5.4 (PEPCK) RNAi lifespans at 25°C using IPTG plates
A Trial 3 R11  A5.4 RNAi in rrf-3(pkl426) Lifespans at 25°C  B Trial 3 R11  A5.4 RNAi in rrf-3(pkl426); daf-2(m577) Lifespans at 25°C
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RNAi of R11A5.4  leads to a small, but non-significant, decrease in  ^  L444Q Control  RNAi of R11  A5.4  leads to a significant decrease in mean  lifespan  in
mean lifespan in this background (p = 0.1132)  —* —RllA5.4 RNAi  this background (p = <0.0001)
2267.4 Discussion
In this chapter I have used RNAi to probe the effects of two different sets of genes that 
show marked difference in expression level between daf-2 mutants and daf-16; daf-2 
mutants in microarray experiments. The first set of genes, ins-7 and ins-35, encodes two 
insulin-like peptides that may be ligands for the DAF-2 receptor, which are down- and 
up-regulated, respectively, in daf-2 mutants (McElwee et al., 2004). The second set of 
genes I examined were part of communal lab experiment. These genes were a subset of 
the top 50 C.  elegans genes whose orthologues in D.  melanogaster exhibited similar 
expression changes in response to reduced IIS were then examined for their effect on 
lifespan in worms. The eight genes from this set that I examined were all significantly 
up regulated in daf-2 mutants (Table 7.2.5).
7.4.1  Quantification of ins-7 and ins-35 gene expression in daf-2 mutants
1  used real-time QPCR to measure the expression levels of both ins-7 and ins-35 in daf-
2 mutants compared to daf-16; daf-2 mutants. In the daf-2 mutants there is a significant 
up regulation of ins-35 compared to daf-16; daf-2 mutants. In two out of three QPCR 
experiments there is a -100 fold increase in the expression level of ins-35, while in the 
third there is a -70 fold increase (Table 7.3.1). These values are much larger than the 
estimated fold-changes from the microarray data (McElwee et al, 2004) (Table 7.1.1).
The microarray data from McElwee et al (2004) found that ins-7 is significantly 
down  regulated  in  daf-2  mutants,  approximately  -75%,  compared  to  daf-16;  daf-2 
mutants. However in my first two QPCR experiments the expression levels of ins-7 are 
only  reduced  by  -40%  in  daf-2  mutants  compared  to  daf-16;  daf-2  mutants  (Table 
7.3.1). In the third QPCR experiment there is a -70% reduction in the expression levels 
of ins-7 in daf-2 mutants, which is closer to the value estimated from the microarray 
data.
There  are  several  probable  reasons  for  the  discrepancies  in  the  values  for the 
expression levels of both ins-7 and ins-35 between the first two QPCR experiments and 
the third (Table 7.3.1). Firstly the RNA samples used in the first two experiments were 
the same as those used in the microarray work of McElwee et al (2004) and were a year
227old. By contrast, the RNA samples used in the third experiment were prepared just prior 
to use. If there had been greater RNA degradation in the daf-16; daf-2 samples used in 
the first two experiments compared to the daf-2 samples then it would have appeared in 
the QPCR that these samples had less ins-7 and ins-25 transcript than they should. This 
in turn would make  the  levels  of ins-7 transcript appear  similar  or not  significantly 
reduced  and  artificially  boost  the  transcript  levels  of  ins-35  in  the  daf-2  samples 
compared to daf-16; daf-2. Because the RNA used in the third QPCR experiment was 
prepared more recently the measured levels of ins-7 and ins-35 in both the daf-2 and 
daf-16; daf-2 samples may be closer to the biological levels. This may explain why the 
ins-7 level in daf-2 mutants in this experiment is closer to the estimated level from the 
microarray data.
A possible reason for the large value for the standard deviations may be the use of 
ama-1  as  the  endogenous  control  gene.  There  are  two  requirements  for  a  good 
endogenous control gene. Firstly the expression of the gene should remain unaffected 
between experimental treatments and secondly its expression level should be similar to 
the target genes (Bustin, 2000). The microarray data in McElwee et al (2004) shows that 
the  gene  expression  of ama-1  in  daf-2  mutants  and  daf-16;  daf-2  mutants  is  not 
significantly different. It has also previously been shown that ama-1 expression is not 
affected  by  post-embryonic  development  (Johnstone  and  Barry,  1996;  Larminie  and 
Johnstone,  1996).  This means ama-1  fulfils the  first requirement for a good control 
gene. As for the second requirement, the expression levels of ama-1  are -100  lower 
than the levels of both ins-7 and ins-35  (data not shown). This is problematic as small 
variations in the ama-1 level of each sample can have a disproportionate effect during 
the normalisation procedure.
A further reason for the discrepancies in the values is the general nature of real­
time QPCR itself.  All  QPCR experiments  have the  same basic  assumptions that the 
efficiency of the reverse-transcription reaction and the subsequent PCR reactions will be 
equal in all the samples.  However this unlikely to be true which is why  samples are 
generally  run  in triplicates.  For  a  detailed review  of problems  of reproducibility  of 
QPCR see Bustin (2000).
2287.4.2 Effect of RNAi of ins-7 and ins-35 on lifespan
RNAi  of the  ins-7  gene  has  previously  been  shown  to  extend  the  lifespan  of rrf- 
3(pkl426)  worms at 20°C  (Murphy et al,  2003).  This result suggests that the INS-7 
protein  may  be  an  agonist  of the  DAF-2  receptor.  This  is  also  consistent  with  the 
microarray data from McElwee et al (2004) and my QPCR experiments which show 
that ins-7 is down regulated in daf-2 mutants compared to daf-16\ daf-2 mutants.  In 
contrast the ins-35 gene is significantly up regulated in daf-2 mutants by -70-100 fold 
compared to daf-16', daf-2 mutants (Table 7.3.1).
This startling up-regulation of ins-35 may be interpreted in two different ways. 
Firstly  the  up-regulation  of ins-35  may  represent  the  C.  elegans  equivalent  of the 
hyperinsulinaemia often associated with mutations in the MR protein (see Taylor et al., 
1992  for a review of the  clinical  features  of MR mutations).  Potentially the  INS-35 
protein  may  act  as  agonist  of the  DAF-2  receptor.  When  IIS  pathway  signalling  is 
reduced by mutation of DAF-2, the subsequent increase in DAF-16 activity may cause 
an increase in the transcription of ins-35, in a futile attempt to reduce DAF-16 activity.
However, given that the INS-7 protein seems to be a DAF-2 agonist and ins-7 is 
down-regulated in daf-2 mutants  it seems unlikely that INS-35  is also  an agonist of 
DAF-2. This then raises the possibility that INS-35 is an antagonist of DAF-2 and that 
ins-35 up-regulation in daf-2 mutants plays a role in the increased longevity of daf-2 
worms.  This  would  mean  that  the  INS-35  protein  might  function  as  a  longevity 
hormone  in  C.  elegans.  In  order  to  test  these  hypotheses  I  used  RNAi  to  reduce 
expression  of ins-35,  and  also  ins-7  as  a  positive  control,  and  test  their  effects  on 
lifespan in variety of genetic backgrounds.
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Genotype Trial RNAi treatment Temperature
+/- % of control 
lifespan
N2 1 ins-7 25°C -0.01
N2 1 ins-3 5 25°C + 0.06
daf-2 1 ins-7 25°C + 4.12
daf-2 1 ins-3 5 25°C + 14.36
glp-4 2 ins-7 25°C -0.12
glp-4 2 ins-35 25°C + 8.71
glp-4; daf-2 2 ins-7 25°C + 1.03
glp-4; daf-2 2 ins-35 25°C -7.83
glp-4 3 ins-7 25°C + 0.35
glp-4 3 ins-3 5 25°C - 1.18
glp-4; daf-2 3 ins-7 25°C -7.17
glp-4; daf-2 3 ins-35 25°C -6.39
rrf-3 3 ins-7 25°C -5.25
rrf-3 3 ins-35 25°C - 10.26
rrf-3; daf-2 3 ins-7 25°C - 11.38
rrf-3; daf-2 3 ins-35 25°C - 10.24
rrf-3 4 ZK1251.2 20°C + 7.25
rrf-3 4 ins-7 20°C +16.26
rrf-3 4 ins-3 5 20°C + 5.36
rrf-3; daf-2 4 ZK1251.2 20°C + 0.48
rrf-3; daf-2 4 ins-7 20°C + 20.04
rrf-3; daf-2 4 ins-35 20°C + 10.17
Summary of the effects of RNAi of ins-7 and ins-35 in different genetic backgrounds and temperatures. 
The magnitude of the change compared to  the control  in  each trial  is  listed  in the final column.  Genes 
listed in bold have ap-value <0.05
The  results  of  all  trials  on  the  effects  of ins-7  and  ins-35  RNAi  on  lifespan  are 
summarised in Table 7.4.1. In general the effect of ins-35 RNAi on lifespan in the glp-4
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and rrf-3; daf-2 backgrounds consistently leads to a -10% reduction in lifespan at this 
temperature. This result is consistent with concept of INS-35 being an antagonist of the 
DAF-2 receptor and functioning as a longevity hormone.
Surprisingly, even though ins-35 levels are -70-100 fold higher in daf-2 mutants 
compared to daf-16; daf-2 mutants, RNAi of ins-35 only leads to -10% reduction of 
lifespan. There are several possible reasons for this result. Firstly the QPCR experiment 
and the microarray data from McElwee et al (2004) do not contain a wild-type control. 
This means that we do not know the expression level of ins-35 in wild type worms. If 
the expression level in wild-type worms is the same as that seen in the daf-2 mutants 
then the QPCR and microarray data could be interpreted as showing significant down- 
regulation  of  ins-35  in  daf-16;  daf-2  mutants.  If this  were  the  case  then  INS-35 
expression  would  not  correlate  with  increased  lifespan  and  therefore  would  not  be 
expected to function as longevity hormone (or at least not a major one, given that RNAi 
does suppress lifespan a little).
A second reason that might explain why RNAi of ins-35 has such a small effect 
on lifespan is functional redundancy. There are 39 insulin-like peptides encoded in the 
C. elegans genome, of which only 23 were represented on the Affymetrix array. One of 
the genes missing from the array is ins-36, whose encoded peptide is the most similar to 
INS-35. Potentially INS-36 can partially compensate for a loss or reduction of INS-35 
activity. It would be interesting to know how ins-36 is regulated by IIS.
A third reason for this effect may be related to the penetrance of the RNAi. It is 
has been shown that RNAi is not very effective in silencing genes that are expressed in 
the  neuronal  cells of C.  elegans  (Timmons  et al,  2001).  Given that the  insulin-like 
peptides of C. elegans are likely to function as neuromodulators/ neurotransmitters it is 
likely  that  ins-35  knockdown  in  neurones  will  not  be  very  effective  even  with  the 
lactose-based induction protocol. If the neurones are the critical target tissue for INS-35 
then the lack of major effect with ins-35 RNAi  is not that surprising.  This could be 
resolved by using an ins-35 deletion allele.
RNAi of the ins-7 gene at 25°C, unexpectedly, lead to a reduction in lifespan in 
both glp-4; daf-2 and rrf-3; daf-2 backgrounds, in two out of three trials. RNAi of ins-7 
has previously been shown to extend lifespan in an rrf-3 background by Murphy et al 
(2003), using the ZK1251.2 construct. However, they did not test for the effects of ins-7 
RNAi on lifespan in rrf-3 at 25°C. Two possible reasons as to why my results at 25°C
231do not replicate the results of Murphy et al (2003) are the use of a different ins-7 RNAi 
construct,  and  the use  of a  different temperature.  To  distinguish between these  two 
factors I repeated my RNAi experiments at 20°C, including the ZK1251.2 construct as 
positive control and using 20°C. I found that RNAi of ins-7 with both the ZK 1251.2 and 
our  ins-7 construct  lead  to  a  significant  extension  of lifespan in  rrf-3  worms.  This 
implies  that  it  is  not  difference  in  construct  but  the  difference  in  temperature  that 
accounts for the lack of replication at 25°C.
Why  RNAi  of the  ins-7  gene  should  extend  lifespan  at  20°C,  yet  lead  to  a 
reduction in lifespan at 25°C remains unclear, and is further complicated by the fact that 
ins-35 RNAi also seems to extend lifespan at 20°C. It is difficult to explain why two 
INS  proteins  that  have  opposite  regulation  by  DAF-16  should  have  the  same 
contradictory phenotypes at two different temperatures. One possible interpretation of 
this data is that INS protein function is temperature-dependent rather than expression- 
level dependent. Thus at 20°C, potentially both peptides act as agonists of the DAF-2 
receptor, but at 25°C both become antagonists.
7.4.3 Additional RNAi lifespan assays:
As  part  of a  larger  screen  carried  out  in  our  lab  I  also  performed  RNAi  on  eight 
additional genes to probe their role in regulating lifespan extension in daf-2 mutants. 
These genes show significant up-regulation in daf-2 mutants and chico1 /+ heterozygotes 
(J. J. McElwee and D. Gems, unpublished data). The initial hypothesis was that these 
genes might be crucial to the lifespan extension seen in daf-2 mutants compared to wild 
type worms. It was therefore predicted RNAi of these genes might suppress the lifespan 
extension seen in daf-2 mutants.
The first trial was carried out at 25°C using NGM-lactose plates in glp-4 and glp- 
4; daf-2 backgrounds. Only H42K12.1  RNAi resulted in a significant effect on lifespan 
in  the  glp-4  background.  The  H42K12.1  gene  corresponds  to  the pdk-1  gene  and 
increased the lifespan of glp-4 worms compared to controls (Table 7.3.6).  The pdk-1 
gene is known to be part of the daf-2 IIS pathway and hypomorphic alleles of this gene 
increase lifespan (Paradis et al., 1999). This is the first example of lifespan extension by 
RNAi of this gene.
232In subsequent trials of RNAi of these genes in the rrf-3; daf-2 background using 
traditional IPTG plates only two genes had consistent,  significant effects on lifespan 
(Table 7.3.7 and 7.3.8). One of these is C06A5.7, which corresponds to tmd-1, which 
encodes  a  tropomodulin  homologue.  Tropomodulins  are  pointed  end  actin  capping 
proteins  that  regulate  various  actin  networks.  The  other  gene  is  R11A5.4,  which 
encodes a member of the phosphoenolpyruvate carboxykinase (PEPCK) protein family. 
Both of these genes reduce lifespan compared to controls, with R11A5.4 RNAi having 
the strongest effect. RNAi of R11A5.4 was also carried out in the rrf-3 background and 
found to have no significant effect on lifespan (Table 7.3.8). This suggests that R11  A5.4 
contributes  to  the  extension  of  lifespan  seen  in  daf-2  mutants.  PEPCK  is  rate- 
determining  enzyme  in  gluconeogenesis.  Thus,  increased  gluconeogenesis  might 
contribute towards longevity assurance.
233Chapter 8 
Final conclusions
2348.1 Summary of this thesis project
The aim of this thesis was to further our understanding of the C. elegans daf-2 gene and 
the protein it encodes. In this thesis I have presented data on the evolution of daf-2 gene 
within three  Caenorhabditis  species,  as  well  as  in the human parasitic  nematode B. 
malayi, which suggests that the C-terminal extension in the Caenorhabditis species has 
evolved to  promote rapid  growth (Chapter 4).  I  have used an integrated  analysis  of 
sequence,  mutant  and  structural  data  for  the  DAF-2,  hIR  and  MGF-1R proteins  to 
generate the hypothesis that the molecular basis  for the  existence of two phenotypic 
classes of daf-2 allele may be due to asymmetric alterations in the signalling outputs of 
DAF-2 (Chapter 5). In chapter 6, I performed some simple tests of my hypothesis and 
found that class  1   alleles  could  develop  certain class  2  traits,  but not  others,  which 
suggests my hypothesis may be too simplistic. In chapter 7,1  probed the role of the ins- 
7 and ins-35 genes in determining longevity. These genes show opposite regulation by 
the transcription factor DAF-16, yet I found RNAi of both genes extended lifespan in 
rrf-3 mutants at 20°C and suppressed lifespan-extension in rrf-3; daf-2 double mutants. 
Below I reflect on the extent to which some of the questions I asked in chapter 2 have 
been answered and suggest future work to investigate the questions arising from this 
thesis.
8.2  Function of the N- and C-terminal extensions of DAF-2
The DAF-2 protein contains large N- and C-terminal extensions compared to MR (see 
Figure 4.3) (Kimura et al., 1997). At the beginning of this thesis project it was unknown 
whether these features were unique to DAF-2, or a common feature of DAF-2 proteins 
in  other nematodes.  The  N-terminal  extension  contains  no  homology  to  any  known 
proteins and is unusual in that it actually precedes the signal sequence (see Figure 4.4). 
The C-terminal extension is similar to that found in D.  melanogaster (Fernandez et al., 
1995; Ruan et al., 1995), and may subserve some of the functions of IRS-like proteins, 
even though the C. elegans genome contains genes encoding IRS, ist-1 (Wolkow et al., 
2002) and Shc-like homologues, F54A5.2 and T27F7.2 (Luzi et al, 2000).
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briggsae  and  C.  remanei  have  homologous  large  N-  and  C-terminal  extensions. 
However, the Bm-DAF-2 protein from the more distantly related B.  malayi does not 
possess an N-terminal extension and its C-terminal extension is much smaller than that 
of the  Caenorhabditis  species  (see  Figure  4.3).  This  suggests  that  the  N-terminal 
extension is a feature that has evolved in the Caenorhabditis species and so presumably 
must have some function, even though no mutations have been identified in this domain 
(Chapter  5).  Interestingly,  the  N-terminal  extension  in  all  three  Caenorhabditids 
contains  two  putative  endoproteolytic  cleavage  sites  just  N-terminal  of the  signal 
sequence (Figure 4.4) and so may be cleaved off prior to cleavage of the signal peptide. 
Potentially  this  region  may  function  as  an  additional  plasma  membrane-targeting 
sequence,  however,  no  other protein  in  C.  elegans has  a  similar  sequence  at its N- 
terminus. Another possibility is that sequence may be involved in an interaction with 
chaperone proteins required for processing of DAF-2.
An  ideal  way  to test  for  a  function  for the N-terminal  extension  would  be to 
express transgenic daf-2 constructs lacking portions of the extension in a daf-2(0)/ qCl 
strain.  If  the  extension  does  have  a  membrane-targeting  or  chaperone-interaction 
function then these constructs would not rescue the Daf-c phenotype of this strain, if 
however, the extension had no function this strain would not segregate dauers. In order 
to differentiate between the membrane-targeting or chaperone-interaction functions one 
would need a good DAF-2 antibody. Using immunolocalization techniques it might be 
possible to visualise whether the N-terminal deletion product was being targeted to the 
plasma membrane or whether it was remaining cytosolic. Using co-immunoprecipitation 
it  might  be  possible  to  see  if wild-type  DAF-2  pulled  down  chaperonins  that  the 
deletion product did not.
No  mutations  were  found  within  the  C-terminal  extension  during  this  project 
(Chapter 5).  However,  this thesis  does provide  the  first direct evidence  of a role  in 
signal transduction for the C-terminal extension. This is shown in chapter 6, where in 
the search for a null allele of daf-2 I found that the tml236 allele, which has an in-frame 
deletion within the  TK domain  and  still possesses the  C-terminal  extension  is  fully 
suppressed by daf-16(0) at 25°C, whereas the m65 nonsense allele, which is predicted to 
produce a receptor truncated within the TK domain, is  100% embryonic lethal at this 
temperature.  This  implies  that  DAF-2  has  a  DAF-16-independent  role  during 
embryogenesis and that the tml236 receptor has more activity than the m65 receptor,
236even  though  both  proteins  are  predicted  to  kinase-dead,  as  daf-16(mgDf50);  daf- 
2(tml236) animals develop into fertile adults.
In  this  project  I  also  found that part of the  C-terminal  extensions  in  all  three 
Caenorhabditis DAF-2 proteins is made of 3 repeats of a peptide sequence (Figure 4.6). 
Each of these repeats is encoded by a single exon, in all three species, implying that this 
feature has evolved by exon duplication. Moreover, these repeated exons appear to be 
related to the terminal exon of the Bm-daf-2 gene, whose C-terminal extension is shorter 
than that of the  Caenorhabditids.  In chapter 4 I  put forward the hypothesis that the 
extended C-terminal extension in the  Caenorhabditids was an adaptive trait that had 
evolved to allow more rapid growth and development, consequently leading to shorter 
lifespan (Figure 4.7).
In order to test this theory a greater number of DAF-2 sequences, from a mixture 
of free-living and parasitic, as well as from long-lived and short-lived nematodes, need 
to  be  analysed  to  trace  the  evolution  of the  C-terminal  extension.  Transgenic  daf-2 
constructs with targeted deletions of each of the repeats could be expressed in daf-2 (0) 
strains. These would be expected to rescue the non-conditional Daf-c phenotype of the 
daf-2(0) allele and lead to an extension in lifespan compared to N2. A second possible 
way to test this theory would be to express these deletion constructs, along with wild- 
type DAF-2  and Rm-DAF-2,  in a heterologous expression system.  It might then be 
possible to assay the level of PIP3 production upon ligand binding by each receptor. By 
taking into account the expression levels of the receptors for each construct it should be 
possible to determine how much PIP3 is produced by each receptor. Wild-type DAF-2 
would be expected to produce the most, followed by the deletion constructs, with Bm- 
DAF-2 expected to produce the least.
8.3  Molecular basis for the class 1 and 2 phenotypes
At the beginning of this project the simple working hypothesis for the molecular nature 
of the class  1/ class 2 distinction was that class  1   alleles had mutations in the ligand- 
binding  domain,  while  class  2  alleles  had  mutations  in  the  TK  domain  or  hyper­
conserved  residues  in  the  CR  domain.  This  was  based  on  the  limited  information 
available  for several  classified  alleles  sequenced by  Kimura et al.  (1997).  However, 
sequencing of more alleles revealed a far more complex distribution of mutations across
237the receptor, for both class 1  and 2 alleles, than previously assumed (see Chapter 5 and 
Figure 5.1). A comparative analysis of mutations in DAF-2 with those in MR and MGF- 
1R suggested the alternative hypothesis that class  1   alleles had mutations that affected 
levels of the receptor at the plasma membrane, but did not affect their function. While 
class 2 alleles had mutations that also affected their membrane levels, but crucially led 
to asymmetric signalling through the receptor, frequently affecting the Ras/ MAP kinase 
pathway more than PI 3-kinase signalling.
However, some simple tests of this hypothesis performed in chapter 6 suggest that 
it is too simplistic. RNAi of the daf-2 gene in class  1   daf-2(m41); daf-12(m20) double 
mutants at 25°C causes animals to arrest as sterile young adults, while controls develop 
into fertile adults. Class 2 daf-2 (el370); daf-12(m20) double mutants arrest in similar 
manner at 22.5°C on standard NGM plates (Gems et al.,  1998;  Larsen et al.,  1995). 
However, RNAi of daf-2 in m41 single mutants does not cause the development of any 
class 2 traits. I also found that the addition of daf-28(sal91) into a class 1   background 
led to the development of the early larval arrest phenotype seen in many class 2 alleles 
at 25°C, but crucially the class 1   daf-2; daf-28 double mutants did not develop Eat and 
Unc phenotypes at this temperature, which are hallmark traits for class 2 alleles of daf- 
2.  Potentially some phenotypes classically associated with class 2 alleles, such as the 
sterile  adult  arrest  in  a  daf-12  background  and  early  larval  arrest,  may  actually  be 
associated with reduced levels of receptor and not asymmetric signalling. While other 
class 2 traits such as the development of the Eat and Unc phenotypes, which have never 
been  seen  in  class  1   alleles,  may  be  associated  with  asymmetric  signalling.  This  is 
supported by the fact that activated Ras (LET-60 gain-of-function) signalling in a class 
2 background suppresses the Eat phenotype (Nanji et al., 2005).
I think that to really understand the molecular basis behind the class  1/ class 2 
distinction  we  need to  know  which daf-2  phenotypes  are  produced  by  reduction  of 
receptors levels and which asymmetric  signalling produces.  Both the daf-2 RNAi,  in 
single and daf-2; daf-12 double mutants, and the daf-2; daf-28 experiments need to be 
repeated in a broader range of class 1  and 2 alleles to ensure that the effects seen in this 
thesis are not idiosyncratic to the particular alleles used in my experiments. Also class 1  
alleles of daf-2 should be tested for the development of Eat and Unc traits using RNAi 
of the components of Ras/ MAP kinase signalling.
2388.4 Function of the insulin-like peptides in C. elegans
The C.  elegans genome contains 39 genes that encode insulin-like peptides, which can 
be  divided  into  four  structural  sub-types  (Figure  1.8).  One  possible  hypothesis 
explaining the existence of some putative ligands for the DAF-2 receptor is that some of 
these peptides behave as classical agonists, while others are actually antagonists (Pierce 
et al., 2001).  The ins-7 and ins-35 genes are oppositely regulated by the transcription 
factor DAF-16 in a daf-2 mutant background(McElwee et al., 2004). The ins-7 gene is 
down-regulated by -40% and ins-35 is up-regulated 100-fold in daf-2 mutants (Chapter 
7). INS-7 is expected to behave as an agonist of DAF-2 and INS-35 an antagonist. This 
expectation is partially confirmed by the finding that ins-7 RNAi extends lifespan in an 
rrf-3(pkl426) background at 20°C (Murphy et al., 2003).
Based on this previous data I anticipated that INS-35 might function as longevity 
hormone and RNAi of the ins-35 gene in a daf-2(m5 77) background might suppress its 
lifespan extension. However, RNAi of both genes seemed to extend lifespan at 20°C in 
a variety of genetic backgrounds and slightly suppress lifespan in both glp-4; daf-2 and 
rrf-3; daf-2 double mutants. This seemingly contradictory result may be due to three 
factors.  The first may be the inherent variability of RNAi through feeding of E.  coli 
expressing dsRNA of the intended target gene. The second factor is the scale of genetic 
redundancy given that there are 39  insulin-like peptide genes.  The third factor is the 
temperature-sensitive  nature  of the  dauer  formation  and  longevity  phenotypes  in  C. 
elegans.  Potentially  INS  peptides  can  act  as  agonists  at  lower  temperatures  and 
antagonists at higher temperatures.
In order to further our understanding of the functions of ins-7 and ins-35, it may 
be better to perform the RNAi experiments in a daf-28(sal91) background. This gene 
encodes mutant insulin-like peptide  that  is thought to  act as  a poisonous  ligand  for 
DAF-2 by forming complexes with other INS peptides and rendering them incapable of 
binding to the receptor (Li et al.,  2003).  In addition,  this allele has  a weak lifespan 
extension of -10-13%, therefore this background may be sensitized to the subtle effects 
of ins-7 and ins-35 RNAi.  Recently the Japanese knockout consortium has produced 
two knockout alleles of ins-7 (tml907 and tm2001), it would be beneficial to test both 
for lifespan extension compared to N2 at a range of temperatures. Other ins genes that 
knockouts are available for are ins-1, -6, -11, -20, -23, -26 and  -29 of which ins-11 and
239ins-23 show significant alteration in expression levels between daf-2 and daf-l6\ daf-2 
mutants (Table 7.1.1) (McElwee et al., 2004). To fully elucidate the roles of all the INS 
peptides will require the construction strains carrying multiple deletions.
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